<SEC-DOCUMENT>0001428336-20-000031.txt : 20201209
<SEC-HEADER>0001428336-20-000031.hdr.sgml : 20201209
<ACCEPTANCE-DATETIME>20201209160506
ACCESSION NUMBER:		0001428336-20-000031
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		61
CONFORMED PERIOD OF REPORT:	20201031
FILED AS OF DATE:		20201209
DATE AS OF CHANGE:		20201209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEALTHEQUITY, INC.
		CENTRAL INDEX KEY:			0001428336
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36568
		FILM NUMBER:		201377893

	BUSINESS ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020
		BUSINESS PHONE:		801-727-1000

	MAIL ADDRESS:	
		STREET 1:		15 WEST SCENIC POINTE DRIVE
		STREET 2:		SUITE 100
		CITY:			DRAPER
		STATE:			UT
		ZIP:			84020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHEQUITY INC
		DATE OF NAME CHANGE:	20080227
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hqy-20201031.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646,d:2c4fb233b505418dacb8bdb47138592f--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:hqy="http://healthequity.com/20201031" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hqy-20201031</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl80LTEtMS0xLTA_02c0829f-c92e-40e7-ba2e-15bc748aacbf">0001428336</ix:nonNumeric><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl81LTEtMS0xLTA_32cb51f9-8119-4841-b37e-94d088c5cfaa">1/31</ix:nonNumeric><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMS0xLTEtMS0w_4c671114-3908-44c8-8c6f-81e2d487fe56">2021</ix:nonNumeric><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMi0xLTEtMS0w_a5488740-c697-4d8e-a32b-a1b06d98647c">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMy0xLTEtMS0w_f2566fcf-b6fb-4910-905d-33c5e1d86653">FALSE</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMS0xLTEtMS0w_3f406ca9-de85-44bc-be2b-5c77a8644d9a">0.6667</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMi0xLTEtMS0w_eedf6b1d-faa4-4d76-b810-c7b166cce1ba">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMy0xLTEtMS0w_7de55f47-e083-4e23-afc3-004b879a98e0">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNC0xLTEtMS0w_8ca1b7f9-fa94-465a-9e60-348cc282bb9b">0.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNS0xLTEtMS0w_682af27a-e81f-40b4-be27-a981ce552704">0.6667</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="4" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNi0xLTEtMS0w_3960eba4-2346-4108-aeea-5988aba77107">0.6667</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hqy-20201031.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i449bf63265634bb0a0d2dc15dd9d1ea4_I20201125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib16f9fff56d24738b1519754780c7d7f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45cb957efb1b4404baaef91f15061ef9_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaa726f7353a405892ef7138baec6e73_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dd807bc6f645aa8efffcedd8ec8168_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728a44a8b9e844d2b3e44fd961a30bb0_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66fb9a6498840c584531c192cbb750f_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830f5e55e2f148619c75a186e62b092a_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i325dd6d30575455eb3528a68d3959890_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15e9026e2bcc4fbda5eb976b88d60ec1_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie544510666474891b6abaeb2f71c3656_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb9e554abf8943638da327cec50b9857_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12bed13866654060afc41b6395363264_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a084639dd944c683e352986cdf225c_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76b0719fb45488e82da5b09436072ce_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ad2506671294a95a4dd823458a6c3be_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe3587113374eca96792f943ab69fc5_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i832a9d56436f4dc487e711fd9d9f1b37_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1ab93c490ba422e8067ee638aa89f8a_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a9294ef6c2a4467ab59ebeb152cd174_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901262a311df4c40a831ef51183cc35f_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d2105b15fb48538124056d84240663_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f820434883469d97b62b57e6b2765e_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093f52c37be1437080529f8202cebe1a_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie50c1af507e14565b249c2e89c3acc10_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf7fea257d4a4064844d660aa4a7626d_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254be2393d1a4c6d8a3240a437574561_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f04871247f84c9ca9f77b217b29052e_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb624d27231459bb251681eee242ddd_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f278c7b4d74e868c0bf4ad932243bb_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63ef3d19e95d456f9d4e91847890e387_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3c2a3814e04a5a8682e946b183fe16_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c457cfd6a5a43cb9558d8b4d9328cdd_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e0fed62fcbd494496c44b5aa87b0d80_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i979c4d22bfc9471f8b4dfb208736616b_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3266aa6f754460aacf098b0298fc3b_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389ea35a3d2e4607abc6c9410c75ebec_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-30</xbrli:startDate><xbrli:endDate>2019-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc6f37ce7f2248f3a06a9f4c38858730_D20190830-20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-30</xbrli:startDate><xbrli:endDate>2019-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-30</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78673cfa6671419b96252591cd5aada4_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a254662184a4106b4379b10205f7880_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec79e8d4a8042d1b80bb68a1480bcc3_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic430d1bd4b994088a513acef3734435e_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60c903d8b1a046ef8d58e35f85bddcdb_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ed676cc45541888a286e697eaf4971_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bbb14b2d0234a85814cdcf59a17f56d_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4364bceadc1640888f5252fff2b05a38_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48937f6ece7149fca3c3b3786e77ec95_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i504cb0661e9f4dae8034503b601a2870_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0205c0743fb47ac8f23fed3e5aedb2e_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e1624fbd3d94920921887290a7ad491_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a29caffc2214b65ade72766d8f08cc1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3627b5c69c44353802952f92fbe50f9_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb51032a2154465cb9cddfdc52f94dc7_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2e76b4ad3e9409e90e86df52d0c70bf_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a3338f2c4043f2920127348167f2c5_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316e7d3a2c2549989b4056855d453948_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04e444c7573c4e11ab6a937593087dfa_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3346b7e4394c4a3cb401ea158a7e6f79_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88892452c8b4467da8e7c754e0bd6661_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70aa4eace1b849b7bc8770af2620a276_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>hqy:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i3e05173272a94406b7f82f6775f29b05_D20180906-20180906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-06</xbrli:startDate><xbrli:endDate>2018-09-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ab953b65e81482fbbdffc410958e5ee_D20180622-20180622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-22</xbrli:startDate><xbrli:endDate>2018-06-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2df1d6cadbd74ff3acfa8a7a9e8f4b3b_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64a2c3285a4640638af6dc4caca32547_D20190830-20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-30</xbrli:startDate><xbrli:endDate>2019-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e31870db3eb4448bf794556196facad_I20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88890494023a48c186377765d88e48b1_D20190830-20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-30</xbrli:startDate><xbrli:endDate>2019-08-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie457aaaa4999415bb337c567a04585da_I20190830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07e01aa0156a47859bbf977de876d1c8_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde5070b333245fea3d90d1f909b0543_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61002ef653844eedae5d38c266aea6c9_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic87db426f4e54f909d15c0c1df63c80a_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf62767aaa44d7c83fe6178855f1be7_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0303734b4942bf81d8cf0ed138de29_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic883d663040343718d8ef69b8d96b305_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704700afcca6430ab84c0cc3541833fc_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id433c681b1c140598cb0e1ba46723af6_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8875a13a7bbd43ffa8102b5c080b479f_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2abd9f5850614a98b0d975f99da08d3e_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i390b5a0159224ba6bd2b58bc11c2b0ad_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92964e404b454b1db362fcdfdeab5c39_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide2d33d6f2a64d8e852283d3699cd837_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd93462fe1f746509d6667375bb9b419_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd67de1d320a48c38e39d726d50f9f41_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991dc368ad8c4c698b4f083f9a6a0a73_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4bd7600e6b442a4930e416576424ba6_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd088dfe1ea487588fdb1a14a83fffb_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9129b833a9b4f6888db58833919b896_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba35bdcc6824faba7770fde57155e08_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75d386528c074f2bbf08a38f3944a4e9_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e7adb81ce6b4eaab1be9f873a9f4de5_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie443b8fdfa9644e38627ed682ec6e547_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d12a4acd5f4578ab68365ed4d50c82_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2dbf47a274d459a8e0c0007cbc26405_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ee172b218d4f5ba07c1dc8b51df50e_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if88ef73955ab42f1abe01f3f7c744f9c_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7bcb862987f4d31a41e21ebf117cc84_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f58c98c5d3a465b9b500d87b1949821_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b4954833a14a5db0d4f1d4321a6f4a_D20200801-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98fb062772b640c887ba8a960fd86c44_D20190801-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64472d16654b400e97654463b5d7e80c_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad3647d44134fbe82f1424566227086_D20190201-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic64248ebfff14817a2f075cb756200da_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hqy:IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9990defe3e97407581f4f0a4af6c6fc4_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0a41dab082f4d569390c26af5e24b25_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hqy:WageWorksIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3646166651746228acb84ea09049053_D20200201-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70be1d14e5f049ea9990ac6488c46bb2_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c3c36c6fb949c6b668af4f989c6df1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13b43e3e97744f2f99ef7eba9252d568_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3843854aae914afaa49721b198e544c7_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="member"><xbrli:measure>hqy:member</xbrli:measure></xbrli:unit><xbrli:context id="i550456057eea4a81a4866ec595bb66fe_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66be3136ba174468819065390931d293_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ee4b3524be43a9bad2db97c312e887_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb0a184b778d46f6bb8363b0ba93ac1d_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851da9c28c4d412f8a32c95d3d5bf732_D20200201-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5035efb5313648a3b06aa3af898d03ce_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e82ed8bc9eb4b0199285a4985c3e872_D20200201-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92cbf523ebd94e99a62188292dc7a98f_D20200201-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001428336</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2c4fb233b505418dacb8bdb47138592f_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc2_87520cce-981b-4b75-b795-5e5ffea5ad81">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6Mzg5ZWIwY2RhZmYwNGZjNThkNmJiN2I0YTAxYzgwZTAvdGFibGVyYW5nZTozODllYjBjZGFmZjA0ZmM1OGQ2YmI3YjRhMDFjODBlMF8wLTAtMS0xLTA_a8622909-7f8d-4aac-a634-9ccbe038e4f4">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl84Nzk2MDkzMDI0MjIy_6bef3e14-a103-45c0-b044-e8a01b42ce6e">October 31, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ODg2YWM4OWE4ZmUzNGYzY2E3MGQ5ZWRkMGI0NzE5NzcvdGFibGVyYW5nZTo4ODZhYzg5YThmZTM0ZjNjYTcwZDllZGQwYjQ3MTk3N18wLTAtMS0xLTA_be623604-9749-4241-9195-bc6d6a938221">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgz_b56efb6a-2d34-4c6b-a704-1f86f2808012">001-36568</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmUzNTU0M2U5NGZlNGExZWI3Yjc4NDNlNzVlMDgyNTgvdGFibGVyYW5nZTpmZTM1NTQzZTk0ZmU0YTFlYjdiNzg0M2U3NWUwODI1OF8xLTAtMS0xLTA_c7738e0f-ad9f-40fe-a091-49429c5a2997">HEALTHEQUITY, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6YmU0ZTQ1NzQ2Y2Q1NGI4N2EzNWRmZTJmZjc2OTljZDYvdGFibGVyYW5nZTpiZTRlNDU3NDZjZDU0Yjg3YTM1ZGZlMmZmNzY5OWNkNl8wLTAtMS0xLTA_aae20ee5-b059-484e-80a7-c27856f5286f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6YmU0ZTQ1NzQ2Y2Q1NGI4N2EzNWRmZTJmZjc2OTljZDYvdGFibGVyYW5nZTpiZTRlNDU3NDZjZDU0Yjg3YTM1ZGZlMmZmNzY5OWNkNl8wLTQtMS0xLTA_cf23714a-a82c-4496-8f2c-1bdc96c0f8d0">52-2383166</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg0_a030684f-56d0-4d7d-823d-ef6db4fc8569">15 West Scenic Pointe Drive</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc3_b036d454-d80f-4646-94fd-b14e05eedb20">Suite 100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg1_bf614363-b088-4f72-b050-baffc8d0ab14">Draper,</ix:nonNumeric> <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg2_5865d04d-5883-4406-a50f-b608d467a0a6">Utah</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc4_c2a7d3ba-88f7-4551-85de-25bcc7dbdf6f">84020</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg3_53aad799-acf5-4517-8236-8ab6b5a53f51">801</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc5_3ec1b942-a284-412f-b979-2bed2c0fae25">727-1000</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant's telephone Number, including Area Code)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTAtMS0xLTA_bb6de053-604f-44c1-b16c-b8d3fa1d673e">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTEtMS0xLTA_d3eb1a3e-de5a-4688-96b6-fa93b2eabe7e">HQY</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTItMS0xLTA_f8277502-65a9-4eb4-846e-1ee4f234374c">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgw_110ca00e-a424-4605-aa85-5718286e68c3">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgx_c437b421-5c14-4b20-a29a-6b5a97c66cca">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:16.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8wLTAtMS0xLTA_5b927b61-7b59-4960-b120-b44d0dceacf7">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8xLTMtMS0xLTA_2cb49f51-6f2b-4b05-887a-9b2b41b2d0ad">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8yLTMtMS0xLTA_4e0392b6-9479-4de5-8e56-aacc0732b388">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange&#160;Act).  Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgy_46d326b2-5729-4886-8fd0-4ee9a39e9913">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9745;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of November&#160;25, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i449bf63265634bb0a0d2dc15dd9d1ea4_I20201125" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTE5_2487516d-98e8-4308-8e78-f307fae26881">76,990,646</ix:nonFraction> shares of the registrant's common stock outstanding.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form 10-Q quarterly report</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Table of contents</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.895%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_10">Financial statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_10">Condensed consolidated balance sheets as of </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_10">October</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_10"> 31, 2020 (unaudited) and January 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13">Condensed consolidated statements of operations and comprehensive income (loss) for the three and </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13">nine</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13"> months ended </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13">October</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13"> 31, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16">Condensed consolidated statements of stockholders' equity for the three and </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16">nine</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16"> months ended </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16">Octo</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16">ber</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16"> 31, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19">Condensed consolidated statements of cash flows for the three and </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19">nine</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19"> months ended </a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19">October</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19"> 31, 2020 and 2019 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_22">Notes to condensed consolidated financial statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_22">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 2. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_58">Management's discussion and analysis of financial condition and results of operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_58">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_76">Quantitative and qualitative disclosures about market risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_76">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 4. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_79">Controls and procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_79">34</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_85">Legal proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_85">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1A. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_88">Risk factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_88">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 6. </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_91">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_91">39</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_94">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_94">40</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Part I. Financial information </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 1. Financial statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Condensed consolidated balance sheets</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except par value)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(unaudited)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNC0xLTEtMS0w_a038587a-c39a-45ff-9585-73bba7b5497d">299,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNC0zLTEtMS0w_a841dc1e-68d4-41e9-86fb-dfce9e490ca4">191,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0wLTEtMS0wL3RleHRyZWdpb246MGM0Nzk2ODVjMTJlNDZjZGJlNjcwN2MxYTVlNzZjMDBfNjc_92bb5818-be5b-4ea9-897b-18c12473db46">3,458</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0wLTEtMS0wL3RleHRyZWdpb246MGM0Nzk2ODVjMTJlNDZjZGJlNjcwN2MxYTVlNzZjMDBfNzQ_5e99fe6c-5404-4345-a1af-b64640da0433">1,216</ix:nonFraction> as of October 31, 2020 and January 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0xLTEtMS0w_b884e4b3-c882-458e-b738-1d56d9216d0b">64,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0zLTEtMS0w_4da505d4-f78f-420f-a024-20f10aa09ce9">70,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNi0xLTEtMS0w_824945fb-c9b2-4b2b-a1d1-546afe874432">32,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNi0zLTEtMS0w_b99c2b2d-9ae1-4f8b-bc9c-92b51d268665">34,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNy0xLTEtMS0w_5a6ac1b4-ab79-4d9c-9c88-6f572f82d7e9">396,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNy0zLTEtMS0w_48a3b6c2-8d55-4c2b-938f-fe3049f2659b">297,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOC0xLTEtMS0w_07f27b79-462f-4a72-80e4-9453b0c7a04a">31,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOC0zLTEtMS0w_b5a4aeec-a678-438e-9c6f-3817c667aff5">33,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOS0xLTEtMS0w_c91b2a48-9471-44f9-a2f1-a562dece478c">92,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOS0zLTEtMS0w_34a62415-dc3c-40e2-a695-59caa05d653f">83,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTAtMS0xLTEtMA_28211c65-d575-4bc3-9d58-e0756e0e275c">776,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTAtMy0xLTEtMA_2a841495-2818-4d5b-bba0-eaa0c3553821">783,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTEtMS0xLTEtMA_b3c95340-2b68-451a-9ce1-1e7e36a668bb">1,326,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTEtMy0xLTEtMA_883e0458-4cf4-4fc1-9ec7-6eb2bd806b33">1,332,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTItMS0xLTEtMA_01369900-7751-44e3-9196-33f5df8c2746">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTItMy0xLTEtMA_2418cc8b-789f-4e7c-aedd-edfed8b31471">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTMtMS0xLTEtMA_5dfd4c17-3abf-4c6c-9724-098505b45dc6">34,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTMtMy0xLTEtMA_f48b676d-afeb-4346-9287-25234aba8384">35,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTQtMS0xLTEtMA_c45268cb-f267-4e77-93fe-0219997b2aca">2,657,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTQtMy0xLTEtMA_cda40d8f-804d-4ace-9e72-dcef20bfe1e1">2,564,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTctMS0xLTEtMA_eb6b16c1-c5df-4700-8c7d-12b42a7afba3">6,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTctMy0xLTEtMA_09cb4d57-1ea4-4bad-a012-cf4bf3d7ee4d">3,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTgtMS0xLTEtMA_225a7095-faaf-43f7-84be-8de6501f7023">34,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTgtMy0xLTEtMA_786c5869-79b9-4b43-9f0a-9735fce18699">50,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTktMS0xLTEtMA_bdfacb6a-9252-40d1-8467-84349ecf49ac">33,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTktMy0xLTEtMA_74a8aa2e-70f3-4bec-99cc-35dabc0bbac7">46,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjAtMS0xLTEtMA_3de294ae-acc7-440f-8b05-9bf126e1f4e1">62,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjAtMy0xLTEtMA_0c1415a5-84ed-4bf7-b65b-0cc75d4c01fb">39,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjEtMS0xLTEtMA_409e9a01-05a4-42b5-8318-01ae8e1c6709">13,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjEtMy0xLTEtMA_3fbf02fb-2e84-46ef-b9b7-2c967d7c11e2">12,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjItMS0xLTEtMA_44b84e38-6a0c-4de0-bf46-b8acd6c1fa21">151,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjItMy0xLTEtMA_30c3a239-9ba9-48fe-9960-c50364a9c272">151,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjQtMS0xLTEtMA_3c3c852c-f2fa-4543-84c0-aff0940a06b1">938,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjQtMy0xLTEtMA_9f220d87-af9c-4b1c-99d1-4cec147f81a4">1,181,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjUtMS0xLTEtMA_a0388608-a801-4a79-a992-10119c9bf9f1">76,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjUtMy0xLTEtMA_b01adbe6-0e3e-4c5c-8468-8b15924bac4e">68,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjYtMS0xLTEtMA_36ab140b-611f-4ce9-ba4d-8c7e083ac386">11,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjYtMy0xLTEtMA_4a0e9673-7aab-4476-981f-4f7dbd631b84">2,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjctMS0xLTEtMA_53755c1d-301e-4197-824d-945a13256a32">123,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjctMy0xLTEtMA_2f6be1be-e1a8-4917-8d1b-6df4167b3a81">130,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjgtMS0xLTEtMA_d9593933-0325-42e7-a2e4-0d92dfe5bbe5">1,150,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjgtMy0xLTEtMA_bbeb8672-13c8-4197-a06a-97808b5bf4e7">1,382,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjktMS0xLTEtMA_7d0c1075-2855-4b28-b57e-5e7c6d390a0b">1,302,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjktMy0xLTEtMA_18da150c-8076-41c4-b649-1e7756ff98a7">1,534,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (see Note 6)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzAtMS0xLTEtMA_181e0c1e-8925-47da-935f-b9a8b557d42e"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzAtMy0xLTEtMA_d528c106-0f48-4ad1-80a2-583febfdf92b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzIx_72c11f8b-eecb-4ae0-8ac8-c70470c75274"><ix:nonFraction unitRef="usdPerShare" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzIx_a2d7e79d-94c3-4b4e-9bbf-4d58a18b2027">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzM1_4f5ac68d-b1ea-46b4-9fa0-b611fd46bd26"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzM1_78a1f1f1-40a6-4b6b-8727-47e0f91d900c">100,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_121a9dfe-b37b-4bbf-80ec-b163aa910dab"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_b6b4f1a4-bd2e-4869-b663-6afcc6ff3fdf"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_ccb43ae0-e4d2-4269-ba76-8428972eebcd"><ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_dba26641-fcee-4e29-aaa7-9ed45a2aa1f3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMS0xLTEtMA_37082c6d-fe90-4bf4-a31f-87d49959a14e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMy0xLTEtMA_76687681-8718-4e8d-aa13-cbd7fe6a27b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzE4_2041cf04-7f99-4161-8750-e790ab5022d3"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzE4_52ef8cd4-8937-4492-8aad-eff568dd190a">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzMy_5622eb7f-f30d-4071-be80-258014211e2f"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzMy_ca1ba129-0641-4105-a128-c52ece7591b7">900,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzU0_4675bdb6-904c-4966-8fbd-5f2e6ee692ec"><ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzU0_c04e97be-482c-4a92-8b63-da9f193f4dc7">76,951</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzYx_bc82927a-af8b-400d-bf51-d4466fc89a45"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzYx_bd35128e-263e-4c9a-83f0-7e209742ed6f">71,051</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMS0xLTEtMA_b9ffbd0b-6eec-4ff4-a5e2-6318e12bb85c">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMy0xLTEtMA_2b4b0970-e280-4b07-8856-4f75b733eb91">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzQtMS0xLTEtMA_b36788ba-e260-4cbf-8944-9e963054d567">1,140,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzQtMy0xLTEtMA_e774d44c-4013-4d0d-96aa-250b571bb075">818,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzUtMS0xLTEtMA_825e94af-68a1-40bb-8a56-9ab9cb99669a">214,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzUtMy0xLTEtMA_889f3e83-9479-4a4d-beb4-6295237ac348">211,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzYtMS0xLTEtMA_f4332663-96b5-4808-a9e2-eab8678ca5e8">1,355,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzYtMy0xLTEtMA_2a102f30-3cbb-408d-953a-84c141161996">1,030,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzctMS0xLTEtMA_e83a3eba-d92e-4a3e-ac39-a932f23d5b8a">2,657,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzctMy0xLTEtMA_8abd6988-2fdd-4bc9-9dc1-8117b859101a">2,564,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Condensed consolidated statements of operations and</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">comprehensive income (loss) (unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Service revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy0xLTEtMS0w_e0c6e1ed-1978-4550-bbe6-7dfc879fa472">104,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy0zLTEtMS0w_a17a578c-cf64-4cd7-89ae-3ab826edabf5">87,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy01LTEtMS0w_41f66730-bae0-4b74-b33d-e9bee5801d2b">319,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy03LTEtMS0w_9e66101f-af5b-4ee4-b6d9-a1c797406703">140,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Custodial revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC0xLTEtMS0w_b3860846-0525-4f51-a46c-4d106d22460a">48,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC0zLTEtMS0w_9f81a40f-4105-4256-b0f2-f60d02482a9c">46,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC01LTEtMS0w_2de5dc01-0c10-43b0-8822-93494ea6ea49">142,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC03LTEtMS0w_0e84453f-453d-4d22-9de1-c713da0204ba">132,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interchange revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS0xLTEtMS0w_b2a3831f-81fe-42d0-82b5-f9388b5a5aa7">26,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS0zLTEtMS0w_73da3b99-c6db-4ea4-a313-80942ac43db5">22,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa726f7353a405892ef7138baec6e73_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS01LTEtMS0w_861340c4-bde5-44f8-830d-b565d705b2bf">83,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS03LTEtMS0w_ed66d6d7-15cb-49c2-8200-2f36d0367209">57,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi0xLTEtMS0w_6e932790-59dd-4069-a7fd-09fe7d571978">179,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi0zLTEtMS0w_aa99a8f9-27d7-423e-bf68-a67ec8fde918">157,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi01LTEtMS0w_adc1b3b6-f918-4dad-bb5b-ad3160bf5fe0">545,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi03LTEtMS0w_d07555cb-6ae0-495a-8d92-159dfb2c3d8b">330,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Service costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC0xLTEtMS0w_10be826f-ff84-4b58-9694-83da8e25533c">65,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC0zLTEtMS0w_140a5c40-9810-4d80-8f49-c23437bf3306">52,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC01LTEtMS0w_eb5fea4e-cf68-4080-9a5a-8821457dc758">202,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC03LTEtMS0w_a15ff476-a636-49f8-9d43-98c2af35a526">92,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Custodial costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS0xLTEtMS0w_af01ecf5-4dbb-4d90-b926-4af382caa144">4,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS0zLTEtMS0w_376c7146-8f8c-4bac-bccc-c81c555fd019">4,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS01LTEtMS0w_8cd55af6-f1d8-4326-ac54-27fc75e6be5b">14,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS03LTEtMS0w_797f8a6f-afb7-4495-adbe-80edd6efaab9">12,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interchange costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtMS0xLTEtMA_dfeeffb2-406b-44c1-9d79-1c2d73e575d4">4,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtMy0xLTEtMA_0595f886-0d44-4bfa-b4cf-020020f6038e">4,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa726f7353a405892ef7138baec6e73_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtNS0xLTEtMA_160d57aa-bf75-4369-9082-d720d463b1fe">13,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtNy0xLTEtMA_07ba958b-1cfc-435c-b687-9575fff3bcd1">13,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtMS0xLTEtMA_88de0648-e1f6-4699-997f-5cac4acacb90">74,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtMy0xLTEtMA_20c5a82f-d90e-4066-b947-08b54e3a16da">61,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtNS0xLTEtMA_f51d57ba-7198-4c28-9ebe-35cf545be704">230,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtNy0xLTEtMA_3d698163-da7b-45fa-adcc-29491f808ae7">118,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItMS0xLTEtMA_0ffbafc2-b3cc-4189-97e8-32fa428774b7">104,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItMy0xLTEtMA_78b4b26b-63d2-49fb-b1a4-28ecacc75f76">96,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItNS0xLTEtMA_00dd0425-f902-492f-9bb7-eb7d21454e73">314,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItNy0xLTEtMA_c3eb2eb9-0396-4d48-a0ea-24339b113282">212,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtMS0xLTEtMA_479b7c53-285e-422c-9749-2ca46f8febbc">12,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtMy0xLTEtMA_ae3ab0df-8cfa-4863-b3cf-d9663e053bf2">12,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtNS0xLTEtMA_cfed7cc4-bc64-4c18-82ea-bc1da26511bd">36,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtNy0xLTEtMA_10e8bc42-34a4-443b-a9f3-0cd42d540830">30,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtMS0xLTEtMA_89ea3d8c-7a9e-49fb-baa9-6648f44be4d1">30,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtMy0xLTEtMA_3dda1084-33e0-4d9d-812b-50e63dfb204d">23,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtNS0xLTEtMA_770f788a-2597-4e66-84d2-4e1f78e8594d">92,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtNy0xLTEtMA_1bd132c4-c353-4c56-8b0c-4de5b15b2fcd">46,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtMS0xLTEtMA_bde0738b-cf45-4c9b-9f55-a4c2ac5995df">22,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtMy0xLTEtMA_3580205d-7836-43e1-8b50-8c072a414cbd">19,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtNS0xLTEtMA_a0400dea-516e-447e-8dee-ba0b853ee3d8">61,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtNy0xLTEtMA_8e49afbc-b440-413f-a888-9a36b6ce8b99">37,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="hqy:AmortizationOfAcquiredIntangible" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctMS0xLTEtMA_0c0b94c5-04b5-40d2-bfcb-244c855c2b71">19,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="hqy:AmortizationOfAcquiredIntangible" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctMy0xLTEtMA_2a4e108b-913b-4f62-b326-5bd761812e68">13,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="hqy:AmortizationOfAcquiredIntangible" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctNS0xLTEtMA_9bf22a8f-105c-4530-b75d-b417b01bb14c">56,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="hqy:AmortizationOfAcquiredIntangible" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctNy0xLTEtMA_07bddc14-7456-4823-b046-b304b1fd1247">16,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtMS0xLTEtMA_d7312856-6911-41a5-977a-3868074ba783">8,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtMy0xLTEtMA_eda57ea0-8dca-42d0-8c3f-ae3ccac29007">17,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtNS0xLTEtMA_b2ba200c-728b-49d8-9d84-dfb5e07f80b5">31,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtNy0xLTEtMA_088ba5e0-98cc-405d-9f64-5394594f2f08">20,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktMS0xLTEtMA_aa5c79b1-3e1a-4d8a-809f-62a0c5f8ebac">93,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktMy0xLTEtMA_982e2b2b-9be4-4346-83ec-24805a5c5f2d">86,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktNS0xLTEtMA_78c63f99-3761-40d8-9ad7-e674618b2718">278,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktNy0xLTEtMA_4d1f64f4-5604-4090-a66f-0aa0b203ca0a">149,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtMS0xLTEtMA_b155c09b-544f-4ed3-bfd7-e83dd07931f3">11,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtMy0xLTEtMA_efdbba59-b3bc-4032-91f3-e06439aa16df">9,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtNS0xLTEtMA_ebb6c3c1-1c48-4fc2-b67a-08f41e9c0746">35,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtNy0xLTEtMA_f019dd0a-d8cb-466f-8927-bfd4c5053cbb">62,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItMS0xLTEtMA_4c08f960-d134-4cfa-b457-caff7d3b8ae7">6,952</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItMy0xLTEtMA_94124117-f3fd-480c-accc-481045d31d7a">10,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItNS0xLTEtMA_89434556-3a03-4db1-b76c-06bc25c089ea">28,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItNy0xLTEtMA_9654c0c0-d60f-4c0c-b2d1-851b40a0a8d3">10,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtMS0xLTEtMA_675e5cd2-dd6e-4c57-940b-1e7205e3c690">421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtMy0xLTEtMA_9fb544fb-f80d-469f-8b4a-aff9cbe75176">30,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtNS0xLTEtMA_3c0dc81b-8cf9-44b9-bdf4-ad178d905aa1">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtNy0xLTEtMA_0a8e4e30-22d3-416b-b20c-2f1fb8fdc5b7">8,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtMS0xLTEtMA_96ffe0bc-0c6a-49ab-8fbe-edd0b34d37e4">7,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtMy0xLTEtMA_8f012ab4-ad8e-48de-a611-790570ae6d52">41,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtNS0xLTEtMA_d513c533-d063-4229-b944-e7ae7159436a">30,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtNy0xLTEtMA_a17cd6ef-3cf4-4a65-98c3-5cd2bb73463b">18,702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtMS0xLTEtMA_b81f57ae-3397-4699-92bf-0cc11509b778">4,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtMy0xLTEtMA_73a6ec47-3473-4fce-9a01-a425e680103e">31,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtNS0xLTEtMA_a0d7efd8-7786-4517-ae12-42991d044a4a">5,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtNy0xLTEtMA_74037c12-dc20-4012-b45f-dd548bc5f162">43,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtMS0xLTEtMA_a51c1abe-aa3a-4708-a87b-23d4a1dfcef9">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtMy0xLTEtMA_c2286a30-40c2-47f8-b1e6-fefd7bb9fc34">9,918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtNS0xLTEtMA_4eb0d841-fffc-4e88-86be-a8606342e5ae">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtNy0xLTEtMA_9a74c361-e7d4-4953-995d-e0971d0f5d5a">3,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) and comprehensive income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMS0xLTEtMA_04cdb92d-3087-41ee-a246-ff6bbd5a7616"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMS0xLTEtMA_77d235b5-e642-4083-8562-0b7b51a5de1a">1,789</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMy0xLTEtMA_a85c9aee-8b90-43ea-9616-f8d828ebb445"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMy0xLTEtMA_c0806338-38c9-42ba-a4ce-b005c0236234">21,334</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNS0xLTEtMA_4311ef56-5094-46df-a5c9-9a0ee835fcb3"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNS0xLTEtMA_7afb139d-a262-42d6-946b-8c50311ca19f">3,467</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNy0xLTEtMA_12d6fe7f-ea7f-4d53-a025-35513a92a2c3"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNy0xLTEtMA_7fda0a24-eb24-4351-8577-90bf1b6a87a9">39,854</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktMS0xLTEtMA_06684ded-ab57-4ad8-aba0-7ae20147038c">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktMy0xLTEtMA_cb06b37d-49a5-40a6-b13f-23e08b775589">0.30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktNS0xLTEtMA_0c5a6d66-c798-45ca-bc4b-ee8d78643b93">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktNy0xLTEtMA_65c672fb-0f7d-41ff-ae62-892deb93064c">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtMS0xLTEtMA_0e90c529-cf68-4423-b866-ec65abf58cb9">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtMy0xLTEtMA_9696f24a-51e8-47cf-a314-f263935740b3">0.30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtNS0xLTEtMA_22b26f71-1c67-4c04-b74a-5c8a58442d6c">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtNy0xLTEtMA_36e10b0a-efe5-47af-810d-222ca8ac0d1b">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average number of shares used in computing net income (loss) per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItMS0xLTEtMA_8e95f2b7-7f3f-4c43-ae1b-921f57548b46">76,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItMy0xLTEtMA_ae91e7ff-a855-404a-9f6f-7e57606967b6">70,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItNS0xLTEtMA_7fbbc44f-d546-4722-9352-d3855618468b">73,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItNy0xLTEtMA_b3e1bbbe-e25d-4fc9-b337-18e01064cd95">65,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtMS0xLTEtMA_b1a83dcd-e01c-4fd3-aec9-31ee56471b1c">77,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtMy0xLTEtMA_9b62b156-3145-4378-b871-8425436679a7">70,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtNS0xLTEtMA_1fda4134-a4aa-4f5b-b75e-72a64196b105">74,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtNy0xLTEtMA_1acc31fe-c955-4e46-a460-fd9190a94a65">67,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Condensed consolidated statements of stockholders&#8217; equity (unaudited) </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders' equity, beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dd807bc6f645aa8efffcedd8ec8168_I20200731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi0xLTEtMS0w_133595c5-4777-4c1c-bed3-b8ed4e019c3a">1,340,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728a44a8b9e844d2b3e44fd961a30bb0_I20190731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi0zLTEtMS0w_4f3d95fd-539a-4720-8c58-b9e7805e3bb5">1,017,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi01LTEtMS0w_fd8533ef-aa85-4fad-b18b-ea1d1c99d42e">1,030,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66fb9a6498840c584531c192cbb750f_I20190131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi03LTEtMS0w_ae6cd2b3-687d-4724-a1fc-bb3033d458e7">477,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830f5e55e2f148619c75a186e62b092a_I20200731" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS0xLTEtMS0w_497cf242-576b-435a-bffd-1976fead3274">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325dd6d30575455eb3528a68d3959890_I20190731" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS0zLTEtMS0w_e523e08e-96fa-4df7-9610-8eb5294c3a43">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e9026e2bcc4fbda5eb976b88d60ec1_I20200131" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS01LTEtMS0w_105ba716-b626-44ab-8086-127b9ec5ba3a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie544510666474891b6abaeb2f71c3656_I20190131" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS03LTEtMS0w_3349b487-ca36-4692-92e9-7cc2921fcb3c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, and for restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi0xLTEtMS0w_9c1c979d-cf92-4b4d-8b1d-692036b493d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9e554abf8943638da327cec50b9857_D20190801-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi0zLTEtMS0w_f65bf5c5-2306-4426-b4b6-d92ef4f73533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12bed13866654060afc41b6395363264_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi01LTEtMS0w_dca4f08a-f28f-497d-bac3-816032eab53a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a084639dd944c683e352986cdf225c_D20190201-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi03LTEtMS0w_cad761b6-c010-431b-8a1c-c926e3a1fa7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy0xLTEtMS0w_9f8ecb4e-3bdb-46a0-a500-b24f055a40f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9e554abf8943638da327cec50b9857_D20190801-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy0zLTEtMS0w_e3fe624d-bcb6-437e-8647-487fd2742ec3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12bed13866654060afc41b6395363264_D20200201-20201031" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy01LTEtMS0w_5f8188b0-ea6e-4cd3-9376-42c7ec7b7151">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a084639dd944c683e352986cdf225c_D20190201-20191031" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy03LTEtMS0w_2ec06616-4de1-48fe-909f-8836c28ce8f0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76b0719fb45488e82da5b09436072ce_I20201031" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC0xLTEtMS0w_b40136c4-9372-47de-b2c9-85312e2f874b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad2506671294a95a4dd823458a6c3be_I20191031" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC0zLTEtMS0w_10f38e82-f0af-49a0-988d-26914c433f4c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76b0719fb45488e82da5b09436072ce_I20201031" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC01LTEtMS0w_bd5dd1b4-fce6-441c-9044-e21ea736bbf0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad2506671294a95a4dd823458a6c3be_I20191031" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC03LTEtMS0w_849e33cc-397a-48b1-992f-4d2d2884b524">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe3587113374eca96792f943ab69fc5_I20200731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtMS0xLTEtMA_e2bbf94e-227e-41eb-8c9b-09cff6392921">1,127,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a9d56436f4dc487e711fd9d9f1b37_I20190731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtMy0xLTEtMA_7c4c5496-326d-4274-ae02-04ddfd14a4c8">783,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1ab93c490ba422e8067ee638aa89f8a_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtNS0xLTEtMA_5cea78c7-69ef-4b79-b029-8ab16348cbd7">818,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a9294ef6c2a4467ab59ebeb152cd174_I20190131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtNy0xLTEtMA_09663dd8-b070-4ead-be60-b8c3e53c2167">305,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options, and for restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtMS0xLTEtMA_f669bba4-eca3-4c1f-a770-f7ce0eec50f1">1,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtMy0xLTEtMA_0cb06e90-331d-4885-9584-4d67b9b51ea1">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtNS0xLTEtMA_da2c7e86-67e3-46a9-8a66-d473b3157a91">4,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtNy0xLTEtMA_9019ef37-4871-4f90-8f37-cd8eb9b7fe1b">7,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItMS0xLTEtMA_1959ab2c-84e7-4f2a-8b1a-76187d2de8d0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItMy0xLTEtMA_b655e69a-2f6f-4693-bdb8-f0ea5948b4f5">3,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItNS0xLTEtMA_0c004167-0aba-4ab8-8cc0-12842c2bb355">286,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItNy0xLTEtMA_3e94bc24-791f-4d6a-aeb2-a11156490062">462,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtMS0xLTEtMA_adf11f2a-6796-47f4-b202-b5b770b1c892">11,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtMy0xLTEtMA_ecf6d98e-78fe-4f1e-994a-2d1d099e0504">17,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtNS0xLTEtMA_543e2d1b-e919-44c4-b5c1-7d48bec3a086">30,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtNy0xLTEtMA_403012c2-b3b5-41c3-b14e-064b8a01b6cb">31,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d2105b15fb48538124056d84240663_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtMS0xLTEtMA_5a5f97ff-f5cd-47a5-b1d0-8768297dd78e">1,140,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtMy0xLTEtMA_0deb59c7-f17c-40f2-a00e-daf533da82c4">806,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d2105b15fb48538124056d84240663_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtNS0xLTEtMA_4e77571d-2c79-488e-987b-b4c86615cd68">1,140,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtNy0xLTEtMA_7a9017b3-763a-459a-bbd5-4893daac11e5">806,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated earnings</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f820434883469d97b62b57e6b2765e_I20200731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtMS0xLTEtMA_4f8d6d25-8a4a-4463-91bd-ab49304a65e1">213,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i093f52c37be1437080529f8202cebe1a_I20190731" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtMy0xLTEtMA_5d1a2a23-d43d-47bc-b867-076e413af7af">233,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50c1af507e14565b249c2e89c3acc10_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtNS0xLTEtMA_787d470a-538b-4cb3-8bbf-7699f6c4e6c9">211,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf7fea257d4a4064844d660aa4a7626d_I20190131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtNy0xLTEtMA_0a685204-4e26-45df-ba6a-2b08bec79940">171,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i254be2393d1a4c6d8a3240a437574561_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctMS0xLTEtMA_1cd0a83b-25a6-4462-a4db-ace7174327f4">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f04871247f84c9ca9f77b217b29052e_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctMy0xLTEtMA_e76b6345-3811-4313-ba99-545c4ef8a92d">21,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb624d27231459bb251681eee242ddd_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctNS0xLTEtMA_b9805751-1356-4bbd-8348-75831c1b4e13">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62f278c7b4d74e868c0bf4ad932243bb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctNy0xLTEtMA_fdd7ac8f-01dd-47be-a6f0-e28303a25fe5">39,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtMS0xLTEtMA_13ee20e0-4c3f-4df4-8e87-12687c759005">214,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ef3d19e95d456f9d4e91847890e387_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtMy0xLTEtMA_58172c66-8698-4587-8078-28a752036fec">211,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtNS0xLTEtMA_d975170e-0b62-446d-a9f1-1363d67c99df">214,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ef3d19e95d456f9d4e91847890e387_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtNy0xLTEtMA_277cd3b3-d809-4120-a980-2541559efbb5">211,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders' equity, ending balance</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtMS0xLTEtMA_9e3ea1f4-5943-4445-8c47-e49f48bf5399">1,355,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtMy0xLTEtMA_f58ff6c5-0062-4258-8170-85341227bf4f">1,017,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtNS0xLTEtMA_733e1b89-7e74-47bf-bd02-a596a09f84a0">1,355,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtNy0xLTEtMA_886faa4f-879e-4aea-a551-9ae8d010e9fb">1,017,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Condensed consolidated statements of cash flows (unaudited)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMy0xLTEtMS0w_a14b7ce2-4c2d-47aa-96ba-047fba86fd18">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMy0zLTEtMS0w_1da8adfd-30f2-4c98-879c-3c1c696bfd30">39,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNS0xLTEtMS0w_59165019-9212-4c4e-b1c4-8093bcc76f76">85,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNS0zLTEtMS0w_ee205702-cd89-42c4-b3c1-610968b826f7">28,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNi0xLTEtMS0w_6eae16d9-6c78-43dd-87ce-f6c7fb568ae0">30,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNi0zLTEtMS0w_9b8e18fc-4c43-4a73-84d6-4b7638a43466">31,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNy0xLTEtMS0w_713d0703-1f4a-4ef6-a3a7-e7d9306d9436">3,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNy0zLTEtMS0w_9c775db8-678d-4392-a4f0-67fe1f176614">1,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gains on marketable equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOC0xLTEtMS0w_5aa4896e-8bf8-4b2a-921f-ca161d41464c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOC0zLTEtMS0w_a34d4e9a-186a-4877-96ac-f959d6bf885f">27,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOS0xLTEtMS0w_6da60782-2518-4794-b3a0-5841497bc380">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOS0zLTEtMS0w_7d45734f-55a7-4f3f-bf0e-3d2bf2cac162">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTAtMS0xLTEtMA_0a19a8fa-b4e9-40dd-8513-b25834bda612">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTAtMy0xLTEtMA_308848ad-fb9b-4a6e-bccf-09945057a070">690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTItMS0xLTEtMA_21e116f8-1277-450f-ab7e-f4e14a0ebaec">8,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTItMy0xLTEtMA_6c7733c7-9db2-48e0-a22e-2f8a10b6399b">1,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTMtMS0xLTEtMA_5ca188da-0c11-452d-80d6-448993d41f25">3,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTMtMy0xLTEtMA_2a105f82-5cde-457b-b286-56fc2c0d10dc">4,863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTQtMS0xLTEtMA_af8595d0-b388-481e-870a-39c0ee3cb986">8,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTQtMy0xLTEtMA_674f7cfb-1db1-44bc-8b9e-8161aae1e1bd">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTYtMS0xLTEtMA_8a4a7b80-1bbd-4ed0-b2af-a19a7ee4397f">15,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTYtMy0xLTEtMA_a9e6d879-f3e8-464f-815a-08cca2b68029">8,012</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable, accrued liabilities, and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTctMS0xLTEtMA_33199a07-efae-4c33-9a30-1a09436bb6ef">7,936</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTctMy0xLTEtMA_068bb083-bb17-46dc-b9ea-984084426e5e">14,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTgtMS0xLTEtMA_0926ec9d-b4c7-4a98-b572-179501be118f">8,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTgtMy0xLTEtMA_034bc72c-ffe1-46c0-a70e-12c3fa424633">2,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTktMS0xLTEtMA_16a0a991-6bda-4f91-97fa-6684fb75f854">8,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTktMy0xLTEtMA_9ec00ecc-0305-4ff7-93f1-62db3b95af7c">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjAtMS0xLTEtMA_93f4c922-5203-46ff-8be7-cea1cf2825b2">120,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjAtMy0xLTEtMA_5ec9da71-8c2e-4d88-9fc0-16aad550d9ae">74,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjItMS0xLTEtMA_96b97f23-0582-4cfb-9ccf-0f044235bac2">11,388</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjItMy0xLTEtMA_461c9553-4b5e-4b54-be21-05d43537f03c">5,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of software and capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjMtMS0xLTEtMA_9060b8d1-cdd1-4e4c-9109-a6b79d734b5b">37,242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjMtMy0xLTEtMA_5334bf38-1cec-4ad7-a755-bb1e1bdef494">17,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of intangible member assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjQtMS0xLTEtMA_6a97ab64-cf4e-4d1b-922d-1e44a4aa2f0c">28,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjQtMy0xLTEtMA_a0d44ee8-8923-43cb-9aba-4636bfd3becf">9,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMS0xLTEtMA_cc86f35d-024c-4e50-aa04-5eb8a94d9e01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMy0xLTEtMA_627e3e95-6474-4e4e-a9f2-80cb60b5113a">53,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMS0xLTEtMzg_cf593770-2fff-4c84-a362-b96e8da1c384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMy0xLTEtMzg_c2095af3-fee3-496b-abfb-af310b12ca04">1,630,066</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjYtMS0xLTEtMA_c24f2f51-129a-4187-988e-d6c0fa44c451">76,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjYtMy0xLTEtMA_91d563b3-3399-47ec-b06c-ab87d16a2aec">1,715,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from follow-on equity offering, net of payments for offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjgtMS0xLTEtMA_6a07e8bc-a1bd-4718-8c06-1da13e2d6460">286,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjgtMy0xLTEtMA_81a3a668-e02e-4970-9b17-b2eedee7af44">458,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjktMS0xLTEtMA_a1667874-5f06-457a-b7f8-b619f1cbe0c9">223,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjktMy0xLTEtMA_d330b6fa-13ae-45b7-be41-62e9631d1170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlement of client-held funds obligation, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="hqy:PaymentsToSettleClientHeldFunds" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzAtMS0xLTEtMA_0ce7fa82-95f8-4450-b143-9ba86d29464f">4,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="hqy:PaymentsToSettleClientHeldFunds" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzAtMy0xLTEtMA_d09c3582-ed61-4feb-b18c-f819a5f596b6">230,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzEtMS0xLTEtMA_f9617a80-5e21-48d9-9830-cb3d6112e80b">4,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzEtMy0xLTEtMA_a65c0b74-eb61-4aac-af8e-4858ce5f2985">7,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMS0xLTEtNDc_ef7785d6-f0ca-48d8-9c74-55b2764baed4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMy0xLTEtNDc_9f752445-93f0-4ebf-82c0-20768cd19273">1,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMS0xLTEtNDc_db018b0d-3d09-4f09-8a53-acd874c1f05a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMy0xLTEtNDc_b64b096e-f607-4a03-b9e0-79d276e4c46d">30,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMS0xLTEtMA_91c31edf-873c-4b34-bd5f-a7d3ac7fad8f">63,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMy0xLTEtMA_655578f9-f1d3-486a-b709-5c000413b0ea">1,454,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMS0xLTEtMA_3e6eee60-7b81-4adb-bad1-291ffe5a0333">107,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMy0xLTEtMA_db0c2702-1e55-4c3f-a5be-a67b1b5a3210">186,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzQtMS0xLTEtMA_e5409d68-274b-479f-951b-bee771ecb46c">191,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66fb9a6498840c584531c192cbb750f_I20190131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzQtMy0xLTEtMA_24c30ede-9360-404e-ac7b-882c2e07862b">361,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzUtMS0xLTEtMA_90e37e9d-0107-4307-aebd-7c2812b2dbc7">299,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzUtMy0xLTEtMA_7b8fd8b7-8b4c-4f42-9305-77c7e87859af">174,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Condensed consolidated statements of cash flows (unaudited) (continued)</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental cash flow data:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense paid in cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMy0xLTEtMS0w_cc2238d2-25ca-4d86-9827-f61dcdac01a8">22,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMy0zLTEtMS0w_2df1390a-e820-480d-8f4f-1da88d2284f2">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid in cash, net of refunds received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNC0xLTEtMS0w_de00111b-5259-4ba2-9aa3-bf0ba51cda9f">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNC0zLTEtMS0w_6d9724fa-faac-4192-b5da-c2bb251f7256">9,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Supplemental disclosures of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment included in accounts payable or accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNi0xLTEtMS0w_576f73fc-c3a7-43c9-9857-87f3b4d102b5">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNi0zLTEtMS0w_94b16632-cb70-4e94-962e-25e9463c45e1">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c457cfd6a5a43cb9558d8b4d9328cdd_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNy0xLTEtMS0w_45186be6-9a1b-48fd-9514-079c9d38970f">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e0fed62fcbd494496c44b5aa87b0d80_D20190201-20191031" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNy0zLTEtMS0w_bc4db409-ef80-4d32-bd86-f288db502d16">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible member assets included in accounts payable or accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979c4d22bfc9471f8b4dfb208736616b_D20200201-20201031" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfOC0xLTEtMS0w_3bdd2dbe-4f83-49e6-acfb-15e432cb9057">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c3266aa6f754460aacf098b0298fc3b_D20190201-20191031" decimals="-3" sign="-" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfOC0zLTEtMS0w_6b9c9b25-ee82-4d6d-99d7-c7705eb86a97">151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease in goodwill due to measurement period adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTItMS0xLTEtMA_0ced49e3-9d35-48ca-93cd-daa6bd434f8b">5,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTItMy0xLTEtMA_b5b5ae9b-556a-42c7-92c2-21d5ad102bb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of common stock options receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="hqy:ExerciseofStockOptionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMS0xLTEtNTI_81e75944-4f7f-4d14-8b83-d628bf12de1e">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="hqy:ExerciseofStockOptionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMy0xLTEtNTI_837f51e6-ec5e-475d-9583-be5ea46f68d6">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity-based acquisition consideration</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMS0xLTEtNjg_597fe2fb-80c5-4f6c-b7c4-c5b80f69db31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMy0xLTEtNjg_4eb9c089-255a-4b6a-8448-6ff9ca12dcf1">3,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-7-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div></div><div><span><br/></span></div><div id="i2c4fb233b505418dacb8bdb47138592f_25"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">HealthEquity, Inc. and subsidiaries</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Notes to condensed consolidated financial statements</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;1. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNTAwNA_94fe2bb8-5e18-4924-b113-6089c14cc5f1" continuedAt="i5424db6f2dd648f1b16193f24915f118" escape="true">Summary of business and significant accounting policies </ix:nonNumeric></span></div><ix:continuation id="i5424db6f2dd648f1b16193f24915f118" continuedAt="idca4023a8e5d466793cfb3e5c17b57d3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthEquity, Inc. ("HealthEquity" or the "Company") was incorporated in the state of Delaware on September&#160;18, 2002. HealthEquity is a leader in administering health savings accounts (&#8220;HSAs&#8221;) and complementary consumer-directed benefits (&#8220;CDBs&#8221;), which empower consumers to access tax-advantaged healthcare savings while also providing corporate tax advantages for employers.</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk5Mw_cb0d1e14-bc7f-4c4f-896d-ce6b9cbb4610" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of consolidation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4MQ_d994498b-7d20-4b04-a85e-494f230aee5e" continuedAt="ibe43d62490094e55945d4e1b825eb564" escape="true">Basis of presentation </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe43d62490094e55945d4e1b825eb564">The accompanying condensed consolidated financial statements as of October&#160;31, 2020 and for the three and nine months ended October&#160;31, 2020 and 2019 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.  The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4Mw_453d835d-a67a-421e-92a7-f2d83be6d8e7" escape="true">Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Follow-on equity offering</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company closed a follow-on public offering of <ix:nonFraction unitRef="shares" contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjE3OQ_3ec737c9-74a3-42b8-8cf6-6a9560552032">5,290,000</ix:nonFraction> shares of common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjIzNQ_e637f197-b965-4aa7-9410-216735ad1056">56.00</ix:nonFraction> per share, less the underwriters' discount. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjMzMw_8e5187b8-4e1b-4f1e-9b98-f101253d24f1">286.8</ix:nonFraction> million after deducting underwriting discounts and commissions of approximately $<ix:nonFraction unitRef="usd" contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjQwOA_33460e7b-5a6e-4a90-a4ac-2e43ca9c1595">8.9</ix:nonFraction> million and other offering expenses of approximately $<ix:nonFraction unitRef="usd" contextRef="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731" decimals="-5" format="ixt:numdotdecimal" name="hqy:StockIssuanceCostsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjQ3OQ_f4f04902-5b4c-404c-a644-5bf619e02739">0.6</ix:nonFraction> million. The Company used $<ix:nonFraction unitRef="usd" contextRef="i389ea35a3d2e4607abc6c9410c75ebec_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjUwMA_aa16ff36-93fe-4a88-bbe1-2d8e1a332cae">200.0</ix:nonFraction>&#160;million of such proceeds to repay debt under its term loan facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the Company&#8217;s significant accounting policies as compared to the significant accounting policies described in the Company&#8217;s Annual Report on&#160;Form&#160;10-K for the fiscal year ended January&#160;31, 2020.</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4NQ_c662088f-a5d3-41e0-9728-6efae209c307" continuedAt="iee325dee9fbd491882825f39d40bc07e" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020 using the modified retrospective transition method. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASU 2018-13&#8221;), which amends ASC 820, "Fair Value Measurement." ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying and adding certain disclosures. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-8-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div><ix:continuation id="idca4023a8e5d466793cfb3e5c17b57d3"><ix:continuation id="iee325dee9fbd491882825f39d40bc07e"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The Company adopted the new standard as of February 1, 2020. </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company retrospectively adopted the provision related to the classification of taxes partially based on income, and prospectively adopted the provisions related to intraperiod tax allocation and interim recognition of enactment of tax laws. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The adoption of this standard did not have a material effect on the Company&#8217;s current- or prior-period condensed consolidated financial statements.</span></ix:continuation></ix:continuation></div><div id="i2c4fb233b505418dacb8bdb47138592f_28"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;2. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNjQ1_cf3b686e-f80e-470d-849d-8f4f19a04730" continuedAt="i76cfe26936fe496b801ef3fdee644060" escape="true">Net income (loss) per share</ix:nonNumeric></span></div><ix:continuation id="i76cfe26936fe496b801ef3fdee644060"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNjQz_23e7349a-f20e-46d4-8409-c4334331612d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Numerator (basic and diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy0xLTEtMS0w_cef75d7d-4e1c-4bc6-a00b-1998f8899679">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy0zLTEtMS0w_4c59b047-2e0e-462b-942f-e63790432162">21,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy01LTEtMS0w_1cac4d2f-5f89-4d58-8601-038408385e98">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy03LTEtMS0w_2bfb91c7-bfb0-4dd9-8d39-f79f52f284fa">39,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (basic):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS0xLTEtMS0w_31029af9-a506-411d-8637-dba22021320c">76,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS0zLTEtMS0w_27092f79-1557-4ff4-bb62-12e307407e69">70,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS01LTEtMS0w_0b2ca0d5-15d4-425e-8575-489338d5de0c">73,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS03LTEtMS0w_f44cc9ce-a8e3-4154-b91b-77c3ec48d300">65,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy0xLTEtMS0w_e387df2e-de87-43ba-894a-8ab375fa298e">76,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy0zLTEtMS0w_e44578f6-d115-409f-853e-c8bb4ac66afd">70,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy01LTEtMS0w_616709cd-d1c8-4ba4-bc31-9b91e0d154bb">73,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy03LTEtMS0w_d0f2e9d4-89dd-4992-80e2-401948360543">65,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC0xLTEtMS0w_b810fc4c-3738-4e3d-92d8-a7ae3c02a01a">1,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC0zLTEtMS0w_677b0f20-87c2-44ac-8775-41233a9d6afe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC01LTEtMS0w_17e90a98-c34c-4e11-a174-11734a1c6d6d">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC03LTEtMS0w_c0930dd4-aef4-40f3-87b7-7d8b706f9a9c">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS0xLTEtMS0w_a6fa97e7-e5b4-4b56-9f8b-475e0aa7f86c">77,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS0zLTEtMS0w_d15963c2-7f3c-4cb6-bec2-d14d1927d4b4">70,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS01LTEtMS0w_719a1b01-84df-4bc0-bfb1-0c1732d0d002">74,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS03LTEtMS0w_e6c166f5-78ee-4412-b0dc-b10ceb03c0ed">67,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtMS0xLTEtMA_d29501b1-c903-477f-93ae-d6966ee6b4f9">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtMy0xLTEtMA_6785a987-a142-464b-b5a2-2280f4ee6f9f">0.30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtNS0xLTEtMA_4211877d-c8e2-4e4d-9b53-044d2e7562fc">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtNy0xLTEtMA_783d04a3-0a69-4854-a127-ddb0b8e6eae7">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItMS0xLTEtMA_46e3e896-213a-45f0-aa16-9b829e0bd660">0.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItMy0xLTEtMA_7396f5a7-17ea-4e70-99f8-fc1a91a567b4">0.30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItNS0xLTEtMA_222b44a9-0771-4f72-86f3-1cff1c87b0e0">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItNy0xLTEtMA_91fe1c24-2be8-4f97-98ba-ab6b23d97618">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended October&#160;31, 2020 and 2019, approximately <ix:nonFraction unitRef="shares" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfMTgw_5c8348c7-fc05-437a-95cc-492abfaba122">1.0</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfMTg3_1f0287a2-788e-4ffd-bcf6-b76caf2a06d6">3.2</ix:nonFraction> million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended October&#160;31, 2020 and 2019, approximately <ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNDM0_031ab26a-4953-415a-946c-1948e994743a">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNDQx_7131eba3-7768-478b-a871-5cf2d80394eb">0.3</ix:nonFraction> million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.</span></div></ix:continuation><div id="i2c4fb233b505418dacb8bdb47138592f_31"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;3. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTQ2MQ_4df09019-957b-487c-b90b-60dd6b29c0b7" continuedAt="i7dbfd7f245774830b01622116d6b9185" escape="true">Business combination</ix:nonNumeric></span></div><ix:continuation id="i7dbfd7f245774830b01622116d6b9185" continuedAt="i66d68d6a278b46c19237ef700c7c2fdd"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of WageWorks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2019, the Company closed the acquisition (the "Acquisition") of WageWorks, Inc. ("WageWorks") for $<ix:nonFraction unitRef="usdPerShare" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTcx_6c9f04e3-3376-4173-87fd-c21bfeb55d43">51.35</ix:nonFraction> per share in cash, or approximately $<ix:nonFraction unitRef="usd" contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMjEw_89eb8611-b9d5-4df2-8838-87d8e04b1314">2.0</ix:nonFraction>&#160;billion to WageWorks stockholders. The Company financed the transaction through a combination of $<ix:nonFraction unitRef="usd" contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMzAy_5b4501f5-22ff-4e2e-a658-8ce01d8b05a9">816.9</ix:nonFraction>&#160;million cash on hand plus net borrowings of approximately $<ix:nonFraction unitRef="usd" contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMzU1_cddca352-0563-4f1d-84e1-43445361bfa4">1.22</ix:nonFraction>&#160;billion, after deducting lender fees of approximately $<ix:nonFraction unitRef="usd" contextRef="ifc6f37ce7f2248f3a06a9f4c38858730_D20190830-20190830" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfNDA0_216e5b2a-3e86-48f7-82b8-08d14ffd5ed4">30.5</ix:nonFraction>&#160;million, under a term loan facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Acquisition was accounted for under the acquisition method of accounting for business combinations. Consideration paid was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the Acquisition date. The initial allocation of the consideration paid was based on a preliminary valuation and was subject to adjustment during the measurement period (up to one year from the Acquisition date). The purchase price allocation was finalized in the third quarter of fiscal 2021.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-9-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i66d68d6a278b46c19237ef700c7c2fdd"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTQ2Mw_16ab20da-e01b-42f0-93ed-79ef4b919416" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's allocation of the consideration paid in the Acquisition:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Allocation</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Updated Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS0xLTEtMS0w_4ed651a6-3848-439b-a126-0d2d62cf2434">406.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" sign="-" name="hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS0zLTEtMS0w_9812e9ce-be17-4c28-910b-1d11db60b700">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS01LTEtMS0w_d6cd0b6b-2f65-4c0d-a67e-388a0cd7cf9a">392.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi0xLTEtMS0w_ee63b483-00e2-4d92-bf58-c74bc8f6ab23">56.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" name="hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi0zLTEtMS0w_fb95fe50-a423-4f80-b2a6-58442d982c03">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi01LTEtMS0w_f2043e1a-54bd-4d2e-9eb8-dca3734c9a52">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMy0xLTEtMS0w_962499db-bbef-403e-aef6-62ee54154283">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMy01LTEtMS0w_a26ae156-a7db-41a2-9a1b-adafe7916642">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNC0xLTEtMS0w_9aa19a14-be1c-4c57-870f-c304a7cef0a7">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNC01LTEtMS0w_9fc3de6e-d865-40fb-90a8-2b4eafc0c312">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNS0xLTEtMS0w_71630070-a1be-4795-866a-433aa5709e85">715.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNS01LTEtMS0w_61b02fcf-f3df-436f-8198-853b748c339e">715.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi0xLTEtMS0w_367197a8-8e2f-4a29-8316-4e1f3ad79bb4">1,330.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi0zLTEtMS0w_a90bbcd3-f7a8-4257-8f0e-7fd6c021a906">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi01LTEtMS0w_b85ce88d-ec8c-437b-8d43-729c1be7788a">1,322.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNy0xLTEtMS0w_7a0df372-d883-420f-997b-630999a6ab98">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNy01LTEtMS0w_69d1a535-f23a-4442-8480-b6f70111b64d">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client-held funds obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC0xLTEtMS0w_4ace103f-0f38-4a5a-9668-a2d667304132">237.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" sign="-" name="hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC0zLTEtMS0w_aef04653-3998-481f-a2f8-67a22ed45283">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC01LTEtMS0w_d4990cef-bdeb-4237-8ed2-ea4163ec7a21">220.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS0xLTEtMS0w_11f176e5-e665-438a-8338-d32fac0be53e">69.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" name="hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS0zLTEtMS0w_6b49d4c9-4e92-45af-9759-d38a9f678906">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS01LTEtMS0w_442226c1-d37b-490a-9df9-8ae00e5c8435">72.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTAtMS0xLTEtMA_935efb34-1864-4b32-9db2-795319299807">26.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTAtNS0xLTEtMA_2a345c34-d3ba-4dfe-9943-646d4ec97e6a">26.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtMS0xLTEtMA_e85ccaf0-c18f-42bf-9a3f-22bcf340edf1">128.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" sign="-" name="hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtMy0xLTEtMA_79379d2d-04fc-49e4-9cce-235119776088">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtNS0xLTEtMA_fb20cf7f-599a-4452-b575-5d1fab4b04f8">122.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total consideration paid</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItMS0xLTEtMA_fc6d84c0-f47e-4171-9622-070748d18f87">2,122.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItMy0xLTEtMA_e36418af-1f9a-49fc-b560-a2981c4c6d95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78673cfa6671419b96252591cd5aada4_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItNS0xLTEtMA_5b14cb3e-bb1b-46e0-a02b-67706c5af75c">2,122.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to the initial allocation were based on more detailed information obtained about the specific assets acquired, liabilities assumed, and tax-related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro forma information</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfODc5NjA5MzA0MTY1Nw_a809c107-3dc1-4005-8846-646cac92f5af" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented below include the effects of the Acquisition as if it had been consummated as of February 1, 2018, with adjustments to give effect to pro forma events that are directly attributable to the Acquisition, which include adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings from the integration of WageWorks. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the Acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations. The estimated pro forma revenue and net income (loss) include the alignment of accounting policies, the effect of fair value adjustments related to the&#160;Acquisition, associated tax effects and the impact of the borrowings to finance the&#160;Acquisition and related expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31, 2019</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMS0xLTEtMS0xMzY5_fe2edbfd-49c2-4c5b-b031-f4209cb5af1b">194,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a254662184a4106b4379b10205f7880_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMS0zLTEtMS0xMzY5_2722489d-94fa-440c-9714-a69afcf9ccb9">598,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMi0xLTEtMS0xMzY5_77170f4f-3234-4ffa-bf1a-ba46110881f4">3,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a254662184a4106b4379b10205f7880_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMi0zLTEtMS0xMzY5_c69a1bff-d8c4-421d-8476-14b85c0672ee">34,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i2c4fb233b505418dacb8bdb47138592f_34"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;4. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMQ_486e2db7-5b12-4f62-a180-2d2c2b51877c" continuedAt="i13179879f4c540ba914bec11d748a3c5" escape="true">Supplemental financial statement information</ix:nonNumeric></span></div><ix:continuation id="i13179879f4c540ba914bec11d748a3c5" continuedAt="i3f90acf6ccdb4b028b3ec88ca681eb44"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected condensed consolidated balance sheet and condensed consolidated statement of operations and comprehensive income components consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and equipment</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMg_e38c7e1e-ed9a-49e6-832d-dbc1cf36273d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec79e8d4a8042d1b80bb68a1480bcc3_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMS0xLTEtMS0w_e4a649c3-65bd-4ce9-a432-9ae919395b00">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic430d1bd4b994088a513acef3734435e_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMS0zLTEtMS0w_baff6c11-4525-4662-919f-a230d0d8b8f7">19,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60c903d8b1a046ef8d58e35f85bddcdb_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMi0xLTEtMS0w_36d2d2f0-92a2-430c-b055-254df9466908">9,219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ed676cc45541888a286e697eaf4971_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMi0zLTEtMS0w_9e7e931b-bb12-495f-8883-4abd32c1fdab">7,929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bbb14b2d0234a85814cdcf59a17f56d_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMy0xLTEtMS0w_23110d13-24ed-4c6a-9057-1b47317862e5">27,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4364bceadc1640888f5252fff2b05a38_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMy0zLTEtMS0w_d6d88d50-bd0a-46f3-b490-e6e757a283c4">22,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNC0xLTEtMS0w_397906e3-893d-4d61-bf38-44c24751ac01">58,907</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNC0zLTEtMS0w_161fd6eb-e47d-424e-808c-8aacee4d3362">49,243</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNS0xLTEtMS0w_284c4284-52ea-4a4a-a9ad-8edcc6e71042">27,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNS0zLTEtMS0w_87e63104-06d7-4310-bd30-d8018de8aab3">15,757</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNi0xLTEtMS0w_4a5fba88-f57a-42bc-8c5d-a47037678c9c">31,774</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNi0zLTEtMS0w_967d6922-7ba4-4d0d-9c58-8773b103153d">33,486</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended October&#160;31, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMzcx_db5c7414-aa5f-47fe-b573-159c928efe9a">4.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMzc4_25367b7d-1ef8-48f3-bb4b-ddcd44271197">3.6</ix:nonFraction> million, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfNDAw_cc6ab558-2c9c-46b2-a288-094a1cd45a0b">12.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfNDA3_2cb5337e-0303-4e7e-849a-b6ee11448ef3">5.4</ix:nonFraction> million for the nine months ended October&#160;31, 2020 and 2019, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-10-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><ix:continuation id="i3f90acf6ccdb4b028b3ec88ca681eb44"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets. The Company records a receivable when revenue is recognized prior to payment and the Company has unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. As of October&#160;31, 2020 and January&#160;31, 2020, the balance of deferred revenue was $<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfOTUz_c90d203a-bae3-4987-9024-36a91c1f6785">7.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfOTYw_019e0c03-2573-4138-a2bd-2c9f8a321d67">3.7</ix:nonFraction> million, respectively. The balances are related to cash received in advance for an interchange revenue arrangement, other up-front fees and other commuter deferred revenue, and are generally recognized within twelve months, with the exception of the interchange arrangement, which is recognized over a term of approximately <ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:durwordsen" name="hqy:ContractWithCustomerRecognitionTermInterchangeArrangement" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTI3OQ_35c997d1-d919-4e1f-91ee-a954e34750f2">ten years</ix:nonNumeric>. During the three and nine months ended October&#160;31, 2020, approximately $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTMzOA_90917bcf-8e23-4b81-8176-e8c1df4fb509">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTM0NQ_59fe7377-8605-4e7b-8b88-91b4d04ad992">2.2</ix:nonFraction> million of revenue, respectively, was recognized that was included in the balance of deferred revenue as of January&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcwOA_99a6438d-2a7f-44e7-b9c2-e4ddc0d28ff4" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease costs were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi0xLTEtMS0w_326fcce4-8601-402d-853d-eb80979b48c2">3,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi0zLTEtMS0w_a8468ecf-2eec-47e8-843e-39b801688b0d">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi01LTEtMS0w_04deed5a-b924-45f4-ac68-9dea17955900">12,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi03LTEtMS0w_a4a0adee-6e68-43c8-b3a8-be9b806fa069">5,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy0xLTEtMS0w_363720ab-33d8-43de-9763-4d08a84beb1c">450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy0zLTEtMS0w_e01cb377-2b24-4216-ab78-9360426a7c3d">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy01LTEtMS0w_af6d9721-8e33-4937-9c56-bf63351a3ba8">1,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy03LTEtMS0w_4c6560c9-c9bd-44ac-9876-cd7ef899bd88">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net operating lease expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC0xLTEtMS0w_21c03285-79ee-43d2-a1d1-003655b6300e">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC0zLTEtMS0w_bf86dffb-37fa-4fbb-b6f5-d429a2949d07">3,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC01LTEtMS0w_7f81b180-782b-40ae-bbb5-8f951906fc86">10,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC03LTEtMS0w_856356da-c58b-48a0-91ec-56cb1992db20">5,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfMy0xLTEtMS0w_6079ae60-4ba8-4864-a3ba-3eb74cd61a48">9,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfMy0zLTEtMS0w_f0707d3b-4055-4364-82a6-939334788078">4,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new operating lease obligations</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfNC0xLTEtMS0w_11ec2e8c-4883-4c71-ab90-620d7a4952d6">17,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfNC0zLTEtMS0w_795a1ae3-3c85-4033-b032-8795d16c4796">34,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other expense, net</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMA_f5b8a276-dd5a-48a1-9e9d-29575e7cf7fa" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi0xLTEtMS0w_0386b816-1416-4df7-a987-e1a3ba39ebec">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi0zLTEtMS0w_3b54beae-2bf6-43a9-ab34-09b168e26b02">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi01LTEtMS0w_160e121c-393b-402e-804b-0295cb41bc09">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi03LTEtMS0w_fd6d28f7-2799-413b-9f59-71312e7bc801">5,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy0xLTEtMS0w_ef75ca89-774d-4f77-9773-fa04786041cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy0zLTEtMS0w_b4b946aa-4e63-4a95-b6a5-142efea55795">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy01LTEtMS0w_3068336d-b207-4d45-9571-d873060a1bb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy03LTEtMS0w_2ed32fb9-cc7c-4465-a159-bb79cd3bcefa">27,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC0xLTEtMS0w_388b8720-266c-4fcc-aeb5-1222458d812e">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC0zLTEtMS0w_ec1a1914-d541-48a2-a65a-71c82da7442c">32,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC01LTEtMS0w_b05f9959-2267-44f2-a747-b9604b7e8987">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC03LTEtMS0w_6914a09b-63a2-4965-b320-62d2ec35f2f7">40,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS0xLTEtMS0w_81e65e55-ac21-4359-bada-81a9359493b6">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS0zLTEtMS0w_2cc8b17f-b564-4766-af9e-c581381bc785">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS01LTEtMS0w_5850b9d6-3903-4c64-94df-ec7a49e825af">2,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" name="us-gaap:OtherNonoperatingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS03LTEtMS0w_fb1b53a6-d0f3-460f-8088-9d2415fc25f8">478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi0xLTEtMS0w_567ab2ed-c76a-48f7-a18c-da3e3ffd7507">421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi0zLTEtMS0w_b121de34-a33c-4098-a12f-32cfc1c41f2f">30,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi01LTEtMS0w_ebb7e6b0-5e25-4b59-8bb0-1cb2f79b86b6">2,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi03LTEtMS0w_c5f80d19-6a61-4f39-91a5-e13712448af9">8,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="i2c4fb233b505418dacb8bdb47138592f_37"></div><div style="margin-bottom:6pt;margin-top:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-11-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;5. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODM1_da59c83e-a725-467d-a79c-0618fc14781b" continuedAt="i3da24e53445945da98b7a32efaafab20" escape="true">Intangible assets and goodwill</ix:nonNumeric></span></div><ix:continuation id="i3da24e53445945da98b7a32efaafab20"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible assets</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODMy_805c37ef-ef5f-47eb-ab63-0434219317de" escape="true"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODQw_ad24cd0e-e6ab-47bb-82f9-61cb8ff726d4" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48937f6ece7149fca3c3b3786e77ec95_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMi0xLTEtMS0w_b3078cf1-198c-4396-9a41-98ceb9a21b91">116,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504cb0661e9f4dae8034503b601a2870_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMi0zLTEtMS0w_04b0ee0c-15a9-4654-b6d3-785f848fb19c">76,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired HSA portfolios</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0205c0743fb47ac8f23fed3e5aedb2e_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMy0xLTEtMS0w_d4b1cbf2-063e-4b80-b2b7-9b390ca731dc">121,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1624fbd3d94920921887290a7ad491_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMy0zLTEtMS0w_efd07bef-93d0-4e9c-b2d6-e2f30d64baa7">92,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a29caffc2214b65ade72766d8f08cc1_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNC0xLTEtMS0w_44ef089c-96f3-4c24-8b1f-d5e71e41866c">601,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3627b5c69c44353802952f92fbe50f9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNC0zLTEtMS0w_3daac722-78bc-49e6-b3fb-c73521f2c874">601,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb51032a2154465cb9cddfdc52f94dc7_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNS0xLTEtMS0w_37e9f9c6-0129-4ceb-93a9-ef3a5f82f73e">96,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2e76b4ad3e9409e90e86df52d0c70bf_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNS0zLTEtMS0w_aae8250b-18e4-402f-927f-7247ad226406">96,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48a3338f2c4043f2920127348167f2c5_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNi0xLTEtMS0w_c8a29636-f21f-4f4c-9fa4-131c4df788db">12,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316e7d3a2c2549989b4056855d453948_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNi0zLTEtMS0w_09d4db39-8842-4840-9ad5-e21a96d4207f">12,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNy0xLTEtMS0w_b8f45c00-ab46-49fd-bfec-a1cac31dc54c">947,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNy0zLTEtMS0w_0599a9ab-ab3d-4b1e-92f9-19b3a1f267f7">879,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOC0xLTEtMS0w_b4c9c895-3a6c-4f14-b6c8-5dd39c12764a">172,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOC0zLTEtMS0w_118d6377-3138-4f94-bfa7-37de96c11e95">98,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total amortizable intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOS0xLTEtMS0w_e621fe54-e5f3-4a2c-8614-580fcc7fac1b">775,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOS0zLTEtMS0w_95d97fd7-1d16-4efd-a6a4-56cf8b620e2f">780,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in process software development costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e444c7573c4e11ab6a937593087dfa_I20201031" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTAtMS0xLTEtMA_604ffc96-78b3-4b8a-9f3a-6b2339aaee9d">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3346b7e4394c4a3cb401ea158a7e6f79_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTAtMy0xLTEtMA_1380aab5-bdb7-4306-984d-614222058a25">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTEtMS0xLTEtMA_6e59b2b8-45d9-45a6-a6e7-edb8e48255ab">776,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTEtMy0xLTEtMA_22db9672-7bd0-4907-a41e-2f980dd83c8b">783,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended October&#160;31, 2020 and 2019, the Company expensed a total of $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjU3_5d8cfd83-43a6-4f38-a1c7-104d06e85577">10.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjY0_14b78bbe-1169-4356-ba55-0c6e6b6178b3">6.2</ix:nonFraction> million, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjg2_f7f305b7-e74d-4294-aa24-8c34ed46b478">31.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjkz_053770b4-7063-4475-bb96-728de560582b">13.8</ix:nonFraction> million for the nine months ended October&#160;31, 2020 and 2019, respectively, in software development costs primarily related to the post-implementation and operation stages of its proprietary software. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended October&#160;31, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTM0_4f067769-4769-48f4-ae09-9f22ae63580e">25.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTQx_8021db6f-160e-4d08-b0f4-507791c96a56">15.7</ix:nonFraction> million, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTYz_39d76cd7-d7f0-4c31-9c41-5e8837275ebe">73.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTcw_35a64fc4-ded2-4e86-a9a4-f261a68c9518">23.6</ix:nonFraction> million for the nine months ended October&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended October&#160;31, 2020, goodwill decreased by $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMTY0OTI2NzQ0MzIyNA_0a3f3dd4-2b9b-4ad9-b61e-4d93f48c320f">7.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNjg4_ea073f78-f1dc-40b0-bc1b-219a8b419391">5.8</ix:nonFraction> million, respectively, due to measurement period adjustments related to the Acquisition of WageWorks.</span></div></ix:continuation><div id="i2c4fb233b505418dacb8bdb47138592f_40"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;6. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNjQyNA_d7acec7a-5c5c-417a-b959-94694a4a7c00" continuedAt="i4f44af6b4a3e48afa21288575ebfd15e" escape="true">Commitments and contingencies</ix:nonNumeric></span></div><ix:continuation id="i4f44af6b4a3e48afa21288575ebfd15e" continuedAt="ic68fce93709e411f9cf6ee66ed128497"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal commitments consist of a term loan facility, operating lease obligations for office space, data storage facilities, and other leases, a processing services agreement with a vendor, and contractual commitments related to network infrastructure, equipment, and certain maintenance agreements under long-term, non-cancelable commitments. Except for the $<ix:nonFraction unitRef="usd" contextRef="i88892452c8b4467da8e7c754e0bd6661_D20200201-20201031" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNDI5_3273705a-cb90-4c8c-80a3-cee5b4723d39"><ix:nonFraction unitRef="usd" contextRef="i70aa4eace1b849b7bc8770af2620a276_D20200801-20201031" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNDI5_5043f5ba-c1a5-4541-b010-e14d90529162">200</ix:nonFraction></ix:nonFraction>&#160;million principal prepayment on our term loan facility, there were no material changes during the three and nine months ended October&#160;31, 2020, outside of the ordinary course of business, in our commitments from those disclosed in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal matters</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks is pursuing affirmative claims against the Office of Personnel Management ("OPM") to obtain payment for services provided by WageWorks between March 1, 2016 and August 31, 2016 pursuant to its contract with OPM. In connection with WageWorks' claims against OPM, OPM has also claimed that an erroneous statement in a certificate signed by a former executive officer constituted a violation of the False Claims Act and moved to dismiss part of WageWorks' claim against OPM as a result. As with all legal proceedings, no assurance can be provided as to the outcome of these matters or if WageWorks or OPM will be successful.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-12-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div><div><span><br/></span></div></div><ix:continuation id="ic68fce93709e411f9cf6ee66ed128497"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2018, a putative class action was filed in the U.S. District Court for the Northern District of California (the &#8220;Securities Class Action&#8221;). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against WageWorks, its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleges claims under the Securities Act of 1933, as amended, arising from WageWorks&#8217; June 19, 2017 common stock offering against those same defendants, as well as the members of its board of directors at the time of that offering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2018 and September 6, 2018, <ix:nonFraction unitRef="lawsuit" contextRef="i3e05173272a94406b7f82f6775f29b05_D20180906-20180906" decimals="INF" format="ixt-sec:numwordsen" name="hqy:LossContingencyNumberOfLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfMjY2MQ_159a0afe-d9f2-468f-a451-7117f7a9ea61"><ix:nonFraction unitRef="lawsuit" contextRef="i7ab953b65e81482fbbdffc410958e5ee_D20180622-20180622" decimals="INF" format="ixt-sec:numwordsen" name="hqy:LossContingencyNumberOfLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfMjY2MQ_6b0611e5-f950-4f8d-847a-73e9b60c4235">two</ix:nonFraction></ix:nonFraction> derivative lawsuits were filed against certain of WageWorks&#8217; former officers and directors and WageWorks (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain former WageWorks&#8217; officers and directors and WageWorks (as nominal defendant) in the U.S. District Court for the Northern District of California (together, the &#8220;Derivative Suits&#8221;). The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages and fees and costs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Plaintiffs in the Superior Court action filed an amended consolidated complaint on October 28, 2019, naming as defendants certain former officers and directors of WageWorks and alleging a direct claim of "inseparable fraud/breach of fiduciary duty" on behalf of a class. WageWorks was not named as a party in that complaint. On June 24, 2020, the court granted the defendants&#8217; motion to dismiss the amended complaint. The plaintiffs subsequently filed a notice of appeal.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks voluntarily contacted the San Francisco office of the SEC Division of Enforcement regarding the restatement of WageWorks' financial statements and related independent investigation. WageWorks is providing information and documents to the SEC and continues to cooperate with the SEC&#8217;s investigation into these matters. The U.S. Attorney&#8217;s Office for the Northern District of California also opened an investigation. WageWorks has provided documents and information to the U.S. Attorney&#8217;s Office and continues to cooperate with any inquiries by the U.S. Attorney&#8217;s Office regarding the matter.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks previously entered into indemnification agreements with its former directors and officers and, pursuant to these indemnification agreements, is covering the defense of its former directors and officers in the legal proceedings described above. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge, that such litigation, proceedings and claims will not have a material impact on the Company&#8217;s financial position, results of operations and cash flows for the period. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains liability insurance coverage that is intended to cover the legal matters described above; however, it is possible that claims may be denied by our insurance carriers or could exceed the amount of our applicable insurance coverage, we may be required by our insurance carriers to contribute to the payment of claims, and our insurance coverage may not continue to be available to us on acceptable terms or in sufficient amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under GAAP, the Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on currently available information, the Company does not believe that any liabilities relating to these matters are probable or that the amount of any resulting loss is estimable. However, litigation is subject to inherent uncertainties and the Company&#8217;s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company&#8217;s financial position, results of operations and cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.</span></div></ix:continuation><div id="i2c4fb233b505418dacb8bdb47138592f_43"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;7. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTk0Mg_321a6f42-31d6-4b96-9214-b0151c6d60f3" continuedAt="ic3196867835b43118a8ab68fcfd9c590" escape="true">Income taxes</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><ix:continuation id="ic3196867835b43118a8ab68fcfd9c590" continuedAt="i367c74a3b69843c6b866c76f20550b05"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows FASB Accounting Standards Codification 740-270, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes - Interim Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the computation and presentation of its interim period tax provision. Accordingly, management estimated the effective annual tax rate and applied this rate to the year-to-date pre-tax book income to determine the interim benefit or provision for income taxes. For the three and nine months ended October&#160;31, 2020, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNDc3_09391150-0e7b-4207-9072-4d3d2a3acb67">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNDg0_a030ad08-c5d6-4ae7-a821-68c8373f1f42">2.0</ix:nonFraction> million, respectively. This resulted in an effective income tax expense rate of <ix:nonFraction unitRef="number" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNTU5_c88280d4-e06f-416f-8136-02ff2c58fc6c">56.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNTY2_821f1316-59f5-4f11-9097-0724f172dcf8">36.8</ix:nonFraction>% for the three and nine months ended October&#160;31, 2020, respectively, compared with an effective income tax benefit rate of <ix:nonFraction unitRef="number" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNjc2_7786090e-8a44-41ab-b32f-0345dcefa65d">31.7</ix:nonFraction>% and an effective income tax expense rate of <ix:nonFraction unitRef="number" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTY0OTI2NzQ0Mzc2OA_a6f71a2e-7f3c-4050-96e9-9dd7017dd9f4">8.9</ix:nonFraction>% for the three and nine months ended October&#160;31, 2019, respectively. For the three and nine months ended October&#160;31, 2020 and 2019, the net </span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-13-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div></div><ix:continuation id="i367c74a3b69843c6b866c76f20550b05"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of discrete tax items caused a <ix:nonFraction unitRef="number" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODE4_ae58fd24-04c0-4b04-942c-de75fddb1a29">6.0</ix:nonFraction> percentage point expense and a <ix:nonFraction unitRef="number" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODI1_3a6c46a5-6332-4121-9258-6fb026d85bc4">9.6</ix:nonFraction> percentage point benefit and a <ix:nonFraction unitRef="number" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODU5_19aa5a33-8355-4749-97d4-589e9070eb3e">1.1</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODY2_bc0036f2-eaec-496d-b5a2-059bf60d786a">8.7</ix:nonFraction> percentage point benefit, respectively, to the effective income tax rate primarily due to the excess tax benefit on stock-based compensation expense and return-to-provision adjustments, which were partially offset by state apportionment changes recognized in the provision for income taxes relative to pre-tax book income. Due to significantly lower pre-tax book income during the nine months ended October&#160;31, 2020, discrete items had a greater impact on the effective income tax rate than during the nine months ended October&#160;31, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020 and January&#160;31, 2020, the Company&#8217;s total gross unrecognized tax benefit was $<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTMyNg_581e23a4-0a8b-4618-b44e-26b48a7627a3">10.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTMzMw_a67035b8-ffa9-4314-b0a5-db657c3310b9">9.4</ix:nonFraction> million, respectively. As of October&#160;31, 2020 and January&#160;31, 2020, a net unrecognized tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" format="ixt:numdotdecimal" name="hqy:UnrecognizedTaxBenefitNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTQwMg_04cfe2d5-7ebf-4ee2-a8d2-cae21c4eee0c"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="hqy:UnrecognizedTaxBenefitNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTQwMg_75a76cd0-35b7-4b98-923d-403b5aa7e81f">0.5</ix:nonFraction></ix:nonFraction> million was recorded in the condensed consolidated balance sheets. If recognized, $<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTUwMQ_e6b19ac5-9e33-4256-947e-4b4cc101e1ba">9.2</ix:nonFraction> million of the total gross unrecognized tax benefits would affect the Company's effective tax rate as of October&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns with U.S. federal and state taxing jurisdictions and is currently under examination with the state of Texas. As a result of the Company's net operating loss carryforwards and tax credit carryforwards, the Company remains subject to examination by one or more jurisdictions for tax years after 2000.</span></div></ix:continuation><div id="i2c4fb233b505418dacb8bdb47138592f_46"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;8. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA3OQ_6ef0926d-125b-47e5-8a86-a4dee504b179" continuedAt="if02e5c6a05484a508a3235e63145a3b3" escape="true">Indebtedness</ix:nonNumeric></span></div><ix:continuation id="if02e5c6a05484a508a3235e63145a3b3" continuedAt="i815149eda93d4afb963e56288bdafc67"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA4MA_075603ba-8486-4bf6-b47e-c0d625a507c6" continuedAt="i1038d2d191f84dea8fe90a12a89b4355" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020, long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loan facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMS0xLTEtMS0w_796e7903-5481-4636-8a73-c954df458e97">1,018.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: unamortized loan issuance costs (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMi0xLTEtMS0w_82250c3a-0c68-4576-af56-da4df906cffc">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of issuance costs</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMy0xLTEtMS0w_bd97e810-0946-451b-a987-906d26f58ab5">1,001.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i1038d2d191f84dea8fe90a12a89b4355">(1) In addition to the $<ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTA0_82250c3a-0c68-4576-af56-da4df906cffc">17.7</ix:nonFraction>&#160;million of unamortized issuance costs related to the term loan facility, $<ix:nonFraction unitRef="usd" contextRef="i2df1d6cadbd74ff3acfa8a7a9e8f4b3b_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTcy_e08bae8f-2b72-41b5-83d6-2b87dec112db">5.3</ix:nonFraction>&#160;million of unamortized issuance costs related to our revolving credit facility are included within other assets on the October&#160;31, 2020 condensed consolidated balance sheet.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Acquisition, on August&#160;30, 2019, the Company entered into a credit facility (the "Credit Agreement&#8221;) that provided for:</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;a <ix:nonNumeric contextRef="i64a2c3285a4640638af6dc4caca32547_D20190830-20190830" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfODc5NjA5MzAyNjM2MA_9d939dd3-fd70-4b15-be7c-6c7455fb2da5">five-year</ix:nonNumeric> senior secured term loan A facility (the &#8220;Term Loan Facility&#8221;), in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i0e31870db3eb4448bf794556196facad_I20190830" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNjA3_f86279fb-d9cb-4c96-b6e8-a1a465c98c8f">1.25</ix:nonFraction> billion, the proceeds of which were used to finance the Acquisition, to refinance substantially all outstanding indebtedness of HealthEquity and WageWorks and to pay related fees and expenses; and</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#160;&#160;a <ix:nonNumeric contextRef="i88890494023a48c186377765d88e48b1_D20190830-20190830" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfODc5NjA5MzAyNjM2MQ_c615afb0-80a5-4927-af6e-bd994871538b">five-year</ix:nonNumeric> senior secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Facilities&#8221;), in an aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="ie457aaaa4999415bb337c567a04585da_I20190830" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTAwNA_24ddaf19-97fa-44d8-a6ed-cd17766eae54">350.0</ix:nonFraction> million, which may be used for working capital and general corporate purposes, including acquisitions and other investments. <ix:nonFraction unitRef="usd" contextRef="i07e01aa0156a47859bbf977de876d1c8_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTEyNA_84d25616-d6dd-42ad-aaa0-6671ca1413db">No</ix:nonFraction> amounts were drawn under the Revolving Credit Facility as of October&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Credit Facilities bear interest at an annual rate equal to, at the option of HealthEquity, either (i)&#160;LIBOR (adjusted for reserves) plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="idde5070b333245fea3d90d1f909b0543_D20200201-20201031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTM3Mw_b711d823-740b-4f18-83bc-8b4897e2da79">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i61002ef653844eedae5d38c266aea6c9_D20200201-20201031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTM3OQ_53112851-6454-4fb8-8dd9-11d46b3dbdfe">2.25</ix:nonFraction>% or (ii)&#160;an alternate base rate plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="ic87db426f4e54f909d15c0c1df63c80a_D20200201-20201031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTQ0MA_c5be833a-95ed-4d71-b79d-0628af040c2c">0.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="iadf62767aaa44d7c83fe6178855f1be7_D20200201-20201031" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTQ0Ng_3c39aa73-23b4-4f3a-8c94-8ef4aa3495f2">1.25</ix:nonFraction>%, with the applicable margin determined by reference to a leverage-based pricing grid set forth in the Credit Agreement. As of October&#160;31, 2020, the stated interest rate was <ix:nonFraction unitRef="number" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTYwOA_26e5e4cf-b38f-42ef-821e-b7afbce9cd1b">1.65</ix:nonFraction>% and the effective interest rate was <ix:nonFraction unitRef="number" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTY0Nw_d1d1a8b1-b053-45d9-9e21-aa331a6119e6">2.18</ix:nonFraction>%. The Company is also required to pay certain fees to the lenders, including, among others, a quarterly commitment fee on the average unused amount of the Revolving Credit Facility at a rate ranging from <ix:nonFraction unitRef="number" contextRef="i2e0303734b4942bf81d8cf0ed138de29_D20200201-20201031" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTg1Mw_4c2f985f-b9c5-4432-8f7d-1fa2dff1738d">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic883d663040343718d8ef69b8d96b305_D20200201-20201031" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTg1OQ_0701cb69-7af4-48c0-96a6-ff52f1c91ebc">0.40</ix:nonFraction>%, with the applicable rate also determined by reference to a leverage-based pricing grid set forth in the Credit Agreement.</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA4Mg_ddecd4a6-c93e-4093-84ae-d0be2fe37cb0" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans made under the Term Loan Facility are required to be repaid as described in the following table:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year ending January 31, (in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMS0xLTEtMS0w_06e2741a-ec3a-4879-9d1a-631432fb020c">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMi0xLTEtMS0w_54a4ace8-9431-47b0-93dd-858ee76362fe">62.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMy0xLTEtMS0w_44bb266c-a5cd-4710-bc51-590013d8f3a3">70.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNC0xLTEtMS0w_9f217925-6522-4d46-9a5b-3276e4296fca">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNS0xLTEtMS0w_fccf93ca-7295-4c35-9d91-9553f5429ea2">768.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNi0xLTEtMS0w_17611726-38db-47d1-a81d-62b441c7cebc">1,018.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The amount required to be repaid in 2025 reflects the $<ix:nonFraction unitRef="usd" contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMjE1Mg_b3d72a44-dae1-4220-afc4-b5ece45b687b">200.0</ix:nonFraction>&#160;million prepayment made in July 2020 with proceeds from the follow-on offering.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit, among other things, the ability of the Company to incur additional indebtedness, create liens, merge or dissolve, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-14-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Table of Contents</span></div></div><ix:continuation id="i815149eda93d4afb963e56288bdafc67"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make investments, dispose of assets, engage in sale and leaseback transactions, make distributions and dividends and prepayments of junior indebtedness, engage in transactions with affiliates, enter into restrictive agreements, amend documentation governing junior indebtedness, modify its fiscal year and modify its organizational documents, in each case, subject to customary exceptions, thresholds, qualifications and &#8220;baskets.&#8221; In addition, the Credit Agreement contains financial performance covenants, which require the Company to maintain (i)&#160;a maximum total net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than <ix:nonFraction unitRef="number" contextRef="i704700afcca6430ab84c0cc3541833fc_I20201031" decimals="INF" name="hqy:DebtInstrumentCovenantDescriptionLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzEwNg_5b406ddf-12fa-43ac-8412-06a48fe5dd1c">5.00</ix:nonFraction> to 1.00, which steps down to&#160;<ix:nonFraction unitRef="number" contextRef="id433c681b1c140598cb0e1ba46723af6_I20201031" decimals="INF" name="hqy:DebtInstrumentCovenantDescriptionLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzEzOA_f0167f8b-1e96-4157-87cf-19a2c874b1b2">4.50</ix:nonFraction> to 1.00 beginning with the fiscal quarter ending July&#160;31, 2021 (subject to a customary &#8220;acquisition holiday&#8221; provision that allows the maximum total net leverage ratio to increase to <ix:nonFraction unitRef="number" contextRef="i8875a13a7bbd43ffa8102b5c080b479f_I20201031" decimals="INF" name="hqy:DebtInstrumentCovenantDescriptionLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzMyNA_6342cfa5-41c2-4216-b3ed-87d9343fb46f">5.00</ix:nonFraction> to 1.00 for the four fiscal quarter period ending on or following the date of a permitted acquisition by the Company in excess of $<ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="hqy:DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzQ1Nw_fe1f7759-2ec3-44dd-bc59-17bb8c4f9f0f">100.0</ix:nonFraction> million), and (ii)&#160;a minimum interest coverage ratio, measured as of the last day of each fiscal quarter, of no less than <ix:nonFraction unitRef="number" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="INF" name="hqy:DebtInstrumentCovenantDescriptionInterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzU3NA_efda12cc-01ef-4140-b0b6-075621cb4429">3.00</ix:nonFraction> to 1.00. The Company was in compliance with all covenants under the Credit Agreement as of October&#160;31, 2020, and for the period then ended.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of HealthEquity under the Credit Agreement are required to be unconditionally guaranteed by WageWorks and each of the Company's subsequently acquired or organized direct and indirect domestic subsidiaries and are secured by security interests in substantially all assets of HealthEquity and the guarantors, in each case, subject to certain customary exceptions.</span></div></ix:continuation><div id="i2c4fb233b505418dacb8bdb47138592f_49"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note&#160;9. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyMA_5212e538-8a24-4f5f-9cd5-c056ff6d84f7" continuedAt="i8aedf51833904abca1c23935a8c99c06" escape="true">Stock-based compensation</ix:nonNumeric></span></div><ix:continuation id="i8aedf51833904abca1c23935a8c99c06" continuedAt="i5f3dc034aab848e38bc14bf37777ea9f"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyNw_66b82800-68d0-4d61-9b8d-bfd5e3852a00" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abd9f5850614a98b0d975f99da08d3e_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi0xLTEtMS0w_063375d0-3def-4867-875e-ef70740562fc">2,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390b5a0159224ba6bd2b58bc11c2b0ad_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi0zLTEtMS0w_987f7d80-c10c-43a9-82b6-27896f19ca91">1,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92964e404b454b1db362fcdfdeab5c39_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi01LTEtMS0w_ed9376c8-be88-4323-af98-db6acddae291">5,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2d33d6f2a64d8e852283d3699cd837_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi03LTEtMS0w_d9448c58-0394-48e9-bc7d-03bb8b9a89ba">3,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd93462fe1f746509d6667375bb9b419_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy0xLTEtMS0w_ed57ab84-b1fb-4978-92fc-1eb8d4f05ec5">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd67de1d320a48c38e39d726d50f9f41_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy0zLTEtMS0w_780dfae5-3819-47de-aed1-6c01e1e7cf20">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991dc368ad8c4c698b4f083f9a6a0a73_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy01LTEtMS0w_ecdb0884-8db1-4037-a239-a4da2df583b9">4,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4bd7600e6b442a4930e416576424ba6_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy03LTEtMS0w_322471f1-b60c-4656-b9ea-a1164205d2b4">3,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd088dfe1ea487588fdb1a14a83fffb_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC0xLTEtMS0w_7fe3ed2c-875f-4f4f-87f0-9e8c5d33bc4b">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9129b833a9b4f6888db58833919b896_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC0zLTEtMS0w_f5717293-35d3-4df0-9d93-707ca2a6ad77">2,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba35bdcc6824faba7770fde57155e08_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC01LTEtMS0w_537bda47-ea9f-4553-ba49-a302e5bbe3cc">8,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d386528c074f2bbf08a38f3944a4e9_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC03LTEtMS0w_a19c56d7-d41c-4bd2-8055-1b565dc33ad7">5,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7adb81ce6b4eaab1be9f873a9f4de5_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS0xLTEtMS0w_4f78944d-18cb-4e56-8edf-c22c356c4d97">4,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie443b8fdfa9644e38627ed682ec6e547_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS0zLTEtMS0w_0ae56668-8a50-4e81-b7a8-c3d8a9e330c8">3,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89d12a4acd5f4578ab68365ed4d50c82_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS01LTEtMS0w_724286f2-1329-4e5d-9616-708c555729ab">11,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2dbf47a274d459a8e0c0007cbc26405_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS03LTEtMS0w_7845d105-3fd3-49a0-a5b4-5153446108c6">9,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ee172b218d4f5ba07c1dc8b51df50e_D20200801-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0xLTEtMS0zNzk_1c391cda-d08c-4435-8d91-b01beb1d7cbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if88ef73955ab42f1abe01f3f7c744f9c_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0zLTEtMS0zNzk_8a9af93a-9f76-4a3d-b7f6-6d7de40b3f7e">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7bcb862987f4d31a41e21ebf117cc84_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi01LTEtMS0zNzk_4799fa69-e136-490d-8752-c1f693cafaa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f58c98c5d3a465b9b500d87b1949821_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi03LTEtMS0zNzk_89684f52-e821-420c-a266-6a48ed530af7">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30b4954833a14a5db0d4f1d4321a6f4a_D20200801-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy0xLTEtMS0zNzk_8be926d4-4923-4da9-954b-227147e74d2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fb062772b640c887ba8a960fd86c44_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy0zLTEtMS0zNzk_c39705eb-2f8c-450c-8a70-a7d67717129a">13,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64472d16654b400e97654463b5d7e80c_D20200201-20201031" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy01LTEtMS0zNzk_62ddae04-d136-4b8d-b90d-fd8197be5052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad3647d44134fbe82f1424566227086_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy03LTEtMS0zNzk_3234b5a5-84a9-49ae-9abb-2494e93c6176">13,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0xLTEtMS0w_50b52f8d-d6d4-480b-8b82-7926eddfb28a">11,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0zLTEtMS0w_a97e75b1-2179-4cac-aa3e-a9c18bf6ec00">23,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi01LTEtMS0w_a6f6b385-1350-4069-ba9e-76f0238b2749">30,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi03LTEtMS0w_f9eb9958-958e-458b-922b-c1e3e4cd4a98">36,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock award plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Plan.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants stock options, restricted stock units ("RSUs"), and restricted stock awards ("RSAs") under the HealthEquity, Inc. 2014 Equity Incentive Plan (as amended and restated, the "Incentive Plan"), which provided for the issuance of stock awards to the directors and team members of the Company to purchase up to an aggregate of&#160;<ix:nonFraction unitRef="shares" contextRef="ic64248ebfff14817a2f075cb756200da_I20201031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNjEx_292bfab4-e899-4b89-b27e-6626a0585ee7">2.6</ix:nonFraction> million&#160;shares of common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Incentive Plan, the number of shares of common stock reserved for issuance under the Incentive Plan automatically increases on February 1 of each year, beginning as of&#160;February&#160;1, 2015&#160;and continuing through and including&#160;February&#160;1, 2024, by&#160;<ix:nonFraction unitRef="number" contextRef="ic64248ebfff14817a2f075cb756200da_I20201031" decimals="INF" name="hqy:SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfOTA0_12187119-0df7-48bd-bfe3-46a7445eff8e">3</ix:nonFraction>%&#160;of the total number of shares of the Company&#8217;s capital stock outstanding on January 31 of the preceding fiscal year, or a lesser number of shares determined by the board of directors. As of October&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="ic64248ebfff14817a2f075cb756200da_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTEwMQ_f73e6747-3320-4de4-89db-a6a18e86b9a6">6.4</ix:nonFraction> million shares were available for grant under the Incentive Plan.</span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">WageWorks Incentive Plan.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Acquisition, and in accordance with the merger agreement related to the Acquisition, certain RSUs with respect to WageWorks common stock, granted under WageWorks, Inc. 2010 Equity Incentive Plan (the "WageWorks Incentive Plan"), were replaced by the Company and converted into RSUs with respect to <ix:nonFraction unitRef="shares" contextRef="i9990defe3e97407581f4f0a4af6c6fc4_D20200201-20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTUxMQ_3b066623-a645-40ba-b425-897a87b12ff6">0.5</ix:nonFraction> million shares of common stock of the Company. No additional shares were issued under the WageWorks Incentive Plan, and the period during which the remaining <ix:nonFraction unitRef="shares" contextRef="ia0a41dab082f4d569390c26af5e24b25_I20201031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTY2NA_ebf53f28-cb3d-4771-823a-8b70fe921825">5.3</ix:nonFraction> million shares were available to be utilized expired on May 26, 2020. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-15-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><ix:continuation id="i5f3dc034aab848e38bc14bf37777ea9f" continuedAt="i0e388fb4493648a68ef95eded23825bf"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock options</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyMQ_eb781dde-b7fb-48f4-a16f-06d6c8510765" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity is as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="27" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding stock options</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for exercise prices and term)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>contractual<br/>term<br/>(in&#160;years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic<br/>value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0xLTEtMS0w_e1cbd828-4576-4614-9ac1-172671e5f319">2,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0zLTEtMS0wL3RleHRyZWdpb246MDNiMGFiN2ZjYWE3NDk4MzhlMDU3Y2NmNjI1ZjE4YjFfODc5NjA5MzAyMjIzMA_fe54a481-359c-48cb-8da9-2af6974e7b32">0.10</ix:nonFraction>&#160;- <ix:nonFraction unitRef="usdPerShare" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0zLTEtMS0wL3RleHRyZWdpb246MDNiMGFiN2ZjYWE3NDk4MzhlMDU3Y2NmNjI1ZjE4YjFfODc5NjA5MzAyMjIzOA_b4d9e6d0-ee6c-4719-a31d-1563fcef4957">82.39</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi01LTEtMS0w_6c58ed8e-228b-4b73-bc8e-0919ba838886">30.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie3646166651746228acb84ea09049053_D20200201-20200430" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi03LTEtMS0w_ab15106e-e8e7-403c-a4de-bc4280c3ecd5">5.90</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi05LTEtMS0w_eac30a29-779d-4039-92b2-ecef7ffb86f8">74,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy0xLTEtMS0w_ec16fe04-9428-4325-b53b-fb46b96faacd">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy0zLTEtMS0w_528c954c-9b52-493f-8c70-566f6defafbe">66.06</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy01LTEtMS0w_0769e19b-f986-44a7-865f-070b9d5053c2">66.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0xLTEtMS0w_7fc66601-4475-4641-97bc-67f2b5283ff3">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0zLTEtMS0wL3RleHRyZWdpb246M2U1NTdlZDgwYmY0NDQxNTg1MDc3NjUwYWIwNDEzN2NfODc5NjA5MzAyMjIzMA_d80ad920-fad4-4c66-b1f7-12f74dfb461f">0.10</ix:nonFraction>&#160;- <ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0zLTEtMS0wL3RleHRyZWdpb246M2U1NTdlZDgwYmY0NDQxNTg1MDc3NjUwYWIwNDEzN2NfODc5NjA5MzAyMjIzOA_5f96aca4-8a2b-4508-b649-b98100b138bd">44.53</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC01LTEtMS0w_c9fb9a32-468c-449d-a889-051377c3c654">24.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0xLTEtMS0w_23c1a666-3269-40b1-a7db-0c9781b21995">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0zLTEtMS0wL3RleHRyZWdpb246NTkxN2QyZTdlYzcwNDFmM2I5YzAyMmFkMmRjOWI4NjNfODc5NjA5MzAyMjIzMg_19c47fd6-78bd-4a2c-958f-ee7b6f214092">25.45</ix:nonFraction>&#160;- <ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0zLTEtMS0wL3RleHRyZWdpb246NTkxN2QyZTdlYzcwNDFmM2I5YzAyMmFkMmRjOWI4NjNfODc5NjA5MzAyMjI0MA_9b1d6253-db5e-4bf1-9c11-fde3d87a6148">44.53</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS01LTEtMS0w_aaaf3bf4-c071-48b0-8514-2d3f526e59a1">38.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0xLTEtMS0w_7d748278-4ea7-4a71-b948-2df8fde1f517">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0zLTEtMS0wL3RleHRyZWdpb246YjZhMDIwYWI4MTU1NDNhNWFhMjc2OTExOWJkZWZlZmNfODc5NjA5MzAyMjIzMA_d23d26dc-27c5-4613-a910-0a021efc993b">1.25</ix:nonFraction>&#160;- <ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="2" name="hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0zLTEtMS0wL3RleHRyZWdpb246YjZhMDIwYWI4MTU1NDNhNWFhMjc2OTExOWJkZWZlZmNfODc5NjA5MzAyMjIzOA_83c00920-4e8b-4359-9e8f-8433f60edb6f">82.39</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi01LTEtMS0w_c99122d5-1c41-4c5a-b7ce-8ae2912ff329">31.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi03LTEtMS0w_7d37a3c7-5e86-435b-9adb-6426dbdd6646">5.10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi05LTEtMS0w_0bf03ffb-e8a9-49b7-a846-88d211a3a84f">42,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and expected to vest as of October 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy0xLTEtMS0w_5c7ed8a5-4961-4ee5-bbae-d53b4f53277c">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy01LTEtMS0w_2bcf6a40-7733-4463-9c55-6f4d1a3060cc">31.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy03LTEtMS0w_b7f9d839-befc-4139-b01d-057b81d3ed1d">5.10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy05LTEtMS0w_67366f1f-1000-44a2-b26c-fc08dce5ea08">42,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercisable as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC0xLTEtMS0w_83b0e16b-f828-467c-a758-8f158be50a43">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC01LTEtMS0w_5e24dfb5-20c1-47dc-94c1-31dda0dca475">26.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC03LTEtMS0w_4afa1d92-df2f-4d0f-9669-84fc4da66e7c">4.70</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC05LTEtMS0w_1d026f7a-5745-4829-b067-a2e0e32546f1">41,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted stock units and restricted stock awards</span></div><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyNg_6787e41f-ab23-4338-a53b-753ec14a57b0" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and RSA activity is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSUs and PRSUs</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs and PRSAs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except weighted-average grant date fair value)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi0xLTEtMS0w_b6ef44b4-e477-4792-9eb7-fe9a174eeb7c">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi0zLTEtMS0w_6392ed2c-72bf-4450-8d69-03ba5ff2f7db">63.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70be1d14e5f049ea9990ac6488c46bb2_I20200131" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi01LTEtMS0w_ddb3b071-275f-4376-a828-7ab92801b659">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70be1d14e5f049ea9990ac6488c46bb2_I20200131" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi03LTEtMS0w_6538d277-d765-426c-9018-7c17487523c3">61.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy0xLTEtMS0w_2d9dd638-58da-4d3c-b7a9-861d0eea4907">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy0zLTEtMS0w_f59cc1b6-a044-4ebc-bc5d-671cbd365a7f">56.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy01LTEtMS0w_628a8319-c7e3-433e-a78e-a0b0adae1077">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy03LTEtMS0w_4691e1f8-1b74-4e06-949a-390860b6f17a">74.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC0xLTEtMS0w_46dc9fed-095f-4804-bd38-34009aa0128f">446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC0zLTEtMS0w_ddc005b6-0868-429e-89e7-81271c76d889">54.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC01LTEtMS0w_37935529-3be6-4435-b8ac-947fb8e665f3">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC03LTEtMS0w_82e9d148-fa1a-4bbb-8ac4-55b4571138b8">62.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS0xLTEtMS0w_f57a084b-5721-40f7-b26f-1e3ff1d4230a">262</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS0zLTEtMS0w_f2d8d4aa-6c51-4291-ae3a-8a2781b1f5d4">66.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS01LTEtMS0w_5832de66-ed1f-40bb-b2bc-d8d5d66e4dd4">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS03LTEtMS0w_974e1479-5728-47c7-a1f2-bef63f49389a">62.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0c3c36c6fb949c6b668af4f989c6df1_I20201031" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi0xLTEtMS0w_563f6fdc-b0ac-4d27-b903-52fdafa987dd">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id0c3c36c6fb949c6b668af4f989c6df1_I20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi0zLTEtMS0w_e51c7088-c500-4b2b-84a9-094cf17e4b2d">60.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13b43e3e97744f2f99ef7eba9252d568_I20201031" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi01LTEtMS0w_e65189b9-bd56-4461-8ab1-edddef4bb296">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i13b43e3e97744f2f99ef7eba9252d568_I20201031" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi03LTEtMS0w_b2cd39ef-e14c-4360-900a-f0e4b6219fad">62.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance restricted stock units and awards.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    In March 2018, the Company awarded <ix:nonFraction unitRef="shares" contextRef="i3843854aae914afaa49721b198e544c7_D20180301-20180331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTk4Nw_84f3f947-da9c-4ede-b026-3a53d72c82c6">227,760</ix:nonFraction> performance-based RSAs ("PRSAs"). The Company records stock-based compensation related to PRSAs when it is considered probable that the performance conditions will be met. The underlying shares were issued at <ix:nonFraction unitRef="number" contextRef="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjE5OQ_a007a393-f99e-4426-ab56-cfbfba9c266c">200</ix:nonFraction>% of the target level of achievement at the grant date. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to two-thirds of the awards to be achieved at <ix:nonFraction unitRef="number" contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjQwOQ_a9db513c-25a8-49bb-9184-b674ee82d57e">100</ix:nonFraction>% and creating a new performance condition related to the remaining one-third of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance condition is based on the achievement of certain financial criteria measured on January 31, 2021. The modification affected <ix:nonFraction unitRef="member" contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331" decimals="INF" name="hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjcxOA_825b8cf3-950f-4912-ab1e-be702675d33e">10</ix:nonFraction> team members and did not result in an adjustment to stock-based compensation expense. The PRSAs cliff vest upon approval by the Compensation Committee. The modified performance condition for the one-third tranche allows for a range of vesting from <ix:nonFraction unitRef="number" contextRef="i550456057eea4a81a4866ec595bb66fe_D20180301-20180331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjk2OQ_97758a16-e911-479b-bad9-141faf58206c">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjk3NQ_3ab183d7-3c8e-4851-a36f-437466fa3e95">200</ix:nonFraction>% based on the level of achievement of the performance condition, and the Company believes it is probable that the PRSAs will vest at least in part. As the underlying shares were issued at grant date, they are subject to clawback based on actual Company performance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company awarded <ix:nonFraction unitRef="shares" contextRef="i66be3136ba174468819065390931d293_D20190301-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzI3OA_9f941c21-282d-459d-b817-ee356e67ef2e">129,963</ix:nonFraction> PRSUs. The Company records stock-based compensation related to PRSUs when it is considered probable that the performance conditions will be met. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to one-third of the awards to be achieved at <ix:nonFraction unitRef="number" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzU3OA_68e55588-e053-4f9f-9c62-4b3bd0aa3851">100</ix:nonFraction>% and creating new performance conditions related to the remaining two-thirds of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance conditions are based on the achievement of certain financial criteria measured on January 31, 2021 and 2022. The modification affected <ix:nonFraction unitRef="member" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="INF" name="hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzg5OA_746072f8-ac4d-47c2-abb5-43aba2d069c4">12</ix:nonFraction> team members and resulted in incremental stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzk3OA_d5f99400-b328-4f6d-98d8-b7433e851d47">6.6</ix:nonFraction>&#160;million, which will be recognized over the remaining service period, adjusted for the level of achievement of the performance conditions and any forfeitures. Prior to the modification, the Company did not believe the PRSUs were likely to vest, and as a result, $<ix:nonFraction unitRef="usd" contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="hqy:ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDIzNA_2e12015e-1f57-4134-aa0c-be426124bdf6">2.9</ix:nonFraction>&#160;million of previously recorded stock-based compensation expense was reversed during the three months ended April 30, 2020. The PRSUs cliff vest upon approval by the Compensation Committee. The modified performance conditions for the two-thirds tranche allow for a range of vesting from <ix:nonFraction unitRef="number" contextRef="i30ee4b3524be43a9bad2db97c312e887_D20190301-20190331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDUxNQ_a2803197-d01f-4a17-9e1b-9d249cadc928">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ifb0a184b778d46f6bb8363b0ba93ac1d_D20190301-20190331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDUyMQ_34887a60-402f-4043-ba68-5dd9e92b99e2">200</ix:nonFraction>% based on the level of achievement of the new performance conditions, and the Company believes it is probable that the PRSUs will vest at least in part.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-16-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0e388fb4493648a68ef95eded23825bf">During the first and second quarters of fiscal 2021, the Company awarded <ix:nonFraction unitRef="shares" contextRef="i851da9c28c4d412f8a32c95d3d5bf732_D20200201-20200731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDczOQ_8dd4ea4f-65ae-4997-8548-2c48b8f7cd54">277,950</ix:nonFraction> PRSUs subject to a market condition based on the Company&#8217;s total shareholder return ("TSR") relative to the Russell 2000 index as measured on January 31, 2023. The Company used a Monte Carlo simulation to determine that the grant date fair value of the awards was approximately $<ix:nonFraction unitRef="usd" contextRef="i5035efb5313648a3b06aa3af898d03ce_I20200731" decimals="-5" format="ixt:numdotdecimal" name="hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTAyMA_51525a47-991a-47cd-8c91-33599da1b842">20.8</ix:nonFraction> million. Compensation expense is recorded if the service condition is met regardless of whether the market condition is satisfied. The market condition allows for a range of vesting from <ix:nonFraction unitRef="number" contextRef="i1e82ed8bc9eb4b0199285a4985c3e872_D20200201-20200731" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTIwMg_3ace3599-2af0-452d-8ce4-e9f2caa68df4">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i92cbf523ebd94e99a62188292dc7a98f_D20200201-20200731" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTIwOA_87b2d40c-6bbb-41bd-8544-7bfeda7f811b">200</ix:nonFraction>% based on the level of performance achieved. The PRSUs cliff vest upon approval by the Compensation Committee.</ix:continuation></span></div><div id="i2c4fb233b505418dacb8bdb47138592f_55"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note 10. </span><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81NS9mcmFnOjk4YjQyYmM4MTJkNTQzOTNiY2M4YmNlNTZkNGFiMjJmL3RleHRyZWdpb246OThiNDJiYzgxMmQ1NDM5M2JjYzhiY2U1NmQ0YWIyMmZfMTY0Ng_1755db64-3192-432b-a38c-a633eced6f89" continuedAt="i15a49d9a04a0470e8c9a640f7beae45b" escape="true"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Fair value</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><ix:continuation id="i15a49d9a04a0470e8c9a640f7beae45b"><ix:nonNumeric contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81NS9mcmFnOjk4YjQyYmM4MTJkNTQzOTNiY2M4YmNlNTZkNGFiMjJmL3RleHRyZWdpb246OThiNDJiYzgxMmQ1NDM5M2JjYzhiY2U1NmQ0YWIyMmZfMTY0OA_cc7216d7-31b1-4599-badf-973dbc61b5f5" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the following fair value hierarchy:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;unobservable inputs based on the Company&#8217;s own assumptions.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of cash and cash equivalents. The carrying value of cash and cash equivalents approximate fair values as of&#160;October&#160;31, 2020&#160;due to the short-term nature of these instruments.&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt is considered a Level 2 instrument and is recorded at book value in our condensed consolidated financial statements. Our long-term debt reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, we believe the fair value of our long-term debt approximates carrying value.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-17-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s discussion and analysis of financial condition and results of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Statements that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements are often identified by the use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions or variations intended to identify forward-looking statements. Such statements include, but are not limited to, statements concerning the impact of the ongoing COVID-19 pandemic on the Company, the anticipated synergies and other benefits of the acquisition of WageWorks, health savings accounts and other tax-advantaged consumer-directed benefits, tax and other regulatory changes, market opportunity, our future financial and operating results, our investment and acquisition strategy, our sales and marketing strategy, management&#8217;s plans, beliefs and objectives for future operations, technology and development, economic and industry trends or trend analysis, expectations about seasonality, opportunity for portfolio purchases and other acquisitions, operating expenses, anticipated income tax rates, capital expenditures, cash flows and liquidity. These statements are based on the beliefs and assumptions of our management based on information currently available to us. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled &#8220;Risk factors&#8221; included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, this Quarterly Report on Form 10-Q, and our other reports filed with the SEC. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such events.</span></div><div><span><br/></span></div><div id="i2c4fb233b505418dacb8bdb47138592f_61"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leader and an innovator in providing technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. Consumers and employers use our platforms to manage tax-advantaged health savings accounts ("HSAs") and other consumer-directed benefits ("CDBs") offered by employers, including flexible spending accounts and health reimbursement arrangements (&#8220;FSAs&#8221; and &#8220;HRAs&#8221;), Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) administration, commuter and other benefits, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit information, access remote and telemedicine benefits, earn wellness incentives, and receive investment advice to grow their tax-advantaged healthcare savings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The core of our offerings is the HSA, a financial account through which consumers spend and save long-term for healthcare expenses on a tax-advantaged basis. As of October&#160;31, 2020, we administered 5.5 million HSAs, with balances totaling $12.4 billion, which we call HSA Assets. Also, as of October&#160;31, 2020, we administered 7.0 million complementary CDBs. We refer to the aggregate number of HSAs and other CDBs on our platforms as Total Accounts, of which we had 12.5 million as of October&#160;31, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reach consumers primarily through relationships with their employers, which we call Clients. We reach Clients primarily through a sales force that calls on Clients directly, relationships with benefits brokers and advisors, and integrated partnerships with a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan recordkeepers, which we call Network Partners.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown our share of the growing HSA market from 4% in calendar year 2010 to 16% in 2020, including by 2% as a result of the acquisition (the "Acquisition") of WageWorks, Inc. ("WageWorks") on August 30, 2019. According to Devenir, today we are the largest HSA provider by accounts and second largest by assets. In addition, we believe we are the largest provider of other CDBs. We seek to differentiate ourselves through our proprietary technology, product breadth, ecosystem connectivity, and service-driven culture. Our proprietary technology is designed to help consumers optimize the value of their HSAs and other CDBs, as they gain confidence and skill in their management of financial responsibility for lifetime healthcare. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-18-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to engage consumers is enhanced by our platforms' capacity to securely share data in both directions with others in the health, benefits, and retirement ecosystems, which we call Ecosystem Partners. Our commuter benefits offering also leverages connectivity to an ecosystem of mass transit, ride hailing, and parking providers. These strengths reflect our &#8220;DEEP Purple&#8221; culture of remarkable service to customers and teammates, achieved by driving excellence, ethics, and process into everything we do.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We earn revenue primarily from three sources: service, custodial, and interchange. We earn service revenue mainly from fees paid by Clients on a recurring per-account per-month basis. We earn custodial revenue mainly from HSA Assets held at our members&#8217; direction in federally insured cash deposits, insurance contracts or mutual funds, and from investment of Client-held funds. We earn interchange revenue mainly from fees paid by merchants on payments that our members make using our physical payment cards and virtual platforms. See &#8220;Key components of our results of operations&#8221; for additional information on our sources of revenue, including regarding the adverse impacts caused by the ongoing COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Acquisition of WageWorks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2019, we completed the Acquisition of WageWorks and paid approximately $2.0 billion in cash to WageWorks stockholders, financed through net borrowings of approximately $1.22 billion under a new term loan facility and approximately $816.9 million of cash on hand.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the Acquisition to enable us to increase the number of our employer sales opportunities, the conversion of these opportunities to Clients, and the value of Clients in generating members, HSA Assets and complementary CDBs. WageWorks&#8217; historic strength of selling to employers directly and through health benefits brokers and advisors complements our distribution through health plans, benefit administrators and retirement record-keeping partners. With WageWorks&#8217; CDB capabilities, we are working to provide employers with a single partner for both HSAs and other CDBs, which is preferred by the vast majority of employers according to research conducted for us by Aite Group. For Clients that partner with us in this way, we believe we can produce more value by encouraging both CDB participants to contribute to HSAs and HSA-only members to take advantage of tax savings available through other CDBs. Accordingly, we believe that there are significant opportunities to expand the scope of services that we provide to our Clients.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Acquisition has significantly increased the number of our Total Accounts, HSA Assets, Client-held funds, Adjusted EBITDA, total revenue, total cost of revenue, operating expenses, and other financial results. These increases impact the comparability of the period-over-period results described in this report.</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_64"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Key factors affecting our performance</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future performance will be driven by a number of factors, including those identified below. Each of these factors presents both significant opportunities and significant risks to our future performance. See also "Results of Operations - Revenue" for information relating to the ongoing COVID-19 pandemic and also the section entitled &#8220;Risk factors&#8221; included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, this Quarterly Report on Form 10-Q and our other reports filed with the SEC.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">WageWorks integration</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2019, we completed the Acquisition of WageWorks. We are continuing our multi-year integration effort that we expect will produce long-term cost savings and revenue synergies. We have identified opportunities of approximately $80 million in annualized ongoing net synergies to be achieved by the end of the fiscal year ending January 31, 2022, of which approximately $55 million have been achieved as of October&#160;31, 2020. Furthermore, we anticipate generating additional revenue synergies over the longer-term as our combined distribution channels and existing client base take advantage of the broader platform and service offerings and as we continue to drive member engagement. We estimate non-recurring costs to achieve these synergies of approximately $100 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">realized within 24 to 36 months of the closing of the Acquisition, resulting from investment in technology platforms, back-office systems and platform integration, as well as rationalization of cost of operations. As of October&#160;31, 2020, we had incurred a total of approximately $63 million of non-recurring merger integration costs related to the Acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Structural change in U.S. health insurance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue primarily from healthcare-related saving and spending by consumers in the U.S., which are driven by changes in the broader healthcare industry, including the structure of health insurance. The average premium for employer-sponsored health insurance has risen by 22% since 2015 and 55% since 2010, resulting in increased participation in HSA-qualified health plans and HSAs and increased consumer cost-sharing in health </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-19-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance more generally. We believe that continued growth in healthcare costs and related factors will spur continued growth in HSA-qualified health plans and HSAs and may encourage policy changes making HSAs or similar vehicles available to new populations such as individuals in Medicare. However, the timing and impact of these and other developments in U.S. healthcare are uncertain. Moreover, changes in healthcare policy, such as "Medicare for all" plans, could materially and adversely affect our business in ways that are difficult to predict.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends in U.S. tax law</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax law has a profound impact on our business. Our offerings to members, Clients, and Network Partners consist primarily of services enabled, mandated, or advantaged by provisions of U.S. tax law and regulations. We believe that the present direction of U.S. tax policy is favorable to our business, as evidenced for example by recent regulatory action and bipartisan policy proposals to expand the availability of HSAs. However, changes in tax policy are speculative, and may affect our business in ways that are difficult to predict.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our client base</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is based on a B2B2C distribution strategy, meaning that we attract Clients and Network Partners to reach consumers to increase the number of our members with HSA accounts and complementary CDBs. We believe that there are significant opportunities to expand the scope of services that we provide to our current Clients.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broad distribution footprint</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have a diverse distribution footprint to attract new Clients and Network Partners. Our sales force calls on enterprise and regional employers in industries across the U.S., as well as potential Network Partners from among health plans, benefits administrators, and retirement plan record keepers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product breadth</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the largest custodian and administrator of HSAs (by number of accounts), as well as a market-share leader in each of the major categories of complementary CDBs, including FSAs and HRAs, COBRA and commuter benefits administration. Our Clients and their benefits advisors increasingly seek HSA providers that can deliver an integrated offering of HSAs and complementary CDBs. With our CDB capabilities, we can provide employers with a single partner for both HSAs and complementary CDBs, which is preferred by the vast majority of employers, according to research conducted for us by Aite Group. We believe that the combination of HSA and complementary CDB offerings significantly strengthens our value proposition to employers, health benefits brokers and consultants, and Network Partners as a leading single-source provider.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our proprietary technology platforms</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that innovations incorporated in our technology that enable consumers to make healthcare saving and spending decisions and maximize the value of their tax-advantaged benefits differentiate us from our competitors and drive our growth. We are building on these innovations by combining our HSA platform with WageWorks' complementary CDB offerings, giving us a full suite of CDB products, and adding to our solutions set and leadership position within the HSA sector. We intend to continue to invest in our technology development to enhance our platforms' capabilities and infrastructure, while maintaining a focus on data security and the privacy of our customers' data. For example, we are making significant investments in our platforms' architecture and related platform infrastructure to improve our transaction processing capabilities and support continued account and transaction growth, as well as in data-driven personalized engagement to help our members spend less, save more, and build wealth for retirement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our &#8220;DEEP Purple&#8221; service culture</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successful healthcare consumer needs education and guidance delivered by people as well as technology. We believe that our "DEEP Purple" culture, which we define as Driving Excellence, Ethics, and Process while providing remarkable service, is a significant factor in our ability to attract and retain customers and to address nimbly, opportunities in the rapidly changing healthcare sector. We make significant efforts to promote and foster DEEP Purple within our workforce. We invest in and intend to continue to invest in human capital through technology-enabled training, career development, and advancement opportunities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest rates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a non-bank custodian, we contract with federally insured banks, credit unions, and insurance company partners, which we collectively call our Depository Partners, to hold custodial cash assets on behalf of our members.  We earn a material portion of our total revenue from interest paid to us by these partners. The lengths of our agreements with Depository Partners typically range from three to five years and may have fixed or variable interest </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-20-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rate terms. The terms of new and renewing agreements may be impacted by the then-prevailing interest rate environment, which in turn is driven by macroeconomic factors and government policies over which we have no control. Such factors, and the response of our competitors to them, also determine the amount of interest retained by our members. We believe that diversification of Depository Partners, varied contract terms and other factors reduce our exposure to short-term fluctuations in prevailing interest rates and mitigate the short-term impact of sustained increases or declines in prevailing interest rates on our custodial revenue. Over longer periods, sustained shifts in prevailing interest rates affect the amount of custodial revenue we can realize on custodial assets and the interest retained by our members.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our custodial revenue to continue to be adversely affected by the interest rate cuts by the Federal Reserve associated with the ongoing COVID-19 pandemic and other market conditions that have caused interest rates to decline significantly and, as a result, funds that we place with our Depository Partners in this environment will receive lower interest rates than we originally expected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on our long-term debt changes frequently due to variable interest rate terms, and as a result, our interest expense is expected to fluctuate based on changes in prevailing interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our competition and industry</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our direct competitors are HSA custodians and other CDB providers. Many of these are state or federally chartered banks and other financial institutions for which we believe technology-based healthcare services are not a core business. Certain of our direct competitors have chosen to exit the market despite increased demand for these services. This has created, and we believe will continue to create, opportunities for us to leverage our technology platforms and capabilities to increase our market share. However, some of our direct competitors (including well-known mutual fund companies such as Fidelity Investments and healthcare service companies such as United Health Group's Optum) are in a position, should they choose, to devote more resources to the development, sale, and support of their products and services than we have at our disposal. In addition, numerous indirect competitors, including benefits administration technology and service providers, partner with banks and other HSA custodians to compete with us. Our Network Partners may also choose to offer competitive services directly, as some health plans have done. Our success depends on our ability to predict and react quickly to these and other industry and competitive dynamics.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the outbreak of the COVID-19 virus, we have seen an adverse impact on sales opportunities, with some opportunities delayed and most now being held virtually. As an increasing number of companies go out of business, the number of our Clients and potential Clients is adversely affected. Increased unemployment may mean that fewer of our members contribute to HSAs, FSAs or other CDBs. We have seen a significant decline in the use of commuter benefits due to many of our members working from home during the outbreak or other impacts from the outbreak, which has negatively impacted both our interchange revenue and service revenue, and this "work from home" trend may continue after the pandemic. We have also seen a decline in interchange revenue across all other products. The extent to which the COVID-19 virus will negatively impact our business is highly uncertain and cannot be accurately predicted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory environment</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law and regulations, including the Affordable Care Act, the Internal Revenue Code, the Employee Retirement Income Security Act and Department of Labor regulations, and public health regulations that govern the provision of health insurance and provide the tax advantages associated with our products, play a pivotal role in determining our market opportunity. Privacy and data security-related laws such as the Health Insurance Portability and Accountability Act, or HIPAA, and the Gramm-Leach-Bliley Act, laws governing the provision of investment advice to consumers, such as the Investment Advisers Act of 1940, or the Advisers Act, the USA PATRIOT Act, anti-money laundering laws, and the Federal Deposit Insurance Act, all play a similar role in determining our competitive landscape. In addition, state-level regulations also have significant implications for our business in some cases. For example, our subsidiary HealthEquity Trust Company is regulated by the Wyoming Division of Banking, and several states are considering, or have already passed, new privacy regulations that can affect our business. Various states also have laws and regulations that impose additional restrictions on our collection, storage, and use of personally identifiable information. Privacy regulation in particular has become a priority issue in many states, including California, which in 2018 enacted the California Consumer Privacy Act broadly regulating California residents&#8217; personal information and providing California residents with various rights to access and control their data, and the new California Privacy Rights Act. We have also seen an increase in regulatory changes related to our products due to government responses to the COVID-19 pandemic and may continue to see additional regulatory changes. Our ability to predict and react quickly to relevant legal and regulatory trends and to correctly interpret their market and competitive implications is important to our success.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-21-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our acquisition strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the WageWorks acquisition, we have a successful history of acquiring HSA portfolios from competitors who have chosen to exit the industry and complementary assets and businesses that strengthen our platform. We seek to continue this growth strategy and are regularly engaged in evaluating different opportunities. We have developed an internal capability to source, evaluate, and integrate acquired HSA portfolios. We intend to continue to thoughtfully pursue acquisitions of complementary assets and businesses that we believe will strengthen our platform.</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_67"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Key financial and operating metrics</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management regularly reviews a number of key operating and financial metrics to evaluate our business, determine the allocation of our resources, make decisions regarding corporate strategies and evaluate forward-looking projections and trends affecting our business. We discuss certain of these key financial metrics, including revenue, below in the section entitled &#8220;Key components of our results of operations.&#8221; In addition, we utilize other key metrics as described below. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Accounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our HSAs, CDBs, and Total Accounts as of and for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2019</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSAs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from Sales - Quarter-to-date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from Sales - Year-to-date</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New HSAs from Acquisitions - Year-to-date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSAs with investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CDBs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Total Accounts - Quarter-to-date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average Total Accounts - Year-to-date</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,429&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,482&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,013&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of our HSAs and CDBs are key metrics because our revenue is driven by the amount we earn from them. The number of our HSAs increased by approximately 0.4 million, or 9%, from October&#160;31, 2019 to October&#160;31, 2020, due to further penetration into existing Network Partners and the addition of new Network Partners. The number of our CDBs decreased by approximately 0.4 million, or 6%, from October&#160;31, 2019 to October&#160;31, 2020, driven primarily by a decrease in commuter benefit accounts resulting from the impact of the COVID-19 pandemic and associated local governmental restrictions around the country.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HSAs are individually owned portable healthcare accounts. As HSA members transition between employers or health plans, they may no longer be enrolled in a high deductible health plan that qualifies them to continue to make contributions to their HSA.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HSA Assets</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our HSA Assets as of and for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2019</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA cash with yield (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA cash without yield (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA investments with yield (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HSA investments without yield (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,857&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total HSA Assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily HSA cash with yield - Year-to-date</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily HSA cash with yield - Quarter-to-date</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,672&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">(1) HSA Assets that generate custodial revenue.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) HSA Assets that do not generate custodial revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-22-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our HSA Assets, which are our HSA members' assets for which we are the custodian or administrator, or from which we generate custodial revenue, consist of the following components: (i)&#160;cash deposits, which are deposits with our Depository Partners or other custodians, (ii) custodial cash deposits invested in annuity contracts with our insurance company partners, and (iii) investments in mutual funds through our custodial investment fund partners. We are continuing to transition HSA cash without yield to HSA cash with yield and expect to complete the transition in fiscal 2022. Measuring our HSA Assets is important because our custodial revenue is directly affected by average daily custodial balances for HSA Assets that are revenue generating.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total HSA Assets increased by $2.0 billion, or 19%, from October&#160;31, 2019 to October&#160;31, 2020, due primarily to HSA contributions, decreased spending per HSA, and appreciation of invested balances. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total HSA cash increased by $1.1 billion, or 13%, from October&#160;31, 2019 to October&#160;31, 2020, due primarily to HSA contributions and decreased spending per HSA.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our HSA investment assets increased by $0.9 billion, or 36%, from October&#160;31, 2019 to October&#160;31, 2020, reflecting our strategy of helping our HSA members build wealth and invest for retirement.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Client-held funds</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except percentages)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2019</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client-held funds (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily Client-held funds - Year-to-date (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average daily Client-held funds - Quarter-to-date (1)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:138%">(1) Client-held funds that generate custodial revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Client-held funds are interest-earning deposits from which we generate custodial revenue. These deposits are amounts remitted by Clients and held by us on their behalf to pre-fund and facilitate administration of CDBs. We deposit the Client-held funds with our Depository Partners in interest-bearing, demand deposit accounts that have a floating interest rate and no set term or duration. Client-held funds fluctuate depending on the timing of funding and spending of CDB balances.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA, which is a non-GAAP financial metric, as adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, merger integration expenses, acquisition costs, gains and losses on marketable equity securities, and certain other non-operating items. We believe that Adjusted EBITDA provides useful information to investors and analysts in understanding and evaluating our operating results in the same manner as our management and our board of directors because it reflects operating profitability before consideration of non-operating expenses and non-cash expenses, and serves as a basis for comparison against other companies in our industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-23-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net income (loss), the most comparable GAAP financial measure, to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,334)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,046)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax provision (benefit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,918)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger integration expenses (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on marketable equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,570)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,139&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184,149&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:20.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">For the three and nine months ended October 31, 2019, includes $1.2 million of stock-based compensation expense from post-Acquisition merger integration activities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:20.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">For the three and nine months ended October 31, 2019, includes $13.7 million of stock-based compensation expense from Acquisition-related cash and equity accelerations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:20.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">For the three months ended October&#160;31, 2020 and 2019, Other consisted of amortization of incremental costs to obtain a contract of $0.6 million and $0.5 million, non-income-based taxes of $0.4 million and $0.2 million, and other costs of $0.2 million and $0.1 million, respectively. For the nine months ended October&#160;31, 2020 and 2019, Other consisted of amortization of incremental costs to obtain a contract of $1.4 million and $1.4 million, non-income-based taxes of $1.2 million and $0.4 million, and other costs of $1.5 million and $0.1 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table further sets forth our Adjusted EBITDA as a percentage of revenue:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,139&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184,149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135,115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">As a percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA increased by $5.6 million, or 10%, from $55.5 million for the three months ended October&#160;31, 2019 to $61.1 million for the three months ended October&#160;31, 2020. The increase in Adjusted EBITDA was driven by the inclusion of WageWorks' results of operations for the full period of the current year, increased efficiency, and the overall growth of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA increased by $49.0 million, or 36%, from $135.1 million for the nine months ended October&#160;31, 2019 to $184.1 million for the nine months ended October&#160;31, 2020. The increase in Adjusted EBITDA was driven by the inclusion of WageWorks' results of operations for the full period of the current year, increased efficiency, and the overall growth of our business.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our use of Adjusted EBITDA has limitations as an analytical tool, and it should not be considered in isolation nor as a substitute for analysis of our results as reported under GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Key components of our results of operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of WageWorks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Acquisition closed on August 30, 2019, WageWorks' results of operations are included in our consolidated results of operations for the three and nine months ended October&#160;31, 2020, but are only included in our consolidated results of operations for approximately two months out of each of the three and nine months ended October&#160;31, 2019. In addition, the results of operations attributable to WageWorks may not be directly comparable to WageWorks' results of operations reported by WageWorks prior to the Acquisition. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-24-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from three primary sources: service revenue, custodial revenue, and interchange revenue. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We earn service revenue from the fees we charge our Network Partners, Clients, and members for the administration services we provide in connection with the HSAs and other CDBs we offer. With respect to our Network Partners and Clients, our fees are generally based on a fixed tiered structure for the duration of the relevant service agreement and are paid to us on a monthly basis. We recognize revenue on a monthly basis as services are rendered to our members and Clients. As a result of the WageWorks Acquisition, service revenue now comprises a majority of our revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We earn custodial revenue primarily from our HSA Assets deposited with our Depository Partners and with our insurance company partners, Client-held funds deposited with our Depository Partners, and recordkeeping fees we earn in respect of mutual funds in which our members invest. We deposit HSA cash with our Depository Partners pursuant to contracts that (i)&#160;typically have terms ranging from three to five years, (ii)&#160;provide for a fixed or variable interest rate payable on the average daily cash balances deposited with the relevant Depository Partner, and (iii)&#160;have minimum and maximum required deposit balances. We deposit the Client-held funds with our Depository Partners in interest-bearing, demand deposit accounts that have a floating interest rate and no set term or duration. We earn custodial revenue on HSA Assets and Client-held funds that is based on the interest rates offered to us by these Depository Partners. In addition, once a member&#8217;s HSA cash balance reaches a certain threshold, the member is able to invest his or her HSA Assets in mutual funds through our custodial investment partner. We earn a recordkeeping fee, calculated as a percentage of custodial investments. We are continuing to transition HSA cash without yield to HSA cash with yield and expect to complete the transition in fiscal 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interchange revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We earn interchange revenue each time one of our members uses one of our physical payment cards or virtual platforms to make a purchase. This revenue is collected each time a member &#8220;swipes&#8221; our payment card to pay expenses. We recognize interchange revenue monthly based on reports received from third parties, namely, the card-issuing banks and card processors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes costs related to servicing accounts, managing Client and Network Partner relationships and processing reimbursement claims. Expenditures include personnel-related costs, depreciation, amortization, stock-based compensation, common expense allocations (such as office rent, supplies, and other overhead expenses), new member and participant supplies, and other operating costs related to servicing our members. Other components of cost of revenue include interest retained by members on HSA cash and interchange costs incurred in connection with processing card transactions for our members.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service costs.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">include the servicing costs described above. Additionally, for new accounts, we incur on-boarding costs associated with the new accounts, such as new member welcome kits, the cost associated with issuance of new payment cards, and costs of marketing materials that we produce for our Network Partners.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial costs.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Custodial costs are comprised of interest retained by our HSA members, in respect of HSA cash with yield, and fees we pay to banking consultants whom we use to help secure agreements with our Depository Partners. Interest retained by HSA members is calculated on a tiered basis. The interest rates retained by HSA members can change based on a formula or upon required notice.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interchange costs.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interchange costs are comprised of costs we incur in connection with processing payment transactions initiated by our members. Due to the substantiation requirement on FSA/HRA-linked payment card transactions, payment card costs are higher for FSA/HRA card transactions. In addition to fixed per card fees, we are assessed additional transaction costs determined by the amount of the transaction.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit and gross margin</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit is our total revenue minus our total cost of revenue, and our gross margin is our gross profit expressed as a percentage of our total revenue. Our gross margin has been and will continue to be affected by a number of factors, including interest rates, the amount we charge our Network Partners, Clients, and members, the mix of our sources of revenue, how many services we deliver per account, and payment processing costs per account. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Sales and marketing expenses consist primarily of personnel and related expenses for our sales and marketing staff, including sales commissions for our direct sales force, external agent/broker commission </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-25-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses, marketing expenses, depreciation, amortization, stock-based compensation, and common expense allocations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology and development.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Technology and development expenses include personnel and related expenses for software development and delivery, information technology, data management, product, and security. Technology and development expenses also include software engineering services, the costs of operating our on-demand technology infrastructure, depreciation, amortization of capitalized software development costs, stock-based compensation, and common expense allocations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;General and administrative expenses include personnel and related expenses of, and professional fees incurred by our executive, finance, legal, internal audit, corporate development, compliance, and people departments. They also include depreciation, amortization, stock-based compensation, and common expense allocations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of acquired intangible assets.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amortization of acquired intangible assets results primarily from intangible assets acquired in connection with business combinations. The assets include acquired customer relationships, acquired developed technology, and acquired trade names and trademarks, which we amortize over the assets' estimated useful lives, estimated to be 10-15 years, 2-5 years, and 3 years, respectively. We also acquired intangible HSA portfolios from third-party custodians. We amortize these assets over the assets&#8217; estimated useful life of 15 years. We evaluate our acquired intangible assets for impairment annually, or at a triggering event.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Merger integration.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Merger integration expenses include personnel and related expenses, including severance, professional fees, legal expenses, and facilities- and technology-related expenses directly related to integration activities to merge operations as a result of the Acquisition. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists of accrued interest expense and amortization of deferred financing costs associated with our credit agreement. Interest on our long-term debt changes frequently due to variable interest rate terms, and as a result, our interest expense is expected to fluctuate based on changes in prevailing interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, primarily consists of acquisition costs, gains and losses on marketable equity securities, and non-income-based taxes, less interest income earned on corporate cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax provision</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2019, we were subject to federal and state income taxes in the United States based on a calendar tax year-end; however, beginning January 31, 2020, we began reporting federal and state income taxes using a January 31 year-end, consistent with the financial reporting fiscal year. We use the asset and liability method to account for income taxes, under which current tax liabilities and assets are recognized for the estimated taxes payable or refundable on the tax returns for the current fiscal year. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, net operating loss carryforwards, and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be realized or settled. Valuation allowances are established when necessary to reduce net deferred tax assets to the amount expected to be realized. As of October&#160;31, 2020, we have recorded an overall net deferred tax liability with the exception of an insignificant amount of federal capital losses recorded as a net deferred tax asset on our condensed consolidated balance sheet.</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_70"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Comparison of the three and nine months ended October 31, 2020 and 2019</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of Acquisition</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of our operating results is impacted by our Acquisition of WageWorks on August 30, 2019. As the Acquisition closed on August 30, 2019, WageWorks' results of operations are included in our consolidated results of operations for the three and nine months ended October&#160;31, 2020, but are only included in our consolidated results of operations for approximately two months out of each of the three and nine months ended October&#160;31, 2019. Revenue and expense attributable to WageWorks generally is not separately identifiable due to the integration of WageWorks into our existing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-26-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Service revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">319,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Custodial revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interchange revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">179,351&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157,118&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,233&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">545,401&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214,608&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service revenue.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $16.9 million, or 19%, increase in service revenue from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of service revenue associated with the CDBs added through the Acquisition in the current year, partially offset by the negative impact of the COVID-19 pandemic on service revenues related to commuter benefits and other CDBs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $178.9 million, or 127%, increase in service revenue from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of service revenue associated with the CDBs added through the Acquisition in the current year, partially offset by the negative impact of the COVID-19 pandemic on service revenues related to commuter benefits and other CDBs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.6 million, or 3%, increase in custodial revenue from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the $1.5 billion, or 21%, increase in the year-over-year average daily balance of HSA cash with yield. The increase was partially offset by a decrease in yield from 2.43% for the three months ended October&#160;31, 2019 to 2.08% for the three months ended October&#160;31, 2020, which was due in part to the interest rate cuts made by the Federal Reserve in response to the COVID-19 pandemic and due to the lower yield on HSA cash with yield added through the Acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $9.8 million, or 7%, increase in custodial revenue from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the $1.8 billion, or 27%, increase in the year-over-year average daily balance of HSA cash with yield. The increase was partially offset by a decrease in yield from 2.50% for the nine months ended October&#160;31, 2019 to 2.10% for the nine months ended October&#160;31, 2020, which was due in part to the interest rate cuts made by the Federal Reserve in response to the COVID-19 pandemic and due to the lower yield on HSA cash with yield added through the Acquisition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuing to transition HSA cash without yield to HSA cash with yield and expect to complete the transition in fiscal 2022. This cash is being placed with our Depository Partners at prevailing interest rates, which we expect will generate additional custodial revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interchange revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $3.7 million, or 17%, increase in interchange revenue from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of interchange revenue associated with the CDBs added through the Acquisition  in the current year and an increased average interchange rate. The increase was partially offset by a decrease in spend per CDB, primarily with respect to FSA and commuter benefit accounts, as well as lower healthcare spending partially attributable to the restrictions imposed by local governments around the country in connection with the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $25.9 million, or 45%, increase in interchange revenue from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of interchange revenue associated with the CDBs added through the Acquisition  in the current year and an increased average interchange rate. The increase was partially offset by a decrease in spend per CDB, primarily with respect to FSA and commuter benefit accounts, as well as lower healthcare spending partially attributable to the restrictions imposed by local governments around the country in connection with the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $22.2 million, or 14%, from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020, and by $214.6 million, or 65% from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020, due to the inclusion for the full period of WageWorks' results of operations and related realized net revenue synergies in the current year.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has been adversely affected by the recent outbreak of the COVID-19 virus, and we expect that it will continue to be adversely affected, including as a result of the associated interest rate cuts by the Federal Reserve and other market conditions that have caused interest rates to decline significantly. As a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-27-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result, funds that we place with our Depository Partners in this environment receive lower interest rates than we originally expected. Sales opportunities have also been impacted, with some opportunities delayed and most now being held virtually. In addition, we are required to support our Clients' open enrollment activities virtually. As an increasing number of companies go out of business, the number of our Clients and potential Clients is adversely affected. Increased unemployment may mean that fewer of our members contribute to HSAs, FSAs or other CDBs. We may be unable to meet our service level commitments to our Clients as a result of disruptions to our work force and disruptions to third party contracts that we rely on to provide our services. Our financial results related to certain of our products have also been adversely affected, such as commuter benefits, due to many of our members working from home during the outbreak and other impacts from the outbreak, and the "work from home" trend may continue after the pandemic. Clients may be unable to pay fees required under contracts and exercise "force majeure" or similar defenses, which would negatively impact our financial results. The extent to which the COVID-19 virus will continue to negatively impact our business remains highly uncertain and as a result may have a material adverse impact on our business and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our cost of revenue for the periods indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Service costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Custodial costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interchange costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,083&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230,985&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118,565&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service costs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $13.7 million, or 26%, increase in service costs from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations  in the current year and the resulting higher volume of accounts being serviced, including additional hiring of personnel to implement and support our new Network Partners and HSAs, increases in stock-based compensation expense, and increases in other expenses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $109.5 million, or 118%, increase in service costs from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year and the resulting higher volume of accounts being serviced, including additional hiring of personnel to implement and support our new Network Partners and HSAs, increases in stock-based compensation expense, and increases in other expenses.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial costs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.4 million, or 9%, increase in custodial costs from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was due to an increase in the average daily balance of HSA cash with yield, which increased from $7.1 billion for the three months ended October&#160;31, 2019 to $8.7 billion for the three months ended October&#160;31, 2020. The increase was partially offset by a lower average interest rate paid on HSA cash with yield, which decreased from 0.21% for the three months ended October&#160;31, 2019 to 0.18% for the three months ended October&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.1 million, or 16%, increase in custodial costs from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was due to an increase in the average daily balance of HSA cash with yield, which increased from $6.7 billion for the nine months ended October&#160;31, 2019 to $8.4 billion for the nine months ended October&#160;31, 2020. The increase was partially offset by a lower average interest rate paid on HSA cash with yield, which decreased from 0.22% for the nine months ended October&#160;31, 2019 to 0.20% for the nine months ended October&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interchange costs.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.3 million, or 7%, decrease in interchange costs from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was due to a decrease in card spend per account as a result of the local government restrictions in response to the COVID-19 pandemic, partially offset by an overall increase in average Total Accounts, which increased primarily due to the inclusion for the full period of accounts added through the Acquisition of WageWorks in the current year.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $0.8 million, or 6%, increase in interchange costs from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was due to an overall increase in average Total Accounts, which increased primarily due to the inclusion for the full period of accounts added through the Acquisition of WageWorks in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-28-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">current year, partially offset by a decrease in card spend per account as a result of the local government restrictions in response to the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total cost of revenue.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to add Total Accounts, we expect that our cost of revenue will increase in dollar amount to support our Network Partners, Clients, and members. Cost of revenue will continue to be affected by a number of different factors, including our ability to scale our service delivery, Network Partner implementation, account management functions, and the impact of the COVID-19 pandemic.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our operating expenses for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,051&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,482)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93,056&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,943&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278,815&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,051&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.2 million, or 2%, increase in sales and marketing expense from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased staffing, increases in other expenses, and higher stock-based compensation expense, partially offset by increased efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $6.5 million, or 22%, increase in sales and marketing expense from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased staffing, increases in other expenses, and higher stock-based compensation expense, partially offset by increased efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our sales and marketing expenses to increase for the foreseeable future as we continue to increase the size of our sales and marketing organization and expand into new markets. On an annual basis, we expect our sales and marketing expenses to remain relatively steady as a percentage of our total revenue. However, our sales and marketing expenses may fluctuate as a percentage of our total revenue from period to period due to the seasonality of our total revenue and the timing and extent of our sales and marketing expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technology and development.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $7.2 million, or 31%, increase in technology and development expense from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased personnel-related expense, increases in professional fees, increased stock-based compensation expense, increases in amortization and depreciation, and other increases, which were partially offset by increases in capitalized development and operating efficiencies. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $46.4 million, or 101%, increase in technology and development expense from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased personnel-related expense, increases in professional fees, increased stock-based compensation expense, increases in amortization and depreciation, and other increases, which were partially offset by increases in capitalized development and operating efficiencies. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our technology and development expenses to increase for the foreseeable future as we continue to invest in the development and security of our proprietary platforms. On an annual basis, we expect our technology and development expenses to increase as a percentage of our total revenue pursuant to our growth initiatives. Our technology and development expenses may fluctuate as a percentage of our total revenue from period to period due to the seasonality of our total revenue and the timing and extent of our technology and development expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.9 million, or 15%, increase in general and administrative expense from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-29-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel-related expense, increases in professional fees, and increased stock-based compensation expense, partially offset by increased efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $24.4 million, or 66%, increase in general and administrative expense from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was primarily due to the inclusion for the full period of WageWorks' results of operations in the current year, which resulted in increased personnel-related expense, increases in professional fees, and increased stock-based compensation expense, partially offset by increased efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our general and administrative expenses to increase for the foreseeable future due to the additional demands on our legal, compliance, accounting, and insurance functions that we incur as we continue to grow our business, as well as other costs associated with being a public company. On an annual basis, we expect our general and administrative expenses to remain relatively steady as a percentage of our total revenue over the near term pursuant to our growth initiatives. Our general and administrative expenses may fluctuate as a percentage of our total revenue from period to period due to the seasonality of our total revenue and the timing and extent of our general and administrative expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of acquired intangible assets.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $6.1 million increase in amortization of acquired intangible assets from the three months ended October&#160;31, 2019 to the three months ended October&#160;31, 2020 was due to the inclusion for the full period of amortization related to identified intangible assets acquired through the Acquisition of WageWorks in the current year. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $40.9 million increase in amortization of acquired intangible assets from the nine months ended October&#160;31, 2019 to the nine months ended October&#160;31, 2020 was due to the inclusion for the full period of amortization related to identified intangible assets acquired through the Acquisition of WageWorks in the current year. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Merger integration.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $8.2 million and $31.3 million in merger integration expense for the three and nine months ended October&#160;31, 2020, respectively, was due to personnel and related expenses, including expenses incurred in conjunction with the migration of accounts, severance, professional fees, technology-related, and facilities expenses directly related to the Acquisition of WageWorks. We expect integration expenses totaling approximately $100 million in the aggregate to continue for 24 to 36 months following the closing of the Acquisition, which closed on August 30, 2019. As of October&#160;31, 2020, we had incurred a total of approximately $63 million of non-recurring merger integration costs related to the Acquisition of WageWorks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $7.0 million and $28.1 million in interest expense for the three and nine months ended October&#160;31, 2020 consists primarily of interest accrued under our term loan facility and amortization of financing costs. We expect interest expense to decrease as a result of the principal repayments under our term loan facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $30.5 million decrease in other expense, net, from $30.9 million during the three months ended October&#160;31, 2019 to $0.4 million during the three months ended October&#160;31, 2020 was primarily due to a $32.9 million decrease in acquisition costs. The remainder of the change was due to a decrease in interest income of $1.9 million, an increase in other expense of $0.2 million, and a $0.3 million non-recurring gain in connection with our equity investment in WageWorks during the three months ended October&#160;31, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $6.3 million decrease in other expense, net, from $8.3 million during the nine months ended October&#160;31, 2019 to $2.0 million during the nine months ended October&#160;31, 2020 was primarily due to a $40.6 million decrease in acquisition costs and a $27.6 million non-recurring gain in connection with our equity investment in WageWorks during the three months ended October&#160;31, 2019. The remainder of the change was due to a decrease in interest income of $4.4 million and an increase in other expense of $2.3 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax provision (benefit)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for the three and nine months ended October&#160;31, 2020 was $2.3 million and $2.0 million, respectively, as compared to income tax benefit of $9.9 million and income tax expense of $3.9 million for the three and nine months ended October&#160;31, 2019, respectively. The tax provision for the three months ended October&#160;31, 2020 increased $12.2 million compared to the three months ended October&#160;31, 2019. The tax provision for the nine months ended October&#160;31, 2020 decreased $1.9 million compared to the nine months ended October&#160;31, 2019. The change was primarily due to a significant decrease in pre-tax book income coupled with a decrease in excess tax benefits on stock-based compensation expense and return-to-provision adjustments, which were partially offset by state apportionment changes recognized in the provision for income taxes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-30-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax provision rate for the three and nine months ended October&#160;31, 2020 was 56.7% and 36.8%, respectively, compared to an income tax benefit rate of 31.7% and income tax provision rate of 8.9% for the three and nine months ended October&#160;31, 2019, respectively. The 88.4 and 27.9 percentage point increase for the three and nine months ended October&#160;31, 2020, respectively, compared to the three and nine months ended October&#160;31, 2019 was primarily due to the impact of excess tax benefits on stock-based compensation expense and return-to-provision adjustments, which were partially offset by state apportionment changes recognized in the provision for income taxes relative to pre-tax book income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seasonal concentration of our growth combined with our recurring revenue model create seasonal variation in our results of operations. Revenue results are seasonally impacted due to ancillary service fees, timing of HSA contributions, and timing of card spend. Cost of Revenue is seasonally impacted as a significant number of new and existing Network Partners bring us new HSAs and CDBs beginning in January of each year concurrent with the start of many employers&#8217; benefit plan years. Before we realize any revenue from these new accounts, we incur costs related to implementing and supporting our new Network Partners and new accounts. These costs of services relate to activating accounts and hiring additional staff, including seasonal help to support our member support center. These expenses begin to ramp up during our third fiscal quarter, with the majority of expenses incurred in our fourth fiscal quarter.</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_73"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents overview</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal source of liquidity is our current cash and cash equivalents balances, collections from our service, custodial, and interchange revenue activities, and availability under our revolving credit facility described below. We rely on cash provided by operating activities to meet our short-term liquidity requirements, which primarily relate to the payment of corporate payroll and other operating costs, payments under our term loan facility, and capital expenditures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020 and January&#160;31, 2020, cash and cash equivalents were $299.4 million and $191.7 million, respectively. Cash and cash equivalents as of October&#160;31, 2020 included approximately $286.8 million of net proceeds we received from our follow-on public offering in July 2020 from the sale of 5,290,000 shares of our common stock, less the $200.0 million we used to prepay long-term debt.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital resources</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a &#8220;shelf&#8221;&#160;registration&#160;statement on Form S-3 on file with the SEC. This&#160;shelf registration&#160;statement, which includes a base prospectus, allows us at any time to offer any combination of securities described in the prospectus in one or more offerings. Unless otherwise specified in a prospectus supplement&#160;accompanying the base prospectus, we would use the net proceeds from the sale of any securities offered pursuant to the&#160;shelf registration&#160;statement for general corporate purposes, including, but not limited to, working capital, sales and marketing activities, general and administrative matters and capital expenditures, and if opportunities arise, for the acquisition of, or investment in, assets, technologies, solutions or businesses that complement our business. Pending such uses, we may invest the net proceeds in interest-bearing securities. In addition, we may conduct concurrent or other financings at any time.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we closed a follow-on public offering of 5,290,000 shares of common stock at a public offering price of $56.00 per share, less the underwriters' discount. We received net proceeds of approximately $286.8 million after deducting underwriting discounts and commissions of approximately $8.9 million and other offering expenses of approximately $0.6 million.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit agreement includes a five-year senior secured revolving credit facility in an aggregate principal amount of up to $350.0 million, which may be used for working capital and general corporate purposes, including the financing of acquisitions and other investments. For a description of the terms of the credit agreement, refer to Note 8&#8212;Indebtedness. We were in compliance with all covenants under the credit agreement as of October&#160;31, 2020, and for the period then ended.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of cash</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used a portion of the net proceeds from the follow-on public offering to prepay $200.0 million under our term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional prepayments under our term loan facility or potential acquisitions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-31-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures for the nine months ended October&#160;31, 2020 and 2019 were $48.6 million and $22.4 million, respectively. We expect to continue our current level of increased capital expenditures for the remainder of the fiscal year ending January&#160;31, 2021 as we continue to devote a significant amount of our capital expenditures to improving the architecture and functionality of our proprietary systems. Costs to improve the architecture of our proprietary systems include computer hardware, personnel and related costs for software engineering and outsourced software engineering services.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash, cash equivalents, and revolving credit facility will be sufficient to meet our operating and capital expenditure requirements for at least the next 12 months. To the extent these current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may need to raise additional funds through public or private equity or debt financing. In the event that additional financing is required, we may not be able to raise it on favorable terms, if at all. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our cash flows from operating activities, investing activities, and financing activities for the stated periods:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(76,730)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,715,393)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,454,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107,630&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(186,918)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">191,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">361,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from operating activities.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities during the nine months ended October&#160;31, 2020 resulted from net income of $3.5 million, plus depreciation and amortization expense of $85.5 million, stock-based compensation expense of $30.3 million, and amortization of debt issuance costs of $3.8 million, partially offset by other non-cash items and working capital changes totaling $2.4 million.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities during the nine months ended October&#160;31, 2019 resulted from net income of $39.9 million, plus stock-based compensation expense of $31.2 million, depreciation and amortization expense of $28.8 million, amortization of debt issuance costs of $1.1 million, and other non-cash items and working capital changes totaling $0.7 million, partially offset by gains on marketable equity securities of $27.6 million.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from investing activities.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the nine months ended October&#160;31, 2020 resulted from $37.2 million in software and capitalized software development, $28.1 million in acquisitions of intangible member assets, and $11.4 million in purchases of property and equipment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities during the nine months ended October&#160;31, 2019 was primarily the result of the Acquisition of WageWorks for $1.63&#160;billion, net of cash acquired, and purchases of marketable equity securities of $53.8 million. In addition, we invested $17.2 million in software and capitalized software development, $5.2 million in purchases of property and equipment, and $9.1 million in acquisitions of intangible member assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flows from financing activities.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash provided by financing activities during the nine months ended October&#160;31, 2020 resulted from $286.8 million of net proceeds from our July 2020 follow-on public offering of 5,290,000 shares of common stock and the exercise of stock options of $4.5 million. These items were partially offset by $223.4 million of principal payments on our long-term debt and $4.2 million used in the settlement of Client-held funds obligation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities during the nine months ended October&#160;31, 2019 resulted from net borrowings of $1.22&#160;billion under our term loan facility, net proceeds of $458.5 million from the sale of 7,762,500 shares of our common stock in our July 2019 follow-on offering, and the exercise of stock options of $7.3 million. These items were partially offset by $230.9 million of cash used to settle Client-held funds obligations.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contractual obligations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the $200.0 million prepayment under our term loan facility in July 2020, there were no material changes during the nine months ended October&#160;31, 2020, outside of the ordinary course of business, in our contractual obligations from those disclosed in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-32-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Off-balance sheet arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020, other than outstanding letters of credit issued under our revolving credit facility, we did not have any off-balance sheet arrangements. The majority of the standby letters of credit expire within one year. However, in the ordinary course of business, we will continue to renew or modify the terms of the letters of credit to support business requirements. The letters of credit are contingent liabilities, supported by our revolving credit facility, and are not reflected on our condensed consolidated balance sheets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical accounting policies and significant management estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are more fully described in Note 1 of the accompanying unaudited condensed consolidated financial statements and in Note 1 to our audited consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020. There have been no significant or material changes in our critical accounting policies during the nine months ended October&#160;31, 2020, as compared to those disclosed in &#8220;Management&#8217;s discussion and analysis of financial condition and results of operations &#8211; Critical accounting policies and significant management estimates&#8221; in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent accounting pronouncements</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1. Summary of business and significant accounting policies within the interim financial statements included in this Form 10-Q for further discussion. </span></div><div id="i2c4fb233b505418dacb8bdb47138592f_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 3. Qualitative and quantitative disclosures about market risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of market risk.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our revenue from providing services to tax-advantaged healthcare account holders. A significant downturn in this market or changes in state and/or federal laws impacting the preferential tax treatment of healthcare accounts such as HSAs could have a material adverse effect on our results of operations. During the nine months ended October&#160;31, 2020 and 2019, no one customer accounted for greater than 10% of our total revenue. We monitor market and regulatory changes regularly and make adjustments to our business if necessary.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflationary factors may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of expenses as a percentage of revenue if our revenue does not correspondingly increase with inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of cash and cash equivalents. We maintain our cash and cash equivalents in bank and other depository accounts, which frequently may exceed federally insured limits. Our cash and cash equivalents as of October&#160;31, 2020 were $299.4 million, of which $2.3 million was covered by federal depository insurance. We have not experienced any material losses in such accounts and believe we are not exposed to any significant credit risk with respect to our cash and cash equivalents. Our accounts receivable balance as of October&#160;31, 2020 was $64.3 million. We have not experienced any significant write-offs to our accounts receivable and believe that we are not exposed to significant credit risk with respect to our accounts receivable; however, the extent to which the ongoing COVID-19 pandemic will negatively impact our credit risk is highly uncertain and cannot be accurately predicted. We continue to monitor our credit risk and place our cash and cash equivalents with reputable financial institutions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-33-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HSA Assets and Client-held funds.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our HSA Assets consists of custodial HSA funds we hold in custody on behalf of our members.  As of October&#160;31, 2020, we had HSA Assets of approximately $12.4 billion. As a non-bank custodian, we contract with our Depository Partners and insurance company partners to hold custodial cash assets on behalf of our members, and we earn a significant portion of our total revenue from interest paid to us by these partners. The contract terms typically range from three to five years and have either fixed or variable interest rates. As our HSA Assets increase and existing contracts expire, we seek to enter into new contracts with Depository Partners, the terms of which are impacted by the then-prevailing interest rate environment. The diversification of deposits among Depository Partners and varied contract terms substantially reduces our exposure to short-term fluctuations in prevailing interest rates and mitigates the short-term impact of a sustained increase or decline in prevailing interest rates on our custodial revenue. A sustained decline in prevailing interest rates may negatively affect our business by reducing the size of the interest rate yield, or yield, available to us and thus the amount of the custodial revenue we can realize. Conversely, a sustained increase in prevailing interest rates can increase our yield. An increase in our yield would increase our custodial revenue as a percentage of total revenue. In addition, if our yield increases, we expect the spread to also increase between the interest offered to us by our Depository Partners and the interest retained by our members, thus increasing our profitability. However, we may be required to increase the interest retained by our members in a rising prevailing interest rate environment. Changes in prevailing interest rates are driven by macroeconomic trends and government policies over which we have no control, such as the interest rate cuts by the Federal Reserve associated with the ongoing COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Client-held funds are interest earning deposits from which we generate custodial revenue.  As of October&#160;31, 2020, we had Client-held funds of approximately $798.0 million. These deposits are amounts remitted by Clients and held by us on their behalf to pre-fund and facilitate administration of our other CDBs. These deposits are held with Depository Partners. We deposit the Client-held funds with our Depository Partners in interest-bearing, demand deposit accounts that have a floating interest rate and no set term or duration. A sustained decline in prevailing interest rates may negatively affect our business by reducing the size of the yield available to us and thus the amount of the custodial revenue we can realize from Client-held funds. Changes in prevailing interest rates are driven by macroeconomic trends and government policies over which we have no control.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and cash equivalents</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments purchased with an original maturity of three months or less to be unrestricted cash equivalents. Our unrestricted cash and cash equivalents are held in institutions in the U.S. and include deposits in a money market account that is unrestricted as to withdrawal or use.&#160;As of October&#160;31, 2020, we had unrestricted cash and cash equivalents of $299.4 million. Due to the short-term nature of these instruments, we believe that we do not have any material exposure to changes in the fair value of our cash and cash equivalents as a result of changes in interest rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit agreement.     </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020, we had $1.02 billion outstanding under our term loan facility and no amounts drawn under our revolving credit facility.&#160;Our overall interest rate sensitivity under these credit facilities is primarily influenced by any amounts borrowed and the prevailing interest rates on these instruments. The interest rate on our term loan credit facility and revolving credit facility is variable and was 1.65 percent at October&#160;31, 2020.&#160;Accordingly, we may incur additional expense if interest rates increase in future periods.&#160;For example, a one percent increase in the interest rate on the amount outstanding under our credit facilities at October&#160;31, 2020 would result in approximately $10.1 million of additional interest expense over the next 12 months.&#160;</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of October 31, 2020, the end of the period covered by this Quarterly Report on Form 10-Q. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to provide reasonable assurance that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-34-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Based on such evaluation, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that, as of October 31, 2020, due to material weaknesses in internal control over financial reporting at its wholly owned subsidiary, WageWorks, which the Company acquired on August 30, 2019, the Company&#8217;s disclosure controls and procedures were not effective. In accordance with interpretive guidance issued by SEC staff, the Company excluded WageWorks from its assessment of disclosure controls and procedures and internal control over financial reporting during the first year after completion of the acquisition. As of October 31, 2020, the WageWorks subsidiary is included in the above assessment regarding the effectiveness of the Company's disclosure controls and procedures. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Notwithstanding the ineffective disclosure controls and procedures as a result of the identified material weaknesses in its WageWorks subsidiary, management has concluded that the consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q present fairly, in all material respects, the Company&#8217;s financial position, results of operations and cash flows in accordance with generally accepted accounting principles in the United States of America.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weaknesses in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Management identified certain deficiencies in WageWorks' internal control over financial reporting that aggregated to material weaknesses in the following components of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO Framework&#8221;):</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Risk Assessment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> - WageWorks did not sufficiently identify and analyze risks arising from changes in the business environment, including risks arising in connection with the integration of acquisitions and financial system implementations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information and Communication</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; WageWorks did not establish cross-functional procedures and policies relating to effective information and communication necessary to support the functioning of internal control over financial reporting. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Monitoring</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; WageWorks did not implement effective monitoring controls that were responsive to changes in the business or the timely remediation of identified control deficiencies. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COSO Framework component material weaknesses described above contributed to deficiencies at the control activity level that aggregated to the material weaknesses described below: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A. Accounting Close and Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The WageWorks subsidiary had inadequate process level and monitoring controls in the area of accounting close and financial reporting specifically, but not exclusively, around the review of account reconciliations, completeness and accuracy of data material to financial reporting, accounting estimates and related cut-off, the establishment, review, and implementation of accounting policies, and the review of the accuracy and completeness of certain manual and complex data feeds into journal entries and reconciliations of high-volume standard transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B. Contract to Cash Process</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The WageWorks subsidiary did not have effective controls around the contract-to-cash life cycle of service fees, including ineffective process level controls around billing set-up during customer implementation, managing change to existing customer billing terms and conditions, timely termination of customers, implementing complex and/or non-standard billing arrangements that require manual intervention or manual controls for billing to customers, processing timely adjustments, lack of robust, established and documented policies to assess collectability and reserve for revenue, bad debts and accounts receivable, availability of customer contracts, and reviews of non-standard contracts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C. Review of New, Unusual or Significant Transactions </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The WageWorks subsidiary did not have adequate controls over the review of the accounting for new, significant or unusual transactions.  </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D. Information Technology General Controls </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The WageWorks subsidiary did not have effective controls related to information technology general controls (ITGCs) in the areas of logical access and change-management over certain information technology systems that supported its financial reporting processes. WageWorks&#8217; business process controls (automated and manual) that are dependent on the affected ITGCs were also deemed ineffective because they could have been adversely impacted. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-35-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These material weaknesses resulted in material misstatements of WageWorks' historical financial statements, which preceded the acquisition, and could result in a misstatement of our account balances or disclosures that would result in a material misstatement to the annual or interim condensed consolidated financial statements that would not be prevented or detected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Integration and Remediation Efforts</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has assessed the impact of the acquisition of WageWorks on its internal control over financial reporting and continues to assess changes driven by the integration of WageWorks with the existing operations at the consolidated Company.  As part of this assessment, management has continued to evaluate its internal control environment to ensure that it has appropriate controls in place to mitigate the risks of a material misstatement to its consolidated financial statements associated with the WageWorks subsidiary and the Company as a whole.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the material weaknesses in WageWorks&#8217; internal control over financial reporting, management has developed a plan to address the deficiencies associated with the disclosed material weaknesses, continues to utilize a third-party internal controls specialist, and has dedicated certain senior finance and accounting leadership team members to work on remediation efforts.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As previously disclosed, the WageWorks subsidiary had a material weakness related to an ineffective control environment, which was driven by the tone at the top of WageWorks.  Due to the tone at the top, there was inadequate or ineffective senior accounting leadership, an insufficient complement of qualified resources with an appropriate level of knowledge, experience and training important to the Company&#8217;s financial reporting requirements, and inadequate mechanisms and oversight to ensure accountability for the performance of internal control over financial reporting responsibilities. This material weakness has now been remediated. The following steps were executed by the Company to remediate the ineffective control environment driven by the tone at the top:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">replacement of WageWorks Audit Committee, Board of Directors, senior managers and executives, and organizational realignment;   </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">incorporation of WageWorks into the Company's training programs, led by the CEO and reinforced by executives throughout the combined Company, on the Company's Code of Business Conduct and Ethics, which included raising awareness and understanding of the importance of financial reporting integrity;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">incorporation of WageWorks control environment into the oversight of the Company&#8217;s Internal Audit function and management&#8217;s certification of internal controls,</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">realignment of the WageWorks annual employee performance process to include consideration of employees&#8217; demonstration of the Company&#8217;s values, including accountability for performance of internal controls; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt">incorporation of WageWorks into the Company&#8217;s process to attract, develop, and retain a sufficient complement of qualified resources with appropriate and relevant competencies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Additionally, in partial response to the other material weaknesses discussed above, management has incorporated certain WageWorks processes into the Company&#8217;s existing entity-level and process-level controls, including, but not limited to, those that address the identification, review and assessment of new, unusual or significant transactions, those that address the monitoring of the accounting close cycle and the evaluation of accounting policies, and those that address certain ITGCs. Management is in the process of testing the operating effectiveness of these controls.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Changes in Internal Control Over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described in the Integration and Remediation Efforts section above, there were no changes in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended October 31, 2020 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-36-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Part II&#8212;Other Information</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_85"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time-to-time, we may be subject to various legal proceedings and claims that arise in the normal course of our business activities. Our wholly owned subsidiary, WageWorks, is party to certain pending material litigation and other legal proceedings. Except for such matters, as of the date of this Quarterly Report on Form 10-Q, we were not a party to any litigation whereby the outcome of such litigation, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our results of operations, cash flows or financial position. For a description of these legal proceedings, see Note 6&#8212;Commitments and contingencies of the Notes to condensed consolidated financial statements.</span></div><div id="i2c4fb233b505418dacb8bdb47138592f_88"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1A. Risk factors</span></div><div style="margin-bottom:6pt"><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks described in &#8220;Risk factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020 could materially and adversely affect our business, financial condition and results of operations. Except as described below, there have been no material changes in such risks. These risk factors do not identify all risks that we face, and our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing COVID-19 pandemic has materially impacted our business and may continue to materially impact our business.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business has been, and may continue to be, materially and adversely affected by the current outbreak of the COVID-19 virus. The Federal Reserve&#8217;s interest rate cut in response to the economic impact of the COVID-19 pandemic and other interest rate market conditions have caused interest rates to decline significantly. As a result, the funds that we place with our depository partners in this environment have been, and are likely to continue to be for the foreseeable future, placed at lower interest rates than we originally expected. In addition, stock market volatility, such as a decline in the stock market, may decrease HSA investment assets and the related fees we earn from HSA investment assets. We have also seen an increase in regulatory changes related to our products due to government responses to the COVID-19 pandemic and may continue to see additional regulatory changes, which changes require substantial time and costs for us to ensure compliance. For example, regulatory changes related to our COBRA product have created uncertainty and additional workload on our team members, which could reduce our operational efficiency and result in additional costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our financial results related to certain of our products have also been adversely affected.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For example, we have seen a significant decline in the use of commuter benefits and our members' spend on healthcare, which has negatively impacted both our interchange revenue and service revenue. In addition, if the "work from home" trend continues after the pandemic, that would further negatively impact the revenue we receive from commuter benefits. We have also seen a decline in interchange revenue across all other products. Going forward, some Clients may be unable to pay fees required under contracts and exercise "force majeure" or similar defenses, which would negatively impact our financial results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, as an increasing number of companies go out of business, the number of our Clients and potential Clients could be adversely affected. Increased unemployment may mean that fewer of our members utilize HSAs or other CDBs.   In the event our financial results continue to be severely impacted or the impact worsens, it may make it more difficult for us to comply with the financial covenants in our credit agreement, which could result in a breach of the financial covenants and the acceleration of our outstanding debt by our lenders. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As a result of the ongoing pandemic, substantially all of our team members are working from home. Sales opportunities have been impacted by the lack of travel and in-person meetings, with some opportunities delayed and most now being held virtually, and we will be supporting the open enrollment activities of our Clients virtually. We may be unable to meet our service level commitments to our Clients as a result of disruptions to our work force and disruptions to third-party contractors that we rely on to provide our services. Our team members may be less efficient at home, and it may take additional time for us to pursue significant business initiatives. The risk of cybersecurity breaches and incidents, and the potential impact of these on our operations, is also higher while our team members log in to our network remotely.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The extent to which the COVID-19 pandemic will continue to negatively impact our business remains highly uncertain and, as a result, may continue to have a material and adverse impact on our business and financial results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-37-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our management has identified material weaknesses in our internal control over financial reporting that could adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act. Our management has determined that our internal control over financial reporting was not effective due to the existence of material weaknesses arising out of our acquisition of WageWorks. See Item 4 - Controls and Procedures.  Until fully remediated, these material weaknesses may materially adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner.  Although we have developed a plan to address the material weaknesses, we cannot provide a timeframe as to when the remediation will be completed and tested, nor can we assure you that the remediation, integration and testing process will not reveal additional material weaknesses or other deficiencies, so that our internal control over financial reporting and related disclosure controls and procedures are effective.  If we are unable to report our results in a timely and accurate manner, we may not be able to comply with the applicable covenants in our credit agreement, and may be required to seek waivers or repay amounts under the credit agreement earlier than anticipated, which could adversely impact our liquidity and financial condition. Although we continually review and evaluate internal control systems to allow management to report on the sufficiency of our internal controls over financial reporting, we cannot assure you that we will not discover additional weaknesses in our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-38-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incorporate by reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit<br/>no.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1+</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-ceo302xfy21.htm">Certification of the Principal Executive Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-cfo302xfy21.htm">Certification of the Principal Financial Officer Pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1*#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-ceo906xfy21.htm">Certification of the Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2*#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-cfo906xfy21.htm">Certification of the Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy schema linkbase document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy calculation linkbase document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy definition linkbase document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy labels linkbase document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy presentation linkbase document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended October 31, 2020, formatted in Inline XBRL.<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">These certifications are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference in any filing the registrant makes under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, irrespective of any general incorporation language in any filings.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-39-</span></div></div></div><div id="i2c4fb233b505418dacb8bdb47138592f_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2c4fb233b505418dacb8bdb47138592f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HEALTHEQUITY, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: December 9, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Darcy Mott</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Darcy Mott</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-40-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-ceo302xfy21.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i3faab7eec21449ce837c0eb5a9c4deaa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exchange Act Rules 13a-14(a) and 15d-14(a),</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">as Adopted Pursuant to</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section&#160;302 of Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Jon Kessler, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.5pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;9, 2020</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.789%"><tr><td style="width:1.0%"></td><td style="width:36.534%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.474%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jon Kessler</font></div><div style="margin-bottom:1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jon Kessler</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer </font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-cfo302xfy21.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i8c485c225cba472486b22fa44e9e5b0b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">pursuant to</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exchange Act Rules 13a-14(a) and 15d-14(a),</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">as adopted pursuant to</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section&#160;302 of Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Darcy Mott, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this Quarterly Report on Form 10-Q of HealthEquity, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15.5pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:58.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;9, 2020</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.005%"><tr><td style="width:1.0%"></td><td style="width:19.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.974%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Darcy Mott</font></div><div style="margin-bottom:1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Darcy Mott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-ceo906xfy21.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ibfddc19780804304b246b93f06ce8f57_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, I, Jon Kessler, the Chief Executive Officer (Principal Executive Officer) of HealthEquity, Inc. (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Our Quarterly Report on Form 10-Q for the quarter ended October&#160;31, 2020 (the &#8220;Report&#8221;), of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;9, 2020</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:39.181%"><tr><td style="width:1.0%"></td><td style="width:17.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.006%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jon Kessler</font></div><div style="margin-bottom:1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jon Kessler</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-cfo906xfy21.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib2e7afd5f1c84c87ba8d1350668219c0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:9pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, I, Darcy Mott, Executive Vice President and Chief Financial Officer (Principal Financial Officer) of HealthEquity, Inc. (the &#8220;Company&#8221;), hereby certify that, to my knowledge&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Our Quarterly Report on Form 10-Q for the quarter ended October&#160;31, 2020 (the &#8220;Report&#8221;), of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;9, 2020</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.497%"><tr><td style="width:1.0%"></td><td style="width:20.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.435%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Darcy Mott</font></div><div style="margin-bottom:1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Darcy Mott</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hqy-20201031.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hqy="http://healthequity.com/20201031" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthequity.com/20201031">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20201031_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20201031_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20201031_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hqy-20201031_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthequity.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Condensedconsolidatedbalancesheets" roleURI="http://healthequity.com/role/Condensedconsolidatedbalancesheets">
        <link:definition>1001002 - Statement - Condensed consolidated balance sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedbalancesheetsParenthetical" roleURI="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed consolidated balance sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited">
        <link:definition>1003004 - Statement - Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Condensedconsolidatedstatementsofstockholdersequityunaudited" roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited">
        <link:definition>1004005 - Statement - Condensed consolidated statements of stockholders' equity (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Condensedconsolidatedstatementsofcashflowsunaudited" roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited">
        <link:definition>1005006 - Statement - Condensed consolidated statements of cash flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Summaryofbusinessandsignificantaccountingpolicies" roleURI="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies">
        <link:definition>2101101 - Disclosure - Summary of business and significant accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofbusinessandsignificantaccountingpoliciesPolicies" roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of business and significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Summary of business and significant accounting policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netincomelosspershare" roleURI="http://healthequity.com/role/Netincomelosspershare">
        <link:definition>2104102 - Disclosure - Net income (loss) per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetincomelosspershareTables" roleURI="http://healthequity.com/role/NetincomelosspershareTables">
        <link:definition>2305301 - Disclosure - Net income (loss) per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetincomelosspershareDetails" roleURI="http://healthequity.com/role/NetincomelosspershareDetails">
        <link:definition>2406402 - Disclosure - Net income (loss) per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Businesscombination" roleURI="http://healthequity.com/role/Businesscombination">
        <link:definition>2107103 - Disclosure - Business combination</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationTables" roleURI="http://healthequity.com/role/BusinesscombinationTables">
        <link:definition>2308302 - Disclosure - Business combination (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationNarrativeDetails" roleURI="http://healthequity.com/role/BusinesscombinationNarrativeDetails">
        <link:definition>2409403 - Disclosure - Business combination (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationPreliminaryAllocationofConsiderationDetails" roleURI="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails">
        <link:definition>2410404 - Disclosure - Business combination (Preliminary Allocation of Consideration) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinesscombinationProFormaResultsDetails" roleURI="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails">
        <link:definition>2411405 - Disclosure - Business combination (Pro Forma Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Supplementalfinancialstatementinformation" roleURI="http://healthequity.com/role/Supplementalfinancialstatementinformation">
        <link:definition>2112104 - Disclosure - Supplemental financial statement information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationTables" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationTables">
        <link:definition>2313303 - Disclosure - Supplemental financial statement information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationPropertyandequipmentDetails" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails">
        <link:definition>2414406 - Disclosure - Supplemental financial statement information (Property and equipment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationNarrativeDetails" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails">
        <link:definition>2415407 - Disclosure - Supplemental financial statement information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationLeaseCostDetails" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails">
        <link:definition>2416408 - Disclosure - Supplemental financial statement information (Lease Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails">
        <link:definition>2417409 - Disclosure - Supplemental financial statement information (Supplemental Cash Flow Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails">
        <link:definition>2418410 - Disclosure - Supplemental financial statement information (Other income (expense), net) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Intangibleassetsandgoodwill" roleURI="http://healthequity.com/role/Intangibleassetsandgoodwill">
        <link:definition>2119105 - Disclosure - Intangible assets and goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillTables" roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillTables">
        <link:definition>2320304 - Disclosure - Intangible assets and goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails">
        <link:definition>2421411 - Disclosure - Intangible assets and goodwill (Schedule of intangible assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleassetsandgoodwillNarrativeDetails" roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails">
        <link:definition>2422412 - Disclosure - Intangible assets and goodwill (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitmentsandcontingencies" roleURI="http://healthequity.com/role/Commitmentsandcontingencies">
        <link:definition>2123106 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesDetails" roleURI="http://healthequity.com/role/CommitmentsandcontingenciesDetails">
        <link:definition>2424413 - Disclosure - Commitments and contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometaxes" roleURI="http://healthequity.com/role/Incometaxes">
        <link:definition>2125107 - Disclosure - Income taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxesDetails" roleURI="http://healthequity.com/role/IncometaxesDetails">
        <link:definition>2426414 - Disclosure - Income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Indebtedness" roleURI="http://healthequity.com/role/Indebtedness">
        <link:definition>2127108 - Disclosure - Indebtedness</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessTables" roleURI="http://healthequity.com/role/IndebtednessTables">
        <link:definition>2328305 - Disclosure - Indebtedness (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofLongtermDebtDetails" roleURI="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails">
        <link:definition>2429415 - Disclosure - Indebtedness Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessNarrativeDetails" roleURI="http://healthequity.com/role/IndebtednessNarrativeDetails">
        <link:definition>2430416 - Disclosure - Indebtedness (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofMaturitiesofLongtermDebtDetails" roleURI="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails">
        <link:definition>2431417 - Disclosure - Indebtedness Schedule of Maturities of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Stockbasedcompensation" roleURI="http://healthequity.com/role/Stockbasedcompensation">
        <link:definition>2132109 - Disclosure - Stock-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationTables" roleURI="http://healthequity.com/role/StockbasedcompensationTables">
        <link:definition>2333306 - Disclosure - Stock-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" roleURI="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails">
        <link:definition>2434418 - Disclosure - Stock-based compensation (Summary of share based compensation recognized) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationNarrativeDetails" roleURI="http://healthequity.com/role/StockbasedcompensationNarrativeDetails">
        <link:definition>2435419 - Disclosure - Stock-based compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationStockoptionactivityDetails" roleURI="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails">
        <link:definition>2436420 - Disclosure - Stock-based compensation (Stock option activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationRestrictedstockunityactivityDetails" roleURI="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails">
        <link:definition>2437421 - Disclosure - Stock-based compensation (Restricted stock unity activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvalue" roleURI="http://healthequity.com/role/Fairvalue">
        <link:definition>2138110 - Disclosure - Fair value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hqy_ExerciseofStockOptionsReceivable" abstract="false" name="ExerciseofStockOptionsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" abstract="false" name="ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hqy_DebtCovenantPeriodFourMember" abstract="true" name="DebtCovenantPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_LossContingencyNumberOfLawsuits" abstract="false" name="LossContingencyNumberOfLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hqy_FollowOnEquityOfferingMember" abstract="true" name="FollowOnEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_StockIssuanceCostsPayable" abstract="false" name="StockIssuanceCostsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" abstract="false" name="ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_MergerIntegrationMember" abstract="true" name="MergerIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_WageWorksIncMember" abstract="true" name="WageWorksIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" abstract="false" name="DebtInstrumentCovenantDescriptionInterestCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_DebtCovenantPeriodThreeMember" abstract="true" name="DebtCovenantPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hqy_WageWorksIncentivePlanMember" abstract="true" name="WageWorksIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_PerformanceRestrictedStockAwardsMember" abstract="true" name="PerformanceRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_AmortizationOfAcquiredIntangible" abstract="false" name="AmortizationOfAcquiredIntangible" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_TechnologyandDevelopmentMember" abstract="true" name="TechnologyandDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_WageWorksInc.Member" abstract="true" name="WageWorksInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" abstract="true" name="WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hqy_IncentivePlanMember" abstract="true" name="IncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" abstract="false" name="ContractWithCustomerRecognitionTermInterchangeArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hqy_PerformanceRestrictedStockUnitsMember" abstract="true" name="PerformanceRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_AcquiredHSAIntangibleAssetsMember" abstract="true" name="AcquiredHSAIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_PaymentsToSettleClientHeldFunds" abstract="false" name="PaymentsToSettleClientHeldFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_UnrecognizedTaxBenefitNet" abstract="false" name="UnrecognizedTaxBenefitNet" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_SalesandMarketingMember" abstract="true" name="SalesandMarketingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_DebtInstrumentCovenantDescriptionLeverageRatio" abstract="false" name="DebtInstrumentCovenantDescriptionLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" abstract="false" name="DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hqy_DebtCovenantPeriodTwoMember" abstract="true" name="DebtCovenantPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hqy-20201031_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20201031.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedbalancesheets"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3128712f-a113-490d-9fad-fe7eec0993f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca0b881c-2637-4633-bb29-8f17825040b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3128712f-a113-490d-9fad-fe7eec0993f5" xlink:to="loc_us-gaap_Liabilities_ca0b881c-2637-4633-bb29-8f17825040b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bc3820f5-81b8-4c0a-93c0-f5ff6bc2590f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3128712f-a113-490d-9fad-fe7eec0993f5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bc3820f5-81b8-4c0a-93c0-f5ff6bc2590f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29938b13-5946-484c-ac38-d7153eef75d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3128712f-a113-490d-9fad-fe7eec0993f5" xlink:to="loc_us-gaap_StockholdersEquity_29938b13-5946-484c-ac38-d7153eef75d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_93807cd6-239b-4aec-9b49-207ae329daac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:to="loc_us-gaap_AccountsPayableCurrent_93807cd6-239b-4aec-9b49-207ae329daac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f35a0203-4fc8-4853-8729-c0cb3d6613a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f35a0203-4fc8-4853-8729-c0cb3d6613a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b3cb0e82-b196-43f1-9b93-f397402a88f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b3cb0e82-b196-43f1-9b93-f397402a88f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_28a0fcda-169b-4f1c-b2af-9cee971e26ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:to="loc_us-gaap_LongTermDebtCurrent_28a0fcda-169b-4f1c-b2af-9cee971e26ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_478573bd-8b1b-4030-ba35-8b5152880621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3588f57c-76aa-4da8-9b2c-8e075202188b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_478573bd-8b1b-4030-ba35-8b5152880621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e96f4a44-09ea-4a97-9b5b-5760e1fae968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:to="loc_us-gaap_LiabilitiesCurrent_e96f4a44-09ea-4a97-9b5b-5760e1fae968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_909f0d91-158d-4795-90ea-7ded406529e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_909f0d91-158d-4795-90ea-7ded406529e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cef78f36-f8b7-43db-9cce-d09ccdd8a640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cef78f36-f8b7-43db-9cce-d09ccdd8a640" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_565641c9-2dc1-41e8-b402-b928f7ecb6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_565641c9-2dc1-41e8-b402-b928f7ecb6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_6c410377-d2d4-4b73-9a52-5705571d8419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3de806c9-c09c-41b9-942a-b93c518af5d5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_6c410377-d2d4-4b73-9a52-5705571d8419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_5b9dafbf-141a-421b-8a93-b8e123026149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3142ba28-049e-4559-bb13-ba9d662824b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5b9dafbf-141a-421b-8a93-b8e123026149" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3142ba28-049e-4559-bb13-ba9d662824b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_32638cd5-7657-4daa-b89c-2c6d7d5ce7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5b9dafbf-141a-421b-8a93-b8e123026149" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_32638cd5-7657-4daa-b89c-2c6d7d5ce7d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1148c8c0-d77f-46f8-8308-9aedd2264a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5b9dafbf-141a-421b-8a93-b8e123026149" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1148c8c0-d77f-46f8-8308-9aedd2264a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c903110e-2100-4e3b-a9d9-98297f9b1f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_5b9dafbf-141a-421b-8a93-b8e123026149" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c903110e-2100-4e3b-a9d9-98297f9b1f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_416a6d3c-3ac8-4428-9398-ea630d57a8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2242e5df-74cf-4125-a16d-bc06f5adff99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_416a6d3c-3ac8-4428-9398-ea630d57a8f1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2242e5df-74cf-4125-a16d-bc06f5adff99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_40ca1d98-5101-425e-910a-4f16323c6075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_416a6d3c-3ac8-4428-9398-ea630d57a8f1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_40ca1d98-5101-425e-910a-4f16323c6075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_f8183cb7-e533-427e-a24e-4ccd5a1e19a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_416a6d3c-3ac8-4428-9398-ea630d57a8f1" xlink:to="loc_us-gaap_OtherAssetsCurrent_f8183cb7-e533-427e-a24e-4ccd5a1e19a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7c3778f0-c66b-4c90-a6d2-481afbdc51d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ca4133a5-bd58-45cb-85f3-aab4cb37464a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c3778f0-c66b-4c90-a6d2-481afbdc51d2" xlink:to="loc_us-gaap_CommonStockValue_ca4133a5-bd58-45cb-85f3-aab4cb37464a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3a778b74-c437-43a3-927f-703a573883dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c3778f0-c66b-4c90-a6d2-481afbdc51d2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3a778b74-c437-43a3-927f-703a573883dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f7a17e6-ec24-47bf-99a6-62e9825a14e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c3778f0-c66b-4c90-a6d2-481afbdc51d2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f7a17e6-ec24-47bf-99a6-62e9825a14e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2ef7de7b-a5cb-4e61-9251-0472a58a7d70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c3778f0-c66b-4c90-a6d2-481afbdc51d2" xlink:to="loc_us-gaap_PreferredStockValue_2ef7de7b-a5cb-4e61-9251-0472a58a7d70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_161dc8f5-edbc-4ec7-bcb6-a64236d9d73b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_AssetsCurrent_161dc8f5-edbc-4ec7-bcb6-a64236d9d73b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_de73c6c3-e51f-4b35-af34-34e3ca82991f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_de73c6c3-e51f-4b35-af34-34e3ca82991f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1cbf5aad-80fc-4162-b3dc-3c0bdb21184e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1cbf5aad-80fc-4162-b3dc-3c0bdb21184e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2b6ae20e-d07a-4cb7-98e8-5cc03246d834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2b6ae20e-d07a-4cb7-98e8-5cc03246d834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a78ea14-8f72-4564-adce-f1fc1797ced2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_Goodwill_3a78ea14-8f72-4564-adce-f1fc1797ced2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a26c6a7-ae81-4288-bea3-a061e10ec1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2a26c6a7-ae81-4288-bea3-a061e10ec1a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5aab557f-85d0-488b-b9a7-2eac64f0f6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_22a302a8-b583-4b64-90d8-e7c92fcac3e5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5aab557f-85d0-488b-b9a7-2eac64f0f6e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="simple" xlink:href="hqy-20201031.xsd#CondensedconsolidatedbalancesheetsParenthetical"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb3c8390-7eb4-40f7-9e3c-d79f3eb3fb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_40fc563c-2070-4efa-85b5-0f07880b8bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb3c8390-7eb4-40f7-9e3c-d79f3eb3fb7b" xlink:to="loc_us-gaap_OperatingIncomeLoss_40fc563c-2070-4efa-85b5-0f07880b8bdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1b83ba99-ad3f-4891-88a9-5d3f766cfaf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb3c8390-7eb4-40f7-9e3c-d79f3eb3fb7b" xlink:to="loc_us-gaap_InterestExpense_1b83ba99-ad3f-4891-88a9-5d3f766cfaf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_26c4b40c-92f5-49c7-8517-23386f0b7d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bb3c8390-7eb4-40f7-9e3c-d79f3eb3fb7b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_26c4b40c-92f5-49c7-8517-23386f0b7d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7ed7cf00-dc28-4968-a851-933e6ee5003c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fae83b50-8412-43d5-94b6-b75cb6801208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7ed7cf00-dc28-4968-a851-933e6ee5003c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fae83b50-8412-43d5-94b6-b75cb6801208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bb4d09c5-48ba-4851-b9d4-5b6a2efbcc26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7ed7cf00-dc28-4968-a851-933e6ee5003c" xlink:to="loc_us-gaap_InterestExpense_bb4d09c5-48ba-4851-b9d4-5b6a2efbcc26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_809f5914-9629-40d8-a896-65ea596bf128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:to="loc_us-gaap_SellingAndMarketingExpense_809f5914-9629-40d8-a896-65ea596bf128" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d86403a0-fb1f-4bcb-ae8c-aa503318ad73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d86403a0-fb1f-4bcb-ae8c-aa503318ad73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_db605cce-02e6-4fef-9c54-1377819ea385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_db605cce-02e6-4fef-9c54-1377819ea385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AmortizationOfAcquiredIntangible_d4729563-87ab-4138-949a-12b0f02144aa" xlink:href="hqy-20201031.xsd#hqy_AmortizationOfAcquiredIntangible"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:to="loc_hqy_AmortizationOfAcquiredIntangible_d4729563-87ab-4138-949a-12b0f02144aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0eb1f3d2-fa85-4164-aba2-85d746ef07cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e3503c9-248c-408e-aa03-a71f13c5792d" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_0eb1f3d2-fa85-4164-aba2-85d746ef07cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a15120d9-955c-4187-b1e6-392c804b03ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb286900-0292-492b-85e8-056063819837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_a15120d9-955c-4187-b1e6-392c804b03ef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb286900-0292-492b-85e8-056063819837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_38135921-ef3f-4737-9749-273e7c86bb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_a15120d9-955c-4187-b1e6-392c804b03ef" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_38135921-ef3f-4737-9749-273e7c86bb42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_227a6d4b-8b9e-446c-a786-a4d033943b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b657f03-1f9d-4969-93d1-def4c98921c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_227a6d4b-8b9e-446c-a786-a4d033943b34" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b657f03-1f9d-4969-93d1-def4c98921c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dcc67f21-ce7d-4c3c-9b62-839c0b278f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_227a6d4b-8b9e-446c-a786-a4d033943b34" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dcc67f21-ce7d-4c3c-9b62-839c0b278f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a45d7f24-2866-4700-a4e6-a9cc9dfc3799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5cc9db56-7466-4af1-ac80-8e97fba7f20f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a45d7f24-2866-4700-a4e6-a9cc9dfc3799" xlink:to="loc_us-gaap_GrossProfit_5cc9db56-7466-4af1-ac80-8e97fba7f20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_dbafc16f-1dfc-47d6-93a7-a61277fa281a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a45d7f24-2866-4700-a4e6-a9cc9dfc3799" xlink:to="loc_us-gaap_OperatingExpenses_dbafc16f-1dfc-47d6-93a7-a61277fa281a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofstockholdersequityunaudited"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofcashflowsunaudited"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7f2521e3-05d7-4a6c-a70e-1345a83c2c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_NetIncomeLoss_7f2521e3-05d7-4a6c-a70e-1345a83c2c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_12dc8c57-a21b-4ce5-9103-47db59e5feba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_12dc8c57-a21b-4ce5-9103-47db59e5feba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_775e80a0-9eec-4c83-bd70-4ceb300116cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_ShareBasedCompensation_775e80a0-9eec-4c83-bd70-4ceb300116cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_fd821624-cf50-4ae6-a0fc-0be2e8707b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_fd821624-cf50-4ae6-a0fc-0be2e8707b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_5acb2edd-bf5e-4e18-9a78-66b419eecde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_5acb2edd-bf5e-4e18-9a78-66b419eecde0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_4efee3cd-fcdd-4c68-9175-db69172fee6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_4efee3cd-fcdd-4c68-9175-db69172fee6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7f8f310c-baf6-4db2-ae6c-11a37392abc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_7f8f310c-baf6-4db2-ae6c-11a37392abc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_38deb94f-d557-4181-8634-265ceb3e786c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_38deb94f-d557-4181-8634-265ceb3e786c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7b229567-d277-4f40-940f-01e4c91ef8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7b229567-d277-4f40-940f-01e4c91ef8f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_9fc35d51-96b7-4439-8bac-b66870928667" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_9fc35d51-96b7-4439-8bac-b66870928667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ecfe282f-ca86-4607-8dba-087617cf2a6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ecfe282f-ca86-4607-8dba-087617cf2a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8f10c19-61c4-47a0-817d-4ae035be55fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c8f10c19-61c4-47a0-817d-4ae035be55fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_17e8d49f-bd11-4827-9c35-a5794f500c7e" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_17e8d49f-bd11-4827-9c35-a5794f500c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_f5011ee1-6019-40b5-9f4d-32e248645c0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b070977b-9daa-4f88-ad5c-4b876d0136e6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_f5011ee1-6019-40b5-9f4d-32e248645c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_39db2414-c60b-4f20-a42c-e7c80cd04f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_39db2414-c60b-4f20-a42c-e7c80cd04f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_537a14be-d927-4d29-a456-6a6841544fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_537a14be-d927-4d29-a456-6a6841544fc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_34b1e30d-d860-45ab-8c4e-23744d180c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:to="loc_us-gaap_PaymentsForSoftware_34b1e30d-d860-45ab-8c4e-23744d180c20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_19740250-514b-484e-9476-78c34858f49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_19740250-514b-484e-9476-78c34858f49c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ccca79b4-55df-4cda-97a2-8421bc5cb9b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2302828b-8b38-4012-a007-3229cd6cab8e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ccca79b4-55df-4cda-97a2-8421bc5cb9b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a2303ea2-5f6c-49c7-8e5c-ffa5cd9a73fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a2303ea2-5f6c-49c7-8e5c-ffa5cd9a73fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ab885ab2-94eb-4790-9800-44e8f6f1acdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ab885ab2-94eb-4790-9800-44e8f6f1acdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PaymentsToSettleClientHeldFunds_fa7d7616-9b39-4193-8c9f-90d0674a0295" xlink:href="hqy-20201031.xsd#hqy_PaymentsToSettleClientHeldFunds"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_hqy_PaymentsToSettleClientHeldFunds_fa7d7616-9b39-4193-8c9f-90d0674a0295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_ece6db7b-84a7-44ac-b42e-804569f03a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_ece6db7b-84a7-44ac-b42e-804569f03a44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_50bb81ed-bb3b-4ade-8124-aa0b0bceb65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_50bb81ed-bb3b-4ade-8124-aa0b0bceb65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c68e7fef-8035-4fa2-92b0-d0fc670d6e8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8260a158-030e-4304-a514-6477be01d6ed" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c68e7fef-8035-4fa2-92b0-d0fc670d6e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d7693a3-2eb0-4818-ab35-8abc1fe3b18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f852be02-f720-495d-a7ef-7f22deaca0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d7693a3-2eb0-4818-ab35-8abc1fe3b18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f852be02-f720-495d-a7ef-7f22deaca0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_96d824ae-78ec-48e5-b10a-0faa3abcc4f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d7693a3-2eb0-4818-ab35-8abc1fe3b18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_96d824ae-78ec-48e5-b10a-0faa3abcc4f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5d9dbdfc-50a3-4cbc-9a74-3c7060a7fd72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6d7693a3-2eb0-4818-ab35-8abc1fe3b18d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5d9dbdfc-50a3-4cbc-9a74-3c7060a7fd72" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Summaryofbusinessandsignificantaccountingpolicies"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesPolicies"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Netincomelosspershare" xlink:type="simple" xlink:href="hqy-20201031.xsd#Netincomelosspershare"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Netincomelosspershare" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8d38a14-2f73-4a7c-b774-03422c16116c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c7ee26e5-8b94-4c66-9177-c2825eb6ace5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8d38a14-2f73-4a7c-b774-03422c16116c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c7ee26e5-8b94-4c66-9177-c2825eb6ace5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_67af21e7-269a-4f02-9772-be24096642dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c8d38a14-2f73-4a7c-b774-03422c16116c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_67af21e7-269a-4f02-9772-be24096642dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Businesscombination" xlink:type="simple" xlink:href="hqy-20201031.xsd#Businesscombination"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Businesscombination" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/BusinesscombinationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationPreliminaryAllocationofConsiderationDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c63de367-4eb8-44de-8c9d-bda57835bc3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c63de367-4eb8-44de-8c9d-bda57835bc3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c7f7086c-336d-459b-bc8d-1c05506473e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_c7f7086c-336d-459b-bc8d-1c05506473e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7527678a-c916-418c-89c0-3f1548e9557a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7527678a-c916-418c-89c0-3f1548e9557a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_149b4516-8ce2-459f-9afd-25d6a6e470d9" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_149b4516-8ce2-459f-9afd-25d6a6e470d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e37154ee-422e-409f-be75-2bc1931c84b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e37154ee-422e-409f-be75-2bc1931c84b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_69164d6e-51ab-4e08-8e3d-e0cf11bffeb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_Goodwill_69164d6e-51ab-4e08-8e3d-e0cf11bffeb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f470442c-8da3-4191-90cd-047d357f496f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_f470442c-8da3-4191-90cd-047d357f496f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_7c73da0f-8282-4d79-849b-86832db1eb24" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_7c73da0f-8282-4d79-849b-86832db1eb24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9590ba2d-4cc7-4962-b786-fb288171ac69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_9590ba2d-4cc7-4962-b786-fb288171ac69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a231d566-07ad-435d-9b6d-eceae42086e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_a231d566-07ad-435d-9b6d-eceae42086e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c7f94cf0-9efe-4061-bbdc-2e643277c942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_91aa0f74-dc22-432e-9cd5-11f9cb68cd87" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_c7f94cf0-9efe-4061-bbdc-2e643277c942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_50910c0a-ecc7-482f-be91-cee538d1bfe9" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_50910c0a-ecc7-482f-be91-cee538d1bfe9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_75fd9102-35f6-49cf-8880-7f0d3557f832" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_75fd9102-35f6-49cf-8880-7f0d3557f832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_252d1a92-05f3-401c-8239-104c77041369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_252d1a92-05f3-401c-8239-104c77041369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_d2997e30-2400-4a1a-aeee-4aef0be90d25" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_d2997e30-2400-4a1a-aeee-4aef0be90d25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_d57c4f4e-7126-49d6-abf4-c73e089be0f1" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_d57c4f4e-7126-49d6-abf4-c73e089be0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_f7962b80-0e90-4ee2-afa6-2fd53ff855cf" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f6e9dcc-b262-4f09-bbfd-1c724fcee8f7" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_f7962b80-0e90-4ee2-afa6-2fd53ff855cf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationProFormaResultsDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Supplementalfinancialstatementinformation"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationPropertyandequipmentDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e61d4052-a0b7-4660-8949-0cd000e67220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70afc12d-8c3c-4ed9-952b-67c5f36fe6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e61d4052-a0b7-4660-8949-0cd000e67220" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70afc12d-8c3c-4ed9-952b-67c5f36fe6e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_98094790-6c60-4456-8314-b63806a87cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e61d4052-a0b7-4660-8949-0cd000e67220" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_98094790-6c60-4456-8314-b63806a87cff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2e292fd6-961e-46e1-be11-a30bddec7072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_7d3903a2-ad6f-454c-a944-2b8c567bb898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2e292fd6-961e-46e1-be11-a30bddec7072" xlink:to="loc_us-gaap_OperatingLeaseExpense_7d3903a2-ad6f-454c-a944-2b8c567bb898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_9a02bc05-59a5-4f11-9001-261f3015d4fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2e292fd6-961e-46e1-be11-a30bddec7072" xlink:to="loc_us-gaap_SubleaseIncome_9a02bc05-59a5-4f11-9001-261f3015d4fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_278a71e4-af2d-4d96-bc17-5668e4199e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_ae37f61b-1a4d-4869-abf9-be5f95cc94db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_278a71e4-af2d-4d96-bc17-5668e4199e3d" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_ae37f61b-1a4d-4869-abf9-be5f95cc94db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_90097d54-c287-40ae-9603-36dd13253cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_278a71e4-af2d-4d96-bc17-5668e4199e3d" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_90097d54-c287-40ae-9603-36dd13253cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_48725ab6-3540-4780-9ad4-75ced7c2d46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_278a71e4-af2d-4d96-bc17-5668e4199e3d" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_48725ab6-3540-4780-9ad4-75ced7c2d46d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_75abba19-f99d-44fc-a056-5545feed0f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_278a71e4-af2d-4d96-bc17-5668e4199e3d" xlink:to="loc_us-gaap_OtherNonoperatingExpense_75abba19-f99d-44fc-a056-5545feed0f42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="simple" xlink:href="hqy-20201031.xsd#Intangibleassetsandgoodwill"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0514525-c3a8-4854-a268-998c406a0d67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7bca88a9-ae90-4a4e-9274-657db88876bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0514525-c3a8-4854-a268-998c406a0d67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7bca88a9-ae90-4a4e-9274-657db88876bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_30136dea-dfef-403a-baba-1d5101bfd5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d0514525-c3a8-4854-a268-998c406a0d67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_30136dea-dfef-403a-baba-1d5101bfd5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd2610ba-065d-4fe2-b318-a17c970c4517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2d0e3a1c-99a6-4054-84ec-f0a493761daf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd2610ba-065d-4fe2-b318-a17c970c4517" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2d0e3a1c-99a6-4054-84ec-f0a493761daf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f26cf6d0-112e-4174-b2a0-cd797a7fefc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd2610ba-065d-4fe2-b318-a17c970c4517" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f26cf6d0-112e-4174-b2a0-cd797a7fefc1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Commitmentsandcontingencies"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#CommitmentsandcontingenciesDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Incometaxes" xlink:type="simple" xlink:href="hqy-20201031.xsd#Incometaxes"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Incometaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IncometaxesDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IncometaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Indebtedness" xlink:type="simple" xlink:href="hqy-20201031.xsd#Indebtedness"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Indebtedness" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IndebtednessTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_561a595c-8e48-4400-88e2-b6034d13f736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1c972c84-c679-42eb-ae77-532b93a56799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_561a595c-8e48-4400-88e2-b6034d13f736" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1c972c84-c679-42eb-ae77-532b93a56799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_36dbaa60-e8bc-4a07-b731-49eec6f1d941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_561a595c-8e48-4400-88e2-b6034d13f736" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_36dbaa60-e8bc-4a07-b731-49eec6f1d941" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5d9f2ff2-8a53-40fb-8c0b-95bffbe9446f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5d9f2ff2-8a53-40fb-8c0b-95bffbe9446f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bf08e953-357a-4e78-bc44-45839b94e0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_bf08e953-357a-4e78-bc44-45839b94e0eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_654ff18f-c4aa-4645-81a6-fa605ce309ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_654ff18f-c4aa-4645-81a6-fa605ce309ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d7eab666-73fc-4f12-b45c-e5dc4cbfff26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d7eab666-73fc-4f12-b45c-e5dc4cbfff26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_938fcf3c-deb3-4a91-8d20-3b62933060fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_2d64518d-9fae-4205-9e69-90ca80e8e0a0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_938fcf3c-deb3-4a91-8d20-3b62933060fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Stockbasedcompensation"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Stockbasedcompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationTables"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationStockoptionactivityDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationRestrictedstockunityactivityDetails"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthequity.com/role/Fairvalue" xlink:type="simple" xlink:href="hqy-20201031.xsd#Fairvalue"/>
  <link:calculationLink xlink:role="http://healthequity.com/role/Fairvalue" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hqy-20201031_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20201031.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended" id="ib27683b4522e476094f53e1947c8e051_CoverPage"/>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedbalancesheets"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="extended" id="i951dc07b39144ed0a567a3526d0ad1e8_Condensedconsolidatedbalancesheets"/>
  <link:roleRef roleURI="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="simple" xlink:href="hqy-20201031.xsd#CondensedconsolidatedbalancesheetsParenthetical"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="extended" id="ia9ac31fd2ba34ebcb3a1af4d54bf6e03_CondensedconsolidatedbalancesheetsParenthetical"/>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="extended" id="i9534823d910f427b85cd799d2a8bf043_Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b86c94b-4391-46e8-b0aa-4642a03b7fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b86c94b-4391-46e8-b0aa-4642a03b7fe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a9eda8eb-ec55-4c81-aa2d-62494afe8fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a9eda8eb-ec55-4c81-aa2d-62494afe8fc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4f98d7f6-d65f-4c16-b517-332ececba2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:to="loc_us-gaap_GrossProfit_4f98d7f6-d65f-4c16-b517-332ececba2f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_6366d1ce-4dc0-4efd-90ba-b83760ec1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_6366d1ce-4dc0-4efd-90ba-b83760ec1121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_03950fc6-fd30-4004-8172-f778bcb44103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_03950fc6-fd30-4004-8172-f778bcb44103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3f53a896-fafb-4055-a152-d49d6a254d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3f53a896-fafb-4055-a152-d49d6a254d71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AmortizationOfAcquiredIntangible_66b69f3a-e528-4c99-8585-85f59fb150fa" xlink:href="hqy-20201031.xsd#hqy_AmortizationOfAcquiredIntangible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_hqy_AmortizationOfAcquiredIntangible_66b69f3a-e528-4c99-8585-85f59fb150fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eb40c49f-7372-4dc4-a092-c5de167da4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eb40c49f-7372-4dc4-a092-c5de167da4ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1273d11a-a7ae-4fe5-820c-dee796926968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_OperatingExpenses_1273d11a-a7ae-4fe5-820c-dee796926968" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8e9c5526-f848-409c-8930-b94fc29e6598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OperatingIncomeLoss_8e9c5526-f848-409c-8930-b94fc29e6598" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7a3e40b3-cc49-4ffc-86f6-06e0249b5035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_InterestExpense_7a3e40b3-cc49-4ffc-86f6-06e0249b5035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_058e4c0c-3dc4-4457-8354-ba752cce739f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_058e4c0c-3dc4-4457-8354-ba752cce739f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_188b887a-e0e4-4d30-a8a2-61be0e0a4e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_188b887a-e0e4-4d30-a8a2-61be0e0a4e39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_16fce13c-c647-4672-bb0d-b9be5e99afd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_16fce13c-c647-4672-bb0d-b9be5e99afd8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d9a348c4-f941-41ad-9f89-52f7e10e38a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d9a348c4-f941-41ad-9f89-52f7e10e38a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d27a9c4-e984-4b86-b81c-40697891a7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_NetIncomeLoss_5d27a9c4-e984-4b86-b81c-40697891a7d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c56ad1d-ec0d-4f04-bdfb-37114880dd63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c56ad1d-ec0d-4f04-bdfb-37114880dd63" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_796c1f1e-24e0-4df5-aec3-281b9e07b78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:to="loc_us-gaap_EarningsPerShareBasic_796c1f1e-24e0-4df5-aec3-281b9e07b78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_28c3f14f-3677-426b-97d0-609a21bbe0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_28c3f14f-3677-426b-97d0-609a21bbe0b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:href="hqy-20201031.xsd#hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f05978d-c4c4-44cd-8182-cdd0369aae3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f05978d-c4c4-44cd-8182-cdd0369aae3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba465875-b260-43c6-a599-6d72b99bd6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba465875-b260-43c6-a599-6d72b99bd6fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:to="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3cbc3a02-d87f-4d69-8a98-07884b21c534_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:to="loc_srt_ProductsAndServicesDomain_3cbc3a02-d87f-4d69-8a98-07884b21c534_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:to="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_19f7e30c-7f7b-4a72-bf24-1a0909e633c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_ServiceMember_19f7e30c-7f7b-4a72-bf24-1a0909e633c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceOtherMember_856d94f4-bde5-4f3e-80bc-d8cdcd6f119f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_FinancialServiceOtherMember_856d94f4-bde5-4f3e-80bc-d8cdcd6f119f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAndDebitCardMember_a0fd11da-a218-4733-b657-604b19e0b4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditAndDebitCardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_CreditAndDebitCardMember_a0fd11da-a218-4733-b657-604b19e0b4f6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofstockholdersequityunaudited"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="extended" id="ia91c2967aaac4992b9c0ac85f1e1976d_Condensedconsolidatedstatementsofstockholdersequityunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_407cfa88-8189-4cbd-920f-59d38495f8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockholdersEquity_407cfa88-8189-4cbd-920f-59d38495f8b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5fa9d0e2-f2b4-4138-b5ae-0058b1dcd3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5fa9d0e2-f2b4-4138-b5ae-0058b1dcd3ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_97f3aa81-abae-422a-81e6-719643626d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_97f3aa81-abae-422a-81e6-719643626d9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f02735da-2b65-407f-a90c-4d34011c498c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f02735da-2b65-407f-a90c-4d34011c498c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5fe1dc8a-6e9d-4951-8251-a9398e69687a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_NetIncomeLoss_5fe1dc8a-6e9d-4951-8251-a9398e69687a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c2c8db27-d647-44c4-95f7-3a3efbfb0b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:to="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8e3129e9-d79c-47a8-8a11-a44edee04bed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:to="loc_us-gaap_EquityComponentDomain_8e3129e9-d79c-47a8-8a11-a44edee04bed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:to="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_19107db2-cf7c-488a-b82c-5a6a5dd194bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_CommonStockMember_19107db2-cf7c-488a-b82c-5a6a5dd194bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d806cf73-8723-465c-9853-7a46f703874b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d806cf73-8723-465c-9853-7a46f703874b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_af67d0bc-b7ff-4e5a-8edf-8e95316da5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_RetainedEarningsMember_af67d0bc-b7ff-4e5a-8edf-8e95316da5eb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofcashflowsunaudited"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="extended" id="i781d96b3fa7445869d60c5e3f5cd5310_Condensedconsolidatedstatementsofcashflowsunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6bb05ce5-0142-4caa-9917-f133963db090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:to="loc_us-gaap_InterestPaidNet_6bb05ce5-0142-4caa-9917-f133963db090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7831f23a-d403-4783-b012-8531f65c7ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_7831f23a-d403-4783-b012-8531f65c7ed7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_36a500a3-4015-447d-9d8b-7c5d3274fea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_36a500a3-4015-447d-9d8b-7c5d3274fea6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_f426d367-d9d9-43dc-8482-4f747306c429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_f426d367-d9d9-43dc-8482-4f747306c429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_502f872e-555d-403e-94b7-2973879c8807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_502f872e-555d-403e-94b7-2973879c8807" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ExerciseofStockOptionsReceivable_d12d43d2-15de-4186-9c05-546cde0ff3a5" xlink:href="hqy-20201031.xsd#hqy_ExerciseofStockOptionsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_hqy_ExerciseofStockOptionsReceivable_d12d43d2-15de-4186-9c05-546cde0ff3a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_54b53a4e-660f-4e23-8d97-75e95574b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_54b53a4e-660f-4e23-8d97-75e95574b609" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:to="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d828a71-6d1f-482c-a825-00568c58fe3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0d828a71-6d1f-482c-a825-00568c58fe3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bc15da12-0e59-4798-a17a-841124928686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bc15da12-0e59-4798-a17a-841124928686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AcquiredHSAIntangibleAssetsMember_d6e6d648-b630-43b7-991a-41259becee0e" xlink:href="hqy-20201031.xsd#hqy_AcquiredHSAIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:to="loc_hqy_AcquiredHSAIntangibleAssetsMember_d6e6d648-b630-43b7-991a-41259becee0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Summaryofbusinessandsignificantaccountingpolicies"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="extended" id="i8ebdd1d0f5864b08a9897144cf460cf1_Summaryofbusinessandsignificantaccountingpolicies"/>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesPolicies"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="extended" id="i077f2c173f6c47228734730cd45d39b2_SummaryofbusinessandsignificantaccountingpoliciesPolicies"/>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended" id="ib674e64cb4b646a2990dde4f5b09dc34_SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bbdda66-4ec6-40af-8db4-90ff8de74a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bbdda66-4ec6-40af-8db4-90ff8de74a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a509be5f-519f-4630-a7a2-48aaecf7fc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a509be5f-519f-4630-a7a2-48aaecf7fc7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eabbc657-f8ee-41d3-954e-8660a9f064c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eabbc657-f8ee-41d3-954e-8660a9f064c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_41c9cc68-f629-4b4c-8212-1b04371457c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_41c9cc68-f629-4b4c-8212-1b04371457c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_StockIssuanceCostsPayable_f037631d-a9c7-4c4d-9625-6611837983a9" xlink:href="hqy-20201031.xsd#hqy_StockIssuanceCostsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_hqy_StockIssuanceCostsPayable_f037631d-a9c7-4c4d-9625-6611837983a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_81dc4e30-1e3b-483f-9cd6-f6d5d795ccbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_81dc4e30-1e3b-483f-9cd6-f6d5d795ccbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18f76342-d526-4f96-b079-742bc23181a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_18f76342-d526-4f96-b079-742bc23181a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_FollowOnEquityOfferingMember_e423b77a-aa7e-41ed-9bfd-621256866c86" xlink:href="hqy-20201031.xsd#hqy_FollowOnEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:to="loc_hqy_FollowOnEquityOfferingMember_e423b77a-aa7e-41ed-9bfd-621256866c86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b5b3cc22-239c-4ea1-b390-5f1900cb3803_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:to="loc_us-gaap_CreditFacilityDomain_b5b3cc22-239c-4ea1-b390-5f1900cb3803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:to="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_831a3736-c1e1-41dd-b3f9-fe0b6f6bf4db" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:to="loc_hqy_TermLoanFacilityMember_831a3736-c1e1-41dd-b3f9-fe0b6f6bf4db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0f393b2c-bcf1-4432-8310-87a3c64edf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:to="loc_us-gaap_LineOfCreditMember_0f393b2c-bcf1-4432-8310-87a3c64edf75" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Netincomelosspershare" xlink:type="simple" xlink:href="hqy-20201031.xsd#Netincomelosspershare"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Netincomelosspershare" xlink:type="extended" id="iafb1d223419047d3875f8520a6f9223f_Netincomelosspershare"/>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="extended" id="i61cc3f104b154ca0b250a60ec15ed999_NetincomelosspershareTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="extended" id="id23e7208821f4f55b87f1c287b90da3b_NetincomelosspershareDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/Businesscombination" xlink:type="simple" xlink:href="hqy-20201031.xsd#Businesscombination"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Businesscombination" xlink:type="extended" id="i466b9e92fe804c2ea2b0446672823b63_Businesscombination"/>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/BusinesscombinationTables" xlink:type="extended" id="if966e5833a14422b8a6bfb4e2190d1ec_BusinesscombinationTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="extended" id="i97ddd0a204a44565b545775195a99208_BusinesscombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_207d45f7-6961-4c17-b584-2e6ce9015202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_207d45f7-6961-4c17-b584-2e6ce9015202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_77d69c42-6348-43d0-a2ed-9c7e0e6fa2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_77d69c42-6348-43d0-a2ed-9c7e0e6fa2c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d7eb7aa-9803-4b17-8055-680c53bc0be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d7eb7aa-9803-4b17-8055-680c53bc0be7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_1c880061-3138-4dd4-a498-cefb623691a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_1c880061-3138-4dd4-a498-cefb623691a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_9de7dc52-55ac-4f18-bde3-c0f4deea7f07" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:to="loc_hqy_WageWorksIncMember_9de7dc52-55ac-4f18-bde3-c0f4deea7f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_153df520-124c-4712-9ffa-43f4fb60519a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_153df520-124c-4712-9ffa-43f4fb60519a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_de5b8412-ed03-4b47-98fe-5e43fead6f43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:to="loc_us-gaap_LineOfCreditMember_de5b8412-ed03-4b47-98fe-5e43fead6f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_187a3db9-0f93-42e1-8f2f-e7334f583022_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:to="loc_us-gaap_CreditFacilityDomain_187a3db9-0f93-42e1-8f2f-e7334f583022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:to="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_80ad75c6-50ca-4212-a408-67d9e9570002" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:to="loc_hqy_TermLoanFacilityMember_80ad75c6-50ca-4212-a408-67d9e9570002" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationPreliminaryAllocationofConsiderationDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="extended" id="ib080b94df03e4362bf9399081c2f0c37_BusinesscombinationPreliminaryAllocationofConsiderationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7015cdc4-226e-4089-b9e4-fd30610d2b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7015cdc4-226e-4089-b9e4-fd30610d2b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_3cd83a5d-bda9-4dca-99a9-71d396327999" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_3cd83a5d-bda9-4dca-99a9-71d396327999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_84177767-225f-45cf-b603-247aa54a48b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_84177767-225f-45cf-b603-247aa54a48b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_6a28f78c-7568-4c59-bc7f-0d4fe2c7ae58" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_6a28f78c-7568-4c59-bc7f-0d4fe2c7ae58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d77366-aa0e-429b-8047-b99b2eecadd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d77366-aa0e-429b-8047-b99b2eecadd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_8eb62a40-cb76-4391-ae5e-56c3f1d7a3b6" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_8eb62a40-cb76-4391-ae5e-56c3f1d7a3b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_41f6750d-7f1b-4733-a817-465c3b8a94fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_41f6750d-7f1b-4733-a817-465c3b8a94fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4ad45dba-8303-4f00-aaca-927cada04dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_Goodwill_4ad45dba-8303-4f00-aaca-927cada04dee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_756bc2ce-e3c4-4459-a0c8-7cafd9bc8afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_756bc2ce-e3c4-4459-a0c8-7cafd9bc8afd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e132dd3-2abb-4cc3-9d7a-e41cf095f513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e132dd3-2abb-4cc3-9d7a-e41cf095f513" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_5cf63825-a73a-41be-a9c8-5625a760a35a" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_5cf63825-a73a-41be-a9c8-5625a760a35a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_89370db4-3111-4048-a598-e41971b7dc3f" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_89370db4-3111-4048-a598-e41971b7dc3f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c3f5954-13a3-4385-b6bd-b2322766d664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c3f5954-13a3-4385-b6bd-b2322766d664" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_f50a77ab-8a5e-40ec-91ef-c9e24f7a97c0" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_f50a77ab-8a5e-40ec-91ef-c9e24f7a97c0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_365dddce-63dc-4bf8-838b-75007a12652c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_365dddce-63dc-4bf8-838b-75007a12652c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3b8c599a-121b-4266-990e-1ffefa1cddea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3b8c599a-121b-4266-990e-1ffefa1cddea" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_196fdcad-f60d-4381-9128-96da9de82f5d" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_196fdcad-f60d-4381-9128-96da9de82f5d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_15301253-8c01-4dec-9686-d16cf4567763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_15301253-8c01-4dec-9686-d16cf4567763" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_d2dc504e-4278-4f3a-a456-0d8566f8cd21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_d2dc504e-4278-4f3a-a456-0d8566f8cd21" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5479c765-b1c3-41f0-8324-2187079b8c09_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5479c765-b1c3-41f0-8324-2187079b8c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_80ea884b-898d-4777-8ffc-68921179365e" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:to="loc_hqy_WageWorksIncMember_80ea884b-898d-4777-8ffc-68921179365e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationProFormaResultsDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="extended" id="ida6ce828146840c09cdffa4831848928_BusinesscombinationProFormaResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1dad787a-a6ed-4b9b-8a29-526c01982d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1dad787a-a6ed-4b9b-8a29-526c01982d95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_648b29aa-9af0-46f4-bc6d-254d7b1f8ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_648b29aa-9af0-46f4-bc6d-254d7b1f8ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3440132-7ca8-4ce2-816d-b05b21ad4676_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3440132-7ca8-4ce2-816d-b05b21ad4676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksInc.Member_0af7ba42-eba4-4dce-8509-ee6d0bea299f" xlink:href="hqy-20201031.xsd#hqy_WageWorksInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:to="loc_hqy_WageWorksInc.Member_0af7ba42-eba4-4dce-8509-ee6d0bea299f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Supplementalfinancialstatementinformation"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="extended" id="i90727d4f71c24451b7f6d03afdda0191_Supplementalfinancialstatementinformation"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="extended" id="i2b206cdd025941cbbe936dd812d234b5_SupplementalfinancialstatementinformationTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationPropertyandequipmentDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="extended" id="ia0928c71658f45b289fd022403e21d8b_SupplementalfinancialstatementinformationPropertyandequipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9fca2aef-b78c-471b-ae8e-adf862a74052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9fca2aef-b78c-471b-ae8e-adf862a74052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2eef16e3-cb9a-4651-a526-13fd5c917182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2eef16e3-cb9a-4651-a526-13fd5c917182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be4926a8-b1c9-4ed0-97c1-0ba5c971aa02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be4926a8-b1c9-4ed0-97c1-0ba5c971aa02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b2996e9-b3fc-4704-ba51-6b2fb305de23_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b2996e9-b3fc-4704-ba51-6b2fb305de23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_08a77f63-3dd9-4a91-88d9-1b6830cd07a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_08a77f63-3dd9-4a91-88d9-1b6830cd07a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f169f885-74b2-4c8f-9932-39428c270898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f169f885-74b2-4c8f-9932-39428c270898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_baef8b6e-61d2-4692-be0e-8c20cb73d39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_ComputerEquipmentMember_baef8b6e-61d2-4692-be0e-8c20cb73d39c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="extended" id="ia084409a6a8d4cfdb22c5fa553a1d18d_SupplementalfinancialstatementinformationNarrativeDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="extended" id="i79e23efea8d94efb8a133b98e10bc3b4_SupplementalfinancialstatementinformationLeaseCostDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="extended" id="i8d3fec714d704e499c29861815b2c4dd_SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="extended" id="i26046b00b6574680a9628e0dc802dd42_SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="simple" xlink:href="hqy-20201031.xsd#Intangibleassetsandgoodwill"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="extended" id="icd6d372cd13146b587bb4f36bbcf0ee3_Intangibleassetsandgoodwill"/>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="extended" id="i296b628436564c5eac143b6cf5163d4e_IntangibleassetsandgoodwillTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="extended" id="i16a8dcbf17bd4621b084e871d60cf115_IntangibleassetsandgoodwillScheduleofintangibleassetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4734f4fa-9eb4-41b3-8856-f0f6a245501f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4734f4fa-9eb4-41b3-8856-f0f6a245501f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7cc1887-3e56-4bb6-bf1c-17ce84188aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7cc1887-3e56-4bb6-bf1c-17ce84188aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cfca6eb4-bd95-4b03-bcc9-d354feb6f818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cfca6eb4-bd95-4b03-bcc9-d354feb6f818" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_431ed7da-ed88-47ac-9be7-5344ebd8f62a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_431ed7da-ed88-47ac-9be7-5344ebd8f62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_aeda1810-3893-47b7-ac61-14e762050015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_aeda1810-3893-47b7-ac61-14e762050015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AcquiredHSAIntangibleAssetsMember_980fd975-a11d-4488-966f-467df0bdbb39" xlink:href="hqy-20201031.xsd#hqy_AcquiredHSAIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_hqy_AcquiredHSAIntangibleAssetsMember_980fd975-a11d-4488-966f-467df0bdbb39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7b52db01-67c7-4e0e-9145-fabfe98b819c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7b52db01-67c7-4e0e-9145-fabfe98b819c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_05333382-5a2f-4915-ad3e-d14f64e10b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_05333382-5a2f-4915-ad3e-d14f64e10b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4d609e38-9102-40ea-8525-391acf1c12d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_TradeNamesMember_4d609e38-9102-40ea-8525-391acf1c12d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d137b22f-9dca-4500-a224-891d8610e52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d137b22f-9dca-4500-a224-891d8610e52b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9b213c5c-a998-49c2-b6e4-e991a90b1196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9b213c5c-a998-49c2-b6e4-e991a90b1196" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="extended" id="id8f23e048c214b18bf6cf93477595a35_IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Commitmentsandcontingencies"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="extended" id="i12926e5dd42a423d9f75d4c363fca72f_Commitmentsandcontingencies"/>
  <link:roleRef roleURI="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#CommitmentsandcontingenciesDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="extended" id="ibc0e0152263642c3a36335b6d8390a1e_CommitmentsandcontingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9d947482-166e-4ad1-92d6-4ab4596c91d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9d947482-166e-4ad1-92d6-4ab4596c91d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_LossContingencyNumberOfLawsuits_758f0240-8e61-40e0-bb89-6e757624903c" xlink:href="hqy-20201031.xsd#hqy_LossContingencyNumberOfLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:to="loc_hqy_LossContingencyNumberOfLawsuits_758f0240-8e61-40e0-bb89-6e757624903c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:to="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:to="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_15de53e0-7a39-492b-8ff1-ed639ab08970_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:to="loc_us-gaap_CreditFacilityDomain_15de53e0-7a39-492b-8ff1-ed639ab08970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:to="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_fb436a0f-a51a-4d7f-a305-f2c8f54024fc" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:to="loc_hqy_TermLoanFacilityMember_fb436a0f-a51a-4d7f-a305-f2c8f54024fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_569a6411-7b52-4328-8577-0f974e4663ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_569a6411-7b52-4328-8577-0f974e4663ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_625b0797-a4ce-4c85-b6ca-e0f6382d4752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:to="loc_us-gaap_LineOfCreditMember_625b0797-a4ce-4c85-b6ca-e0f6382d4752" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Incometaxes" xlink:type="simple" xlink:href="hqy-20201031.xsd#Incometaxes"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Incometaxes" xlink:type="extended" id="if8aae33d560d4c11b6ad3cf3198cc2b0_Incometaxes"/>
  <link:roleRef roleURI="http://healthequity.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IncometaxesDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IncometaxesDetails" xlink:type="extended" id="i3f91751f6d5b4308aa4206299134690f_IncometaxesDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/Indebtedness" xlink:type="simple" xlink:href="hqy-20201031.xsd#Indebtedness"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Indebtedness" xlink:type="extended" id="icd1becb012704cb38f955f6d53aa1646_Indebtedness"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IndebtednessTables" xlink:type="extended" id="id8d4ef6361644fde83af8c12d1733919_IndebtednessTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended" id="i31190803ad4745b5bc3fe5b58c477066_IndebtednessScheduleofLongtermDebtDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="extended" id="i50bf20976cbf4409b89fdbf63e1e06f0_IndebtednessNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_cd693b5f-2136-46c6-8cef-c06ce74ab217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_cd693b5f-2136-46c6-8cef-c06ce74ab217" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bc0469b3-79bd-4b53-b8cd-9c1bf1371c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentTerm_bc0469b3-79bd-4b53-b8cd-9c1bf1371c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac13e58-27e8-4abb-993f-9ff4b33a0c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac13e58-27e8-4abb-993f-9ff4b33a0c6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_513c3dea-c38e-4578-92a0-ccd29b7db8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCredit_513c3dea-c38e-4578-92a0-ccd29b7db8d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4e2def3b-216e-443b-a5a8-69af72e864e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4e2def3b-216e-443b-a5a8-69af72e864e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fef63d1b-96d1-458a-90e8-11a9be5c49c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fef63d1b-96d1-458a-90e8-11a9be5c49c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cd634a0b-7f9f-4e0a-a94c-7acc800e968f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cd634a0b-7f9f-4e0a-a94c-7acc800e968f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_e899d6b9-6eaf-4016-9106-5e8dfa3c7364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_e899d6b9-6eaf-4016-9106-5e8dfa3c7364" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_08a9a11f-315c-4ac1-8b69-db96d4c26329" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_08a9a11f-315c-4ac1-8b69-db96d4c26329" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_b3c532cf-c960-4c0e-bafd-3db844224194" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_b3c532cf-c960-4c0e-bafd-3db844224194" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_b8b97452-bf19-4e09-8fd5-9efa6f64ede8" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_b8b97452-bf19-4e09-8fd5-9efa6f64ede8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6ad1ae21-9925-402e-843e-021540ddf2a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6ad1ae21-9925-402e-843e-021540ddf2a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4480a59a-71ec-47e1-af31-6a9d3a3573db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:to="loc_us-gaap_OtherAssetsMember_4480a59a-71ec-47e1-af31-6a9d3a3573db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5e37b661-42bb-4c67-a938-941198b3b732_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5e37b661-42bb-4c67-a938-941198b3b732_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_CreditAgreementMember_8f1597c6-a8b6-427f-aea4-55238a6872e7" xlink:href="hqy-20201031.xsd#hqy_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:to="loc_hqy_CreditAgreementMember_8f1597c6-a8b6-427f-aea4-55238a6872e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7ab16cca-688e-43ac-966b-1dcccf2ea970_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7ab16cca-688e-43ac-966b-1dcccf2ea970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_51b04d8a-5097-4de9-b86e-bf383c3bccf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:to="loc_us-gaap_SecuredDebtMember_51b04d8a-5097-4de9-b86e-bf383c3bccf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_127efc5d-43d0-4bdc-b356-9e7cf8ec479c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:to="loc_us-gaap_LineOfCreditMember_127efc5d-43d0-4bdc-b356-9e7cf8ec479c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ca360f82-b45a-426e-a307-abdc650c5e26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:to="loc_us-gaap_CreditFacilityDomain_ca360f82-b45a-426e-a307-abdc650c5e26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:to="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ecbe3cff-80c8-4257-890b-fa84ba3645b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_us-gaap_LineOfCreditMember_ecbe3cff-80c8-4257-890b-fa84ba3645b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_1bdb0161-ac2d-4e1a-a367-3779e11f0609" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_hqy_TermLoanFacilityMember_1bdb0161-ac2d-4e1a-a367-3779e11f0609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dfa66fa3-a6a9-433c-a4cb-109d5828cfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dfa66fa3-a6a9-433c-a4cb-109d5828cfc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_03b229e4-391d-4960-8440-9b4d53d37e81_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:to="loc_us-gaap_VariableRateDomain_03b229e4-391d-4960-8440-9b4d53d37e81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:to="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cfd800f8-8211-40ab-89ad-67edb5bb900e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cfd800f8-8211-40ab-89ad-67edb5bb900e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d43b1814-41b8-41e8-977c-d60ffa7939ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:to="loc_us-gaap_BaseRateMember_d43b1814-41b8-41e8-977c-d60ffa7939ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:to="loc_srt_RangeMember_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:to="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5824d389-a84b-4ea8-87f4-a21636f689d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:to="loc_srt_MinimumMember_5824d389-a84b-4ea8-87f4-a21636f689d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e42cd631-bae8-406f-b010-0fefc9cba398" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:to="loc_srt_MaximumMember_e42cd631-bae8-406f-b010-0fefc9cba398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodDomain_76cb852c-36c1-4186-b840-68ba27e9472a_default" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:to="loc_hqy_DebtCovenantPeriodDomain_76cb852c-36c1-4186-b840-68ba27e9472a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:to="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodTwoMember_a14e9e1f-8d38-48f1-a85a-d5cb85a5847f" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodTwoMember_a14e9e1f-8d38-48f1-a85a-d5cb85a5847f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodThreeMember_c10dee5f-3d65-41e3-8fd4-b8225f554915" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodThreeMember_c10dee5f-3d65-41e3-8fd4-b8225f554915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodFourMember_aa5eb687-ddb7-4c88-833b-fcca9111c2f0" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodFourMember_aa5eb687-ddb7-4c88-833b-fcca9111c2f0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended" id="i339a5426e1c7466dac9f2a09739fd421_IndebtednessScheduleofMaturitiesofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8f3af3f4-93cf-412c-84b3-4038ea188c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8f3af3f4-93cf-412c-84b3-4038ea188c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c8d01564-a27f-434e-909e-363bc06e556a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c8d01564-a27f-434e-909e-363bc06e556a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ddfd978c-3132-4860-a2db-26898d96b88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ddfd978c-3132-4860-a2db-26898d96b88b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_16b48a05-cdb8-4409-a4bf-d42da740b34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_16b48a05-cdb8-4409-a4bf-d42da740b34a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_45657fe0-eeb4-4117-b228-a8df349d79d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_45657fe0-eeb4-4117-b228-a8df349d79d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b038633a-5d54-4a13-adc3-d208f4b3ab0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b038633a-5d54-4a13-adc3-d208f4b3ab0f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6573ca2e-1d66-468b-9644-849384a1329b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6573ca2e-1d66-468b-9644-849384a1329b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_FollowOnEquityOfferingMember_ce6a0a20-7fb3-4478-b53b-9fc6c03f1d19" xlink:href="hqy-20201031.xsd#hqy_FollowOnEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:to="loc_hqy_FollowOnEquityOfferingMember_ce6a0a20-7fb3-4478-b53b-9fc6c03f1d19" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Stockbasedcompensation"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Stockbasedcompensation" xlink:type="extended" id="id4f6624f583e4d52a27cf5d94b577f94_Stockbasedcompensation"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationTables"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="extended" id="iae5a01e181d64bf595acbb3d52658b97_StockbasedcompensationTables"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="extended" id="i6445eab1afdb46cf845265c73b4de365_StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_52e6ef48-30fd-4bcf-bc47-6b9521d0edd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_52e6ef48-30fd-4bcf-bc47-6b9521d0edd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4b3fd7f8-3082-481b-9970-2c87922667e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_CostOfSalesMember_4b3fd7f8-3082-481b-9970-2c87922667e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SalesandMarketingMember_67460e76-9cf4-4082-ad59-29c80d2f541f" xlink:href="hqy-20201031.xsd#hqy_SalesandMarketingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_SalesandMarketingMember_67460e76-9cf4-4082-ad59-29c80d2f541f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TechnologyandDevelopmentMember_fdccb48f-af24-4dae-9a58-e61d777be0f4" xlink:href="hqy-20201031.xsd#hqy_TechnologyandDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_TechnologyandDevelopmentMember_fdccb48f-af24-4dae-9a58-e61d777be0f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b8d956ac-7505-4ce8-9101-cbf2016f12dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b8d956ac-7505-4ce8-9101-cbf2016f12dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_MergerIntegrationMember_d7bb6fb3-c81f-4ab9-bc9a-067741a48804" xlink:href="hqy-20201031.xsd#hqy_MergerIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_MergerIntegrationMember_d7bb6fb3-c81f-4ab9-bc9a-067741a48804" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_6a25d7a5-ed78-408e-9b9e-efe5e22f8bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_OtherExpenseMember_6a25d7a5-ed78-408e-9b9e-efe5e22f8bd5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended" id="ide543f1909f24bd2a18dc474300294b1_StockbasedcompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_07156faa-9b0c-4cf5-a391-7e8639294231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_07156faa-9b0c-4cf5-a391-7e8639294231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_3dff7ad2-25de-47db-9af3-082424c2949f" xlink:href="hqy-20201031.xsd#hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_3dff7ad2-25de-47db-9af3-082424c2949f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d543088f-c3ef-4532-8f7c-4257d8433100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d543088f-c3ef-4532-8f7c-4257d8433100" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_38da3acb-c7e8-474b-b4ec-2ba9d4dd2951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_38da3acb-c7e8-474b-b4ec-2ba9d4dd2951" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_39ca0c26-19a2-492f-b1ae-09e3bfb49917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_39ca0c26-19a2-492f-b1ae-09e3bfb49917" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_69c3c1f8-990e-45b6-ac7f-d10ffe03d150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_69c3c1f8-990e-45b6-ac7f-d10ffe03d150" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_245f0172-be48-494a-ba45-d9b31503b187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_245f0172-be48-494a-ba45-d9b31503b187" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_0c7cc1d0-ab8a-4c57-bcf4-c8ce71c1bb40" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_0c7cc1d0-ab8a-4c57-bcf4-c8ce71c1bb40" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_04d371df-b949-4aca-94a1-264202be5b6d" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_04d371df-b949-4aca-94a1-264202be5b6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_9a27cb26-2ebe-4be9-8979-f083e01cae19" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_9a27cb26-2ebe-4be9-8979-f083e01cae19" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_26934a09-3115-4d5e-882a-38d84f31c526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_26934a09-3115-4d5e-882a-38d84f31c526" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_bd0aee47-5520-4494-b982-a8fdca7d414a" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_bd0aee47-5520-4494-b982-a8fdca7d414a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_add82cbd-7494-4af0-9e2d-4595d8f4699e" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_add82cbd-7494-4af0-9e2d-4595d8f4699e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9ca04d73-ec71-4ed2-b90b-172b23966961_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:to="loc_us-gaap_PlanNameDomain_9ca04d73-ec71-4ed2-b90b-172b23966961_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:to="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncentivePlanMember_ae5839d0-fb0f-4db7-b3e7-03f3ebd43c03" xlink:href="hqy-20201031.xsd#hqy_IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:to="loc_hqy_IncentivePlanMember_ae5839d0-fb0f-4db7-b3e7-03f3ebd43c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncentivePlanMember_6c1c36cd-d9bf-4361-ab96-b003d298bc1f" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:to="loc_hqy_WageWorksIncentivePlanMember_6c1c36cd-d9bf-4361-ab96-b003d298bc1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_db664b39-721f-40d3-b50d-261d79d86750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_db664b39-721f-40d3-b50d-261d79d86750" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ddb24be-c2d8-4746-8245-92aa26777c1b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ddb24be-c2d8-4746-8245-92aa26777c1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_6757ef31-23d2-4c48-806a-78b034019f2d" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:to="loc_hqy_WageWorksIncMember_6757ef31-23d2-4c48-806a-78b034019f2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7efc5977-d266-458d-aefa-280a4eaf5d51_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7efc5977-d266-458d-aefa-280a4eaf5d51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_db750098-6d07-41f4-9e44-a65fb81fb021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_db750098-6d07-41f4-9e44-a65fb81fb021" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockAwardsMember_b014e8c9-d980-4796-9a48-728d482d68ac" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_hqy_PerformanceRestrictedStockAwardsMember_b014e8c9-d980-4796-9a48-728d482d68ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockUnitsMember_5f3b38eb-4ce9-481a-89f5-ffc16c1fe183" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_hqy_PerformanceRestrictedStockUnitsMember_5f3b38eb-4ce9-481a-89f5-ffc16c1fe183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e1db09a-ff60-46d0-b8f7-ad20778b62a3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:to="loc_srt_RangeMember_0e1db09a-ff60-46d0-b8f7-ad20778b62a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:to="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d0805ae-3527-44e0-b63b-0b4c8f225caa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:to="loc_srt_MinimumMember_8d0805ae-3527-44e0-b63b-0b4c8f225caa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db08ca76-2a00-4626-82b1-5701ce2b3447" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:to="loc_srt_MaximumMember_db08ca76-2a00-4626-82b1-5701ce2b3447" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationStockoptionactivityDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="extended" id="i84a9901c4ed34b8fb044c8c855d99419_StockbasedcompensationStockoptionactivityDetails"/>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationRestrictedstockunityactivityDetails"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="extended" id="id1cc1aa23c344fefbce5f961804229fa_StockbasedcompensationRestrictedstockunityactivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5481de71-6d66-422f-9c65-d7294963abf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5481de71-6d66-422f-9c65-d7294963abf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_386618bb-87b8-4bfd-91ae-36517ef93426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_386618bb-87b8-4bfd-91ae-36517ef93426" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c12a452-a19d-4b94-b659-76a381c023ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c12a452-a19d-4b94-b659-76a381c023ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_950c2d06-7216-4104-8fd0-33e6904ef43c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_950c2d06-7216-4104-8fd0-33e6904ef43c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_00078699-efe9-4a9b-880d-b6aafc8c497f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_13c06489-276c-42df-a8e8-cc5ce905196f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_13c06489-276c-42df-a8e8-cc5ce905196f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c3f9e748-5b8b-4349-b458-53f17bc28273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c3f9e748-5b8b-4349-b458-53f17bc28273" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_909f9590-14f0-44e6-8e5c-a3d45a5a012d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_909f9590-14f0-44e6-8e5c-a3d45a5a012d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f904eaf-43f3-439c-bc0f-038c751d2b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f904eaf-43f3-439c-bc0f-038c751d2b9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_325ea912-d35e-40f3-8d14-6a0958b7ac96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:to="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_52d1948a-5fee-4a76-9f45-1079ef86f20b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_52d1948a-5fee-4a76-9f45-1079ef86f20b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0cde9554-f804-48eb-a36a-cd4f347c91ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0cde9554-f804-48eb-a36a-cd4f347c91ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_05fa52aa-963d-438e-ae07-8d4a8f60d83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:to="loc_us-gaap_RestrictedStockMember_05fa52aa-963d-438e-ae07-8d4a8f60d83b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthequity.com/role/Fairvalue" xlink:type="simple" xlink:href="hqy-20201031.xsd#Fairvalue"/>
  <link:definitionLink xlink:role="http://healthequity.com/role/Fairvalue" xlink:type="extended" id="idc994738428943189fe0b967e9e60ddb_Fairvalue"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hqy-20201031_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_61b9013d-c3b0-4c90-a1d5-437938730ede_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance units awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fed7148a-0d3b-46f8-9b83-7246cc586cd9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2abc86b6-f656-419d-af51-42870d6868dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, outstanding stock options, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a1cfb626-6e32-4560-ad37-bb7b4bfa9742_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, outstanding stock options, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3a2df614-576d-419f-93c6-9c13126cf3bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d2c146e7-8e6b-4fbc-bae4-c6995563d446_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_AmortizationOfAcquiredIntangible_cd32b238-e683-4bb8-8f26-835e6a7bf09c_terseLabel_en-US" xlink:label="lab_hqy_AmortizationOfAcquiredIntangible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_hqy_AmortizationOfAcquiredIntangible_label_en-US" xlink:label="lab_hqy_AmortizationOfAcquiredIntangible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Acquired Intangible</link:label>
    <link:label id="lab_hqy_AmortizationOfAcquiredIntangible_documentation_en-US" xlink:label="lab_hqy_AmortizationOfAcquiredIntangible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AmortizationOfAcquiredIntangible" xlink:href="hqy-20201031.xsd#hqy_AmortizationOfAcquiredIntangible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_AmortizationOfAcquiredIntangible" xlink:to="lab_hqy_AmortizationOfAcquiredIntangible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_02beed0b-6bb8-4fd2-a897-bf119f5122ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bfd40744-5433-4514-8702-99e35348799f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_8540bdf5-5200-4fe7-9179-84c073246f70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_30445844-2acc-4eb0-8cb8-8c6613aed0fa_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_8e7b5d6b-0ecb-497b-b277-e46e169653d4_terseLabel_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, adjustments</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94df918d-07e7-45b4-b710-41daa04db837_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_9b67782f-79e8-407c-97e9-5fc01e993d99_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_b2c3a1d7-a89b-4eb1-a78c-681ba683dc6b_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in goodwill due to measurement period adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6ecebc83-ebe0-4767-adb2-3076ea0e51e9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtCovenantPeriodFourMember_368a14b0-aa46-4808-8de5-c1ee9bf6fe8e_terseLabel_en-US" xlink:label="lab_hqy_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, acquisition holiday provision</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodFourMember_label_en-US" xlink:label="lab_hqy_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Four [Member]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodFourMember_documentation_en-US" xlink:label="lab_hqy_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodFourMember" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtCovenantPeriodFourMember" xlink:to="lab_hqy_DebtCovenantPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8b28d4d4-f63b-451f-bf7a-315dc02780fd_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c9c667f5-2d68-4a5b-afd2-f50527653e62_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_StockIssuanceCostsPayable_cc650a1c-4078-407e-9b22-89dd3c498b0f_terseLabel_en-US" xlink:label="lab_hqy_StockIssuanceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other offering expenses payable</link:label>
    <link:label id="lab_hqy_StockIssuanceCostsPayable_label_en-US" xlink:label="lab_hqy_StockIssuanceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Payable</link:label>
    <link:label id="lab_hqy_StockIssuanceCostsPayable_documentation_en-US" xlink:label="lab_hqy_StockIssuanceCostsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_StockIssuanceCostsPayable" xlink:href="hqy-20201031.xsd#hqy_StockIssuanceCostsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_StockIssuanceCostsPayable" xlink:to="lab_hqy_StockIssuanceCostsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_f042b545-82e0-4225-92af-f1be7684abdc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_30faecac-3983-4019-8dc3-7ba0ac59978d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_15fe0ec8-4f4e-4468-a325-c7e285cb7886_periodStartLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, maximum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_5ee26c34-ec52-4e1e-a777-e7215dffcb9e_periodEndLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, maximum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_86b25970-24a3-49e5-b187-d74fa4334b14_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bda7094a-70c6-45f1-a534-d01828acbf6e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_255e76cb-7afa-43e3-a678-ce1b343a411e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_16482bdb-8ab3-45cb-a90e-d3e6655c0a04_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_17c5ec69-7e66-4bec-a973-c8c3622c6228_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f421305e-8c8b-40db-80f5-e330f411bc4a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_528cdd8e-3926-4463-827d-c4fdc93c02bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_351f05f9-239a-43d3-b774-76326972fdbf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8988132e-7cc6-462a-9502-49e35716d8d9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3c3fd1ad-7079-4f39-a02f-e67191017ae6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, beginning balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7a09ec1c-ef74-498d-9594-d5e27a93696c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, ending balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_3b98a91a-aa69-4841-8e71-82707a5d9815_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_1cdefe23-6bb4-40c0-8862-69c1f2c63049_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2cf4d4aa-da00-4fc6-aeed-a6c503138439_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e096c3fe-67be-469b-ad70-2b14413ab039_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (see Note 6)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b0b6c16e-5dfb-4b45-b7cb-b0555f99afe5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c84bedba-e3fc-4268-aebf-6af9f0549baf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_7e2e0ac6-29fc-4f35-8f03-4829c0cb321a_negatedTerseLabel_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client-held funds obligation</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_label_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Client Held Funds Obligation</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Client Held Funds Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:to="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_5a81f6d5-b3f1-427a-9f38-714561833afc_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_23fcc4e9-61c2-43b0-8b66-99bac1df1f62_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options, and for restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_eeb56cac-6e8a-4424-964f-9ae46cdee9dd_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9d299b4e-d07b-4ada-819c-cc3ad36df3eb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_784958cf-dc5e-4ef2-9252-c063178f23f4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_96f8eb0b-818d-468f-a80c-b605e35226c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_f1f9603f-e3b3-434e-84c9-efeca5afdb5a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1da79349-9f4e-4764-af14-22788fe4b482_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_37b6dd35-0360-454e-89d4-96413e8f6081_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ee092080-7848-4e1c-98c5-32627c497426_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6fd6b73e-ff71-49e0-aeb8-a1144e9c86bd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_72f26fa3-775c-49d6-b1a5-33d3d3c3c81f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpenseMember_7a701741-78f8-4e9e-aa60-a028c9e9f39e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpenseMember" xlink:to="lab_us-gaap_OtherExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_16c89506-79f4-4a90-b606-5d37bc06abcb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dba4dc29-9e00-4f71-adbb-26487cc62088_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6fe7d676-2047-4ef7-a78b-2f3a7ca9a6d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised_300084d5-3afa-45f1-8de0-deb6f606c34e_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, minimum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Exercised</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_dbdc98cd-d7f9-4766-b44c-c48d70187cf1_negatedLabel_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client-held funds obligation, adjustments</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_label_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Client Held Funds Obligation</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Client Held Funds Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:to="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_193a4c3c-351b-4f13-9c25-09c57617e276_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4038c5d4-8dce-43fd-be50-7acba86e6f10_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_8a8071f8-0ece-4263-aedb-ce096cb155f3_periodStartLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, minimum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_be5bb789-f373-48b0-8ef3-5b4d917a7912_periodEndLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, minimum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_da2a4bb6-8d1e-4798-a9d9-d98419fb5c52_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_b310527a-cfa5-4b0b-bcb6-fb445a0e09ef_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e8cab628-b439-41cb-8606-59603c6e6087_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_97c57c68-3240-4cca-956b-c206e2785288_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e25f93f4-dfd4-4d52-80ab-7ffb6f228d6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_852b7639-d434-4434-9c61-78c900c05486_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_99913105-5057-4892-9819-0a3e7768252b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_d57d2446-e1a1-436f-9665-a03307c506cf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_6a577ead-8976-476b-8957-5d46f9cf64c2_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_79c7aff6-c9f3-4589-a18a-a7b37eef5b91_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_293ef058-fd17-4b2b-bd7d-983cb4710fa3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_f1bfca94-8e60-433d-b854-0503620f552c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator (basic):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited_ead98b52-2407-403b-9ed5-44ac4562491f_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, minimum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Forfeited</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_a81dd637-8983-412c-953f-b66c9bb493a7_terseLabel_en-US" xlink:label="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of capital stock</link:label>
    <link:label id="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_label_en-US" xlink:label="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Available for Grants, Percentage of Capital Stock Outstanding, Percentage</link:label>
    <link:label id="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_documentation_en-US" xlink:label="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Available for Grants, Percentage of Capital Stock Outstanding, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:href="hqy-20201031.xsd#hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:to="lab_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8b402f39-f20c-403c-be94-f930789463b0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_01005009-5525-4fdb-9381-b29b75d6aa0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_fa0d9fa4-50c0-4e0f-a1a1-91acd5d8eeab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ac16cede-7049-4ecf-96fc-98ed2d51e863_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c405299-15c9-4b78-813b-ff0bd1965300_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_2065982d-dc26-4fbe-b094-9b1dea2da623_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_722962fd-7261-4651-970f-8e2fffb27002_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f0bfe626-034d-4efb-989d-6a119bb252e8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dac83001-4a31-46fb-b5e8-1152c21ddf51_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_88580fc3-ce75-4b6e-b857-353bd5034e13_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c8368e8e-36e7-40e4-a8ea-1abfa312934e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_9a54a170-6d23-43d1-8e35-a7bb0d3509e2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_f3c8cf12-f1f4-4438-a336-1f8d072dc778_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_69c5e364-fd28-44bc-9fd4-0a3de36d802e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_aa9111c2-372b-43bb-9e4a-99af39b4b1a2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_1affb2fd-cd53-4e55-a0d7-b0cd63b94f93_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_581d597c-1317-444a-a81d-72ea3ef11da8_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised_9cdad300-885b-4683-b283-d6a6d528cb6b_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised, maximum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Exercised</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a141c8ab-93d1-4ea3-89c8-de8e8c377220_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9525cecf-66de-4011-82c6-e773d6696d75_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_6beb681b-4342-4a0b-b29e-0fd34fea85ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_55e0f8de-05ed-447f-9acb-360534c10d6f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable as of year end, weighted-average contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_154a4290-20ae-4292-b447-c5f989cdd43a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from follow-on equity offering, net of payments for offering costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_a31c191b-5495-4252-8267-aa7340067ad9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate, primarily due to excess tax benefit on stock-based compensation expense (benefit)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e3b654b5-4d8a-4aa6-b747-391949f3cf3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of earnings (loss) per share, basic and diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8729d718-ba70-46c0-bfde-aca3b35a44cf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator (diluted):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5e569ce6-3206-4376-8d5a-37912fda00ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e330cf17-eee9-4cce-84c7-2235d8306fc1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_0594cf65-5dc7-4a8f-8758-055ac5d1d103_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preliminary Allocation of Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_85b5a539-49ce-4ca3-8d8b-b9f5ac558448_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1f6b0e4e-f1f3-40b5-a229-21a6fb24faef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant under incentive plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_4b255826-977d-4194-a928-b5499fd0b0d7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_901cc9b4-1174-49cc-82c5-ca1072648ee3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_105dbc1b-e3dd-405d-ad29-766256ddc093_terseLabel_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liability, Noncurrent</link:label>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:to="lab_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_11a4b5fa-50bf-4fce-92aa-31d13b3698fa_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_c0f77263-5c14-4500-a5fc-258ae2699a9e_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software intangible asset</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_05cef35a-dcbe-4a78-8985-a929e9c7abca_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software development costs incurred and expensed</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Software (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_b353feb8-bfbf-430b-acbf-f7a1fc90d9b0_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fraction of awards fully achieved</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fully Achieved, Ratio</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fully Achieved, Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:to="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_63c0cc00-05a0-41e2-a813-846c7867da26_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1343c4bd-2813-4564-890b-17af6f79a917_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_6f5ccb99-a120-4a63-acae-ad07535c83dc_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment included in accounts payable or accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7d0cd241-9819-4245-91cc-d2891a1a8283_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a5fa50d5-3c2a-4316-9280-c49bb3ac9295_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_6a124121-04f3-4eac-9701-72fb1abfa5f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_595fb720-f083-4c1d-88ba-b074687bb0c5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cb9ed1cb-697c-4f45-b2a2-ad2162fa5bc8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5123bd87-5a80-4208-b8ac-776d1fdcab4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c1965106-a139-47c7-8960-ac339fdcd90c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7c86b466-94b9-4a9b-adb5-529401deeb39_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_94123b6a-dd90-4d86-ad16-e94d160f3ad1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f2afcefb-1f77-4b27-a197-1813de7c160c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b04f3af5-0e9e-495b-a034-ecf5d8e59021_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1cdde807-38b1-4760-9ae8-bfbeff77529e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_b92db6d1-d4f7-4ccd-a02f-05b60447f2ff_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_992ea4ba-6b69-4a6c-a680-4c5d0fc88512_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_346cbf6b-78b5-4c3e-8d87-4161ac795139_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_87c0bb8f-00f1-425b-b898-5975b54a95e0_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on marketable equity securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1b6ac4b7-0b91-4029-a316-cd6fe8759eca_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtCovenantPeriodAxis_824b45ee-9b9f-48a3-a4ca-48896b4384c4_terseLabel_en-US" xlink:label="lab_hqy_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_hqy_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_hqy_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodAxis" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtCovenantPeriodAxis" xlink:to="lab_hqy_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e5d20a3f-f811-492a-ac18-12d639fecea1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_155fb95c-c395-4e85-938c-e3549f6a4e1e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_d422b495-2523-49fb-af29-d7122d812288_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_1fdbb179-4fa7-41dd-b3a7-b3409c3b1d9c_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total amortizable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f2ba9870-7be1-4a80-a568-12d50318cbd8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_2b1b4227-33c5-4800-97e2-0fe3f22acae3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9ede11c8-dd0b-445b-bad5-073abb90f8b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_0b8b755f-cfb6-48a9-ab98-ee393b00f14d_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from follow on offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_566addef-3b3e-4ef1-bce2-914aa80c2569_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3d00758a-de37-4e5f-b23d-08a3543461aa_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c056330b-363f-45d5-adc0-6001c71b1d1f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_e84579e2-91fa-4d9b-a2fb-c43ed98b7bd5_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of team members modification affected</link:label>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_label_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost, Number Of Team Members</link:label>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_documentation_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost, Number Of Team Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:to="lab_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_988f658d-4332-4453-8978-3e8da318f63d_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_94e62b5c-5ed2-46f5-a141-462118e88f1c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_21524b35-0c8a-4211-8061-7a70672b0798_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_e5861b0e-e290-4d51-a6c1-5a67ee9582d3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f6c80fbb-03b1-4c5a-9673-bdfb570be466_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_533f346c-72fe-4d00-b504-dd95d8c02530_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_cd69e7c9-6a2a-473f-94e6-61d9204538eb_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of intangible assets</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_446aef9f-6ee7-42af-9fde-dcd1eea3dffc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c6951699-e920-470e-a073-103899800bff_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest as of year end, weighted average contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_ab522c4e-1db1-4721-aa2e-ecb4237c385c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c1dbef55-065f-41e0-989a-78d12efb7201_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d0389341-167f-44c4-a8e6-fc832955214c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_caff1567-09de-4985-9987-f58d422b810f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4b914c4d-e237-46aa-89e2-406d86bf802d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_ea88698d-78fd-44e9-9b8d-2557dd04e5bd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_ba5bdf97-c2ae-4acc-8d25-c38b69dd6b1a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued liabilities, and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f613341e-5473-4b2e-8ee7-1e9517897441_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2fcedb72-6b29-4c55-8b14-408326ad5255_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_70a89a1b-8a93-4da7-8ae4-2ab9f7ca22e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1ca564c8-5cdb-47cb-a59e-135b5e215056_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a9e4e82e-fb69-45cd-b7d4-e2878cfba47c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8fb8736b-aa15-46eb-962f-3cedeef411b0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_9197b2d3-8eb3-4e4b-96d9-488768f0db59_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger integration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_deff1890-a79d-41f4-af27-2838e6ba36fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13744926-ce82-4dbd-820f-664485f7d509_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_217bd53e-ee8c-447e-9d9c-59840521aa4c_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_eaac5b29-a695-4757-8f4d-7539573ab597_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_5e879f48-5e08-41a0-9e4b-0bf8a3e11479_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_953ab783-17e7-4cd3-89a0-c1f020a73a8f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a7e11ee7-07d5-4bf0-b661-966fe8881cdf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f35b37c9-479e-4ee5-bfa7-df3da09e5f03_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average dilutive effect of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_695c965f-6d2d-42ce-92c1-136a239b9fba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_a27f86c2-bedb-432e-984f-4e184e836fec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing pursuant to term loan facility</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_05a10d96-944d-473f-b7fa-f492327078b2_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_1e51d46b-52af-489c-bbb6-bbc654a975fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a9c5f550-93e6-4ebe-8d8d-0f45b9169620_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8945fd9d-6e9d-45e8-9164-ea4ed9b0eb4f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited_e9df988d-832e-4a36-a0c1-a7541ca81832_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited, maximum (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Forfeited</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b2184684-8f34-4c93-9df9-fd1528b3a3e8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_MergerIntegrationMember_04b7a235-4543-4e90-9710-e202920f138e_terseLabel_en-US" xlink:label="lab_hqy_MergerIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Integration</link:label>
    <link:label id="lab_hqy_MergerIntegrationMember_label_en-US" xlink:label="lab_hqy_MergerIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Integration [Member]</link:label>
    <link:label id="lab_hqy_MergerIntegrationMember_documentation_en-US" xlink:label="lab_hqy_MergerIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_MergerIntegrationMember" xlink:href="hqy-20201031.xsd#hqy_MergerIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_MergerIntegrationMember" xlink:to="lab_hqy_MergerIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ea12b1f8-bb59-4b77-934b-a62b1f3645bf_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_4aa098da-34bc-4082-96db-acfb186e52d8_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c2448c10-8f7e-4c08-9003-0739e3be8315_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement_0c24f0b9-7eb3-46bf-b682-f2ac745c3ab9_terseLabel_en-US" xlink:label="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue interchange arrangement recognition term</link:label>
    <link:label id="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement_label_en-US" xlink:label="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Recognition Term, Interchange Arrangement</link:label>
    <link:label id="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement_documentation_en-US" xlink:label="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Recognition Term, Interchange Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:href="hqy-20201031.xsd#hqy_ContractWithCustomerRecognitionTermInterchangeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:to="lab_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtCovenantPeriodDomain_183be8e3-d06e-477e-bfba-d5ec7e18a697_terseLabel_en-US" xlink:label="lab_hqy_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_hqy_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_hqy_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Debt Covenant Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodDomain" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtCovenantPeriodDomain" xlink:to="lab_hqy_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_408e2adb-870f-4b5f-a8cb-94ad8aabdd74_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_SalesandMarketingMember_52c92bd5-680e-450a-bcd8-2974d119011f_terseLabel_en-US" xlink:label="lab_hqy_SalesandMarketingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_hqy_SalesandMarketingMember_label_en-US" xlink:label="lab_hqy_SalesandMarketingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Marketing [Member]</link:label>
    <link:label id="lab_hqy_SalesandMarketingMember_documentation_en-US" xlink:label="lab_hqy_SalesandMarketingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Marketing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SalesandMarketingMember" xlink:href="hqy-20201031.xsd#hqy_SalesandMarketingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_SalesandMarketingMember" xlink:to="lab_hqy_SalesandMarketingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e1c85a67-99c4-4a1c-870b-23a25be481eb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForSoftware_a8fe4d6d-8e9d-47fb-bf4b-faab71a4a741_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of software and capitalized software development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsForSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForSoftware" xlink:to="lab_us-gaap_PaymentsForSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f9fc69e1-3f31-47d6-8697-33f13d537602_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b245615b-bd30-4e4a-aa01-990ceb776053_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_aca9218a-de00-4c1c-b4f0-771021374fcd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_9eb66086-92b1-4034-b2db-b8f7adb93ae6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_16b10010-3c2e-4aaf-9110-14d452d0ba19_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock issuable (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ce454699-43ef-4397-b132-8779fb31525a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_ee2335b9-7c8e-4973-b708-6b3432c56b2c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0bb650d9-bfb1-4682-b9af-2b211d84ae06_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b75bfc44-768a-49f6-a023-41072b24cc87_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining 2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_c587c0e3-342c-4491-b8ed-a77f31607b50_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_a00f2b98-63fa-47ec-802d-2bf39addb6c6_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customary Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_aa8ae910-20b2-4855-9e1f-38a0e4d1d8e5_terseLabel_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum interest coverage ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_label_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Interest Coverage Ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_documentation_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:to="lab_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_dcddc704-94fb-4c14-a5ba-486c52b41222_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_b5f2c2d8-fe50-4301-b626-924e3f94efc7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5b93efe3-4ac5-4d32-9260-e7dc1a1c4822_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtCovenantPeriodTwoMember_2f14e82b-e9b7-43aa-abe5-f2410c892d4f_terseLabel_en-US" xlink:label="lab_hqy_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, beginning July 31, 2020</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodTwoMember_label_en-US" xlink:label="lab_hqy_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Two [Member]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodTwoMember_documentation_en-US" xlink:label="lab_hqy_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodTwoMember" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtCovenantPeriodTwoMember" xlink:to="lab_hqy_DebtCovenantPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_17468633-7dba-4ca9-9cea-df80a5422686_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_485a8dd3-faf5-41bd-a47a-18d39ae0afbf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_993466a6-c55b-4115-92d0-14c37998468c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0d41a4fd-eb02-49bd-a1f9-a4e870249d1d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_d3347a78-f47b-476c-9752-fbe13ab09a43_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4b19b7c8-ff01-4b10-865a-e0aefd2ab340_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_5dacee95-7f03-453c-8422-8db86baf2323_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_7d58ec14-4fe6-40d8-86fe-1d9fd87b34c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range of exercise prices (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d8df6d09-bd2c-4b0d-bcc0-e8a933c62201_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9e533c5c-8977-4103-ab2d-ed08160bf13d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_4a34a2cd-18b7-45e5-b750-c89aaeac5a57_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_IncentivePlanMember_c6a22261-e868-458e-930f-a162af4d2f98_terseLabel_en-US" xlink:label="lab_hqy_IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Plan</link:label>
    <link:label id="lab_hqy_IncentivePlanMember_label_en-US" xlink:label="lab_hqy_IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Plan [Member]</link:label>
    <link:label id="lab_hqy_IncentivePlanMember_documentation_en-US" xlink:label="lab_hqy_IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncentivePlanMember" xlink:href="hqy-20201031.xsd#hqy_IncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_IncentivePlanMember" xlink:to="lab_hqy_IncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_4153864e-1cca-4a3a-b502-39373e1d67e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8e89e62e-16b5-4bd4-86a2-085cdeb67889_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ExerciseofStockOptionsReceivable_9b27e5e8-4f3b-4e37-9784-d4046c056624_terseLabel_en-US" xlink:label="lab_hqy_ExerciseofStockOptionsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock options receivable</link:label>
    <link:label id="lab_hqy_ExerciseofStockOptionsReceivable_label_en-US" xlink:label="lab_hqy_ExerciseofStockOptionsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Stock Options Receivable</link:label>
    <link:label id="lab_hqy_ExerciseofStockOptionsReceivable_documentation_en-US" xlink:label="lab_hqy_ExerciseofStockOptionsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Stock Options Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ExerciseofStockOptionsReceivable" xlink:href="hqy-20201031.xsd#hqy_ExerciseofStockOptionsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ExerciseofStockOptionsReceivable" xlink:to="lab_hqy_ExerciseofStockOptionsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b0ebcc1f-1cf6-478a-a590-a93eab627548_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_064f0085-10ff-40a4-bd1b-f0f25bcff4fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c5415cae-39fc-4cd8-bda9-8375a67f042b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_95918f9c-fd04-4c54-afef-9785aae7003f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4d83f492-c713-4b34-bebb-09d1de9ce143_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_WageWorksIncentivePlanMember_6bce0c84-a9aa-47c6-bb03-feae187ffba1_terseLabel_en-US" xlink:label="lab_hqy_WageWorksIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks Incentive Plan</link:label>
    <link:label id="lab_hqy_WageWorksIncentivePlanMember_label_en-US" xlink:label="lab_hqy_WageWorksIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks Incentive Plan [Member]</link:label>
    <link:label id="lab_hqy_WageWorksIncentivePlanMember_documentation_en-US" xlink:label="lab_hqy_WageWorksIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncentivePlanMember" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_WageWorksIncentivePlanMember" xlink:to="lab_hqy_WageWorksIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_UnrecognizedTaxBenefitNet_66aed475-2cd9-4f21-851e-8a497d790f77_terseLabel_en-US" xlink:label="lab_hqy_UnrecognizedTaxBenefitNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit</link:label>
    <link:label id="lab_hqy_UnrecognizedTaxBenefitNet_label_en-US" xlink:label="lab_hqy_UnrecognizedTaxBenefitNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit, Net</link:label>
    <link:label id="lab_hqy_UnrecognizedTaxBenefitNet_documentation_en-US" xlink:label="lab_hqy_UnrecognizedTaxBenefitNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_UnrecognizedTaxBenefitNet" xlink:href="hqy-20201031.xsd#hqy_UnrecognizedTaxBenefitNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_UnrecognizedTaxBenefitNet" xlink:to="lab_hqy_UnrecognizedTaxBenefitNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_db5ef1ad-7f24-4b0e-99ca-c0920abd5492_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d94a937b-ea5b-4808-9803-f9bd5b97d806_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_b5f9b4ba-0635-468e-8a27-9802e6edcc22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable as of year end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditAndDebitCardMember_199e9248-4ae7-4450-ad93-c946641b39cd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditAndDebitCardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interchange revenue</link:label>
    <link:label id="lab_us-gaap_CreditAndDebitCardMember_label_en-US" xlink:label="lab_us-gaap_CreditAndDebitCardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit and Debit Card [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAndDebitCardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditAndDebitCardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditAndDebitCardMember" xlink:to="lab_us-gaap_CreditAndDebitCardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_9509df9b-cf26-45f5-8ce2-65160e591d23_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized loan issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_5d2be582-f5c3-45ff-8e65-e67ad8e426ef_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized loan issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b2deee5f-26f2-41a3-ac10-be51bdc86755_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtCovenantPeriodThreeMember_a5a44dcc-0118-4933-a351-634dba5a823b_terseLabel_en-US" xlink:label="lab_hqy_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, beginning July 31, 2021</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodThreeMember_label_en-US" xlink:label="lab_hqy_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Three [Member]</link:label>
    <link:label id="lab_hqy_DebtCovenantPeriodThreeMember_documentation_en-US" xlink:label="lab_hqy_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodThreeMember" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtCovenantPeriodThreeMember" xlink:to="lab_hqy_DebtCovenantPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_d2ed990d-dbd6-457c-8852-365b4b46d613_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e782def5-bb40-4ec7-873a-69f76eacd00b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $3,458 and $1,216 as of October 31, 2020 and January 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_4c815a4b-bfbf-4b43-9e44-a58e2ada90ed_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_eaa0755f-f1c2-4e01-afa5-cb791c3b1249_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_e1acaa1d-1478-492d-aff2-3bc73a9f4801_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_9ef42eae-1641-44d0-af33-1ee663882a09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_PerformanceRestrictedStockAwardsMember_aee026e8-020f-449a-8a5b-9fe8411ef8c5_terseLabel_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance restricted stock awards</link:label>
    <link:label id="lab_hqy_PerformanceRestrictedStockAwardsMember_label_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Awards [Member]</link:label>
    <link:label id="lab_hqy_PerformanceRestrictedStockAwardsMember_documentation_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockAwardsMember" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_PerformanceRestrictedStockAwardsMember" xlink:to="lab_hqy_PerformanceRestrictedStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_1f30a0c7-1539-4de9-a02f-bcbd9678ee7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_8e4b28bd-7407-48bd-ac6d-53891faecafb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4e87e49b-0d66-48b4-a594-0b95180472c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_a0b09c92-3ac3-47c4-a906-f7e5b45b4f89_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_14ca1209-4117-4d13-9088-f98957969702_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f40e8ac5-541e-403c-97b3-8881dd8037b8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_64770c26-71f9-446e-858c-a5e48341e66c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental financial statement information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_340cf792-3246-4fe6-a6e9-21e6b6b320bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9d47250d-9b55-47f7-9b68-8298d890375e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest as of year end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e23618f1-5859-4f3a-a5ad-8005ae5c5c4c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69cc74bb-38ce-42cd-ae76-4e3a397b8521_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5b98a50e-e7bf-415a-931b-13aa6781beb5_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_51926db8-cc7b-4ad9-bf12-a47d6f698b84_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3e4cb0f8-a9e0-4453-b1ba-f1cba0bfd0a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_5cf3edc9-a1b9-4166-83b3-539952ab8b6d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_b43e71ee-624b-4d5a-843c-ecd03dd1b019_verboseLabel_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, decrease in expense due to modification of terms</link:label>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_label_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease In Expense Due To Modification Of Terms</link:label>
    <link:label id="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_documentation_en-US" xlink:label="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease In Expense Due To Modification Of Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:to="lab_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2b7241b9-e825-4dd1-b6c4-80a8fad35b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7cf8b7d4-ac45-479c-8f62-088f7c39f8ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5235bb2d-7621-4c06-8254-8a955323088e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialServiceOtherMember_d4f59c75-988c-4cd9-8f4e-f39a162e4707_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Custodial revenue</link:label>
    <link:label id="lab_us-gaap_FinancialServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_FinancialServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialServiceOtherMember" xlink:to="lab_us-gaap_FinancialServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_177ea3b2-cb2c-4d2d-8932-096b185ea278_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ee798aa6-9f8f-4ab1-9adc-b8df17967bfc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a6ea527c-a6da-49bb-9006-4e742a8c83ff_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_0f66bff1-bcfb-4382-ab93-11f4cf0ea9e7_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_bfbd1638-f1ca-4aa2-b62a-ec9c2f66f0a5_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_56fcbcc2-2b38-4972-a3f1-758653f1501e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest as of year end, aggregate intrinsic value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_9ea9d2a6-0db7-455b-be66-40e0386aec1b_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4d5ade05-3a4b-44e3-954d-be6d3d64755b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_a2a3d470-b863-4bca-9cbd-e73bdb3ad997_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_70dc8901-ee77-46e0-98cd-4513e2627d30_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value, 900,000 shares authorized, 76,951 and 71,051 shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2da05c60-9523-41b5-aeb0-31f455fa4367_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_e7432cfc-e401-40d1-99e3-18238726e773_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_52fc5514-c475-458d-a60d-134867d3e15a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable as of year end, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_61faef91-9fe5-4cb3-adca-1a14e8d95e9f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_af26925f-d5fb-4581-b92f-28c0d325d4af_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_580a9ed9-0ab3-4d7e-aab9-2dea59d50743_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_9d8f4b48-0fa1-4e0c-aca6-44f4b0edd36f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration paid</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d3ba550-127c-4ecd-b2b0-bcfe9409061a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_b403e9ed-8aff-4eef-a2b5-d25e3141b667_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger related costs, price per share</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_62cfbae7-1b73-40d2-a730-a9d950e95810_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7a452db8-6d42-4b95-9f1b-6351d78b6fb5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c11b6eb8-57a3-4b78-a4d4-2b8bed197266_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_eaf7fd21-88fc-42e5-abd4-70fc90731168_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_ba544085-3a76-4b8f-a658-97ec40ebf6e7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c612b0fc-c29b-4299-9ae5-4d36d5bf126b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_211510ae-aa8e-4480-810a-6619d59e9a50_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_97ca0ef8-40d8-46a2-b4a7-c94c64c21ff4_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_36528c71-7742-4aa1-83c3-2ab2c60e12dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a28d7b02-5207-42f2-97ba-3019b39e0a94_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_1b106dd5-814c-40d3-8089-b04c85ce4927_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_3d8f41ed-ab41-4962-8497-1c524033e8b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate fair value of WageWorks stock acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_adc82a72-ffa2-4d22-98db-91ff58964944_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_9f14f79b-4aeb-4f96-b3a3-c2f4ae4da6aa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of service-based common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_040c6793-2d64-4120-8596-3a5cad0d417c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_9dc32bc3-5c96-4b86-b979-226ed5b35302_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_a6ad781f-532f-45b8-8d98-a7ea9314c96c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_dc18ff3a-45fe-4ae0-bf95-759677991a49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental compensation cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_309df0b1-56ab-486c-bb79-d1e5e0423dec_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_e7d7f2f8-3f2e-4569-b69e-453c32cdb172_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of intangible member assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_517c4a69-7525-4334-81c5-473577a4704d_netLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a0acc760-015f-4c6b-a867-63a30bbeceb1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_c12e3315-f148-4859-bf5b-aade2e7a4e51_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration paid, adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_38c9da66-8560-4fa8-ad17-595261040cad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_09d9e1a7-b575-4eaa-9695-462ab9271865_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_669a8e4e-2e12-4a7b-936e-0487d331b5b9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_b6dcb73c-997b-4e1e-afcb-d41a1b7597cc_terseLabel_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum leverage ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_label_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Leverage Ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_documentation_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:to="lab_hqy_DebtInstrumentCovenantDescriptionLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_da31894d-802a-4229-a92d-7663b34cb32c_terseLabel_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_label_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:to="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_TechnologyandDevelopmentMember_fded59c1-1f3b-46d2-a9a8-21bf97c79150_terseLabel_en-US" xlink:label="lab_hqy_TechnologyandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and development</link:label>
    <link:label id="lab_hqy_TechnologyandDevelopmentMember_label_en-US" xlink:label="lab_hqy_TechnologyandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and Development [Member]</link:label>
    <link:label id="lab_hqy_TechnologyandDevelopmentMember_documentation_en-US" xlink:label="lab_hqy_TechnologyandDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TechnologyandDevelopmentMember" xlink:href="hqy-20201031.xsd#hqy_TechnologyandDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_TechnologyandDevelopmentMember" xlink:to="lab_hqy_TechnologyandDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b127a153-fc69-4f92-9dd7-215a4141ce2b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a4df8890-a382-4c0a-8172-caa0257af567_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f3576d8f-d80b-48e5-87d0-88bdfe976943_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_7f0877c4-82c7-4f71-a940-0a20513eb71e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7a6cea05-41a3-4bf4-b6fb-23c104a5805d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_5d847b6a-e56a-4905-a5a9-3aee7ad7f396_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_c06729a1-2290-470c-92a6-510ec12f3b09_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_dcc854b9-ebb4-4b82-a605-fcc7793700f3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7a409090-900f-44d9-ac48-cd43945b8cd1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_787b6893-cd2a-47e4-9487-092ab4f11e72_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1891393f-ecdb-4d35-b871-dcfcf79562fb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8a3a00db-b92a-45ff-b743-890deab11ca2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_495e3c59-ce1d-48fc-b6cf-a14e4d6188ec_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_477221b7-abe6-4d74-9992-7682edb7042f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ba1403d2-358e-4080-a146-6bd62e18fc83_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_a76d660b-b88a-440c-ac63-69895e23455e_negatedLabel_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities, adjustments</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_label_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustment, Current Liabilities, Other</link:label>
    <link:label id="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustment, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:to="lab_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_845552fd-c6ee-4541-b0c7-f2fff2cffcdf_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_f9a98a74-4aee-4a51-8655-97bd74959dc1_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_3e23453c-7570-429f-9e9b-2cb622f0e77b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of business and significant accounting policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_bf460264-4c06-414e-b78f-f79416ef4c8a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9b4d5e59-7987-47a2-ba92-f88ab8db651e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_03bdd6fa-783a-4e5e-a54f-9d97a555697c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ca6c7358-9441-473c-b1de-13b1a7e9a91c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a18140b9-e78c-4be4-8eff-806a88bd4bcf_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_c30bbd88-0dd8-48a0-8fc1-92a140665e80_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_683d59ca-c786-48ae-8546-34544d4b30d6_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_32fafe77-e4db-46b4-a7d0-7230a7480ffb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb1ffd07-b2ee-4328-9c50-6fde4b0e65bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of options (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b018119f-1d46-4b4a-9215-7654dffa7bdf_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_AcquiredHSAIntangibleAssetsMember_bfb69f02-9fb6-445c-a806-70bbb591e7a3_terseLabel_en-US" xlink:label="lab_hqy_AcquiredHSAIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired HSA portfolios</link:label>
    <link:label id="lab_hqy_AcquiredHSAIntangibleAssetsMember_label_en-US" xlink:label="lab_hqy_AcquiredHSAIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired HSA Intangible Assets [Member]</link:label>
    <link:label id="lab_hqy_AcquiredHSAIntangibleAssetsMember_documentation_en-US" xlink:label="lab_hqy_AcquiredHSAIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired HSA Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AcquiredHSAIntangibleAssetsMember" xlink:href="hqy-20201031.xsd#hqy_AcquiredHSAIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_AcquiredHSAIntangibleAssetsMember" xlink:to="lab_hqy_AcquiredHSAIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_beb07720-e08c-4faf-9003-899d9b57c550_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_197c2eca-e803-4aa1-a40d-8ed643266e36_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow data:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_548f7777-28ad-446b-8b08-9f5d2c65013c_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:to="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_8170f6ca-9ff8-40e6-95e2-cd7692a9bc3d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_b50f25c5-db0b-4aa6-bd80-9d82bd798191_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fraction of awards modified</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Remaining Modified, Ratio</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Remaining Modified, Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:to="lab_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_59e90aaf-7edb-48e7-b54b-034a09270464_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of share based compensation recognized</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_98f0fa3c-c431-4437-98dc-72015df34cc9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b93988dd-c86e-4cd0-b678-d64f6050bdf3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b1745094-5c7f-46ac-bccb-cc30989352f8_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_abaf177e-0061-4555-b5dd-50a6d2844a03_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e368c00e-7134-4cc8-a50c-2ad0cbb7f0b8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_f95b2003-4239-4e9d-ad58-e1ccab467282_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_ff059c9c-dce6-48f7-98e9-7e1f7a50c72d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_41460c6b-3883-452d-8d9c-dc5339f55079_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortizable intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_fd622a37-ccd8-4ec8-9453-deda6d7f9ef6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_WageWorksInc.Member_de5391f1-56f6-4a8b-b199-a8c9b02d81e1_terseLabel_en-US" xlink:label="lab_hqy_WageWorksInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks, Inc</link:label>
    <link:label id="lab_hqy_WageWorksInc.Member_label_en-US" xlink:label="lab_hqy_WageWorksInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks Inc. [Member]</link:label>
    <link:label id="lab_hqy_WageWorksInc.Member_documentation_en-US" xlink:label="lab_hqy_WageWorksInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WageWorks Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksInc.Member" xlink:href="hqy-20201031.xsd#hqy_WageWorksInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_WageWorksInc.Member" xlink:to="lab_hqy_WageWorksInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d559c2d4-a576-4b0e-9c6a-e15cea02a960_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4e42985f-a37b-4e86-9ebe-e46c4a229ff1_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_10e511f3-1b31-4045-8677-6dcab4be3217_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e57d9764-c959-4a91-815c-cec8a283736f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_ac95df76-e5f9-49d0-9691-2b59edb1c975_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_cc20e5d8-7383-45fe-948e-f7aa4ed83d2a_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a59d569e-1aca-4760-a10d-82001cdd18fd_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b8f9391-2567-4f52-90ab-70280ef362bc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_892cd530-51ef-4705-a1df-6372b941f3a2_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f511961-adb0-45bf-bcf2-abc730ce8092_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_17425908-706c-4ed9-831b-017a50ec751b_terseLabel_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition threshold for maximum total net leverage ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_label_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Acquisition Threshold For Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_documentation_en-US" xlink:label="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Description, Acquisition Threshold For Maximum Total Net Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:to="lab_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_562ebf1d-bf48-4cc2-817d-3dbced10427e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate borrowing spread</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted_852eec7a-29d9-43ac-b868-672f9154b4b0_terseLabel_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted_label_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Granted</link:label>
    <link:label id="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted_documentation_en-US" xlink:label="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:to="lab_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_TermLoanFacilityMember_1727a1ce-a6ca-49ea-bad4-d57a564c6040_terseLabel_en-US" xlink:label="lab_hqy_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_hqy_TermLoanFacilityMember_label_en-US" xlink:label="lab_hqy_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_hqy_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_hqy_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_TermLoanFacilityMember" xlink:to="lab_hqy_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_e6a79c80-5dac-4593-9ab4-c0a95328badf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-based acquisition consideration</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_PerformanceRestrictedStockUnitsMember_d802ecf2-e3da-4f49-aaab-9360f042af9a_terseLabel_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance restricted stock units</link:label>
    <link:label id="lab_hqy_PerformanceRestrictedStockUnitsMember_label_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units [Member]</link:label>
    <link:label id="lab_hqy_PerformanceRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_hqy_PerformanceRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockUnitsMember" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_PerformanceRestrictedStockUnitsMember" xlink:to="lab_hqy_PerformanceRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_53debda2-02c3-4855-994c-50a2bb079ed0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_5dabc9fc-0ef2-49d9-a306-70794dfe84ad_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d7b59e40-af93-4ede-8003-c04bf35f9442_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_FollowOnEquityOfferingMember_d64737a3-b50e-4ae2-bc73-05d8d959a460_terseLabel_en-US" xlink:label="lab_hqy_FollowOnEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow on equity offering</link:label>
    <link:label id="lab_hqy_FollowOnEquityOfferingMember_label_en-US" xlink:label="lab_hqy_FollowOnEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Equity Offering [Member]</link:label>
    <link:label id="lab_hqy_FollowOnEquityOfferingMember_documentation_en-US" xlink:label="lab_hqy_FollowOnEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Follow On Equity Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_FollowOnEquityOfferingMember" xlink:href="hqy-20201031.xsd#hqy_FollowOnEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_FollowOnEquityOfferingMember" xlink:to="lab_hqy_FollowOnEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_137fead8-9e12-4f39-be59-a7412aa36583_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense paid in cash</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_3eba04e7-2975-492e-963b-e7da81ef80cd_negatedTerseLabel_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_583e4816-ecef-4691-b49f-765c3e2ff1a2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets obtained in exchange for new operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_4a3e083a-2971-4f61-8d07-4d07f722bd31_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7d899f1b-7ada-4229-8f79-9a670ce8227f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_db565c31-2e94-4a0b-a4e8-bf5e6f69237a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_6fdbac62-5d05-4988-a554-9aab443697f7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid in cash, net of refunds received</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74ee5dc0-91dd-4b7d-907a-0fbe33cd436a_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_610e9025-82e3-45cb-829f-ef526d71edf7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c896c9f4-054f-41d6-9ddb-2273e200dbdd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e79c4b80-4c6f-49a7-89ad-28ab5f4cb0c3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2294b274-883b-40de-87a1-c9bd19a7de7a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f13aaa71-b4a9-46ec-aeb4-30f2a26fc060_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_3272e96f-67e1-4c42-b9e6-5a345f36db38_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_5c1e5209-37bb-48cc-977a-7dd950d5c225_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_c3e03f15-c699-465b-b5c9-43d98bb42512_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_1e1734d8-e050-4c33-9de7-01812717e8e2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_WageWorksIncMember_c37a611b-2906-4664-86df-006023d010ca_terseLabel_en-US" xlink:label="lab_hqy_WageWorksIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage Works Inc.</link:label>
    <link:label id="lab_hqy_WageWorksIncMember_label_en-US" xlink:label="lab_hqy_WageWorksIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage Works Inc. [Member]</link:label>
    <link:label id="lab_hqy_WageWorksIncMember_documentation_en-US" xlink:label="lab_hqy_WageWorksIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage Works Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_WageWorksIncMember" xlink:to="lab_hqy_WageWorksIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_181e8077-ccb1-4b34-a497-526b1c3f2850_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_a4bc7d8a-8b9e-4a54-ad07-6cdcf4695823_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator (basic and diluted):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1f7c148a-6612-432f-b478-3be3d6206d1a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_f30617fc-f5e7-461b-bb71-a2d1dc2867cd_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total principal payments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0f5fd403-bd29-49e1-b472-bb6ca4ee1dde_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9ebe869d-f9a8-4ee2-bfde-c5b0653ca74f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_813647eb-fc80-4b9c-81e7-df7db8a22915_terseLabel_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets, adjustments</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_label_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:to="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c837a472-4c21-4802-9b7f-22b74ac0deb0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_ca57d48b-4727-4432-b966-49c1f80a08a8_terseLabel_en-US" xlink:label="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares used in computing net income (loss) per share:</link:label>
    <link:label id="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_label_en-US" xlink:label="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Used In Computing Net Income Per Share Attributable To Common Stockholders, Basic And Diluted [Abstract]</link:label>
    <link:label id="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_documentation_en-US" xlink:label="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares Used In Computing Net Income Per Share Attributable To Common Stockholders, Basic And Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:href="hqy-20201031.xsd#hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:to="lab_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ef12b605-f9b6-419c-a1d2-ed09d8f233ea_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in process software development costs</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b3864ff1-ca3f-41b6-8523-f0c199887da4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_7b6ed73a-b660-44d8-9baa-25cc976b2752_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b2e96d6a-20b0-41d7-a520-549b9e54a272_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_025ff005-2ed9-4f96-aa5b-f746c109356b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_CreditAgreementMember_95ba8b04-b989-4915-8e3d-b75afcacf646_terseLabel_en-US" xlink:label="lab_hqy_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_hqy_CreditAgreementMember_label_en-US" xlink:label="lab_hqy_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_hqy_CreditAgreementMember_documentation_en-US" xlink:label="lab_hqy_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_CreditAgreementMember" xlink:href="hqy-20201031.xsd#hqy_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_CreditAgreementMember" xlink:to="lab_hqy_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc21873e-4aa2-4ddb-b506-3e00d89c502c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_927d09c5-6d98-499a-8d7c-0ad685c1e512_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f0c0e9fc-66d4-4fbd-ac50-f6f0e17753a7_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_48c91ce7-1626-4b32-a513-625ad5d261ff_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7ce9bea1-0a28-4012-baaf-eab3f97bd8d8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dfb0cbc3-e1cf-4ebf-93b2-459d910d73ab_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_137c5978-7fca-446a-85e5-86b2590f86f2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_87587bc6-d306-4426-90a2-d8d14d03c578_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_LossContingencyNumberOfLawsuits_c5854ae2-5464-4b0e-a83a-7d34516985cb_terseLabel_en-US" xlink:label="lab_hqy_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of derivative lawsuits</link:label>
    <link:label id="lab_hqy_LossContingencyNumberOfLawsuits_label_en-US" xlink:label="lab_hqy_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number Of Lawsuits</link:label>
    <link:label id="lab_hqy_LossContingencyNumberOfLawsuits_documentation_en-US" xlink:label="lab_hqy_LossContingencyNumberOfLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number Of Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_LossContingencyNumberOfLawsuits" xlink:href="hqy-20201031.xsd#hqy_LossContingencyNumberOfLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_LossContingencyNumberOfLawsuits" xlink:to="lab_hqy_LossContingencyNumberOfLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_3d5f304e-e6eb-4ecd-b143-c42c67844339_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8924a199-b8a6-49ee-83b1-7c4b47979405_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fd575c56-23c6-44b2-b0ef-2566c7cb7674_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_34b4cf6f-98e9-4a3b-877c-fd46e38d1771_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7ad88533-0541-4ef5-82e9-120da7cbb995_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding stock options, weighted average contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cdd198da-1363-4ff9-aafa-edbd0b887bd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f24a663f-cc53-4ac0-9b6d-ed7e581b9174_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_fd1e8a78-4dd8-407f-81ca-6977c64b0026_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_632caa47-14a2-4545-bbf6-1a89c52e8934_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_491186b0-12aa-4436-8e78-a885a869830a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_402f9419-24cf-4e2d-b7f7-af930006e063_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable as of year end, weighted-average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_d697cd32-081b-48ff-abd7-eaced08be31c_negatedLabel_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability, adjustments</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_label_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:label id="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_documentation_en-US" xlink:label="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:to="lab_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_hqy_PaymentsToSettleClientHeldFunds_b2092223-28d3-4171-9747-25461ce0b118_negatedTerseLabel_en-US" xlink:label="lab_hqy_PaymentsToSettleClientHeldFunds" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of client-held funds obligation, net</link:label>
    <link:label id="lab_hqy_PaymentsToSettleClientHeldFunds_label_en-US" xlink:label="lab_hqy_PaymentsToSettleClientHeldFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Settle Client Held Funds</link:label>
    <link:label id="lab_hqy_PaymentsToSettleClientHeldFunds_documentation_en-US" xlink:label="lab_hqy_PaymentsToSettleClientHeldFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Settle Client Held Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PaymentsToSettleClientHeldFunds" xlink:href="hqy-20201031.xsd#hqy_PaymentsToSettleClientHeldFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hqy_PaymentsToSettleClientHeldFunds" xlink:to="lab_hqy_PaymentsToSettleClientHeldFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_990db1fd-3960-426f-9677-0cabb2204519_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7a59ed8-f739-4df5-aafb-dfa1e1b30e97_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_52ea89e2-cb1d-44ad-bba8-5a34bda1e1c7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3c30dc5a-b370-42e6-85cd-1eaaa9283b58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest as of year end, weighted average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_a7447922-e2d4-49af-ae3c-91462dd3c030_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other issuance of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_cd34e068-4b07-4f7b-bb4a-6352715ad679_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent adopted accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_514fbfe8-4ec9-4c69-bd23-2da96e94ffdf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hqy-20201031_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:89446445-04cb-480c-a9b1-4904a6ee822b,g:833e705b-1998-4416-a90a-67ed8e31f646-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthequity.com/role/CoverPage" xlink:type="simple" xlink:href="hqy-20201031.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c679ff5e-89d3-4b78-a0f0-83371cd91fa1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentType_c679ff5e-89d3-4b78-a0f0-83371cd91fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b0ccca7b-09e8-4567-ad37-41c33771b15f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentQuarterlyReport_b0ccca7b-09e8-4567-ad37-41c33771b15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c10ca5d-f189-41cf-94f3-c351db1e4936" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentPeriodEndDate_8c10ca5d-f189-41cf-94f3-c351db1e4936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_fc49c5bc-1cce-4f92-a508-66d39afc0753" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentTransitionReport_fc49c5bc-1cce-4f92-a508-66d39afc0753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c9a7a0a9-6bd5-4459-8343-29e7ec3b5609" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityFileNumber_c9a7a0a9-6bd5-4459-8343-29e7ec3b5609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9e6d049d-48ec-4d35-a3a2-fd96abb4b3c7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityRegistrantName_9e6d049d-48ec-4d35-a3a2-fd96abb4b3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3aa72090-c93d-4109-9dad-e155c43e1913" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3aa72090-c93d-4109-9dad-e155c43e1913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_61f30b7b-6865-48df-b380-3a7ba53107ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityTaxIdentificationNumber_61f30b7b-6865-48df-b380-3a7ba53107ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ce73fdce-264c-4437-a683-114704745f0d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityAddressAddressLine1_ce73fdce-264c-4437-a683-114704745f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_54ddf6eb-e950-4c18-a008-378a2fd2a891" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityAddressAddressLine2_54ddf6eb-e950-4c18-a008-378a2fd2a891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1599dad5-a52c-405c-9467-e942b02cd338" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityAddressCityOrTown_1599dad5-a52c-405c-9467-e942b02cd338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d0f05456-bb63-4153-9574-6537ba088552" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityAddressStateOrProvince_d0f05456-bb63-4153-9574-6537ba088552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c41c04a-fcfc-4a81-a03e-e65684483c9e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityAddressPostalZipCode_1c41c04a-fcfc-4a81-a03e-e65684483c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b5c942cc-a151-48cd-8ebb-b42add8b92a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_CityAreaCode_b5c942cc-a151-48cd-8ebb-b42add8b92a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_97698cbd-a363-4df9-9858-823b67d6d2a4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_LocalPhoneNumber_97698cbd-a363-4df9-9858-823b67d6d2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_10e09728-59fb-45a0-91b2-db69b9182b63" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_Security12bTitle_10e09728-59fb-45a0-91b2-db69b9182b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4e9a4953-b1ce-4d2b-81e7-fbded6ea1401" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_TradingSymbol_4e9a4953-b1ce-4d2b-81e7-fbded6ea1401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4b7bd48b-62e2-4cb7-88fe-d72e75dabd24" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_SecurityExchangeName_4b7bd48b-62e2-4cb7-88fe-d72e75dabd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9a3cb32e-6cc1-43aa-8b5d-2bd9f3de86a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityCurrentReportingStatus_9a3cb32e-6cc1-43aa-8b5d-2bd9f3de86a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3c461785-232b-4a85-a665-130b09783edf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityInteractiveDataCurrent_3c461785-232b-4a85-a665-130b09783edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_03171e9b-135f-4d87-af86-7c5956d99c43" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityFilerCategory_03171e9b-135f-4d87-af86-7c5956d99c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d839b7ad-491f-4218-9e1c-6455387cbf72" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntitySmallBusiness_d839b7ad-491f-4218-9e1c-6455387cbf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_35d8654f-e94f-451e-b0eb-1f2eab33b52f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityEmergingGrowthCompany_35d8654f-e94f-451e-b0eb-1f2eab33b52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_23b6c129-4f68-4705-90dd-ef7db5c46060" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityShellCompany_23b6c129-4f68-4705-90dd-ef7db5c46060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_89f49fb4-983a-4320-8e82-f6e2909130be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_89f49fb4-983a-4320-8e82-f6e2909130be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b5402e3-0620-44e9-b89f-d1e330d0f80f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_EntityCentralIndexKey_7b5402e3-0620-44e9-b89f-d1e330d0f80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9f04cec1-c585-4720-ac71-54668772c0b8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_CurrentFiscalYearEndDate_9f04cec1-c585-4720-ac71-54668772c0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_28d76d9f-c517-4787-bf1d-7a425ed6d2b7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentFiscalYearFocus_28d76d9f-c517-4787-bf1d-7a425ed6d2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e2c014d0-5655-45a9-a480-342742a183f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e2c014d0-5655-45a9-a480-342742a183f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eb2e2471-eb9d-4084-a366-ff933eb84468" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94b4beeb-8985-47c0-98c0-a1754f22b57c" xlink:to="loc_dei_AmendmentFlag_eb2e2471-eb9d-4084-a366-ff933eb84468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedbalancesheets"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedbalancesheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_75ec3992-4843-4331-b57b-c75ec100576c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_75ec3992-4843-4331-b57b-c75ec100576c" xlink:to="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98ca3113-e318-44ca-a148-5d3a945cd174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_98ca3113-e318-44ca-a148-5d3a945cd174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_543e338b-9501-4e4a-a521-cc0b9dee23fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_543e338b-9501-4e4a-a521-cc0b9dee23fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_9ef269be-2115-4b42-9b70-d352521d6566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:to="loc_us-gaap_OtherAssetsCurrent_9ef269be-2115-4b42-9b70-d352521d6566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_264d1511-ff8b-4929-8bd4-1a5ec3b26b5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c30144d8-de59-412b-92af-9872081702bd" xlink:to="loc_us-gaap_AssetsCurrent_264d1511-ff8b-4929-8bd4-1a5ec3b26b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6b5a939c-c1e1-44e7-8d70-7b4f7710abba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6b5a939c-c1e1-44e7-8d70-7b4f7710abba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_69755508-869d-4282-893b-2110c2a267a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_69755508-869d-4282-893b-2110c2a267a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6797fff6-c3cb-43c7-a275-5e2039f37091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6797fff6-c3cb-43c7-a275-5e2039f37091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_125ab190-22c6-4dcb-870d-c999b8f8a68c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_Goodwill_125ab190-22c6-4dcb-870d-c999b8f8a68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_aced8aa7-e192-4b20-b648-70226598f1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_aced8aa7-e192-4b20-b648-70226598f1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_609cd55b-f083-4383-9fe5-d86d4e076dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_609cd55b-f083-4383-9fe5-d86d4e076dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_311bf0d3-4214-48bc-8318-01de6a8df92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e3ce19b3-6edc-408b-82e2-30d9e9fad8fe" xlink:to="loc_us-gaap_Assets_311bf0d3-4214-48bc-8318-01de6a8df92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_75ec3992-4843-4331-b57b-c75ec100576c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4a59257-11f1-4798-943b-41c03cc14d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4a59257-11f1-4798-943b-41c03cc14d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c9574475-878f-42a8-ae32-83420931fe9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c9574475-878f-42a8-ae32-83420931fe9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6b33c92d-eaab-4f43-9a42-3239a6c8d291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6b33c92d-eaab-4f43-9a42-3239a6c8d291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_09cae8eb-7314-4d56-bbc0-cd1c8e6758a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_LongTermDebtCurrent_09cae8eb-7314-4d56-bbc0-cd1c8e6758a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d286840-9cfd-49ce-8f92-652aead98143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8d286840-9cfd-49ce-8f92-652aead98143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0fd375c6-5375-46d5-b81b-ca24a325f050" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_03068b25-8ece-4413-a1ef-73e6070333a7" xlink:to="loc_us-gaap_LiabilitiesCurrent_0fd375c6-5375-46d5-b81b-ca24a325f050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3b8c40f0-2edb-49b8-89e7-482c3bd38136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3b8c40f0-2edb-49b8-89e7-482c3bd38136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fcba8bb6-6979-4049-bcb1-fa8bad5da6ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fcba8bb6-6979-4049-bcb1-fa8bad5da6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_550938b5-8e8b-4d2c-9285-a88a6ef5856d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_550938b5-8e8b-4d2c-9285-a88a6ef5856d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0e7f58f5-6f29-4bf5-a304-25c8a517636b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0e7f58f5-6f29-4bf5-a304-25c8a517636b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_a199f99d-e2b0-4d95-907b-8d3ae847741b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_a199f99d-e2b0-4d95-907b-8d3ae847741b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5f10ccd1-2a24-4881-91f6-a10741ec63ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_Liabilities_5f10ccd1-2a24-4881-91f6-a10741ec63ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6d937422-6218-45f4-9b63-152bf23809f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_5f0dd939-66eb-4ad8-8a65-e036ee48c157" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6d937422-6218-45f4-9b63-152bf23809f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_939e5953-902d-4ddd-b3b3-316455856be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:to="loc_us-gaap_PreferredStockValue_939e5953-902d-4ddd-b3b3-316455856be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7d127e5c-0e91-4d0f-9db4-3eec72f6cc99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:to="loc_us-gaap_CommonStockValue_7d127e5c-0e91-4d0f-9db4-3eec72f6cc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4a0ee93d-1e5b-4048-8367-b908bdafb8fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4a0ee93d-1e5b-4048-8367-b908bdafb8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f60b8070-c231-4b9b-89eb-e83eda4ffe4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f60b8070-c231-4b9b-89eb-e83eda4ffe4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bb1e3a23-7f9f-4688-b9d4-ec4db27fd2e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_934c11f0-69e0-4b7f-ad5a-cef1914d8d7e" xlink:to="loc_us-gaap_StockholdersEquity_bb1e3a23-7f9f-4688-b9d4-ec4db27fd2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_344a374a-8f9f-42c4-a247-94f5ec3105f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f328bc3f-85ea-4e40-8e95-33fef227864e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_344a374a-8f9f-42c4-a247-94f5ec3105f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="simple" xlink:href="hqy-20201031.xsd#CondensedconsolidatedbalancesheetsParenthetical"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_70cf9f05-4e39-4ea0-9a57-33116df9f493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_70cf9f05-4e39-4ea0-9a57-33116df9f493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7bb805f6-fe30-47e7-b6da-6a5741b2d03b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_7bb805f6-fe30-47e7-b6da-6a5741b2d03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_8e993687-c68d-4fef-a60a-6f1148a81e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_8e993687-c68d-4fef-a60a-6f1148a81e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_5e0224ed-1f07-4f51-8413-0c28ca4fed81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_PreferredStockSharesIssued_5e0224ed-1f07-4f51-8413-0c28ca4fed81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_cd2fff51-ea77-4db5-9877-b3f728f4afc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_cd2fff51-ea77-4db5-9877-b3f728f4afc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_32d59ea5-5dc1-4469-bf69-c6ace2e6cf36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_32d59ea5-5dc1-4469-bf69-c6ace2e6cf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bb980e6e-d728-4005-9c29-f393c97c3922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bb980e6e-d728-4005-9c29-f393c97c3922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_fb8e505a-f7df-4fc9-a006-faba5f4fa2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_CommonStockSharesIssued_fb8e505a-f7df-4fc9-a006-faba5f4fa2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_733f55d5-35cd-4b8b-96d0-947d495fd4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3d43a930-15cf-4c0b-9e52-afc290c5885c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_733f55d5-35cd-4b8b-96d0-947d495fd4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bd41323c-7850-487b-b025-e166d0600a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bd41323c-7850-487b-b025-e166d0600a01" xlink:to="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:to="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_3cbc3a02-d87f-4d69-8a98-07884b21c534" xlink:to="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_19f7e30c-7f7b-4a72-bf24-1a0909e633c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_ServiceMember_19f7e30c-7f7b-4a72-bf24-1a0909e633c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialServiceOtherMember_856d94f4-bde5-4f3e-80bc-d8cdcd6f119f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_FinancialServiceOtherMember_856d94f4-bde5-4f3e-80bc-d8cdcd6f119f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditAndDebitCardMember_a0fd11da-a218-4733-b657-604b19e0b4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditAndDebitCardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2cdf71cd-2cf8-4751-9345-5a1d77deafd1" xlink:to="loc_us-gaap_CreditAndDebitCardMember_a0fd11da-a218-4733-b657-604b19e0b4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0764070e-c75f-43c2-8988-ff50a013c77d" xlink:to="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b86c94b-4391-46e8-b0aa-4642a03b7fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d9c9ab72-a604-4c9d-86c9-263ed33e3ace" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9b86c94b-4391-46e8-b0aa-4642a03b7fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a9eda8eb-ec55-4c81-aa2d-62494afe8fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a9eda8eb-ec55-4c81-aa2d-62494afe8fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4f98d7f6-d65f-4c16-b517-332ececba2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_a4da455a-bcd2-496c-9304-28ef0b952a59" xlink:to="loc_us-gaap_GrossProfit_4f98d7f6-d65f-4c16-b517-332ececba2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_6366d1ce-4dc0-4efd-90ba-b83760ec1121" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_6366d1ce-4dc0-4efd-90ba-b83760ec1121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_03950fc6-fd30-4004-8172-f778bcb44103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_03950fc6-fd30-4004-8172-f778bcb44103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3f53a896-fafb-4055-a152-d49d6a254d71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3f53a896-fafb-4055-a152-d49d6a254d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AmortizationOfAcquiredIntangible_66b69f3a-e528-4c99-8585-85f59fb150fa" xlink:href="hqy-20201031.xsd#hqy_AmortizationOfAcquiredIntangible"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_hqy_AmortizationOfAcquiredIntangible_66b69f3a-e528-4c99-8585-85f59fb150fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eb40c49f-7372-4dc4-a092-c5de167da4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_eb40c49f-7372-4dc4-a092-c5de167da4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1273d11a-a7ae-4fe5-820c-dee796926968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_da9c2daf-6752-4ac6-ae47-a93768adbe4c" xlink:to="loc_us-gaap_OperatingExpenses_1273d11a-a7ae-4fe5-820c-dee796926968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8e9c5526-f848-409c-8930-b94fc29e6598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OperatingIncomeLoss_8e9c5526-f848-409c-8930-b94fc29e6598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_7a3e40b3-cc49-4ffc-86f6-06e0249b5035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_InterestExpense_7a3e40b3-cc49-4ffc-86f6-06e0249b5035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_058e4c0c-3dc4-4457-8354-ba752cce739f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_058e4c0c-3dc4-4457-8354-ba752cce739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_188b887a-e0e4-4d30-a8a2-61be0e0a4e39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_30ddf1ee-737d-401d-85df-a9528c6000e3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_188b887a-e0e4-4d30-a8a2-61be0e0a4e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_16fce13c-c647-4672-bb0d-b9be5e99afd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_16fce13c-c647-4672-bb0d-b9be5e99afd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d9a348c4-f941-41ad-9f89-52f7e10e38a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d9a348c4-f941-41ad-9f89-52f7e10e38a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d27a9c4-e984-4b86-b81c-40697891a7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_NetIncomeLoss_5d27a9c4-e984-4b86-b81c-40697891a7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c56ad1d-ec0d-4f04-bdfb-37114880dd63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c56ad1d-ec0d-4f04-bdfb-37114880dd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_796c1f1e-24e0-4df5-aec3-281b9e07b78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:to="loc_us-gaap_EarningsPerShareBasic_796c1f1e-24e0-4df5-aec3-281b9e07b78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_28c3f14f-3677-426b-97d0-609a21bbe0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3c8b981c-5e25-4280-a17c-d102cd9559be" xlink:to="loc_us-gaap_EarningsPerShareDiluted_28c3f14f-3677-426b-97d0-609a21bbe0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:href="hqy-20201031.xsd#hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2ae4ace1-fa90-4674-9d8b-109d61bef513" xlink:to="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f05978d-c4c4-44cd-8182-cdd0369aae3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7f05978d-c4c4-44cd-8182-cdd0369aae3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba465875-b260-43c6-a599-6d72b99bd6fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract_14690d3f-d224-4930-a397-016a24e47579" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ba465875-b260-43c6-a599-6d72b99bd6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofstockholdersequityunaudited"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_06e3330a-188f-46b6-8396-59cae8133562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_06e3330a-188f-46b6-8396-59cae8133562" xlink:to="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8e3129e9-d79c-47a8-8a11-a44edee04bed" xlink:to="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_19107db2-cf7c-488a-b82c-5a6a5dd194bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_CommonStockMember_19107db2-cf7c-488a-b82c-5a6a5dd194bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d806cf73-8723-465c-9853-7a46f703874b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d806cf73-8723-465c-9853-7a46f703874b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_af67d0bc-b7ff-4e5a-8edf-8e95316da5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2cb53cc-02ed-419e-a018-98d5a31b0f4d" xlink:to="loc_us-gaap_RetainedEarningsMember_af67d0bc-b7ff-4e5a-8edf-8e95316da5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3eb0ab46-309e-428d-9f23-bf15ac8b370d" xlink:to="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_12a7e64e-9dd4-4ccf-8429-c6a23f3a7360" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_407cfa88-8189-4cbd-920f-59d38495f8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockholdersEquity_407cfa88-8189-4cbd-920f-59d38495f8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5fa9d0e2-f2b4-4138-b5ae-0058b1dcd3ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_5fa9d0e2-f2b4-4138-b5ae-0058b1dcd3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_97f3aa81-abae-422a-81e6-719643626d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_97f3aa81-abae-422a-81e6-719643626d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f02735da-2b65-407f-a90c-4d34011c498c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f02735da-2b65-407f-a90c-4d34011c498c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5fe1dc8a-6e9d-4951-8251-a9398e69687a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_NetIncomeLoss_5fe1dc8a-6e9d-4951-8251-a9398e69687a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c2c8db27-d647-44c4-95f7-3a3efbfb0b10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6cca35c-bd5c-466a-9d62-4f64f5862eb2" xlink:to="loc_us-gaap_StockholdersEquity_c2c8db27-d647-44c4-95f7-3a3efbfb0b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="simple" xlink:href="hqy-20201031.xsd#Condensedconsolidatedstatementsofcashflowsunaudited"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_117a4d09-abed-4fee-8958-203a0f9089e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_117a4d09-abed-4fee-8958-203a0f9089e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d6ff70d5-74b8-4127-9007-e0ff6883519e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_117a4d09-abed-4fee-8958-203a0f9089e6" xlink:to="loc_us-gaap_NetIncomeLoss_d6ff70d5-74b8-4127-9007-e0ff6883519e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_117a4d09-abed-4fee-8958-203a0f9089e6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5851bc11-0a85-42d4-a44b-2ae28c10ca98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5851bc11-0a85-42d4-a44b-2ae28c10ca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_49bb6d79-4293-456b-9646-74ff89679482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_ShareBasedCompensation_49bb6d79-4293-456b-9646-74ff89679482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_95e7faa0-f26f-4f2b-8c5d-be041996979a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_95e7faa0-f26f-4f2b-8c5d-be041996979a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_e6769997-7959-484c-816f-d76c7fb2ca37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_e6769997-7959-484c-816f-d76c7fb2ca37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019beb38-9b90-4517-be3c-733bd93a225d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019beb38-9b90-4517-be3c-733bd93a225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bdbe0cdf-4acd-431f-8c4a-e53b5c092260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_bdbe0cdf-4acd-431f-8c4a-e53b5c092260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cbbe9ed1-2b5f-42bd-b849-d26b73fde535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cbbe9ed1-2b5f-42bd-b849-d26b73fde535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_13f25f8a-193e-4e1d-a1b9-6251b2f72680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_13f25f8a-193e-4e1d-a1b9-6251b2f72680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_b21ef45b-eb15-4606-8361-b26f95ab8869" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_b21ef45b-eb15-4606-8361-b26f95ab8869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f4b1973e-57f1-40bb-9670-1dd8bc37e818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f4b1973e-57f1-40bb-9670-1dd8bc37e818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3c841524-db7b-4a31-a345-deb2417c9695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3c841524-db7b-4a31-a345-deb2417c9695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_914280ef-3120-4553-b137-7574987d066e" xlink:href="hqy-20201031.xsd#hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent_914280ef-3120-4553-b137-7574987d066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_7ef535b3-bb56-4bf0-875f-1261369cea84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8778012a-3fe7-4db7-a5cf-c7f707debe7c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_7ef535b3-bb56-4bf0-875f-1261369cea84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_33e47625-00c3-4246-9fa7-b8819f66ba82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a326f7f-def4-499e-9e56-926aedad9883" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_33e47625-00c3-4246-9fa7-b8819f66ba82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_685b6f3f-b6b2-4fe7-8263-59c392ce30a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_685b6f3f-b6b2-4fe7-8263-59c392ce30a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_f57c8f18-7d40-4f93-8671-a8a519e29cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_PaymentsForSoftware_f57c8f18-7d40-4f93-8671-a8a519e29cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_91996836-5d9e-4a74-85cf-692195f305ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_91996836-5d9e-4a74-85cf-692195f305ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_5ba87443-e8c8-4ce9-83cc-4d12bfd3899f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_5ba87443-e8c8-4ce9-83cc-4d12bfd3899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3fcbf2ab-13e9-48d6-8782-0ffc26d9f129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3fcbf2ab-13e9-48d6-8782-0ffc26d9f129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54e2a45b-e286-417a-a8a0-d48d738a1139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7d89e1bc-1449-407e-bfd0-380f931f11d9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54e2a45b-e286-417a-a8a0-d48d738a1139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_73ab70ca-055d-46b2-ac23-8a7f85379d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_73ab70ca-055d-46b2-ac23-8a7f85379d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2ec983af-9520-4b8b-a950-ffcb1aca8e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2ec983af-9520-4b8b-a950-ffcb1aca8e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PaymentsToSettleClientHeldFunds_2bbe6493-a018-4101-8908-d88467a1d05f" xlink:href="hqy-20201031.xsd#hqy_PaymentsToSettleClientHeldFunds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_hqy_PaymentsToSettleClientHeldFunds_2bbe6493-a018-4101-8908-d88467a1d05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f5d32530-3175-4f8d-b3b5-93fcca9fbc74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f5d32530-3175-4f8d-b3b5-93fcca9fbc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_899bc9e4-e23d-47e3-91b6-0fd54a1ef5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_899bc9e4-e23d-47e3-91b6-0fd54a1ef5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4bdedd84-2fa9-4fbc-a126-28aab5e8e56d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4bdedd84-2fa9-4fbc-a126-28aab5e8e56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5719480f-8524-409e-8e50-9f17f74c452d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ee4df74f-4a7d-42fc-914c-ae644040aca9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5719480f-8524-409e-8e50-9f17f74c452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e8d54a-efd2-4c8c-9020-6da985e4a722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e8d54a-efd2-4c8c-9020-6da985e4a722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97760487-c5aa-44e6-b8d0-f775b6b3eee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97760487-c5aa-44e6-b8d0-f775b6b3eee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50d9fa12-9f6d-4677-9e15-75079a9b3aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_50d9fa12-9f6d-4677-9e15-75079a9b3aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_db4dd566-e009-4c0d-9df8-549fe16773d8" xlink:to="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0d828a71-6d1f-482c-a825-00568c58fe3d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bc15da12-0e59-4798-a17a-841124928686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bc15da12-0e59-4798-a17a-841124928686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AcquiredHSAIntangibleAssetsMember_d6e6d648-b630-43b7-991a-41259becee0e" xlink:href="hqy-20201031.xsd#hqy_AcquiredHSAIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47460b32-cb2e-43da-aa00-232eff4c6d49" xlink:to="loc_hqy_AcquiredHSAIntangibleAssetsMember_d6e6d648-b630-43b7-991a-41259becee0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_914f0aa2-f7ff-45c2-8fe6-0a09e05be535" xlink:to="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6bb05ce5-0142-4caa-9917-f133963db090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:to="loc_us-gaap_InterestPaidNet_6bb05ce5-0142-4caa-9917-f133963db090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7831f23a-d403-4783-b012-8531f65c7ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5aa898a3-59ff-4354-8426-8e157a09e7b2" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_7831f23a-d403-4783-b012-8531f65c7ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_531e5e50-d370-4359-a6a1-fc946e1b5aae" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_36a500a3-4015-447d-9d8b-7c5d3274fea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_36a500a3-4015-447d-9d8b-7c5d3274fea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_f426d367-d9d9-43dc-8482-4f747306c429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_f426d367-d9d9-43dc-8482-4f747306c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_502f872e-555d-403e-94b7-2973879c8807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_502f872e-555d-403e-94b7-2973879c8807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ExerciseofStockOptionsReceivable_d12d43d2-15de-4186-9c05-546cde0ff3a5" xlink:href="hqy-20201031.xsd#hqy_ExerciseofStockOptionsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_hqy_ExerciseofStockOptionsReceivable_d12d43d2-15de-4186-9c05-546cde0ff3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_54b53a4e-660f-4e23-8d97-75e95574b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_90ec5c06-f9f3-4ac4-8afe-283411bbbf5c" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_54b53a4e-660f-4e23-8d97-75e95574b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Summaryofbusinessandsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da9325ce-ce91-4a95-a548-5914a783d0bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_ca43fe67-85f5-4999-b148-2ec1cd948080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_da9325ce-ce91-4a95-a548-5914a783d0bf" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_ca43fe67-85f5-4999-b148-2ec1cd948080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_40661dd7-0e54-4a7a-a5ab-82766d429e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_40661dd7-0e54-4a7a-a5ab-82766d429e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c9f0fb7c-ae69-4280-90ae-dd583148683b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c9f0fb7c-ae69-4280-90ae-dd583148683b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_b4b644b6-7932-4c66-aaf5-d365e01b0e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_b4b644b6-7932-4c66-aaf5-d365e01b0e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e2eeb9da-c3fb-4fc3-b69b-d1fb07ece980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e2eeb9da-c3fb-4fc3-b69b-d1fb07ece980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c3176796-b652-49ba-acbf-a6a5713909ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_db033f78-eb37-485b-911b-192e3aaa8788" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_c3176796-b652-49ba-acbf-a6a5713909ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b2281f73-c89a-44fc-9e76-e45898224a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b2281f73-c89a-44fc-9e76-e45898224a61" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_18f76342-d526-4f96-b079-742bc23181a6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_FollowOnEquityOfferingMember_e423b77a-aa7e-41ed-9bfd-621256866c86" xlink:href="hqy-20201031.xsd#hqy_FollowOnEquityOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c072b48f-9d0d-4ca1-89f9-86bebd146a85" xlink:to="loc_hqy_FollowOnEquityOfferingMember_e423b77a-aa7e-41ed-9bfd-621256866c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b5b3cc22-239c-4ea1-b390-5f1900cb3803" xlink:to="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_831a3736-c1e1-41dd-b3f9-fe0b6f6bf4db" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8b864e7c-6f26-4924-8932-b2244ecb0a4e" xlink:to="loc_hqy_TermLoanFacilityMember_831a3736-c1e1-41dd-b3f9-fe0b6f6bf4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb64cd8-5f4d-48c2-83e1-65fd5ccfc314" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_0f393b2c-bcf1-4432-8310-87a3c64edf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f93c2823-f9b2-46df-b194-7a11988afca4" xlink:to="loc_us-gaap_LineOfCreditMember_0f393b2c-bcf1-4432-8310-87a3c64edf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_cbb2842c-7169-4ece-bd4b-ef2f8d0293db" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bbdda66-4ec6-40af-8db4-90ff8de74a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6bbdda66-4ec6-40af-8db4-90ff8de74a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a509be5f-519f-4630-a7a2-48aaecf7fc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a509be5f-519f-4630-a7a2-48aaecf7fc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eabbc657-f8ee-41d3-954e-8660a9f064c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_eabbc657-f8ee-41d3-954e-8660a9f064c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_41c9cc68-f629-4b4c-8212-1b04371457c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_41c9cc68-f629-4b4c-8212-1b04371457c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_StockIssuanceCostsPayable_f037631d-a9c7-4c4d-9625-6611837983a9" xlink:href="hqy-20201031.xsd#hqy_StockIssuanceCostsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_hqy_StockIssuanceCostsPayable_f037631d-a9c7-4c4d-9625-6611837983a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_81dc4e30-1e3b-483f-9cd6-f6d5d795ccbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e91a5d1d-61ee-473b-a0cb-5fe1e673938b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_81dc4e30-1e3b-483f-9cd6-f6d5d795ccbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Netincomelosspershare" xlink:type="simple" xlink:href="hqy-20201031.xsd#Netincomelosspershare"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Netincomelosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2d73085d-22f4-4a80-a1ac-aff7b85b2db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_05d8467e-f2a6-4caa-9324-d9bcbb599a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2d73085d-22f4-4a80-a1ac-aff7b85b2db7" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_05d8467e-f2a6-4caa-9324-d9bcbb599a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/NetincomelosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_26563923-42af-4767-96dd-40a3d67f0be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_916e92ba-95a4-4dad-89dd-9e186cce0a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_26563923-42af-4767-96dd-40a3d67f0be9" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_916e92ba-95a4-4dad-89dd-9e186cce0a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#NetincomelosspershareDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/NetincomelosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_7164fbba-5f2c-4e44-abff-cb476a76ac6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_7164fbba-5f2c-4e44-abff-cb476a76ac6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_acfdb402-2732-4290-bc8a-020213c2ecad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_7164fbba-5f2c-4e44-abff-cb476a76ac6e" xlink:to="loc_us-gaap_NetIncomeLoss_acfdb402-2732-4290-bc8a-020213c2ecad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_1c55c9f1-8d09-4026-bd23-55a1088ff1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_1c55c9f1-8d09-4026-bd23-55a1088ff1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f44a687-c7db-4d77-9629-b2ca0afcc9dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_1c55c9f1-8d09-4026-bd23-55a1088ff1c5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f44a687-c7db-4d77-9629-b2ca0afcc9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b130a8-eb6d-4624-806a-66667d74ae2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b130a8-eb6d-4624-806a-66667d74ae2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4a26777b-7279-477f-8932-ad818d765a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b130a8-eb6d-4624-806a-66667d74ae2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4a26777b-7279-477f-8932-ad818d765a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3b95e747-7ca5-4f52-8404-4a02ebf4a1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b130a8-eb6d-4624-806a-66667d74ae2d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3b95e747-7ca5-4f52-8404-4a02ebf4a1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2306c4c7-97cb-409d-a9b7-30dd4ebbe161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_34b130a8-eb6d-4624-806a-66667d74ae2d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2306c4c7-97cb-409d-a9b7-30dd4ebbe161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d31a2389-2797-4ff2-9830-3a5a6a98c02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d31a2389-2797-4ff2-9830-3a5a6a98c02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_65a79625-ff7e-49f8-949f-372b6834d0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d31a2389-2797-4ff2-9830-3a5a6a98c02a" xlink:to="loc_us-gaap_EarningsPerShareBasic_65a79625-ff7e-49f8-949f-372b6834d0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d608c7ca-1f7d-40e7-b078-b0f8d95ebb29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d31a2389-2797-4ff2-9830-3a5a6a98c02a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d608c7ca-1f7d-40e7-b078-b0f8d95ebb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ba9e217-4d40-4710-94f5-1f8108b303ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64a941f-c4b1-4f52-8461-fcaed05cd092" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2ba9e217-4d40-4710-94f5-1f8108b303ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Businesscombination" xlink:type="simple" xlink:href="hqy-20201031.xsd#Businesscombination"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Businesscombination" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_2721b48d-f019-4733-a213-3c50c3c9c2f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e39ba821-52f2-4d79-a1bf-31a93f3625d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_2721b48d-f019-4733-a213-3c50c3c9c2f3" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e39ba821-52f2-4d79-a1bf-31a93f3625d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/BusinesscombinationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_caeb0455-3a8b-493a-9963-e2177bd39949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_591636d4-a575-437e-828c-572e2e04bec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_caeb0455-3a8b-493a-9963-e2177bd39949" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_591636d4-a575-437e-828c-572e2e04bec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7d69c065-41cb-4291-948f-eb5f53117ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_caeb0455-3a8b-493a-9963-e2177bd39949" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7d69c065-41cb-4291-948f-eb5f53117ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/BusinesscombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8b0f7073-2ebf-46cb-bddf-51ad51f9ff40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8b0f7073-2ebf-46cb-bddf-51ad51f9ff40" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a989ba0f-0dd0-4acc-9ffe-4b20f82a1c3a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_9de7dc52-55ac-4f18-bde3-c0f4deea7f07" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8c956575-2a26-4edc-a36e-f064f88bea5d" xlink:to="loc_hqy_WageWorksIncMember_9de7dc52-55ac-4f18-bde3-c0f4deea7f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_153df520-124c-4712-9ffa-43f4fb60519a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_de5b8412-ed03-4b47-98fe-5e43fead6f43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fab4a7da-1326-4c21-9d67-11ebae3ad753" xlink:to="loc_us-gaap_LineOfCreditMember_de5b8412-ed03-4b47-98fe-5e43fead6f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_187a3db9-0f93-42e1-8f2f-e7334f583022" xlink:to="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_80ad75c6-50ca-4212-a408-67d9e9570002" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ffe227e1-8816-4762-8ede-a672c4a317ca" xlink:to="loc_hqy_TermLoanFacilityMember_80ad75c6-50ca-4212-a408-67d9e9570002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_da6e9836-4bfb-4cfb-8930-b7e854500865" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_207d45f7-6961-4c17-b584-2e6ce9015202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_207d45f7-6961-4c17-b584-2e6ce9015202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_77d69c42-6348-43d0-a2ed-9c7e0e6fa2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_77d69c42-6348-43d0-a2ed-9c7e0e6fa2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d7eb7aa-9803-4b17-8055-680c53bc0be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3d7eb7aa-9803-4b17-8055-680c53bc0be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_1c880061-3138-4dd4-a498-cefb623691a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_928962f1-bb83-4944-9d8a-c8334ce30f5a" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_1c880061-3138-4dd4-a498-cefb623691a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationPreliminaryAllocationofConsiderationDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_26974423-79a1-4ed5-8bd8-01ec8c0ec09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_26974423-79a1-4ed5-8bd8-01ec8c0ec09b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5479c765-b1c3-41f0-8324-2187079b8c09" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_80ea884b-898d-4777-8ffc-68921179365e" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2034723-413d-4b39-aa0f-f069325b1c3d" xlink:to="loc_hqy_WageWorksIncMember_80ea884b-898d-4777-8ffc-68921179365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1e45edc7-e150-476f-a0a4-291d1918dbce" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7015cdc4-226e-4089-b9e4-fd30610d2b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7015cdc4-226e-4089-b9e4-fd30610d2b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_3cd83a5d-bda9-4dca-99a9-71d396327999" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_3cd83a5d-bda9-4dca-99a9-71d396327999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_84177767-225f-45cf-b603-247aa54a48b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_84177767-225f-45cf-b603-247aa54a48b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_6a28f78c-7568-4c59-bc7f-0d4fe2c7ae58" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets_6a28f78c-7568-4c59-bc7f-0d4fe2c7ae58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d77366-aa0e-429b-8047-b99b2eecadd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d77366-aa0e-429b-8047-b99b2eecadd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_8eb62a40-cb76-4391-ae5e-56c3f1d7a3b6" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets_8eb62a40-cb76-4391-ae5e-56c3f1d7a3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_41f6750d-7f1b-4733-a817-465c3b8a94fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_41f6750d-7f1b-4733-a817-465c3b8a94fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4ad45dba-8303-4f00-aaca-927cada04dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_Goodwill_4ad45dba-8303-4f00-aaca-927cada04dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_756bc2ce-e3c4-4459-a0c8-7cafd9bc8afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_756bc2ce-e3c4-4459-a0c8-7cafd9bc8afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e132dd3-2abb-4cc3-9d7a-e41cf095f513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e132dd3-2abb-4cc3-9d7a-e41cf095f513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_5cf63825-a73a-41be-a9c8-5625a760a35a" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation_5cf63825-a73a-41be-a9c8-5625a760a35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_89370db4-3111-4048-a598-e41971b7dc3f" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation_89370db4-3111-4048-a598-e41971b7dc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c3f5954-13a3-4385-b6bd-b2322766d664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2c3f5954-13a3-4385-b6bd-b2322766d664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_f50a77ab-8a5e-40ec-91ef-c9e24f7a97c0" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther_f50a77ab-8a5e-40ec-91ef-c9e24f7a97c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_365dddce-63dc-4bf8-838b-75007a12652c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_365dddce-63dc-4bf8-838b-75007a12652c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3b8c599a-121b-4266-990e-1ffefa1cddea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3b8c599a-121b-4266-990e-1ffefa1cddea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_196fdcad-f60d-4381-9128-96da9de82f5d" xlink:href="hqy-20201031.xsd#hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes_196fdcad-f60d-4381-9128-96da9de82f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_15301253-8c01-4dec-9686-d16cf4567763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_15301253-8c01-4dec-9686-d16cf4567763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_d2dc504e-4278-4f3a-a456-0d8566f8cd21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fc23e911-9a69-4fe7-b518-709c90cdb03d" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_d2dc504e-4278-4f3a-a456-0d8566f8cd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#BusinesscombinationProFormaResultsDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/BusinesscombinationProFormaResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_36f71b23-a4d4-4c0c-951b-59312abcb002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_36f71b23-a4d4-4c0c-951b-59312abcb002" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_f3440132-7ca8-4ce2-816d-b05b21ad4676" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksInc.Member_0af7ba42-eba4-4dce-8509-ee6d0bea299f" xlink:href="hqy-20201031.xsd#hqy_WageWorksInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5dc1382c-9989-4496-af6e-78f49150a1a5" xlink:to="loc_hqy_WageWorksInc.Member_0af7ba42-eba4-4dce-8509-ee6d0bea299f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d017f2df-e2a6-4a7a-8900-52f54461b6e4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1dad787a-a6ed-4b9b-8a29-526c01982d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_1dad787a-a6ed-4b9b-8a29-526c01982d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_648b29aa-9af0-46f4-bc6d-254d7b1f8ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8f15eefe-75fb-43df-948a-afc00a8fb987" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_648b29aa-9af0-46f4-bc6d-254d7b1f8ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Supplementalfinancialstatementinformation"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Supplementalfinancialstatementinformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b06477b0-830a-4271-b4ea-82e24319a320" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_467e51e8-d66d-4bb9-8fd1-0092909814c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b06477b0-830a-4271-b4ea-82e24319a320" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_467e51e8-d66d-4bb9-8fd1-0092909814c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2a3f8-c7a1-4003-ab30-80951875dcab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_86398ae1-02e6-4cb6-aadd-79442f4457b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2a3f8-c7a1-4003-ab30-80951875dcab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_86398ae1-02e6-4cb6-aadd-79442f4457b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_efcb611c-d1a4-45ef-a9e2-b8351b121af7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2a3f8-c7a1-4003-ab30-80951875dcab" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_efcb611c-d1a4-45ef-a9e2-b8351b121af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_b769a36b-e420-454e-96e3-1d62446b06e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_32d2a3f8-c7a1-4003-ab30-80951875dcab" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_b769a36b-e420-454e-96e3-1d62446b06e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationPropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4b95ff6-fe99-43ef-af8b-53f0a4ae457e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e4b95ff6-fe99-43ef-af8b-53f0a4ae457e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b2996e9-b3fc-4704-ba51-6b2fb305de23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_08a77f63-3dd9-4a91-88d9-1b6830cd07a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_08a77f63-3dd9-4a91-88d9-1b6830cd07a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f169f885-74b2-4c8f-9932-39428c270898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f169f885-74b2-4c8f-9932-39428c270898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_baef8b6e-61d2-4692-be0e-8c20cb73d39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_41835f09-aaec-419a-897b-68ebfa53ba4d" xlink:to="loc_us-gaap_ComputerEquipmentMember_baef8b6e-61d2-4692-be0e-8c20cb73d39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d17e9255-1586-494c-90eb-1092f7a2c37a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9fca2aef-b78c-471b-ae8e-adf862a74052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9fca2aef-b78c-471b-ae8e-adf862a74052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2eef16e3-cb9a-4651-a526-13fd5c917182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2eef16e3-cb9a-4651-a526-13fd5c917182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be4926a8-b1c9-4ed0-97c1-0ba5c971aa02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bf54c690-f8a8-496d-af97-d64aad9c376d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be4926a8-b1c9-4ed0-97c1-0ba5c971aa02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e789d18e-493c-4fcb-9d88-8a43235a546d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_438e729e-ec1b-418b-9597-15278f289271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e789d18e-493c-4fcb-9d88-8a43235a546d" xlink:to="loc_us-gaap_Depreciation_438e729e-ec1b-418b-9597-15278f289271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_413ddc4d-97ed-44c6-920e-39dbce07e533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e789d18e-493c-4fcb-9d88-8a43235a546d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_413ddc4d-97ed-44c6-920e-39dbce07e533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement_7ecb565c-b157-49c6-bc48-9c806f0d9385" xlink:href="hqy-20201031.xsd#hqy_ContractWithCustomerRecognitionTermInterchangeArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e789d18e-493c-4fcb-9d88-8a43235a546d" xlink:to="loc_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement_7ecb565c-b157-49c6-bc48-9c806f0d9385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a9a4ff00-d2a8-4aaa-8f14-89583cae3a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e789d18e-493c-4fcb-9d88-8a43235a546d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a9a4ff00-d2a8-4aaa-8f14-89583cae3a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30adec9d-7a75-404d-b4ea-8518c95eb035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_0956120e-ee2d-46f8-acb3-ee233ad82f26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30adec9d-7a75-404d-b4ea-8518c95eb035" xlink:to="loc_us-gaap_OperatingLeaseExpense_0956120e-ee2d-46f8-acb3-ee233ad82f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_9b25b223-62cb-4ab8-9a5e-954e1a23b592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30adec9d-7a75-404d-b4ea-8518c95eb035" xlink:to="loc_us-gaap_SubleaseIncome_9b25b223-62cb-4ab8-9a5e-954e1a23b592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ce5d2903-1842-49a6-880e-6e498fea1f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_30adec9d-7a75-404d-b4ea-8518c95eb035" xlink:to="loc_us-gaap_LeaseCost_ce5d2903-1842-49a6-880e-6e498fea1f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71847e7e-fa19-4ed4-8078-84264a678efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b3eafc68-9995-4a1a-a53f-41f27cded928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_71847e7e-fa19-4ed4-8078-84264a678efa" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b3eafc68-9995-4a1a-a53f-41f27cded928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_d506b421-7a9f-4626-9c6d-1bc79c0b8147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b3eafc68-9995-4a1a-a53f-41f27cded928" xlink:to="loc_us-gaap_OperatingLeasePayments_d506b421-7a9f-4626-9c6d-1bc79c0b8147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b7153ccd-74c8-4f95-92ff-ab7ff64fad85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_b3eafc68-9995-4a1a-a53f-41f27cded928" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b7153ccd-74c8-4f95-92ff-ab7ff64fad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_c0dc940f-9359-4880-b756-5c77b463a961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_c0dc940f-9359-4880-b756-5c77b463a961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_41d24bdd-d6ca-4afe-87e6-7de3c09762cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_41d24bdd-d6ca-4afe-87e6-7de3c09762cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_091cfde5-7ae4-4196-8b58-0e54f7b4c45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_091cfde5-7ae4-4196-8b58-0e54f7b4c45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_9e56eba1-1f8a-4942-b74e-f289ca500ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:to="loc_us-gaap_OtherNonoperatingExpense_9e56eba1-1f8a-4942-b74e-f289ca500ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b8a861b9-0083-4fe1-aed9-f1a96f479ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e43a326d-cf9c-4639-ac93-0ce0ea17b850" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b8a861b9-0083-4fe1-aed9-f1a96f479ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="simple" xlink:href="hqy-20201031.xsd#Intangibleassetsandgoodwill"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Intangibleassetsandgoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a030445e-0a56-4076-8e36-b6f46bc0f231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4a9ce55a-d5f3-46e0-9b0e-9042b23d02dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a030445e-0a56-4076-8e36-b6f46bc0f231" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4a9ce55a-d5f3-46e0-9b0e-9042b23d02dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2557658d-f3ea-4caa-80e9-6fdfa157b448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e546eeec-a20b-4d1f-b448-795d6f949392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2557658d-f3ea-4caa-80e9-6fdfa157b448" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e546eeec-a20b-4d1f-b448-795d6f949392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_552a9553-ab44-408f-b599-641eac37b889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2557658d-f3ea-4caa-80e9-6fdfa157b448" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_552a9553-ab44-408f-b599-641eac37b889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2612c83a-e2fa-4c94-9e66-0158a4e40f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2612c83a-e2fa-4c94-9e66-0158a4e40f37" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_431ed7da-ed88-47ac-9be7-5344ebd8f62a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_aeda1810-3893-47b7-ac61-14e762050015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_aeda1810-3893-47b7-ac61-14e762050015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_AcquiredHSAIntangibleAssetsMember_980fd975-a11d-4488-966f-467df0bdbb39" xlink:href="hqy-20201031.xsd#hqy_AcquiredHSAIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_hqy_AcquiredHSAIntangibleAssetsMember_980fd975-a11d-4488-966f-467df0bdbb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7b52db01-67c7-4e0e-9145-fabfe98b819c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7b52db01-67c7-4e0e-9145-fabfe98b819c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_05333382-5a2f-4915-ad3e-d14f64e10b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_05333382-5a2f-4915-ad3e-d14f64e10b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4d609e38-9102-40ea-8525-391acf1c12d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8e72fed8-2e4f-4b21-8a43-f3b4eb8760f0" xlink:to="loc_us-gaap_TradeNamesMember_4d609e38-9102-40ea-8525-391acf1c12d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d99d836f-1e2e-4188-b3f6-a74bc647f0fe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4734f4fa-9eb4-41b3-8856-f0f6a245501f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4734f4fa-9eb4-41b3-8856-f0f6a245501f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7cc1887-3e56-4bb6-bf1c-17ce84188aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7cc1887-3e56-4bb6-bf1c-17ce84188aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cfca6eb4-bd95-4b03-bcc9-d354feb6f818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_04cb12ff-a19d-438a-9988-bd52ecb008e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cfca6eb4-bd95-4b03-bcc9-d354feb6f818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2612c83a-e2fa-4c94-9e66-0158a4e40f37" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae18611f-7fa6-4ca7-afb7-69f4e3c71d55" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_9b213c5c-a998-49c2-b6e4-e991a90b1196" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6a56a2c0-3f4b-487c-b6dc-fb59934d0c85" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_9b213c5c-a998-49c2-b6e4-e991a90b1196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3a10a366-f472-4ca2-b7bc-3cfd2a1a7470" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d137b22f-9dca-4500-a224-891d8610e52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_dfa87a95-63a7-47e8-83b8-e188d705ee97" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d137b22f-9dca-4500-a224-891d8610e52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_500829a3-e090-47e5-92f9-ef4aee91ee84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2612c83a-e2fa-4c94-9e66-0158a4e40f37" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_500829a3-e090-47e5-92f9-ef4aee91ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_32786dc6-77a4-454d-9430-18f852f65352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_500829a3-e090-47e5-92f9-ef4aee91ee84" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_32786dc6-77a4-454d-9430-18f852f65352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IntangibleassetsandgoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e06a0660-0b0d-4c49-a8cc-ac10cc6be7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_6604b529-9bb7-4736-a854-a450677479d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e06a0660-0b0d-4c49-a8cc-ac10cc6be7ee" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost_6604b529-9bb7-4736-a854-a450677479d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_c32db7d8-af70-42ad-9c9e-be0453170308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e06a0660-0b0d-4c49-a8cc-ac10cc6be7ee" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_c32db7d8-af70-42ad-9c9e-be0453170308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_798028a8-4dbc-4c2e-b448-4e71bd213df9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e06a0660-0b0d-4c49-a8cc-ac10cc6be7ee" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_798028a8-4dbc-4c2e-b448-4e71bd213df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="hqy-20201031.xsd#Commitmentsandcontingencies"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Commitmentsandcontingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_43b7250c-693f-4832-829c-b235d9d4dfc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ecdd57b-f42a-42c1-9cd2-c50693daf519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_43b7250c-693f-4832-829c-b235d9d4dfc0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5ecdd57b-f42a-42c1-9cd2-c50693daf519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#CommitmentsandcontingenciesDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/CommitmentsandcontingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a49ed17-0cba-4b2b-9e1d-e83ec71b33c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4a49ed17-0cba-4b2b-9e1d-e83ec71b33c0" xlink:to="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:to="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_15de53e0-7a39-492b-8ff1-ed639ab08970" xlink:to="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_fb436a0f-a51a-4d7f-a305-f2c8f54024fc" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_82151050-69e1-40a5-b3f4-1572457d914a" xlink:to="loc_hqy_TermLoanFacilityMember_fb436a0f-a51a-4d7f-a305-f2c8f54024fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_569a6411-7b52-4328-8577-0f974e4663ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_625b0797-a4ce-4c85-b6ca-e0f6382d4752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d14df101-ca7b-4757-a4eb-22c92505f54c" xlink:to="loc_us-gaap_LineOfCreditMember_625b0797-a4ce-4c85-b6ca-e0f6382d4752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_51603897-43bd-445b-9fd4-649f34494b78" xlink:to="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9d947482-166e-4ad1-92d6-4ab4596c91d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9d947482-166e-4ad1-92d6-4ab4596c91d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_LossContingencyNumberOfLawsuits_758f0240-8e61-40e0-bb89-6e757624903c" xlink:href="hqy-20201031.xsd#hqy_LossContingencyNumberOfLawsuits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_03e24b0a-750e-4117-9df1-e12ada26d83b" xlink:to="loc_hqy_LossContingencyNumberOfLawsuits_758f0240-8e61-40e0-bb89-6e757624903c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Incometaxes" xlink:type="simple" xlink:href="hqy-20201031.xsd#Incometaxes"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Incometaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0a3675f7-2835-410b-8927-7d1115582c16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_cc042c3b-f95b-4a3e-aaa4-e99fdfa64a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a3675f7-2835-410b-8927-7d1115582c16" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_cc042c3b-f95b-4a3e-aaa4-e99fdfa64a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IncometaxesDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IncometaxesDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IncometaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a3a7b185-32c7-4409-aa53-9e99ff9cfe3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a3a7b185-32c7-4409-aa53-9e99ff9cfe3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f55329d4-095c-4e46-8711-bbd42c99deda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f55329d4-095c-4e46-8711-bbd42c99deda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_ad2d429e-f2ae-4f1c-9e4b-4cb6cf5f3546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_ad2d429e-f2ae-4f1c-9e4b-4cb6cf5f3546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_e0646c70-3d31-4fc0-984f-4db3b2ce6fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_e0646c70-3d31-4fc0-984f-4db3b2ce6fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_UnrecognizedTaxBenefitNet_6cb8ca4d-aec2-4f61-8265-329be027f7d2" xlink:href="hqy-20201031.xsd#hqy_UnrecognizedTaxBenefitNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_hqy_UnrecognizedTaxBenefitNet_6cb8ca4d-aec2-4f61-8265-329be027f7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4dfc5ffa-b189-4484-91ee-244de6c7864e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fb2156-4553-44e3-8727-0b969937e527" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4dfc5ffa-b189-4484-91ee-244de6c7864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Indebtedness" xlink:type="simple" xlink:href="hqy-20201031.xsd#Indebtedness"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Indebtedness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7ad5ea40-efdd-4169-adaf-14ca72ed502b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1317e1bd-1c3a-4ec7-933f-a87b50a29357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7ad5ea40-efdd-4169-adaf-14ca72ed502b" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1317e1bd-1c3a-4ec7-933f-a87b50a29357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IndebtednessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d4698fd9-ec51-4fe9-9832-d186b557dd76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f82409ee-ad79-4785-98c9-9a68e39930be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d4698fd9-ec51-4fe9-9832-d186b557dd76" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f82409ee-ad79-4785-98c9-9a68e39930be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_262015fa-3324-42b3-8910-eff1ae1979fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d4698fd9-ec51-4fe9-9832-d186b557dd76" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_262015fa-3324-42b3-8910-eff1ae1979fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bf8d9f5c-51ec-4d57-91f1-838fd5bb396e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6762053b-35d7-48a3-a45b-79f321cdad72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf8d9f5c-51ec-4d57-91f1-838fd5bb396e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6762053b-35d7-48a3-a45b-79f321cdad72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_fedd31aa-38bb-4116-a428-df6033680f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf8d9f5c-51ec-4d57-91f1-838fd5bb396e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_fedd31aa-38bb-4116-a428-df6033680f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ff5684f8-c842-4d52-8954-aff0e04db19c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf8d9f5c-51ec-4d57-91f1-838fd5bb396e" xlink:to="loc_us-gaap_LongTermDebt_ff5684f8-c842-4d52-8954-aff0e04db19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IndebtednessNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_43d56775-0d40-4159-b6f8-a652f47fc4e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_43d56775-0d40-4159-b6f8-a652f47fc4e4" xlink:to="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6ad1ae21-9925-402e-843e-021540ddf2a0" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4480a59a-71ec-47e1-af31-6a9d3a3573db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4da76708-8a2f-4f32-b41b-c4324602d324" xlink:to="loc_us-gaap_OtherAssetsMember_4480a59a-71ec-47e1-af31-6a9d3a3573db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5e37b661-42bb-4c67-a938-941198b3b732" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_CreditAgreementMember_8f1597c6-a8b6-427f-aea4-55238a6872e7" xlink:href="hqy-20201031.xsd#hqy_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_61d30cf0-a67f-4da2-8021-b981da514748" xlink:to="loc_hqy_CreditAgreementMember_8f1597c6-a8b6-427f-aea4-55238a6872e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7ab16cca-688e-43ac-966b-1dcccf2ea970" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_51b04d8a-5097-4de9-b86e-bf383c3bccf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:to="loc_us-gaap_SecuredDebtMember_51b04d8a-5097-4de9-b86e-bf383c3bccf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_127efc5d-43d0-4bdc-b356-9e7cf8ec479c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_168d295b-9fb5-4aa4-aa22-b13a7bdb7758" xlink:to="loc_us-gaap_LineOfCreditMember_127efc5d-43d0-4bdc-b356-9e7cf8ec479c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ca360f82-b45a-426e-a307-abdc650c5e26" xlink:to="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ecbe3cff-80c8-4257-890b-fa84ba3645b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_us-gaap_LineOfCreditMember_ecbe3cff-80c8-4257-890b-fa84ba3645b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TermLoanFacilityMember_1bdb0161-ac2d-4e1a-a367-3779e11f0609" xlink:href="hqy-20201031.xsd#hqy_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_hqy_TermLoanFacilityMember_1bdb0161-ac2d-4e1a-a367-3779e11f0609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dfa66fa3-a6a9-433c-a4cb-109d5828cfc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_63ad4f46-a70a-44b9-9c02-b909ed676a5d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dfa66fa3-a6a9-433c-a4cb-109d5828cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_03b229e4-391d-4960-8440-9b4d53d37e81" xlink:to="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cfd800f8-8211-40ab-89ad-67edb5bb900e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cfd800f8-8211-40ab-89ad-67edb5bb900e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d43b1814-41b8-41e8-977c-d60ffa7939ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8ae5f863-6b34-45fb-bb6b-8258e4476e95" xlink:to="loc_us-gaap_BaseRateMember_d43b1814-41b8-41e8-977c-d60ffa7939ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_59da44c7-f1a9-40d6-80c4-b14e9b7fe6e2" xlink:to="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5824d389-a84b-4ea8-87f4-a21636f689d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:to="loc_srt_MinimumMember_5824d389-a84b-4ea8-87f4-a21636f689d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e42cd631-bae8-406f-b010-0fefc9cba398" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6667ec78-2b8c-4963-81cd-20f8293cbfc7" xlink:to="loc_srt_MaximumMember_e42cd631-bae8-406f-b010-0fefc9cba398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_DebtCovenantPeriodAxis_76cb852c-36c1-4186-b840-68ba27e9472a" xlink:to="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodTwoMember_a14e9e1f-8d38-48f1-a85a-d5cb85a5847f" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodTwoMember_a14e9e1f-8d38-48f1-a85a-d5cb85a5847f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodThreeMember_c10dee5f-3d65-41e3-8fd4-b8225f554915" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodThreeMember_c10dee5f-3d65-41e3-8fd4-b8225f554915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtCovenantPeriodFourMember_aa5eb687-ddb7-4c88-833b-fcca9111c2f0" xlink:href="hqy-20201031.xsd#hqy_DebtCovenantPeriodFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hqy_DebtCovenantPeriodDomain_1779d38f-9e60-4d96-8d6a-0179199dcd8e" xlink:to="loc_hqy_DebtCovenantPeriodFourMember_aa5eb687-ddb7-4c88-833b-fcca9111c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b912e0d4-3846-47e6-abf6-cf40185896c5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_cd693b5f-2136-46c6-8cef-c06ce74ab217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_cd693b5f-2136-46c6-8cef-c06ce74ab217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_bc0469b3-79bd-4b53-b8cd-9c1bf1371c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentTerm_bc0469b3-79bd-4b53-b8cd-9c1bf1371c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac13e58-27e8-4abb-993f-9ff4b33a0c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ac13e58-27e8-4abb-993f-9ff4b33a0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_513c3dea-c38e-4578-92a0-ccd29b7db8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCredit_513c3dea-c38e-4578-92a0-ccd29b7db8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4e2def3b-216e-443b-a5a8-69af72e864e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4e2def3b-216e-443b-a5a8-69af72e864e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fef63d1b-96d1-458a-90e8-11a9be5c49c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_fef63d1b-96d1-458a-90e8-11a9be5c49c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cd634a0b-7f9f-4e0a-a94c-7acc800e968f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_cd634a0b-7f9f-4e0a-a94c-7acc800e968f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_e899d6b9-6eaf-4016-9106-5e8dfa3c7364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_e899d6b9-6eaf-4016-9106-5e8dfa3c7364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_08a9a11f-315c-4ac1-8b69-db96d4c26329" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionLeverageRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionLeverageRatio_08a9a11f-315c-4ac1-8b69-db96d4c26329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_b3c532cf-c960-4c0e-bafd-3db844224194" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio_b3c532cf-c960-4c0e-bafd-3db844224194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_b8b97452-bf19-4e09-8fd5-9efa6f64ede8" xlink:href="hqy-20201031.xsd#hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c49e5545-0c7b-4f43-9ef3-9598f130b723" xlink:to="loc_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio_b8b97452-bf19-4e09-8fd5-9efa6f64ede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#IndebtednessScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f3a1a384-69c3-45d7-97d8-95ccba7dbeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3a1a384-69c3-45d7-97d8-95ccba7dbeb4" xlink:to="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fa0dc7ab-a2dc-45cc-a895-15b1438d9d44" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_FollowOnEquityOfferingMember_ce6a0a20-7fb3-4478-b53b-9fc6c03f1d19" xlink:href="hqy-20201031.xsd#hqy_FollowOnEquityOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1f61d1eb-7c26-4da1-acec-a5f87ec2a122" xlink:to="loc_hqy_FollowOnEquityOfferingMember_ce6a0a20-7fb3-4478-b53b-9fc6c03f1d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7c033786-82c6-487d-a660-c7bf2573252f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8f3af3f4-93cf-412c-84b3-4038ea188c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8f3af3f4-93cf-412c-84b3-4038ea188c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c8d01564-a27f-434e-909e-363bc06e556a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c8d01564-a27f-434e-909e-363bc06e556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ddfd978c-3132-4860-a2db-26898d96b88b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ddfd978c-3132-4860-a2db-26898d96b88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_16b48a05-cdb8-4409-a4bf-d42da740b34a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_16b48a05-cdb8-4409-a4bf-d42da740b34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_45657fe0-eeb4-4117-b228-a8df349d79d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_45657fe0-eeb4-4117-b228-a8df349d79d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b038633a-5d54-4a13-adc3-d208f4b3ab0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b038633a-5d54-4a13-adc3-d208f4b3ab0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_6573ca2e-1d66-468b-9644-849384a1329b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c094420-ec13-436b-bc1c-3cc4cec8285b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_6573ca2e-1d66-468b-9644-849384a1329b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="hqy-20201031.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4d65539f-15eb-4d6f-a836-1c9fb599d0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_664800db-55c9-40d4-8cbd-8c6722352ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4d65539f-15eb-4d6f-a836-1c9fb599d0bd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_664800db-55c9-40d4-8cbd-8c6722352ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationTables"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/StockbasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41bed60a-3283-45e5-a41d-da70cd05ff2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_193c9644-13bb-4119-a81a-5a94f89b8ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41bed60a-3283-45e5-a41d-da70cd05ff2e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_193c9644-13bb-4119-a81a-5a94f89b8ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_82613b11-d8ff-4026-aff1-816a319ef3a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41bed60a-3283-45e5-a41d-da70cd05ff2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_82613b11-d8ff-4026-aff1-816a319ef3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f58addc3-b026-490e-8e27-cd77d6334e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41bed60a-3283-45e5-a41d-da70cd05ff2e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f58addc3-b026-490e-8e27-cd77d6334e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f1ba1b0-f2bd-4f1b-a406-55316a719835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f1ba1b0-f2bd-4f1b-a406-55316a719835" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92fc9f8e-7f31-4ba1-98dd-bb9e52e29760" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4b3fd7f8-3082-481b-9970-2c87922667e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_CostOfSalesMember_4b3fd7f8-3082-481b-9970-2c87922667e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SalesandMarketingMember_67460e76-9cf4-4082-ad59-29c80d2f541f" xlink:href="hqy-20201031.xsd#hqy_SalesandMarketingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_SalesandMarketingMember_67460e76-9cf4-4082-ad59-29c80d2f541f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_TechnologyandDevelopmentMember_fdccb48f-af24-4dae-9a58-e61d777be0f4" xlink:href="hqy-20201031.xsd#hqy_TechnologyandDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_TechnologyandDevelopmentMember_fdccb48f-af24-4dae-9a58-e61d777be0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b8d956ac-7505-4ce8-9101-cbf2016f12dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b8d956ac-7505-4ce8-9101-cbf2016f12dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_MergerIntegrationMember_d7bb6fb3-c81f-4ab9-bc9a-067741a48804" xlink:href="hqy-20201031.xsd#hqy_MergerIntegrationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_hqy_MergerIntegrationMember_d7bb6fb3-c81f-4ab9-bc9a-067741a48804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenseMember_6a25d7a5-ed78-408e-9b9e-efe5e22f8bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpenseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b9aa709d-3077-45f2-8f25-d5f7b7e3df3b" xlink:to="loc_us-gaap_OtherExpenseMember_6a25d7a5-ed78-408e-9b9e-efe5e22f8bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c32d2ac4-a261-4557-89dd-c2f740a7b41c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_52e6ef48-30fd-4bcf-bc47-6b9521d0edd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25d4cd83-e0f9-4b47-ab59-1e08068fdeb0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_52e6ef48-30fd-4bcf-bc47-6b9521d0edd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b6e15d25-03f6-4419-a8c7-1c680ab40693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b6e15d25-03f6-4419-a8c7-1c680ab40693" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9ca04d73-ec71-4ed2-b90b-172b23966961" xlink:to="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_IncentivePlanMember_ae5839d0-fb0f-4db7-b3e7-03f3ebd43c03" xlink:href="hqy-20201031.xsd#hqy_IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:to="loc_hqy_IncentivePlanMember_ae5839d0-fb0f-4db7-b3e7-03f3ebd43c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncentivePlanMember_6c1c36cd-d9bf-4361-ab96-b003d298bc1f" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_238c4f8a-b530-4ed9-aa36-74b49082273f" xlink:to="loc_hqy_WageWorksIncentivePlanMember_6c1c36cd-d9bf-4361-ab96-b003d298bc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_4cd40eaf-c7f1-4868-a57a-f9e641a92c7d" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_db664b39-721f-40d3-b50d-261d79d86750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22293fbb-47f1-4543-9cd9-6d3810c2ad60" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_db664b39-721f-40d3-b50d-261d79d86750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ddb24be-c2d8-4746-8245-92aa26777c1b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_WageWorksIncMember_6757ef31-23d2-4c48-806a-78b034019f2d" xlink:href="hqy-20201031.xsd#hqy_WageWorksIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba5fba27-40dc-4bf0-bda5-8cdf645a5b78" xlink:to="loc_hqy_WageWorksIncMember_6757ef31-23d2-4c48-806a-78b034019f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7efc5977-d266-458d-aefa-280a4eaf5d51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_db750098-6d07-41f4-9e44-a65fb81fb021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_db750098-6d07-41f4-9e44-a65fb81fb021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockAwardsMember_b014e8c9-d980-4796-9a48-728d482d68ac" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_hqy_PerformanceRestrictedStockAwardsMember_b014e8c9-d980-4796-9a48-728d482d68ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_PerformanceRestrictedStockUnitsMember_5f3b38eb-4ce9-481a-89f5-ffc16c1fe183" xlink:href="hqy-20201031.xsd#hqy_PerformanceRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06f6681b-7e38-4709-926d-e7c1ca648939" xlink:to="loc_hqy_PerformanceRestrictedStockUnitsMember_5f3b38eb-4ce9-481a-89f5-ffc16c1fe183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0e1db09a-ff60-46d0-b8f7-ad20778b62a3" xlink:to="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8d0805ae-3527-44e0-b63b-0b4c8f225caa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:to="loc_srt_MinimumMember_8d0805ae-3527-44e0-b63b-0b4c8f225caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db08ca76-2a00-4626-82b1-5701ce2b3447" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_10f97d98-2099-478a-be06-c4e42021dbab" xlink:to="loc_srt_MaximumMember_db08ca76-2a00-4626-82b1-5701ce2b3447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0def46b3-ce21-4ecc-a0d6-a6b5846e6f21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_07156faa-9b0c-4cf5-a391-7e8639294231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_07156faa-9b0c-4cf5-a391-7e8639294231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_3dff7ad2-25de-47db-9af3-082424c2949f" xlink:href="hqy-20201031.xsd#hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage_3dff7ad2-25de-47db-9af3-082424c2949f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d543088f-c3ef-4532-8f7c-4257d8433100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d543088f-c3ef-4532-8f7c-4257d8433100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_38da3acb-c7e8-474b-b4ec-2ba9d4dd2951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_38da3acb-c7e8-474b-b4ec-2ba9d4dd2951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_39ca0c26-19a2-492f-b1ae-09e3bfb49917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_39ca0c26-19a2-492f-b1ae-09e3bfb49917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_69c3c1f8-990e-45b6-ac7f-d10ffe03d150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_69c3c1f8-990e-45b6-ac7f-d10ffe03d150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_245f0172-be48-494a-ba45-d9b31503b187" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_245f0172-be48-494a-ba45-d9b31503b187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_0c7cc1d0-ab8a-4c57-bcf4-c8ce71c1bb40" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio_0c7cc1d0-ab8a-4c57-bcf4-c8ce71c1bb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_04d371df-b949-4aca-94a1-264202be5b6d" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio_04d371df-b949-4aca-94a1-264202be5b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_9a27cb26-2ebe-4be9-8979-f083e01cae19" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers_9a27cb26-2ebe-4be9-8979-f083e01cae19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_26934a09-3115-4d5e-882a-38d84f31c526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_26934a09-3115-4d5e-882a-38d84f31c526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_bd0aee47-5520-4494-b982-a8fdca7d414a" xlink:href="hqy-20201031.xsd#hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms_bd0aee47-5520-4494-b982-a8fdca7d414a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_add82cbd-7494-4af0-9e2d-4595d8f4699e" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f7eb876-f1a0-44b2-afd0-e82c4499ab9c" xlink:to="loc_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue_add82cbd-7494-4af0-9e2d-4595d8f4699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationStockoptionactivityDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b57dc2d3-7e2b-4e24-9cd5-4c14cc4bf862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b57dc2d3-7e2b-4e24-9cd5-4c14cc4bf862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dd428f36-af7d-4572-b887-652dcb0cd9a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dd428f36-af7d-4572-b887-652dcb0cd9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6bc3495a-c5a4-4998-b36e-3124d447c14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6bc3495a-c5a4-4998-b36e-3124d447c14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e24361a9-00ed-49ac-adf5-4737446a1c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_e24361a9-00ed-49ac-adf5-4737446a1c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bcebcff0-706c-4382-bccb-324faab787ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadd3369-f741-40a0-a4be-ecf0920227ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bcebcff0-706c-4382-bccb-324faab787ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e26a14b8-d612-4023-9ad7-b1eaa8ee4f58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_e26a14b8-d612-4023-9ad7-b1eaa8ee4f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_cbebeed4-c3fa-419c-a4e4-8457459c42ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_cbebeed4-c3fa-419c-a4e4-8457459c42ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_59ad54da-10cb-46ab-b418-022a540cc562" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_59ad54da-10cb-46ab-b418-022a540cc562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_61dc6632-079a-4f35-99f3-d1086480455f" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_61dc6632-079a-4f35-99f3-d1086480455f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted_75e3a131-5927-4c03-86d3-f0f4d175981a" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted_75e3a131-5927-4c03-86d3-f0f4d175981a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised_718c8930-236f-4f7b-bc46-aefb8649153f" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised_718c8930-236f-4f7b-bc46-aefb8649153f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised_ebfab9eb-3927-440d-9227-470ab92a5354" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised_ebfab9eb-3927-440d-9227-470ab92a5354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited_ab76cef8-6e4d-46a3-8c0f-c7de6099b5a5" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited_ab76cef8-6e4d-46a3-8c0f-c7de6099b5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited_63d2ec13-4157-46bc-866b-34c3867bd0d1" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited_63d2ec13-4157-46bc-866b-34c3867bd0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_8fc926e6-2be8-4dcc-b12f-88fd88f813be" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding_8fc926e6-2be8-4dcc-b12f-88fd88f813be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_caf36b4c-bcd6-468d-8a4d-04ff6bdb77c2" xlink:href="hqy-20201031.xsd#hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract_47f22d6c-d623-42bf-8f82-e4c4471d5b5c" xlink:to="loc_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding_caf36b4c-bcd6-468d-8a4d-04ff6bdb77c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5454429e-2f62-4140-89d0-5cd72a375c83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5454429e-2f62-4140-89d0-5cd72a375c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6deb1b8c-5c4d-40c4-9b63-119e4017ea96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6deb1b8c-5c4d-40c4-9b63-119e4017ea96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30931cb4-fede-4308-aa6f-baa8b85016c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30931cb4-fede-4308-aa6f-baa8b85016c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_df4bf431-be6d-462e-838f-80cf4b696662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_df4bf431-be6d-462e-838f-80cf4b696662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852028be-85af-477a-9fdf-63006a0d58e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ca6addae-2a99-4e0e-a686-11fc55dbcbbf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852028be-85af-477a-9fdf-63006a0d58e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0bc501ca-19fc-4d6e-8cf5-948c28bb6189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0bc501ca-19fc-4d6e-8cf5-948c28bb6189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_de0904a2-f54b-4bed-9ac0-03f88100c3ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_de0904a2-f54b-4bed-9ac0-03f88100c3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8fc487d4-e4af-4655-b913-0eb1d8522026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8fc487d4-e4af-4655-b913-0eb1d8522026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_7486c158-569a-4693-9ac0-e8d3c2b66330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_7486c158-569a-4693-9ac0-e8d3c2b66330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_53a54749-dea3-493b-a506-723d8cc70fcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_53a54749-dea3-493b-a506-723d8cc70fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fafc4419-c0ad-4ca7-bae6-245f1bf3f569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fafc4419-c0ad-4ca7-bae6-245f1bf3f569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_22fc5e63-8628-439c-aaee-088fff921051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_22fc5e63-8628-439c-aaee-088fff921051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_657bb7c4-a48b-4337-ac77-0d2ad18abe9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_657bb7c4-a48b-4337-ac77-0d2ad18abe9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_93c4fe55-d373-42c8-b5d8-4cd10b7624fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_77a46a78-e124-435a-a15f-f632c54ff06b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_93c4fe55-d373-42c8-b5d8-4cd10b7624fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="simple" xlink:href="hqy-20201031.xsd#StockbasedcompensationRestrictedstockunityactivityDetails"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d70916a3-1e69-4bbb-8c05-7c197b58ffd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d70916a3-1e69-4bbb-8c05-7c197b58ffd5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:to="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_52d1948a-5fee-4a76-9f45-1079ef86f20b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0cde9554-f804-48eb-a36a-cd4f347c91ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0cde9554-f804-48eb-a36a-cd4f347c91ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_05fa52aa-963d-438e-ae07-8d4a8f60d83b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_086ca56d-78ea-4a3b-881c-fd1b466e1e26" xlink:to="loc_us-gaap_RestrictedStockMember_05fa52aa-963d-438e-ae07-8d4a8f60d83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a915dae5-f58e-4128-ac39-9b1cb46e616e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5481de71-6d66-422f-9c65-d7294963abf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5481de71-6d66-422f-9c65-d7294963abf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_386618bb-87b8-4bfd-91ae-36517ef93426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_386618bb-87b8-4bfd-91ae-36517ef93426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c12a452-a19d-4b94-b659-76a381c023ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c12a452-a19d-4b94-b659-76a381c023ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_950c2d06-7216-4104-8fd0-33e6904ef43c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_950c2d06-7216-4104-8fd0-33e6904ef43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_00078699-efe9-4a9b-880d-b6aafc8c497f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ac7edb5c-ffff-4507-9962-c450c5ca48bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_00078699-efe9-4a9b-880d-b6aafc8c497f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f5492b53-98cd-4d7c-af22-9449702e8e56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_13c06489-276c-42df-a8e8-cc5ce905196f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_13c06489-276c-42df-a8e8-cc5ce905196f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c3f9e748-5b8b-4349-b458-53f17bc28273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c3f9e748-5b8b-4349-b458-53f17bc28273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_909f9590-14f0-44e6-8e5c-a3d45a5a012d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_909f9590-14f0-44e6-8e5c-a3d45a5a012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f904eaf-43f3-439c-bc0f-038c751d2b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5f904eaf-43f3-439c-bc0f-038c751d2b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_325ea912-d35e-40f3-8d14-6a0958b7ac96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_69cf771c-690e-49cc-888a-cbd2268fdb8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_325ea912-d35e-40f3-8d14-6a0958b7ac96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthequity.com/role/Fairvalue" xlink:type="simple" xlink:href="hqy-20201031.xsd#Fairvalue"/>
  <link:presentationLink xlink:role="http://healthequity.com/role/Fairvalue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_85f2ca91-be47-40de-8fbb-bd0813e9dacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_dbaa53b7-4f51-4314-9484-890e2e1e1340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_85f2ca91-be47-40de-8fbb-bd0813e9dacc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_dbaa53b7-4f51-4314-9484-890e2e1e1340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>hqy-20201031_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:hqy="http://healthequity.com/20201031"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hqy-20201031.xsd" xlink:type="simple"/>
    <context id="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i449bf63265634bb0a0d2dc15dd9d1ea4_I20201125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2020-11-25</instant>
        </period>
    </context>
    <context id="ib16f9fff56d24738b1519754780c7d7f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i45cb957efb1b4404baaef91f15061ef9_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:FinancialServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="icaa726f7353a405892ef7138baec6e73_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:CreditAndDebitCardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i25dd807bc6f645aa8efffcedd8ec8168_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i728a44a8b9e844d2b3e44fd961a30bb0_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="if66fb9a6498840c584531c192cbb750f_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i830f5e55e2f148619c75a186e62b092a_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i325dd6d30575455eb3528a68d3959890_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i15e9026e2bcc4fbda5eb976b88d60ec1_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="ie544510666474891b6abaeb2f71c3656_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibb9e554abf8943638da327cec50b9857_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i12bed13866654060afc41b6395363264_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i89a084639dd944c683e352986cdf225c_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="id76b0719fb45488e82da5b09436072ce_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i0ad2506671294a95a4dd823458a6c3be_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ibfe3587113374eca96792f943ab69fc5_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i832a9d56436f4dc487e711fd9d9f1b37_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ib1ab93c490ba422e8067ee638aa89f8a_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i5a9294ef6c2a4467ab59ebeb152cd174_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i901262a311df4c40a831ef51183cc35f_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i60d2105b15fb48538124056d84240663_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ia4f820434883469d97b62b57e6b2765e_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i093f52c37be1437080529f8202cebe1a_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ie50c1af507e14565b249c2e89c3acc10_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="ibf7fea257d4a4064844d660aa4a7626d_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="i254be2393d1a4c6d8a3240a437574561_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i3f04871247f84c9ca9f77b217b29052e_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i7bb624d27231459bb251681eee242ddd_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i62f278c7b4d74e868c0bf4ad932243bb_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i63ef3d19e95d456f9d4e91847890e387_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i3f3c2a3814e04a5a8682e946b183fe16_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="i3c457cfd6a5a43cb9558d8b4d9328cdd_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i0e0fed62fcbd494496c44b5aa87b0d80_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i979c4d22bfc9471f8b4dfb208736616b_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7c3266aa6f754460aacf098b0298fc3b_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i389ea35a3d2e4607abc6c9410c75ebec_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hqy:FollowOnEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ied9feb80b5a64b01bbfd227ff97374ae_I20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2019-08-30</endDate>
        </period>
    </context>
    <context id="ifc6f37ce7f2248f3a06a9f4c38858730_D20190830-20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2019-08-30</endDate>
        </period>
    </context>
    <context id="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i78673cfa6671419b96252591cd5aada4_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i8a254662184a4106b4379b10205f7880_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iaec79e8d4a8042d1b80bb68a1480bcc3_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ic430d1bd4b994088a513acef3734435e_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i60c903d8b1a046ef8d58e35f85bddcdb_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ic3ed676cc45541888a286e697eaf4971_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i5bbb14b2d0234a85814cdcf59a17f56d_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i4364bceadc1640888f5252fff2b05a38_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i48937f6ece7149fca3c3b3786e77ec95_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i504cb0661e9f4dae8034503b601a2870_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="if0205c0743fb47ac8f23fed3e5aedb2e_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i3e1624fbd3d94920921887290a7ad491_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hqy:AcquiredHSAIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i7a29caffc2214b65ade72766d8f08cc1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id3627b5c69c44353802952f92fbe50f9_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="idb51032a2154465cb9cddfdc52f94dc7_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ia2e76b4ad3e9409e90e86df52d0c70bf_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i48a3338f2c4043f2920127348167f2c5_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i316e7d3a2c2549989b4056855d453948_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i04e444c7573c4e11ab6a937593087dfa_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i3346b7e4394c4a3cb401ea158a7e6f79_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i88892452c8b4467da8e7c754e0bd6661_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i70aa4eace1b849b7bc8770af2620a276_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i3e05173272a94406b7f82f6775f29b05_D20180906-20180906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2018-09-06</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="i7ab953b65e81482fbbdffc410958e5ee_D20180622-20180622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2018-06-22</startDate>
            <endDate>2018-06-22</endDate>
        </period>
    </context>
    <context id="i2df1d6cadbd74ff3acfa8a7a9e8f4b3b_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i64a2c3285a4640638af6dc4caca32547_D20190830-20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2019-08-30</endDate>
        </period>
    </context>
    <context id="i0e31870db3eb4448bf794556196facad_I20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">hqy:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="i88890494023a48c186377765d88e48b1_D20190830-20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-30</startDate>
            <endDate>2019-08-30</endDate>
        </period>
    </context>
    <context id="ie457aaaa4999415bb337c567a04585da_I20190830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-30</instant>
        </period>
    </context>
    <context id="i07e01aa0156a47859bbf977de876d1c8_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hqy:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="idde5070b333245fea3d90d1f909b0543_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i61002ef653844eedae5d38c266aea6c9_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic87db426f4e54f909d15c0c1df63c80a_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="iadf62767aaa44d7c83fe6178855f1be7_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i2e0303734b4942bf81d8cf0ed138de29_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ic883d663040343718d8ef69b8d96b305_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i704700afcca6430ab84c0cc3541833fc_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="id433c681b1c140598cb0e1ba46723af6_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i8875a13a7bbd43ffa8102b5c080b479f_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hqy:DebtCovenantPeriodAxis">hqy:DebtCovenantPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i2abd9f5850614a98b0d975f99da08d3e_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i390b5a0159224ba6bd2b58bc11c2b0ad_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i92964e404b454b1db362fcdfdeab5c39_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ide2d33d6f2a64d8e852283d3699cd837_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ifd93462fe1f746509d6667375bb9b419_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibd67de1d320a48c38e39d726d50f9f41_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i991dc368ad8c4c698b4f083f9a6a0a73_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie4bd7600e6b442a4930e416576424ba6_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:SalesandMarketingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i2fd088dfe1ea487588fdb1a14a83fffb_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="id9129b833a9b4f6888db58833919b896_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ibba35bdcc6824faba7770fde57155e08_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i75d386528c074f2bbf08a38f3944a4e9_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:TechnologyandDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i8e7adb81ce6b4eaab1be9f873a9f4de5_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie443b8fdfa9644e38627ed682ec6e547_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i89d12a4acd5f4578ab68365ed4d50c82_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ib2dbf47a274d459a8e0c0007cbc26405_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ic6ee172b218d4f5ba07c1dc8b51df50e_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="if88ef73955ab42f1abe01f3f7c744f9c_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ie7bcb862987f4d31a41e21ebf117cc84_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i6f58c98c5d3a465b9b500d87b1949821_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hqy:MergerIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i30b4954833a14a5db0d4f1d4321a6f4a_D20200801-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i98fb062772b640c887ba8a960fd86c44_D20190801-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="i64472d16654b400e97654463b5d7e80c_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i7ad3647d44134fbe82f1424566227086_D20190201-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ic64248ebfff14817a2f075cb756200da_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hqy:IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i9990defe3e97407581f4f0a4af6c6fc4_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hqy:WageWorksIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ia0a41dab082f4d569390c26af5e24b25_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hqy:WageWorksIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="ie3646166651746228acb84ea09049053_D20200201-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i70be1d14e5f049ea9990ac6488c46bb2_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="id0c3c36c6fb949c6b668af4f989c6df1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i13b43e3e97744f2f99ef7eba9252d568_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i3843854aae914afaa49721b198e544c7_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i550456057eea4a81a4866ec595bb66fe_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i66be3136ba174468819065390931d293_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i30ee4b3524be43a9bad2db97c312e887_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ifb0a184b778d46f6bb8363b0ba93ac1d_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i851da9c28c4d412f8a32c95d3d5bf732_D20200201-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i5035efb5313648a3b06aa3af898d03ce_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i1e82ed8bc9eb4b0199285a4985c3e872_D20200201-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i92cbf523ebd94e99a62188292dc7a98f_D20200201-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001428336</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hqy:PerformanceRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="lawsuit">
        <measure>hqy:lawsuit</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="member">
        <measure>hqy:member</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl80LTEtMS0xLTA_02c0829f-c92e-40e7-ba2e-15bc748aacbf">0001428336</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl81LTEtMS0xLTA_32cb51f9-8119-4841-b37e-94d088c5cfaa">--01-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMS0xLTEtMS0w_4c671114-3908-44c8-8c6f-81e2d487fe56">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMi0xLTEtMS0w_a5488740-c697-4d8e-a32b-a1b06d98647c">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80L2ZyYWc6MmZmZmRlMTk5YWM3NGZlZGE4OWQ4N2MwZGM0OTY2ZDgvdGFibGU6MmE1NThiMTVmNjUzNDY2N2EzOGZlNjI3ZDUyOWI3YmIvdGFibGVyYW5nZToyYTU1OGIxNWY2NTM0NjY3YTM4ZmU2MjdkNTI5YjdiYl8xMy0xLTEtMS0w_f2566fcf-b6fb-4910-905d-33c5e1d86653">false</dei:AmendmentFlag>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio
      contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMS0xLTEtMS0w_3f406ca9-de85-44bc-be2b-5c77a8644d9a"
      unitRef="number">0.6667</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio
      contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMi0xLTEtMS0w_eedf6b1d-faa4-4d76-b810-c7b166cce1ba"
      unitRef="number">0.3333</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio
      contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfMy0xLTEtMS0w_7de55f47-e083-4e23-afc3-004b879a98e0"
      unitRef="number">0.3333</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNC0xLTEtMS0w_8ca1b7f9-fa94-465a-9e60-348cc282bb9b"
      unitRef="number">0.3333</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNS0xLTEtMS0w_682af27a-e81f-40b4-be27-a981ce552704"
      unitRef="number">0.6667</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81Mi9mcmFnOjg5Y2IzMWEwNGUzYTRmZmY4Zjg4NzdiNzVmZDBiMjYwL3RhYmxlOjk4YjRjZDYzNDJjODRlMTJiZGFjNGRmMjdmYjhmZGVlL3RhYmxlcmFuZ2U6OThiNGNkNjM0MmM4NGUxMmJkYWM0ZGYyN2ZiOGZkZWVfNi0xLTEtMS0w_3960eba4-2346-4108-aeea-5988aba77107"
      unitRef="number">0.6667</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio>
    <dei:DocumentType
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc2_87520cce-981b-4b75-b795-5e5ffea5ad81">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6Mzg5ZWIwY2RhZmYwNGZjNThkNmJiN2I0YTAxYzgwZTAvdGFibGVyYW5nZTozODllYjBjZGFmZjA0ZmM1OGQ2YmI3YjRhMDFjODBlMF8wLTAtMS0xLTA_a8622909-7f8d-4aac-a634-9ccbe038e4f4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl84Nzk2MDkzMDI0MjIy_6bef3e14-a103-45c0-b044-e8a01b42ce6e">2020-10-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ODg2YWM4OWE4ZmUzNGYzY2E3MGQ5ZWRkMGI0NzE5NzcvdGFibGVyYW5nZTo4ODZhYzg5YThmZTM0ZjNjYTcwZDllZGQwYjQ3MTk3N18wLTAtMS0xLTA_be623604-9749-4241-9195-bc6d6a938221">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgz_b56efb6a-2d34-4c6b-a704-1f86f2808012">001-36568</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmUzNTU0M2U5NGZlNGExZWI3Yjc4NDNlNzVlMDgyNTgvdGFibGVyYW5nZTpmZTM1NTQzZTk0ZmU0YTFlYjdiNzg0M2U3NWUwODI1OF8xLTAtMS0xLTA_c7738e0f-ad9f-40fe-a091-49429c5a2997">HEALTHEQUITY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6YmU0ZTQ1NzQ2Y2Q1NGI4N2EzNWRmZTJmZjc2OTljZDYvdGFibGVyYW5nZTpiZTRlNDU3NDZjZDU0Yjg3YTM1ZGZlMmZmNzY5OWNkNl8wLTAtMS0xLTA_aae20ee5-b059-484e-80a7-c27856f5286f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6YmU0ZTQ1NzQ2Y2Q1NGI4N2EzNWRmZTJmZjc2OTljZDYvdGFibGVyYW5nZTpiZTRlNDU3NDZjZDU0Yjg3YTM1ZGZlMmZmNzY5OWNkNl8wLTQtMS0xLTA_cf23714a-a82c-4496-8f2c-1bdc96c0f8d0">52-2383166</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg0_a030684f-56d0-4d7d-823d-ef6db4fc8569">15 West Scenic Pointe Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc3_b036d454-d80f-4646-94fd-b14e05eedb20">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg1_bf614363-b088-4f72-b050-baffc8d0ab14">Draper,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg2_5865d04d-5883-4406-a50f-b608d467a0a6">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc4_c2a7d3ba-88f7-4551-85de-25bcc7dbdf6f">84020</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTg3_53aad799-acf5-4517-8236-8ab6b5a53f51">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTc5_3ec1b942-a284-412f-b979-2bed2c0fae25">727-1000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTAtMS0xLTA_bb6de053-604f-44c1-b16c-b8d3fa1d673e">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTEtMS0xLTA_d3eb1a3e-de5a-4688-96b6-fa93b2eabe7e">HQY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6MWU4NGQxNTg1MWU5NDRhYjhlZGVlZDI2OTM3YzcwODgvdGFibGVyYW5nZToxZTg0ZDE1ODUxZTk0NGFiOGVkZWVkMjY5MzdjNzA4OF8xLTItMS0xLTA_f8277502-65a9-4eb4-846e-1ee4f234374c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgw_110ca00e-a424-4605-aa85-5718286e68c3">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgx_c437b421-5c14-4b20-a29a-6b5a97c66cca">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8wLTAtMS0xLTA_5b927b61-7b59-4960-b120-b44d0dceacf7">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8xLTMtMS0xLTA_2cb49f51-6f2b-4b05-887a-9b2b41b2d0ad">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGFibGU6ZmViNjg4NWRkZDYxNDAyYzllNmEyMzJmZWE0M2Y5MTkvdGFibGVyYW5nZTpmZWI2ODg1ZGRkNjE0MDJjOWU2YTIzMmZlYTQzZjkxOV8yLTMtMS0xLTA_4e0392b6-9479-4de5-8e56-aacc0732b388">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTgy_46d326b2-5729-4886-8fd0-4ee9a39e9913">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i449bf63265634bb0a0d2dc15dd9d1ea4_I20201125"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xL2ZyYWc6MzQ3OWQ5Mzk5NmYyNGY2NDkwNGRiNDhhN2QwMGY0MTYvdGV4dHJlZ2lvbjozNDc5ZDkzOTk2ZjI0ZjY0OTA0ZGI0OGE3ZDAwZjQxNl8xOTE5_2487516d-98e8-4308-8e78-f307fae26881"
      unitRef="shares">76990646</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNC0xLTEtMS0w_a038587a-c39a-45ff-9585-73bba7b5497d"
      unitRef="usd">299356000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNC0zLTEtMS0w_a841dc1e-68d4-41e9-86fb-dfce9e490ca4"
      unitRef="usd">191726000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0wLTEtMS0wL3RleHRyZWdpb246MGM0Nzk2ODVjMTJlNDZjZGJlNjcwN2MxYTVlNzZjMDBfNjc_92bb5818-be5b-4ea9-897b-18c12473db46"
      unitRef="usd">3458000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0wLTEtMS0wL3RleHRyZWdpb246MGM0Nzk2ODVjMTJlNDZjZGJlNjcwN2MxYTVlNzZjMDBfNzQ_5e99fe6c-5404-4345-a1af-b64640da0433"
      unitRef="usd">1216000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0xLTEtMS0w_b884e4b3-c882-458e-b738-1d56d9216d0b"
      unitRef="usd">64291000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNS0zLTEtMS0w_4da505d4-f78f-420f-a024-20f10aa09ce9"
      unitRef="usd">70863000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNi0xLTEtMS0w_824945fb-c9b2-4b2b-a1d1-546afe874432"
      unitRef="usd">32383000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNi0zLTEtMS0w_b99c2b2d-9ae1-4f8b-bc9c-92b51d268665"
      unitRef="usd">34711000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNy0xLTEtMS0w_5a6ac1b4-ab79-4d9c-9c88-6f572f82d7e9"
      unitRef="usd">396030000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfNy0zLTEtMS0w_48a3b6c2-8d55-4c2b-938f-fe3049f2659b"
      unitRef="usd">297300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOC0xLTEtMS0w_07f27b79-462f-4a72-80e4-9453b0c7a04a"
      unitRef="usd">31774000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOC0zLTEtMS0w_b5a4aeec-a678-438e-9c6f-3817c667aff5"
      unitRef="usd">33486000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOS0xLTEtMS0w_c91b2a48-9471-44f9-a2f1-a562dece478c"
      unitRef="usd">92314000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfOS0zLTEtMS0w_34a62415-dc3c-40e2-a695-59caa05d653f"
      unitRef="usd">83178000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTAtMS0xLTEtMA_28211c65-d575-4bc3-9d58-e0756e0e275c"
      unitRef="usd">776311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTAtMy0xLTEtMA_2a841495-2818-4d5b-bba0-eaa0c3553821"
      unitRef="usd">783279000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTEtMS0xLTEtMA_b3c95340-2b68-451a-9ce1-1e7e36a668bb"
      unitRef="usd">1326793000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTEtMy0xLTEtMA_883e0458-4cf4-4fc1-9ec7-6eb2bd806b33"
      unitRef="usd">1332631000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTItMS0xLTEtMA_01369900-7751-44e3-9196-33f5df8c2746"
      unitRef="usd">21000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTItMy0xLTEtMA_2418cc8b-789f-4e7c-aedd-edfed8b31471"
      unitRef="usd">18000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTMtMS0xLTEtMA_5dfd4c17-3abf-4c6c-9724-098505b45dc6"
      unitRef="usd">34019000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTMtMy0xLTEtMA_f48b676d-afeb-4346-9287-25234aba8384"
      unitRef="usd">35089000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTQtMS0xLTEtMA_c45268cb-f267-4e77-93fe-0219997b2aca"
      unitRef="usd">2657262000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTQtMy0xLTEtMA_cda40d8f-804d-4ace-9e72-dcef20bfe1e1"
      unitRef="usd">2564981000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTctMS0xLTEtMA_eb6b16c1-c5df-4700-8c7d-12b42a7afba3"
      unitRef="usd">6746000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTctMy0xLTEtMA_09cb4d57-1ea4-4bad-a012-cf4bf3d7ee4d"
      unitRef="usd">3980000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTgtMS0xLTEtMA_225a7095-faaf-43f7-84be-8de6501f7023"
      unitRef="usd">34839000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTgtMy0xLTEtMA_786c5869-79b9-4b43-9f0a-9735fce18699"
      unitRef="usd">50121000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTktMS0xLTEtMA_bdfacb6a-9252-40d1-8467-84349ecf49ac"
      unitRef="usd">33380000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMTktMy0xLTEtMA_74a8aa2e-70f3-4bec-99cc-35dabc0bbac7"
      unitRef="usd">46372000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjAtMS0xLTEtMA_3de294ae-acc7-440f-8b05-9bf126e1f4e1"
      unitRef="usd">62500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjAtMy0xLTEtMA_0c1415a5-84ed-4bf7-b65b-0cc75d4c01fb"
      unitRef="usd">39063000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjEtMS0xLTEtMA_409e9a01-05a4-42b5-8318-01ae8e1c6709"
      unitRef="usd">13894000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjEtMy0xLTEtMA_3fbf02fb-2e84-46ef-b9b7-2c967d7c11e2"
      unitRef="usd">12401000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjItMS0xLTEtMA_44b84e38-6a0c-4de0-bf46-b8acd6c1fa21"
      unitRef="usd">151359000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjItMy0xLTEtMA_30c3a239-9ba9-48fe-9960-c50364a9c272"
      unitRef="usd">151937000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjQtMS0xLTEtMA_3c3c852c-f2fa-4543-84c0-aff0940a06b1"
      unitRef="usd">938558000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjQtMy0xLTEtMA_9f220d87-af9c-4b1c-99d1-4cec147f81a4"
      unitRef="usd">1181615000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjUtMS0xLTEtMA_a0388608-a801-4a79-a992-10119c9bf9f1"
      unitRef="usd">76666000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjUtMy0xLTEtMA_b01adbe6-0e3e-4c5c-8468-8b15924bac4e"
      unitRef="usd">68017000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjYtMS0xLTEtMA_36ab140b-611f-4ce9-ba4d-8c7e083ac386"
      unitRef="usd">11429000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjYtMy0xLTEtMA_4a0e9673-7aab-4476-981f-4f7dbd631b84"
      unitRef="usd">2625000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjctMS0xLTEtMA_53755c1d-301e-4197-824d-945a13256a32"
      unitRef="usd">123993000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjctMy0xLTEtMA_2f6be1be-e1a8-4917-8d1b-6df4167b3a81"
      unitRef="usd">130492000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjgtMS0xLTEtMA_d9593933-0325-42e7-a2e4-0d92dfe5bbe5"
      unitRef="usd">1150646000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjgtMy0xLTEtMA_bbeb8672-13c8-4197-a06a-97808b5bf4e7"
      unitRef="usd">1382749000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjktMS0xLTEtMA_7d0c1075-2855-4b28-b57e-5e7c6d390a0b"
      unitRef="usd">1302005000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMjktMy0xLTEtMA_18da150c-8076-41c4-b649-1e7756ff98a7"
      unitRef="usd">1534686000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzAtMS0xLTEtMA_181e0c1e-8925-47da-935f-b9a8b557d42e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzAtMy0xLTEtMA_d528c106-0f48-4ad1-80a2-583febfdf92b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzIx_72c11f8b-eecb-4ae0-8ac8-c70470c75274"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzIx_a2d7e79d-94c3-4b4e-9bbf-4d58a18b2027"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzM1_4f5ac68d-b1ea-46b4-9fa0-b611fd46bd26"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzM1_78a1f1f1-40a6-4b6b-8727-47e0f91d900c"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_121a9dfe-b37b-4bbf-80ec-b163aa910dab"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_b6b4f1a4-bd2e-4869-b663-6afcc6ff3fdf"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_ccb43ae0-e4d2-4269-ba76-8428972eebcd"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjlhYmM4NjVmNjNhOTRjZTc4ZjBlMjI1OWZkYTBlY2NiXzU3_dba26641-fcee-4e29-aaa7-9ed45a2aa1f3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMS0xLTEtMA_37082c6d-fe90-4bf4-a31f-87d49959a14e"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzItMy0xLTEtMA_76687681-8718-4e8d-aa13-cbd7fe6a27b4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzE4_2041cf04-7f99-4161-8750-e790ab5022d3"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzE4_52ef8cd4-8937-4492-8aad-eff568dd190a"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzMy_5622eb7f-f30d-4071-be80-258014211e2f"
      unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzMy_ca1ba129-0641-4105-a128-c52ece7591b7"
      unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzU0_4675bdb6-904c-4966-8fbd-5f2e6ee692ec"
      unitRef="shares">76951000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzU0_c04e97be-482c-4a92-8b63-da9f193f4dc7"
      unitRef="shares">76951000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzYx_bc82927a-af8b-400d-bf51-d4466fc89a45"
      unitRef="shares">71051000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmY5MDNkMTFhMDU0ODQ4ZjI4ZDI4MDI3ODg3ZmJiZTQ5XzYx_bd35128e-263e-4c9a-83f0-7e209742ed6f"
      unitRef="shares">71051000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMS0xLTEtMA_b9ffbd0b-6eec-4ff4-a5e2-6318e12bb85c"
      unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzMtMy0xLTEtMA_2b4b0970-e280-4b07-8856-4f75b733eb91"
      unitRef="usd">7000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzQtMS0xLTEtMA_b36788ba-e260-4cbf-8944-9e963054d567"
      unitRef="usd">1140268000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzQtMy0xLTEtMA_e774d44c-4013-4d0d-96aa-250b571bb075"
      unitRef="usd">818774000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzUtMS0xLTEtMA_825e94af-68a1-40bb-8a56-9ab9cb99669a"
      unitRef="usd">214981000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzUtMy0xLTEtMA_889f3e83-9479-4a4d-beb4-6295237ac348"
      unitRef="usd">211514000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzYtMS0xLTEtMA_f4332663-96b5-4808-a9e2-eab8678ca5e8"
      unitRef="usd">1355257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzYtMy0xLTEtMA_2a102f30-3cbb-408d-953a-84c141161996"
      unitRef="usd">1030295000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzctMS0xLTEtMA_e83a3eba-d92e-4a3e-ac39-a932f23d5b8a"
      unitRef="usd">2657262000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMC9mcmFnOmY4MWY4NzIzY2NmODRiMzlhNDkyOWMzM2NlYjAyNjc4L3RhYmxlOmNkMjkyZDE2NDFiNzRmMTBiZTk5ODc2MGY5OTg2ZWNkL3RhYmxlcmFuZ2U6Y2QyOTJkMTY0MWI3NGYxMGJlOTk4NzYwZjk5ODZlY2RfMzctMy0xLTEtMA_8abd6988-2fdd-4bc9-9dc1-8117b859101a"
      unitRef="usd">2564981000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy0xLTEtMS0w_e0c6e1ed-1978-4550-bbe6-7dfc879fa472"
      unitRef="usd">104562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy0zLTEtMS0w_a17a578c-cf64-4cd7-89ae-3ab826edabf5"
      unitRef="usd">87620000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy01LTEtMS0w_41f66730-bae0-4b74-b33d-e9bee5801d2b"
      unitRef="usd">319638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMy03LTEtMS0w_9e66101f-af5b-4ee4-b6d9-a1c797406703"
      unitRef="usd">140710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC0xLTEtMS0w_b3860846-0525-4f51-a46c-4d106d22460a"
      unitRef="usd">48544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC0zLTEtMS0w_9f81a40f-4105-4256-b0f2-f60d02482a9c"
      unitRef="usd">46972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC01LTEtMS0w_2de5dc01-0c10-43b0-8822-93494ea6ea49"
      unitRef="usd">142352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNC03LTEtMS0w_0e84453f-453d-4d22-9de1-c713da0204ba"
      unitRef="usd">132538000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS0xLTEtMS0w_b2a3831f-81fe-42d0-82b5-f9388b5a5aa7"
      unitRef="usd">26245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS0zLTEtMS0w_73da3b99-c6db-4ea4-a313-80942ac43db5"
      unitRef="usd">22526000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icaa726f7353a405892ef7138baec6e73_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS01LTEtMS0w_861340c4-bde5-44f8-830d-b565d705b2bf"
      unitRef="usd">83411000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNS03LTEtMS0w_ed66d6d7-15cb-49c2-8200-2f36d0367209"
      unitRef="usd">57545000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi0xLTEtMS0w_6e932790-59dd-4069-a7fd-09fe7d571978"
      unitRef="usd">179351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi0zLTEtMS0w_aa99a8f9-27d7-423e-bf68-a67ec8fde918"
      unitRef="usd">157118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi01LTEtMS0w_adc1b3b6-f918-4dad-bb5b-ad3160bf5fe0"
      unitRef="usd">545401000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfNi03LTEtMS0w_d07555cb-6ae0-495a-8d92-159dfb2c3d8b"
      unitRef="usd">330793000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib0a7c981ffc240baa7d8635fa93fd14a_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC0xLTEtMS0w_10be826f-ff84-4b58-9694-83da8e25533c"
      unitRef="usd">65936000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7169c18c103c493c9f7ea1fd3889b18b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC0zLTEtMS0w_140a5c40-9810-4d80-8f49-c23437bf3306"
      unitRef="usd">52278000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib3743d622f7e4581a306e279ca39103f_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC01LTEtMS0w_eb5fea4e-cf68-4080-9a5a-8821457dc758"
      unitRef="usd">202195000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9e5466528d6544cfb62781649ddfef55_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOC03LTEtMS0w_a15ff476-a636-49f8-9d43-98c2af35a526"
      unitRef="usd">92672000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie264a5b2422144fa98b0b9f8e5f75c54_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS0xLTEtMS0w_af01ecf5-4dbb-4d90-b926-4af382caa144"
      unitRef="usd">4762000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibc1469a22f944913aac636d735e0eca8_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS0zLTEtMS0w_376c7146-8f8c-4bac-bccc-c81c555fd019"
      unitRef="usd">4384000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie99d8aabca8646f6af1eaaee9b820f1e_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS01LTEtMS0w_8cd55af6-f1d8-4326-ac54-27fc75e6be5b"
      unitRef="usd">14805000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9a0e8be739da4d9088e22ed4fdcef451_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfOS03LTEtMS0w_797f8a6f-afb7-4495-adbe-80edd6efaab9"
      unitRef="usd">12716000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0ccc55a3147a45cb897ec2cbb39b2fd8_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtMS0xLTEtMA_dfeeffb2-406b-44c1-9d79-1c2d73e575d4"
      unitRef="usd">4095000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie8b8af8ff45f427496c49c6984fadc2b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtMy0xLTEtMA_0595f886-0d44-4bfa-b4cf-020020f6038e"
      unitRef="usd">4421000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icaa726f7353a405892ef7138baec6e73_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtNS0xLTEtMA_160d57aa-bf75-4369-9082-d720d463b1fe"
      unitRef="usd">13985000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic6a692f59ebd45e5b6df285444c6298a_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTAtNy0xLTEtMA_07ba958b-1cfc-435c-b687-9575fff3bcd1"
      unitRef="usd">13177000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtMS0xLTEtMA_88de0648-e1f6-4699-997f-5cac4acacb90"
      unitRef="usd">74793000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtMy0xLTEtMA_20c5a82f-d90e-4066-b947-08b54e3a16da"
      unitRef="usd">61083000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtNS0xLTEtMA_f51d57ba-7198-4c28-9ebe-35cf545be704"
      unitRef="usd">230985000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTEtNy0xLTEtMA_3d698163-da7b-45fa-adcc-29491f808ae7"
      unitRef="usd">118565000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItMS0xLTEtMA_0ffbafc2-b3cc-4189-97e8-32fa428774b7"
      unitRef="usd">104558000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItMy0xLTEtMA_78b4b26b-63d2-49fb-b1a4-28ecacc75f76"
      unitRef="usd">96035000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItNS0xLTEtMA_00dd0425-f902-492f-9bb7-eb7d21454e73"
      unitRef="usd">314416000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTItNy0xLTEtMA_c3eb2eb9-0396-4d48-a0ea-24339b113282"
      unitRef="usd">212228000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtMS0xLTEtMA_479b7c53-285e-422c-9749-2ca46f8febbc"
      unitRef="usd">12880000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtMy0xLTEtMA_ae3ab0df-8cfa-4863-b3cf-d9663e053bf2"
      unitRef="usd">12654000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtNS0xLTEtMA_cfed7cc4-bc64-4c18-82ea-bc1da26511bd"
      unitRef="usd">36502000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTQtNy0xLTEtMA_10e8bc42-34a4-443b-a9f3-0cd42d540830"
      unitRef="usd">30015000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtMS0xLTEtMA_89ea3d8c-7a9e-49fb-baa9-6648f44be4d1"
      unitRef="usd">30758000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtMy0xLTEtMA_3dda1084-33e0-4d9d-812b-50e63dfb204d"
      unitRef="usd">23511000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtNS0xLTEtMA_770f788a-2597-4e66-84d2-4e1f78e8594d"
      unitRef="usd">92490000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTUtNy0xLTEtMA_1bd132c4-c353-4c56-8b0c-4de5b15b2fcd"
      unitRef="usd">46061000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtMS0xLTEtMA_bde0738b-cf45-4c9b-9f55-a4c2ac5995df"
      unitRef="usd">22099000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtMy0xLTEtMA_3580205d-7836-43e1-8b50-8c072a414cbd"
      unitRef="usd">19222000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtNS0xLTEtMA_a0400dea-516e-447e-8dee-ba0b853ee3d8"
      unitRef="usd">61590000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTYtNy0xLTEtMA_8e49afbc-b440-413f-a888-9a36b6ce8b99"
      unitRef="usd">37193000</us-gaap:GeneralAndAdministrativeExpense>
    <hqy:AmortizationOfAcquiredIntangible
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctMS0xLTEtMA_0c0b94c5-04b5-40d2-bfcb-244c855c2b71"
      unitRef="usd">19126000</hqy:AmortizationOfAcquiredIntangible>
    <hqy:AmortizationOfAcquiredIntangible
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctMy0xLTEtMA_2a4e108b-913b-4f62-b326-5bd761812e68"
      unitRef="usd">13051000</hqy:AmortizationOfAcquiredIntangible>
    <hqy:AmortizationOfAcquiredIntangible
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctNS0xLTEtMA_9bf22a8f-105c-4530-b75d-b417b01bb14c"
      unitRef="usd">56905000</hqy:AmortizationOfAcquiredIntangible>
    <hqy:AmortizationOfAcquiredIntangible
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTctNy0xLTEtMA_07bddc14-7456-4823-b046-b304b1fd1247"
      unitRef="usd">16036000</hqy:AmortizationOfAcquiredIntangible>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtMS0xLTEtMA_d7312856-6911-41a5-977a-3868074ba783"
      unitRef="usd">8193000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtMy0xLTEtMA_eda57ea0-8dca-42d0-8c3f-ae3ccac29007"
      unitRef="usd">17675000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtNS0xLTEtMA_b2ba200c-728b-49d8-9d84-dfb5e07f80b5"
      unitRef="usd">31328000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTgtNy0xLTEtMA_088ba5e0-98cc-405d-9f64-5394594f2f08"
      unitRef="usd">20459000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:OperatingExpenses
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktMS0xLTEtMA_aa5c79b1-3e1a-4d8a-809f-62a0c5f8ebac"
      unitRef="usd">93056000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktMy0xLTEtMA_982e2b2b-9be4-4346-83ec-24805a5c5f2d"
      unitRef="usd">86113000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktNS0xLTEtMA_78c63f99-3761-40d8-9ad7-e674618b2718"
      unitRef="usd">278815000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMTktNy0xLTEtMA_4d1f64f4-5604-4090-a66f-0aa0b203ca0a"
      unitRef="usd">149764000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtMS0xLTEtMA_b155c09b-544f-4ed3-bfd7-e83dd07931f3"
      unitRef="usd">11502000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtMy0xLTEtMA_efdbba59-b3bc-4032-91f3-e06439aa16df"
      unitRef="usd">9922000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtNS0xLTEtMA_ebb6c3c1-1c48-4fc2-b67a-08f41e9c0746"
      unitRef="usd">35601000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjAtNy0xLTEtMA_f019dd0a-d8cb-466f-8927-bfd4c5053cbb"
      unitRef="usd">62464000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItMS0xLTEtMA_4c08f960-d134-4cfa-b457-caff7d3b8ae7"
      unitRef="usd">6952000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItMy0xLTEtMA_94124117-f3fd-480c-accc-481045d31d7a"
      unitRef="usd">10225000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItNS0xLTEtMA_89434556-3a03-4db1-b76c-06bc25c089ea"
      unitRef="usd">28110000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjItNy0xLTEtMA_9654c0c0-d60f-4c0c-b2d1-851b40a0a8d3"
      unitRef="usd">10355000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtMS0xLTEtMA_675e5cd2-dd6e-4c57-940b-1e7205e3c690"
      unitRef="usd">-421000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtMy0xLTEtMA_9fb544fb-f80d-469f-8b4a-aff9cbe75176"
      unitRef="usd">-30949000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtNS0xLTEtMA_3c0dc81b-8cf9-44b9-bdf4-ad178d905aa1"
      unitRef="usd">-2009000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjMtNy0xLTEtMA_0a8e4e30-22d3-416b-b20c-2f1fb8fdc5b7"
      unitRef="usd">-8347000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtMS0xLTEtMA_96ffe0bc-0c6a-49ab-8fbe-edd0b34d37e4"
      unitRef="usd">-7373000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtMy0xLTEtMA_8f012ab4-ad8e-48de-a611-790570ae6d52"
      unitRef="usd">-41174000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtNS0xLTEtMA_d513c533-d063-4229-b944-e7ae7159436a"
      unitRef="usd">-30119000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjQtNy0xLTEtMA_a17cd6ef-3cf4-4a65-98c3-5cd2bb73463b"
      unitRef="usd">-18702000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtMS0xLTEtMA_b81f57ae-3397-4699-92bf-0cc11509b778"
      unitRef="usd">4129000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtMy0xLTEtMA_73a6ec47-3473-4fce-9a01-a425e680103e"
      unitRef="usd">-31252000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtNS0xLTEtMA_a0d7efd8-7786-4517-ae12-42991d044a4a"
      unitRef="usd">5482000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjUtNy0xLTEtMA_74037c12-dc20-4012-b45f-dd548bc5f162"
      unitRef="usd">43762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtMS0xLTEtMA_a51c1abe-aa3a-4708-a87b-23d4a1dfcef9"
      unitRef="usd">2340000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtMy0xLTEtMA_c2286a30-40c2-47f8-b1e6-fefd7bb9fc34"
      unitRef="usd">-9918000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtNS0xLTEtMA_4eb0d841-fffc-4e88-86be-a8606342e5ae"
      unitRef="usd">2015000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjYtNy0xLTEtMA_9a74c361-e7d4-4953-995d-e0971d0f5d5a"
      unitRef="usd">3908000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMS0xLTEtMA_04cdb92d-3087-41ee-a246-ff6bbd5a7616"
      unitRef="usd">1789000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMS0xLTEtMA_77d235b5-e642-4083-8562-0b7b51a5de1a"
      unitRef="usd">1789000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMy0xLTEtMA_a85c9aee-8b90-43ea-9616-f8d828ebb445"
      unitRef="usd">-21334000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctMy0xLTEtMA_c0806338-38c9-42ba-a4ce-b005c0236234"
      unitRef="usd">-21334000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNS0xLTEtMA_4311ef56-5094-46df-a5c9-9a0ee835fcb3"
      unitRef="usd">3467000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNS0xLTEtMA_7afb139d-a262-42d6-946b-8c50311ca19f"
      unitRef="usd">3467000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNy0xLTEtMA_12d6fe7f-ea7f-4d53-a025-35513a92a2c3"
      unitRef="usd">39854000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjctNy0xLTEtMA_7fda0a24-eb24-4351-8577-90bf1b6a87a9"
      unitRef="usd">39854000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktMS0xLTEtMA_06684ded-ab57-4ad8-aba0-7ae20147038c"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktMy0xLTEtMA_cb06b37d-49a5-40a6-b13f-23e08b775589"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktNS0xLTEtMA_0c5a6d66-c798-45ca-bc4b-ee8d78643b93"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMjktNy0xLTEtMA_65c672fb-0f7d-41ff-ae62-892deb93064c"
      unitRef="usdPerShare">0.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtMS0xLTEtMA_0e90c529-cf68-4423-b866-ec65abf58cb9"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtMy0xLTEtMA_9696f24a-51e8-47cf-a314-f263935740b3"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtNS0xLTEtMA_22b26f71-1c67-4c04-b74a-5c8a58442d6c"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzAtNy0xLTEtMA_36e10b0a-efe5-47af-810d-222ca8ac0d1b"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItMS0xLTEtMA_8e95f2b7-7f3f-4c43-ae1b-921f57548b46"
      unitRef="shares">76701000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItMy0xLTEtMA_ae91e7ff-a855-404a-9f6f-7e57606967b6"
      unitRef="shares">70524000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItNS0xLTEtMA_7fbbc44f-d546-4722-9352-d3855618468b"
      unitRef="shares">73358000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzItNy0xLTEtMA_b3e1bbbe-e25d-4fc9-b337-18e01064cd95"
      unitRef="shares">65727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtMS0xLTEtMA_b1a83dcd-e01c-4fd3-aec9-31ee56471b1c"
      unitRef="shares">77845000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtMy0xLTEtMA_9b62b156-3145-4378-b871-8425436679a7"
      unitRef="shares">70524000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtNS0xLTEtMA_1fda4134-a4aa-4f5b-b75e-72a64196b105"
      unitRef="shares">74665000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xMy9mcmFnOjIxMGIwZTY1MWU1NDQ5ZWQ4OGRlMDZjNWM5OGYwNTMzL3RhYmxlOjUwNzE1MmQ3YzllODQyNmZhODQyMjNiZjg3ZTI0NWJmL3RhYmxlcmFuZ2U6NTA3MTUyZDdjOWU4NDI2ZmE4NDIyM2JmODdlMjQ1YmZfMzMtNy0xLTEtMA_1acc31fe-c955-4e46-a460-fd9190a94a65"
      unitRef="shares">67150000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i25dd807bc6f645aa8efffcedd8ec8168_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi0xLTEtMS0w_133595c5-4777-4c1c-bed3-b8ed4e019c3a"
      unitRef="usd">1340336000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i728a44a8b9e844d2b3e44fd961a30bb0_I20190731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi0zLTEtMS0w_4f3d95fd-539a-4720-8c58-b9e7805e3bb5"
      unitRef="usd">1017031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi01LTEtMS0w_fd8533ef-aa85-4fad-b18b-ea1d1c99d42e"
      unitRef="usd">1030295000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if66fb9a6498840c584531c192cbb750f_I20190131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMi03LTEtMS0w_ae6cd2b3-687d-4724-a1fc-bb3033d458e7"
      unitRef="usd">477079000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i830f5e55e2f148619c75a186e62b092a_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS0xLTEtMS0w_497cf242-576b-435a-bffd-1976fead3274"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i325dd6d30575455eb3528a68d3959890_I20190731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS0zLTEtMS0w_e523e08e-96fa-4df7-9610-8eb5294c3a43"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15e9026e2bcc4fbda5eb976b88d60ec1_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS01LTEtMS0w_105ba716-b626-44ab-8086-127b9ec5ba3a"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie544510666474891b6abaeb2f71c3656_I20190131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNS03LTEtMS0w_3349b487-ca36-4692-92e9-7cc2921fcb3c"
      unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi0xLTEtMS0w_9c1c979d-cf92-4b4d-8b1d-692036b493d6"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibb9e554abf8943638da327cec50b9857_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi0zLTEtMS0w_f65bf5c5-2306-4426-b4b6-d92ef4f73533"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i12bed13866654060afc41b6395363264_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi01LTEtMS0w_dca4f08a-f28f-497d-bac3-816032eab53a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i89a084639dd944c683e352986cdf225c_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNi03LTEtMS0w_cad761b6-c010-431b-8a1c-c926e3a1fa7f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i75518d5df60a4354bbebdeff4496e1ea_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy0xLTEtMS0w_9f8ecb4e-3bdb-46a0-a500-b24f055a40f1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ibb9e554abf8943638da327cec50b9857_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy0zLTEtMS0w_e3fe624d-bcb6-437e-8647-487fd2742ec3"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i12bed13866654060afc41b6395363264_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy01LTEtMS0w_5f8188b0-ea6e-4cd3-9376-42c7ec7b7151"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i89a084639dd944c683e352986cdf225c_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfNy03LTEtMS0w_2ec06616-4de1-48fe-909f-8836c28ce8f0"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockholdersEquity
      contextRef="id76b0719fb45488e82da5b09436072ce_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC0xLTEtMS0w_b40136c4-9372-47de-b2c9-85312e2f874b"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ad2506671294a95a4dd823458a6c3be_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC0zLTEtMS0w_10f38e82-f0af-49a0-988d-26914c433f4c"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id76b0719fb45488e82da5b09436072ce_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC01LTEtMS0w_bd5dd1b4-fce6-441c-9044-e21ea736bbf0"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ad2506671294a95a4dd823458a6c3be_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfOC03LTEtMS0w_849e33cc-397a-48b1-992f-4d2d2884b524"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfe3587113374eca96792f943ab69fc5_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtMS0xLTEtMA_e2bbf94e-227e-41eb-8c9b-09cff6392921"
      unitRef="usd">1127136000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i832a9d56436f4dc487e711fd9d9f1b37_I20190731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtMy0xLTEtMA_7c4c5496-326d-4274-ae02-04ddfd14a4c8"
      unitRef="usd">783986000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib1ab93c490ba422e8067ee638aa89f8a_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtNS0xLTEtMA_5cea78c7-69ef-4b79-b029-8ab16348cbd7"
      unitRef="usd">818774000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a9294ef6c2a4467ab59ebeb152cd174_I20190131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTAtNy0xLTEtMA_09663dd8-b070-4ead-be60-b8c3e53c2167"
      unitRef="usd">305223000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtMS0xLTEtMA_f669bba4-eca3-4c1f-a770-f7ce0eec50f1"
      unitRef="usd">1651000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtMy0xLTEtMA_0cb06e90-331d-4885-9584-4d67b9b51ea1"
      unitRef="usd">712000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtNS0xLTEtMA_da2c7e86-67e3-46a9-8a66-d473b3157a91"
      unitRef="usd">4402000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTEtNy0xLTEtMA_9019ef37-4871-4f90-8f37-cd8eb9b7fe1b"
      unitRef="usd">7363000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItMS0xLTEtMA_1959ab2c-84e7-4f2a-8b1a-76187d2de8d0"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItMy0xLTEtMA_b655e69a-2f6f-4693-bdb8-f0ea5948b4f5"
      unitRef="usd">3776000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItNS0xLTEtMA_0c004167-0aba-4ab8-8cc0-12842c2bb355"
      unitRef="usd">286779000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTItNy0xLTEtMA_3e94bc24-791f-4d6a-aeb2-a11156490062"
      unitRef="usd">462270000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2e9fda195f2146aab00169039c819e6e_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtMS0xLTEtMA_adf11f2a-6796-47f4-b202-b5b770b1c892"
      unitRef="usd">11479000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2d6badc49b8a4cb0a6170c5812d3715b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtMy0xLTEtMA_ecf6d98e-78fe-4f1e-994a-2d1d099e0504"
      unitRef="usd">17576000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i901262a311df4c40a831ef51183cc35f_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtNS0xLTEtMA_543e2d1b-e919-44c4-b5c1-7d48bec3a086"
      unitRef="usd">30313000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie49dab1577c74828a7a8ad668e35076d_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTMtNy0xLTEtMA_403012c2-b3b5-41c3-b14e-064b8a01b6cb"
      unitRef="usd">31194000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i60d2105b15fb48538124056d84240663_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtMS0xLTEtMA_5a5f97ff-f5cd-47a5-b1d0-8768297dd78e"
      unitRef="usd">1140268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtMy0xLTEtMA_0deb59c7-f17c-40f2-a00e-daf533da82c4"
      unitRef="usd">806050000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60d2105b15fb48538124056d84240663_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtNS0xLTEtMA_4e77571d-2c79-488e-987b-b4c86615cd68"
      unitRef="usd">1140268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i903fa26a51cd4b2aae31a1670ef63ffa_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTQtNy0xLTEtMA_7a9017b3-763a-459a-bbd5-4893daac11e5"
      unitRef="usd">806050000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia4f820434883469d97b62b57e6b2765e_I20200731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtMS0xLTEtMA_4f8d6d25-8a4a-4463-91bd-ab49304a65e1"
      unitRef="usd">213192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i093f52c37be1437080529f8202cebe1a_I20190731"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtMy0xLTEtMA_5d1a2a23-d43d-47bc-b867-076e413af7af"
      unitRef="usd">233038000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie50c1af507e14565b249c2e89c3acc10_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtNS0xLTEtMA_787d470a-538b-4cb3-8bbf-7699f6c4e6c9"
      unitRef="usd">211514000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibf7fea257d4a4064844d660aa4a7626d_I20190131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTYtNy0xLTEtMA_0a685204-4e26-45df-ba6a-2b08bec79940"
      unitRef="usd">171850000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i254be2393d1a4c6d8a3240a437574561_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctMS0xLTEtMA_1cd0a83b-25a6-4462-a4db-ace7174327f4"
      unitRef="usd">1789000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3f04871247f84c9ca9f77b217b29052e_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctMy0xLTEtMA_e76b6345-3811-4313-ba99-545c4ef8a92d"
      unitRef="usd">-21334000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7bb624d27231459bb251681eee242ddd_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctNS0xLTEtMA_b9805751-1356-4bbd-8348-75831c1b4e13"
      unitRef="usd">3467000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i62f278c7b4d74e868c0bf4ad932243bb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTctNy0xLTEtMA_fdd7ac8f-01dd-47be-a6f0-e28303a25fe5"
      unitRef="usd">39854000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtMS0xLTEtMA_13ee20e0-4c3f-4df4-8e87-12687c759005"
      unitRef="usd">214981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63ef3d19e95d456f9d4e91847890e387_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtMy0xLTEtMA_58172c66-8698-4587-8078-28a752036fec"
      unitRef="usd">211704000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7e2d83a18c54734896f0fb55f1c0e03_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtNS0xLTEtMA_d975170e-0b62-446d-a9f1-1363d67c99df"
      unitRef="usd">214981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63ef3d19e95d456f9d4e91847890e387_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMTgtNy0xLTEtMA_277cd3b3-d809-4120-a980-2541559efbb5"
      unitRef="usd">211704000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtMS0xLTEtMA_9e3ea1f4-5943-4445-8c47-e49f48bf5399"
      unitRef="usd">1355257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtMy0xLTEtMA_f58ff6c5-0062-4258-8170-85341227bf4f"
      unitRef="usd">1017761000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtNS0xLTEtMA_733e1b89-7e74-47bf-bd02-a596a09f84a0"
      unitRef="usd">1355257000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xNi9mcmFnOjU2MzIzOWEwNzQxNDRkY2Y5NWNiZDRlMmU0NGVmMGI5L3RhYmxlOmExZGFhMTY3YTU4YzRlMTRiYTI5ZTU4ZGJhYjkyMzg5L3RhYmxlcmFuZ2U6YTFkYWExNjdhNThjNGUxNGJhMjllNThkYmFiOTIzODlfMjAtNy0xLTEtMA_886faa4f-879e-4aea-a551-9ae8d010e9fb"
      unitRef="usd">1017761000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMy0xLTEtMS0w_a14b7ce2-4c2d-47aa-96ba-047fba86fd18"
      unitRef="usd">3467000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMy0zLTEtMS0w_1da8adfd-30f2-4c98-879c-3c1c696bfd30"
      unitRef="usd">39854000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNS0xLTEtMS0w_59165019-9212-4c4e-b1c4-8093bcc76f76"
      unitRef="usd">85485000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNS0zLTEtMS0w_ee205702-cd89-42c4-b3c1-610968b826f7"
      unitRef="usd">28791000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNi0xLTEtMS0w_6eae16d9-6c78-43dd-87ce-f6c7fb568ae0"
      unitRef="usd">30313000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNi0zLTEtMS0w_9b8e18fc-4c43-4a73-84d6-4b7638a43466"
      unitRef="usd">31194000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNy0xLTEtMS0w_713d0703-1f4a-4ef6-a3a7-e7d9306d9436"
      unitRef="usd">3818000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfNy0zLTEtMS0w_9c775db8-678d-4392-a4f0-67fe1f176614"
      unitRef="usd">1138000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOC0xLTEtMS0w_5aa4896e-8bf8-4b2a-921f-ca161d41464c"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOC0zLTEtMS0w_a34d4e9a-186a-4877-96ac-f959d6bf885f"
      unitRef="usd">27570000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOS0xLTEtMS0w_6da60782-2518-4794-b3a0-5841497bc380"
      unitRef="usd">-1727000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfOS0zLTEtMS0w_7d45734f-55a7-4f3f-bf0e-3d2bf2cac162"
      unitRef="usd">-139000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTAtMS0xLTEtMA_0a19a8fa-b4e9-40dd-8513-b25834bda612"
      unitRef="usd">-973000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTAtMy0xLTEtMA_308848ad-fb9b-4a6e-bccf-09945057a070"
      unitRef="usd">690000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTItMS0xLTEtMA_21e116f8-1277-450f-ab7e-f4e14a0ebaec"
      unitRef="usd">-8063000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTItMy0xLTEtMA_6c7733c7-9db2-48e0-a22e-2f8a10b6399b"
      unitRef="usd">1901000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTMtMS0xLTEtMA_5ca188da-0c11-452d-80d6-448993d41f25"
      unitRef="usd">-3309000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTMtMy0xLTEtMA_2a105f82-5cde-457b-b286-56fc2c0d10dc"
      unitRef="usd">4863000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTQtMS0xLTEtMA_af8595d0-b388-481e-870a-39c0ee3cb986"
      unitRef="usd">-8344000</hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTQtMy0xLTEtMA_674f7cfb-1db1-44bc-8b9e-8161aae1e1bd"
      unitRef="usd">-3340000</hqy:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTYtMS0xLTEtMA_8a4a7b80-1bbd-4ed0-b2af-a19a7ee4397f"
      unitRef="usd">-15251000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTYtMy0xLTEtMA_a9e6d879-f3e8-464f-815a-08cca2b68029"
      unitRef="usd">-8012000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTctMS0xLTEtMA_33199a07-efae-4c33-9a30-1a09436bb6ef"
      unitRef="usd">-7936000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTctMy0xLTEtMA_068bb083-bb17-46dc-b9ea-984084426e5e"
      unitRef="usd">14179000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTgtMS0xLTEtMA_0926ec9d-b4c7-4a98-b572-179501be118f"
      unitRef="usd">-8361000</hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent>
    <hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTgtMy0xLTEtMA_034bc72c-ffe1-46c0-a70e-12c3fa424633"
      unitRef="usd">-2859000</hqy:IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTktMS0xLTEtMA_16a0a991-6bda-4f91-97fa-6684fb75f854"
      unitRef="usd">8712000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMTktMy0xLTEtMA_9ec00ecc-0305-4ff7-93f1-62db3b95af7c"
      unitRef="usd">-50000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjAtMS0xLTEtMA_93f4c922-5203-46ff-8be7-cea1cf2825b2"
      unitRef="usd">120717000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjAtMy0xLTEtMA_5ec9da71-8c2e-4d88-9fc0-16aad550d9ae"
      unitRef="usd">74070000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjItMS0xLTEtMA_96b97f23-0582-4cfb-9ccf-0f044235bac2"
      unitRef="usd">11388000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjItMy0xLTEtMA_461c9553-4b5e-4b54-be21-05d43537f03c"
      unitRef="usd">5180000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForSoftware
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjMtMS0xLTEtMA_9060b8d1-cdd1-4e4c-9109-a6b79d734b5b"
      unitRef="usd">37242000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjMtMy0xLTEtMA_5334bf38-1cec-4ad7-a755-bb1e1bdef494"
      unitRef="usd">17232000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjQtMS0xLTEtMA_6a97ab64-cf4e-4d1b-922d-1e44a4aa2f0c"
      unitRef="usd">28100000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjQtMy0xLTEtMA_a0d44ee8-8923-43cb-9aba-4636bfd3becf"
      unitRef="usd">9070000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMS0xLTEtMA_cc86f35d-024c-4e50-aa04-5eb8a94d9e01"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMy0xLTEtMA_627e3e95-6474-4e4e-a9f2-80cb60b5113a"
      unitRef="usd">53845000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMS0xLTEtMzg_cf593770-2fff-4c84-a362-b96e8da1c384"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjUtMy0xLTEtMzg_c2095af3-fee3-496b-abfb-af310b12ca04"
      unitRef="usd">1630066000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjYtMS0xLTEtMA_c24f2f51-129a-4187-988e-d6c0fa44c451"
      unitRef="usd">-76730000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjYtMy0xLTEtMA_91d563b3-3399-47ec-b06c-ab87d16a2aec"
      unitRef="usd">-1715393000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjgtMS0xLTEtMA_6a07e8bc-a1bd-4718-8c06-1da13e2d6460"
      unitRef="usd">286779000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjgtMy0xLTEtMA_81a3a668-e02e-4970-9b17-b2eedee7af44"
      unitRef="usd">458495000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjktMS0xLTEtMA_a1667874-5f06-457a-b7f8-b619f1cbe0c9"
      unitRef="usd">223438000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMjktMy0xLTEtMA_d330b6fa-13ae-45b7-be41-62e9631d1170"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <hqy:PaymentsToSettleClientHeldFunds
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzAtMS0xLTEtMA_0ce7fa82-95f8-4450-b143-9ba86d29464f"
      unitRef="usd">4189000</hqy:PaymentsToSettleClientHeldFunds>
    <hqy:PaymentsToSettleClientHeldFunds
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzAtMy0xLTEtMA_d09c3582-ed61-4feb-b18c-f819a5f596b6"
      unitRef="usd">230928000</hqy:PaymentsToSettleClientHeldFunds>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzEtMS0xLTEtMA_f9617a80-5e21-48d9-9830-cb3d6112e80b"
      unitRef="usd">4491000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzEtMy0xLTEtMA_a65c0b74-eb61-4aac-af8e-4858ce5f2985"
      unitRef="usd">7342000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMS0xLTEtNDc_ef7785d6-f0ca-48d8-9c74-55b2764baed4"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMy0xLTEtNDc_9f752445-93f0-4ebf-82c0-20768cd19273"
      unitRef="usd">1250000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMS0xLTEtNDc_db018b0d-3d09-4f09-8a53-acd874c1f05a"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMy0xLTEtNDc_b64b096e-f607-4a03-b9e0-79d276e4c46d"
      unitRef="usd">30504000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMS0xLTEtMA_91c31edf-873c-4b34-bd5f-a7d3ac7fad8f"
      unitRef="usd">63643000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzItMy0xLTEtMA_655578f9-f1d3-486a-b709-5c000413b0ea"
      unitRef="usd">1454405000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMS0xLTEtMA_3e6eee60-7b81-4adb-bad1-291ffe5a0333"
      unitRef="usd">107630000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzMtMy0xLTEtMA_db0c2702-1e55-4c3f-a5be-a67b1b5a3210"
      unitRef="usd">-186918000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzQtMS0xLTEtMA_e5409d68-274b-479f-951b-bee771ecb46c"
      unitRef="usd">191726000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if66fb9a6498840c584531c192cbb750f_I20190131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzQtMy0xLTEtMA_24c30ede-9360-404e-ac7b-882c2e07862b"
      unitRef="usd">361475000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzUtMS0xLTEtMA_90e37e9d-0107-4307-aebd-7c2812b2dbc7"
      unitRef="usd">299356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3f3c2a3814e04a5a8682e946b183fe16_I20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmQxMDIxMjM0ZjRlYTQxZWZiZDNiZmEwMjdkZTllODgwL3RhYmxlcmFuZ2U6ZDEwMjEyMzRmNGVhNDFlZmJkM2JmYTAyN2RlOWU4ODBfMzUtMy0xLTEtMA_7b8fd8b7-8b4c-4f42-9305-77c7e87859af"
      unitRef="usd">174557000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMy0xLTEtMS0w_cc2238d2-25ca-4d86-9827-f61dcdac01a8"
      unitRef="usd">22849000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMy0zLTEtMS0w_2df1390a-e820-480d-8f4f-1da88d2284f2"
      unitRef="usd">249000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNC0xLTEtMS0w_de00111b-5259-4ba2-9aa3-bf0ba51cda9f"
      unitRef="usd">1053000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNC0zLTEtMS0w_6d9724fa-faac-4192-b5da-c2bb251f7256"
      unitRef="usd">9127000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNi0xLTEtMS0w_576f73fc-c3a7-43c9-9857-87f3b4d102b5"
      unitRef="usd">167000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNi0zLTEtMS0w_94b16632-cb70-4e94-962e-25e9463c45e1"
      unitRef="usd">168000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
      contextRef="i3c457cfd6a5a43cb9558d8b4d9328cdd_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNy0xLTEtMS0w_45186be6-9a1b-48fd-9514-079c9d38970f"
      unitRef="usd">1346000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
      contextRef="i0e0fed62fcbd494496c44b5aa87b0d80_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfNy0zLTEtMS0w_bc4db409-ef80-4d32-bd86-f288db502d16"
      unitRef="usd">316000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
      contextRef="i979c4d22bfc9471f8b4dfb208736616b_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfOC0xLTEtMS0w_3bdd2dbe-4f83-49e6-acfb-15e432cb9057"
      unitRef="usd">289000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
      contextRef="i7c3266aa6f754460aacf098b0298fc3b_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfOC0zLTEtMS0w_6b9c9b25-ee82-4d6d-99d7-c7705eb86a97"
      unitRef="usd">-151000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTItMS0xLTEtMA_0ced49e3-9d35-48ca-93cd-daa6bd434f8b"
      unitRef="usd">5838000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTItMy0xLTEtMA_b5b5ae9b-556a-42c7-92c2-21d5ad102bb2"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <hqy:ExerciseofStockOptionsReceivable
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMS0xLTEtNTI_81e75944-4f7f-4d14-8b83-d628bf12de1e"
      unitRef="usd">89000</hqy:ExerciseofStockOptionsReceivable>
    <hqy:ExerciseofStockOptionsReceivable
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMy0xLTEtNTI_837f51e6-ec5e-475d-9583-be5ea46f68d6"
      unitRef="usd">21000</hqy:ExerciseofStockOptionsReceivable>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMS0xLTEtNjg_597fe2fb-80c5-4f6c-b7c4-c5b80f69db31"
      unitRef="usd">0</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8xOS9mcmFnOjk5ZjU3NWMwZDdhMTQ2ODg5YmU4NWZkZDk2OGFmYTRkL3RhYmxlOmNlOTEyMzdlMDkwNTQzNDViNDdiODA5Y2I2MGMxYmIxL3RhYmxlcmFuZ2U6Y2U5MTIzN2UwOTA1NDM0NWI0N2I4MDljYjYwYzFiYjFfMTMtMy0xLTEtNjg_4eb9c089-255a-4b6a-8448-6ff9ca12dcf1"
      unitRef="usd">3776000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNTAwNA_94fe2bb8-5e18-4924-b113-6089c14cc5f1">Summary of business and significant accounting policies &lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HealthEquity, Inc. ("HealthEquity" or the "Company") was incorporated in the state of Delaware on September&#160;18, 2002. HealthEquity is a leader in administering health savings accounts (&#x201c;HSAs&#x201d;) and complementary consumer-directed benefits (&#x201c;CDBs&#x201d;), which empower consumers to access tax-advantaged healthcare savings while also providing corporate tax advantages for employers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of presentation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements as of October&#160;31, 2020 and for the three and nine months ended October&#160;31, 2020 and 2019 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.  The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Follow-on equity offering&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, the Company closed a follow-on public offering of 5,290,000 shares of common stock at a public offering price of $56.00 per share, less the underwriters' discount. The Company received net proceeds of approximately $286.8 million after deducting underwriting discounts and commissions of approximately $8.9 million and other offering expenses of approximately $0.6 million. The Company used $200.0&#160;million of such proceeds to repay debt under its term loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant accounting policies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no material changes in the Company&#x2019;s significant accounting policies as compared to the significant accounting policies described in the Company&#x2019;s Annual Report on&#160;Form&#160;10-K for the fiscal year ended January&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020 using the modified retrospective transition method. The adoption of this standard did not have a material effect on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASU 2018-13&#x201d;), which amends ASC 820, "Fair Value Measurement." ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying and adding certain disclosures. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020. The adoption of this standard did not have a material effect on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The Company adopted the new standard as of February 1, 2020. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company retrospectively adopted the provision related to the classification of taxes partially based on income, and prospectively adopted the provisions related to intraperiod tax allocation and interim recognition of enactment of tax laws. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The adoption of this standard did not have a material effect on the Company&#x2019;s current- or prior-period condensed consolidated financial statements.&lt;/span&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk5Mw_cb0d1e14-bc7f-4c4f-896d-ce6b9cbb4610">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4MQ_d994498b-7d20-4b04-a85e-494f230aee5e">Basis of presentation The accompanying condensed consolidated financial statements as of October&#160;31, 2020 and for the three and nine months ended October&#160;31, 2020 and 2019 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.  The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4Mw_453d835d-a67a-421e-92a7-f2d83be6d8e7">Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjE3OQ_3ec737c9-74a3-42b8-8cf6-6a9560552032"
      unitRef="shares">5290000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjIzNQ_e637f197-b965-4aa7-9410-216735ad1056"
      unitRef="usdPerShare">56.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjMzMw_8e5187b8-4e1b-4f1e-9b98-f101253d24f1"
      unitRef="usd">286800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjQwOA_33460e7b-5a6e-4a90-a4ac-2e43ca9c1595"
      unitRef="usd">8900000</us-gaap:PaymentsOfStockIssuanceCosts>
    <hqy:StockIssuanceCostsPayable
      contextRef="i291bd2eb2ff64c2ebf876541cb9b1eda_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjQ3OQ_f4f04902-5b4c-404c-a644-5bf619e02739"
      unitRef="usd">600000</hqy:StockIssuanceCostsPayable>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i389ea35a3d2e4607abc6c9410c75ebec_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfMjUwMA_aa16ff36-93fe-4a88-bbe1-2d8e1a332cae"
      unitRef="usd">200000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yNS9mcmFnOmVlNzE1MDg3OGY2ZjRmMGQ4ZGI0ZmNiZTk4ZjFlM2FkL3RleHRyZWdpb246ZWU3MTUwODc4ZjZmNGYwZDhkYjRmY2JlOThmMWUzYWRfNDk4NQ_c662088f-a5d3-41e0-9728-6efae209c307">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020 using the modified retrospective transition method. The adoption of this standard did not have a material effect on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;ASU 2018-13&#x201d;), which amends ASC 820, "Fair Value Measurement." ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying and adding certain disclosures. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020. The adoption of this standard did not have a material effect on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The Company adopted the new standard as of February 1, 2020. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company retrospectively adopted the provision related to the classification of taxes partially based on income, and prospectively adopted the provisions related to intraperiod tax allocation and interim recognition of enactment of tax laws. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The adoption of this standard did not have a material effect on the Company&#x2019;s current- or prior-period condensed consolidated financial statements.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNjQ1_cf3b686e-f80e-470d-849d-8f4f19a04730">Net income (loss) per share&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Numerator (basic and diluted):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Denominator (basic):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Denominator (diluted):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended October&#160;31, 2020 and 2019, approximately 1.0 million and 3.2 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended October&#160;31, 2020 and 2019, approximately 0.6 million and 0.3 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNjQz_23e7349a-f20e-46d4-8409-c4334331612d">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income (loss) per share: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Numerator (basic and diluted):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Denominator (basic):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Denominator (diluted):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;73,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted-average dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss) per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy0xLTEtMS0w_cef75d7d-4e1c-4bc6-a00b-1998f8899679"
      unitRef="usd">1789000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy0zLTEtMS0w_4c59b047-2e0e-462b-942f-e63790432162"
      unitRef="usd">-21334000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy01LTEtMS0w_1cac4d2f-5f89-4d58-8601-038408385e98"
      unitRef="usd">3467000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMy03LTEtMS0w_2bfb91c7-bfb0-4dd9-8d39-f79f52f284fa"
      unitRef="usd">39854000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS0xLTEtMS0w_31029af9-a506-411d-8637-dba22021320c"
      unitRef="shares">76701000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS0zLTEtMS0w_27092f79-1557-4ff4-bb62-12e307407e69"
      unitRef="shares">70524000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS01LTEtMS0w_0b2ca0d5-15d4-425e-8575-489338d5de0c"
      unitRef="shares">73358000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNS03LTEtMS0w_f44cc9ce-a8e3-4154-b91b-77c3ec48d300"
      unitRef="shares">65727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy0xLTEtMS0w_e387df2e-de87-43ba-894a-8ab375fa298e"
      unitRef="shares">76701000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy0zLTEtMS0w_e44578f6-d115-409f-853e-c8bb4ac66afd"
      unitRef="shares">70524000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy01LTEtMS0w_616709cd-d1c8-4ba4-bc31-9b91e0d154bb"
      unitRef="shares">73358000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfNy03LTEtMS0w_d0f2e9d4-89dd-4992-80e2-401948360543"
      unitRef="shares">65727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC0xLTEtMS0w_b810fc4c-3738-4e3d-92d8-a7ae3c02a01a"
      unitRef="shares">1144000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC0zLTEtMS0w_677b0f20-87c2-44ac-8775-41233a9d6afe"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC01LTEtMS0w_17e90a98-c34c-4e11-a174-11734a1c6d6d"
      unitRef="shares">1307000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOC03LTEtMS0w_c0930dd4-aef4-40f3-87b7-7d8b706f9a9c"
      unitRef="shares">1423000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS0xLTEtMS0w_a6fa97e7-e5b4-4b56-9f8b-475e0aa7f86c"
      unitRef="shares">77845000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS0zLTEtMS0w_d15963c2-7f3c-4cb6-bec2-d14d1927d4b4"
      unitRef="shares">70524000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS01LTEtMS0w_719a1b01-84df-4bc0-bfb1-0c1732d0d002"
      unitRef="shares">74665000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfOS03LTEtMS0w_e6c166f5-78ee-4412-b0dc-b10ceb03c0ed"
      unitRef="shares">67150000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtMS0xLTEtMA_d29501b1-c903-477f-93ae-d6966ee6b4f9"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtMy0xLTEtMA_6785a987-a142-464b-b5a2-2280f4ee6f9f"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtNS0xLTEtMA_4211877d-c8e2-4e4d-9b53-044d2e7562fc"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTEtNy0xLTEtMA_783d04a3-0a69-4854-a127-ddb0b8e6eae7"
      unitRef="usdPerShare">0.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItMS0xLTEtMA_46e3e896-213a-45f0-aa16-9b829e0bd660"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItMy0xLTEtMA_7396f5a7-17ea-4e70-99f8-fc1a91a567b4"
      unitRef="usdPerShare">-0.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItNS0xLTEtMA_222b44a9-0771-4f72-86f3-1cff1c87b0e0"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RhYmxlOjgxMjljNjcyZWFiMzQzMWQ4NTMyMmQ5Y2JlNjYzMzEzL3RhYmxlcmFuZ2U6ODEyOWM2NzJlYWIzNDMxZDg1MzIyZDljYmU2NjMzMTNfMTItNy0xLTEtMA_91fe1c24-2be8-4f97-98ba-ab6b23d97618"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfMTgw_5c8348c7-fc05-437a-95cc-492abfaba122"
      unitRef="shares">1000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfMTg3_1f0287a2-788e-4ffd-bcf6-b76caf2a06d6"
      unitRef="shares">3200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNDM0_031ab26a-4953-415a-946c-1948e994743a"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8yOC9mcmFnOjY2MGM3MGM4ZjA4MTQ5MGJiOTc2MWRjZDQzNzgzYjRhL3RleHRyZWdpb246NjYwYzcwYzhmMDgxNDkwYmI5NzYxZGNkNDM3ODNiNGFfNDQx_7131eba3-7768-478b-a871-5cf2d80394eb"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTQ2MQ_4df09019-957b-487c-b90b-60dd6b29c0b7">Business combination&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acquisition of WageWorks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 30, 2019, the Company closed the acquisition (the "Acquisition") of WageWorks, Inc. ("WageWorks") for $51.35 per share in cash, or approximately $2.0&#160;billion to WageWorks stockholders. The Company financed the transaction through a combination of $816.9&#160;million cash on hand plus net borrowings of approximately $1.22&#160;billion, after deducting lender fees of approximately $30.5&#160;million, under a term loan facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Acquisition was accounted for under the acquisition method of accounting for business combinations. Consideration paid was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the Acquisition date. The initial allocation of the consideration paid was based on a preliminary valuation and was subject to adjustment during the measurement period (up to one year from the Acquisition date). The purchase price allocation was finalized in the third quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's allocation of the consideration paid in the Acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Updated Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;392.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,330.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,322.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Client-held funds obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(237.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(220.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(69.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(72.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(128.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(122.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjustments to the initial allocation were based on more detailed information obtained about the specific assets acquired, liabilities assumed, and tax-related matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pro forma information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results presented below include the effects of the Acquisition as if it had been consummated as of February 1, 2018, with adjustments to give effect to pro forma events that are directly attributable to the Acquisition, which include adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings from the integration of WageWorks. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the Acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations. The estimated pro forma revenue and net income (loss) include the alignment of accounting policies, the effect of fair value adjustments related to the&#160;Acquisition, associated tax effects and the impact of the borrowings to finance the&#160;Acquisition and related expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;194,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTcx_6c9f04e3-3376-4173-87fd-c21bfeb55d43"
      unitRef="usdPerShare">51.35</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMjEw_89eb8611-b9d5-4df2-8838-87d8e04b1314"
      unitRef="usd">2000000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMzAy_5b4501f5-22ff-4e2e-a658-8ce01d8b05a9"
      unitRef="usd">816900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ib5bf95f590fe4c76badc0a100bd8ed99_D20190830-20190830"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMzU1_cddca352-0563-4f1d-84e1-43445361bfa4"
      unitRef="usd">1220000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifc6f37ce7f2248f3a06a9f4c38858730_D20190830-20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfNDA0_216e5b2a-3e86-48f7-82b8-08d14ffd5ed4"
      unitRef="usd">30500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfMTQ2Mw_16ab20da-e01b-42f0-93ed-79ef4b919416">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's allocation of the consideration paid in the Acquisition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Initial Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Updated Allocation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;406.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;392.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;715.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,330.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,322.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Client-held funds obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(237.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(220.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(69.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(72.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(128.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(122.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,122.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS0xLTEtMS0w_4ed651a6-3848-439b-a126-0d2d62cf2434"
      unitRef="usd">406800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS0zLTEtMS0w_9812e9ce-be17-4c28-910b-1d11db60b700"
      unitRef="usd">-14500000</hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMS01LTEtMS0w_d6cd0b6b-2f65-4c0d-a67e-388a0cd7cf9a"
      unitRef="usd">392300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi0xLTEtMS0w_ee63b483-00e2-4d92-bf58-c74bc8f6ab23"
      unitRef="usd">56500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi0zLTEtMS0w_fb95fe50-a423-4f80-b2a6-58442d982c03"
      unitRef="usd">2500000</hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMi01LTEtMS0w_f2043e1a-54bd-4d2e-9eb8-dca3734c9a52"
      unitRef="usd">59000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMy0xLTEtMS0w_962499db-bbef-403e-aef6-62ee54154283"
      unitRef="usd">26600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMy01LTEtMS0w_a26ae156-a7db-41a2-9a1b-adafe7916642"
      unitRef="usd">26600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNC0xLTEtMS0w_9aa19a14-be1c-4c57-870f-c304a7cef0a7"
      unitRef="usd">42500000</hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets>
    <hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNC01LTEtMS0w_9fc3de6e-d865-40fb-90a8-2b4eafc0c312"
      unitRef="usd">42500000</hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNS0xLTEtMS0w_71630070-a1be-4795-866a-433aa5709e85"
      unitRef="usd">715300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNS01LTEtMS0w_61b02fcf-f3df-436f-8198-853b748c339e"
      unitRef="usd">715300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi0xLTEtMS0w_367197a8-8e2f-4a29-8316-4e1f3ad79bb4"
      unitRef="usd">1330500000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi0zLTEtMS0w_a90bbcd3-f7a8-4257-8f0e-7fd6c021a906"
      unitRef="usd">-8400000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNi01LTEtMS0w_b85ce88d-ec8c-437b-8d43-729c1be7788a"
      unitRef="usd">1322100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNy0xLTEtMS0w_7a0df372-d883-420f-997b-630999a6ab98"
      unitRef="usd">5900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfNy01LTEtMS0w_69d1a535-f23a-4442-8480-b6f70111b64d"
      unitRef="usd">5900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC0xLTEtMS0w_4ace103f-0f38-4a5a-9668-a2d667304132"
      unitRef="usd">237500000</hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation>
    <hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC0zLTEtMS0w_aef04653-3998-481f-a2f8-67a22ed45283"
      unitRef="usd">-17200000</hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation>
    <hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOC01LTEtMS0w_d4990cef-bdeb-4237-8ed2-ea4163ec7a21"
      unitRef="usd">220300000</hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS0xLTEtMS0w_11f176e5-e665-438a-8338-d32fac0be53e"
      unitRef="usd">69100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS0zLTEtMS0w_6b49d4c9-4e92-45af-9759-d38a9f678906"
      unitRef="usd">3300000</hqy:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfOS01LTEtMS0w_442226c1-d37b-490a-9df9-8ae00e5c8435"
      unitRef="usd">72400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTAtMS0xLTEtMA_935efb34-1864-4b32-9db2-795319299807"
      unitRef="usd">26700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTAtNS0xLTEtMA_2a345c34-d3ba-4dfe-9943-646d4ec97e6a"
      unitRef="usd">26700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtMS0xLTEtMA_e85ccaf0-c18f-42bf-9a3f-22bcf340edf1"
      unitRef="usd">128700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtMy0xLTEtMA_79379d2d-04fc-49e4-9cce-235119776088"
      unitRef="usd">-6500000</hqy:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTEtNS0xLTEtMA_fb20cf7f-599a-4452-b575-5d1fab4b04f8"
      unitRef="usd">122200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ied9feb80b5a64b01bbfd227ff97374ae_I20190830"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItMS0xLTEtMA_fc6d84c0-f47e-4171-9622-070748d18f87"
      unitRef="usd">2122100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="i7994f8e8fb2c4bdeb1f4476862c7b92d_D20190830-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItMy0xLTEtMA_e36418af-1f9a-49fc-b560-a2981c4c6d95"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i78673cfa6671419b96252591cd5aada4_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmIzNDQ3ZTFiOTQ0MTRiNjk4ZmVkMmUzNGM2ZjE2ZjQ1L3RhYmxlcmFuZ2U6YjM0NDdlMWI5NDQxNGI2OThmZWQyZTM0YzZmMTZmNDVfMTItNS0xLTEtMA_5b14cb3e-bb1b-46e0-a02b-67706c5af75c"
      unitRef="usd">2122100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RleHRyZWdpb246MjIyYTY4N2NjM2NiNDhhNDhkOGFiMTdlNjRjY2M5YTJfODc5NjA5MzA0MTY1Nw_a809c107-3dc1-4005-8846-646cac92f5af">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results presented below include the effects of the Acquisition as if it had been consummated as of February 1, 2018, with adjustments to give effect to pro forma events that are directly attributable to the Acquisition, which include adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings from the integration of WageWorks. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the Acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations. The estimated pro forma revenue and net income (loss) include the alignment of accounting policies, the effect of fair value adjustments related to the&#160;Acquisition, associated tax effects and the impact of the borrowings to finance the&#160;Acquisition and related expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;194,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMS0xLTEtMS0xMzY5_fe2edbfd-49c2-4c5b-b031-f4209cb5af1b"
      unitRef="usd">194450000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i8a254662184a4106b4379b10205f7880_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMS0zLTEtMS0xMzY5_2722489d-94fa-440c-9714-a69afcf9ccb9"
      unitRef="usd">598815000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMi0xLTEtMS0xMzY5_77170f4f-3234-4ffa-bf1a-ba46110881f4"
      unitRef="usd">-3286000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8a254662184a4106b4379b10205f7880_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zMS9mcmFnOjIyMmE2ODdjYzNjYjQ4YTQ4ZDhhYjE3ZTY0Y2NjOWEyL3RhYmxlOmU3YWUzMDkxNGY0OTRlNmY5YTRkMzE0MWYzNDBjODFiL3RhYmxlcmFuZ2U6ZTdhZTMwOTE0ZjQ5NGU2ZjlhNGQzMTQxZjM0MGM4MWJfMi0zLTEtMS0xMzY5_c69a1bff-d8c4-421d-8476-14b85c0672ee"
      unitRef="usd">34559000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMQ_486e2db7-5b12-4f62-a180-2d2c2b51877c">Supplemental financial statement information&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected condensed consolidated balance sheet and condensed consolidated statement of operations and comprehensive income components consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following as of October&#160;31, 2020 and January&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the three months ended October&#160;31, 2020 and 2019 was $4.0 million and $3.6 million, respectively, and $12.0 million and $5.4 million for the nine months ended October&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets. The Company records a receivable when revenue is recognized prior to payment and the Company has unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. As of October&#160;31, 2020 and January&#160;31, 2020, the balance of deferred revenue was $7.0 million and $3.7 million, respectively. The balances are related to cash received in advance for an interchange revenue arrangement, other up-front fees and other commuter deferred revenue, and are generally recognized within twelve months, with the exception of the interchange arrangement, which is recognized over a term of approximately ten years. During the three and nine months ended October&#160;31, 2020, approximately $0.4 million and $2.2 million of revenue, respectively, was recognized that was included in the balance of deferred revenue as of January&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company's operating leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets obtained in exchange for new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(40,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMg_e38c7e1e-ed9a-49e6-832d-dbc1cf36273d">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following as of October&#160;31, 2020 and January&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iaec79e8d4a8042d1b80bb68a1480bcc3_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMS0xLTEtMS0w_e4a649c3-65bd-4ce9-a432-9ae919395b00"
      unitRef="usd">22310000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic430d1bd4b994088a513acef3734435e_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMS0zLTEtMS0w_baff6c11-4525-4662-919f-a230d0d8b8f7"
      unitRef="usd">19240000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i60c903d8b1a046ef8d58e35f85bddcdb_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMi0xLTEtMS0w_36d2d2f0-92a2-430c-b055-254df9466908"
      unitRef="usd">9219000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic3ed676cc45541888a286e697eaf4971_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMi0zLTEtMS0w_9e7e931b-bb12-495f-8883-4abd32c1fdab"
      unitRef="usd">7929000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5bbb14b2d0234a85814cdcf59a17f56d_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMy0xLTEtMS0w_23110d13-24ed-4c6a-9057-1b47317862e5"
      unitRef="usd">27378000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4364bceadc1640888f5252fff2b05a38_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfMy0zLTEtMS0w_d6d88d50-bd0a-46f3-b490-e6e757a283c4"
      unitRef="usd">22074000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNC0xLTEtMS0w_397906e3-893d-4d61-bf38-44c24751ac01"
      unitRef="usd">58907000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNC0zLTEtMS0w_161fd6eb-e47d-424e-808c-8aacee4d3362"
      unitRef="usd">49243000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNS0xLTEtMS0w_284c4284-52ea-4a4a-a9ad-8edcc6e71042"
      unitRef="usd">27133000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNS0zLTEtMS0w_87e63104-06d7-4310-bd30-d8018de8aab3"
      unitRef="usd">15757000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNi0xLTEtMS0w_4a5fba88-f57a-42bc-8c5d-a47037678c9c"
      unitRef="usd">31774000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjJhYTdmODBlNTA2NjRlODY5NTcwNmVjNDNhZTQwNDFjL3RhYmxlcmFuZ2U6MmFhN2Y4MGU1MDY2NGU4Njk1NzA2ZWM0M2FlNDA0MWNfNi0zLTEtMS0w_967d6922-7ba4-4d0d-9c58-8773b103153d"
      unitRef="usd">33486000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMzcx_db5c7414-aa5f-47fe-b573-159c928efe9a"
      unitRef="usd">4000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMzc4_25367b7d-1ef8-48f3-bb4b-ddcd44271197"
      unitRef="usd">3600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfNDAw_cc6ab558-2c9c-46b2-a288-094a1cd45a0b"
      unitRef="usd">12000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfNDA3_2cb5337e-0303-4e7e-849a-b6ee11448ef3"
      unitRef="usd">5400000</us-gaap:Depreciation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfOTUz_c90d203a-bae3-4987-9024-36a91c1f6785"
      unitRef="usd">7000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfOTYw_019e0c03-2573-4138-a2bd-2c9f8a321d67"
      unitRef="usd">3700000</us-gaap:RevenueRemainingPerformanceObligation>
    <hqy:ContractWithCustomerRecognitionTermInterchangeArrangement
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTI3OQ_35c997d1-d919-4e1f-91ee-a954e34750f2">P10Y</hqy:ContractWithCustomerRecognitionTermInterchangeArrangement>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTMzOA_90917bcf-8e23-4b81-8176-e8c1df4fb509"
      unitRef="usd">400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTM0NQ_59fe7377-8605-4e7b-8b88-91b4d04ad992"
      unitRef="usd">2200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcwOA_99a6438d-2a7f-44e7-b9c2-e4ddc0d28ff4">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease costs were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company's operating leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets obtained in exchange for new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi0xLTEtMS0w_326fcce4-8601-402d-853d-eb80979b48c2"
      unitRef="usd">3777000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi0zLTEtMS0w_a8468ecf-2eec-47e8-843e-39b801688b0d"
      unitRef="usd">3354000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi01LTEtMS0w_04deed5a-b924-45f4-ac68-9dea17955900"
      unitRef="usd">12297000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMi03LTEtMS0w_a4a0adee-6e68-43c8-b3a8-be9b806fa069"
      unitRef="usd">5515000</us-gaap:OperatingLeaseExpense>
    <us-gaap:SubleaseIncome
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy0xLTEtMS0w_363720ab-33d8-43de-9763-4d08a84beb1c"
      unitRef="usd">450000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy0zLTEtMS0w_e01cb377-2b24-4216-ab78-9360426a7c3d"
      unitRef="usd">249000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy01LTEtMS0w_af6d9721-8e33-4937-9c56-bf63351a3ba8"
      unitRef="usd">1349000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfMy03LTEtMS0w_4c6560c9-c9bd-44ac-9876-cd7ef899bd88"
      unitRef="usd">249000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC0xLTEtMS0w_21c03285-79ee-43d2-a1d1-003655b6300e"
      unitRef="usd">3327000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC0zLTEtMS0w_bf86dffb-37fa-4fbb-b6f5-d429a2949d07"
      unitRef="usd">3105000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC01LTEtMS0w_7f81b180-782b-40ae-bbb5-8f951906fc86"
      unitRef="usd">10948000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjUwMjY0NmU2ZWUxNjQwMmE4ODY5MDk2ZjIzNjY1OTNmL3RhYmxlcmFuZ2U6NTAyNjQ2ZTZlZTE2NDAyYTg4NjkwOTZmMjM2NjU5M2ZfNC03LTEtMS0w_856356da-c58b-48a0-91ec-56cb1992db20"
      unitRef="usd">5266000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfMy0xLTEtMS0w_6079ae60-4ba8-4864-a3ba-3eb74cd61a48"
      unitRef="usd">9739000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfMy0zLTEtMS0w_f0707d3b-4055-4364-82a6-939334788078"
      unitRef="usd">4575000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfNC0xLTEtMS0w_11ec2e8c-4883-4c71-ab90-620d7a4952d6"
      unitRef="usd">17480000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjk0MTg3YzJkOWZkNDQyMjg4ODFlZTBjNTRkY2QyMjg3L3RhYmxlcmFuZ2U6OTQxODdjMmQ5ZmQ0NDIyODg4MWVlMGM1NGRjZDIyODdfNC0zLTEtMS0w_795a1ae3-3c85-4033-b032-8795d16c4796"
      unitRef="usd">34394000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RleHRyZWdpb246ZjVhMTA4MzkzNzg4NGUxNmE4NGU1OTUyY2JhNzVlZmVfMTcxMA_f5b8a276-dd5a-48a1-9e9d-29575e7cf7fa">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(40,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi0xLTEtMS0w_0386b816-1416-4df7-a987-e1a3ba39ebec"
      unitRef="usd">174000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi0zLTEtMS0w_3b54beae-2bf6-43a9-ab34-09b168e26b02"
      unitRef="usd">2046000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi01LTEtMS0w_160e121c-393b-402e-804b-0295cb41bc09"
      unitRef="usd">850000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMi03LTEtMS0w_fd6d28f7-2799-413b-9f59-71312e7bc801"
      unitRef="usd">5273000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy0xLTEtMS0w_ef75ca89-774d-4f77-9773-fa04786041cc"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy0zLTEtMS0w_b4b946aa-4e63-4a95-b6a5-142efea55795"
      unitRef="usd">285000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy01LTEtMS0w_3068336d-b207-4d45-9571-d873060a1bb0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfMy03LTEtMS0w_2ed32fb9-cc7c-4465-a159-bb79cd3bcefa"
      unitRef="usd">27570000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC0xLTEtMS0w_388b8720-266c-4fcc-aeb5-1222458d812e"
      unitRef="usd">13000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC0zLTEtMS0w_ec1a1914-d541-48a2-a65a-71c82da7442c"
      unitRef="usd">32932000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC01LTEtMS0w_b05f9959-2267-44f2-a747-b9604b7e8987"
      unitRef="usd">79000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNC03LTEtMS0w_6914a09b-63a2-4965-b320-62d2ec35f2f7"
      unitRef="usd">40712000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS0xLTEtMS0w_81e65e55-ac21-4359-bada-81a9359493b6"
      unitRef="usd">582000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS0zLTEtMS0w_2cc8b17f-b564-4766-af9e-c581381bc785"
      unitRef="usd">348000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS01LTEtMS0w_5850b9d6-3903-4c64-94df-ec7a49e825af"
      unitRef="usd">2780000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNS03LTEtMS0w_fb1b53a6-d0f3-460f-8088-9d2415fc25f8"
      unitRef="usd">478000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi0xLTEtMS0w_567ab2ed-c76a-48f7-a18c-da3e3ffd7507"
      unitRef="usd">-421000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi0zLTEtMS0w_b121de34-a33c-4098-a12f-32cfc1c41f2f"
      unitRef="usd">-30949000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi01LTEtMS0w_ebb7e6b0-5e25-4b59-8bb0-1cb2f79b86b6"
      unitRef="usd">-2009000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNC9mcmFnOmY1YTEwODM5Mzc4ODRlMTZhODRlNTk1MmNiYTc1ZWZlL3RhYmxlOjI5MjA1OWEwZTkxZjRiZWI5ODU3ZGVhZTNkMmUyODRmL3RhYmxlcmFuZ2U6MjkyMDU5YTBlOTFmNGJlYjk4NTdkZWFlM2QyZTI4NGZfNi03LTEtMS0w_c5f80d19-6a61-4f39-91a5-e13712448af9"
      unitRef="usd">-8347000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODM1_da59c83e-a725-467d-a79c-0618fc14781b">Intangible assets and goodwill&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software and software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired HSA portfolios&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;947,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(172,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(98,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;775,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;780,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired in process software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;776,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;783,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended October&#160;31, 2020 and 2019, the Company expensed a total of $10.5 million and $6.2 million, respectively, and $31.1 million and $13.8 million for the nine months ended October&#160;31, 2020 and 2019, respectively, in software development costs primarily related to the post-implementation and operation stages of its proprietary software. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for the three months ended October&#160;31, 2020 and 2019 was $25.3 million and $15.7 million, respectively, and $73.5 million and $23.6 million for the nine months ended October&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and nine months ended October&#160;31, 2020, goodwill decreased by $7.0 million and $5.8 million, respectively, due to measurement period adjustments related to the Acquisition of WageWorks.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODMy_805c37ef-ef5f-47eb-ab63-0434219317de">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software and software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired HSA portfolios&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;947,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(172,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(98,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;775,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;780,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired in process software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;776,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;783,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfODQw_ad24cd0e-e6ab-47bb-82f9-61cb8ff726d4">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software and software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;116,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired HSA portfolios&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;121,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;601,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;96,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortizable intangible assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;947,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(172,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(98,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total amortizable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;775,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;780,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquired in process software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;776,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;783,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i48937f6ece7149fca3c3b3786e77ec95_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMi0xLTEtMS0w_b3078cf1-198c-4396-9a41-98ceb9a21b91"
      unitRef="usd">116206000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i504cb0661e9f4dae8034503b601a2870_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMi0zLTEtMS0w_04b0ee0c-15a9-4654-b6d3-785f848fb19c"
      unitRef="usd">76221000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if0205c0743fb47ac8f23fed3e5aedb2e_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMy0xLTEtMS0w_d4b1cbf2-063e-4b80-b2b7-9b390ca731dc"
      unitRef="usd">121159000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3e1624fbd3d94920921887290a7ad491_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMy0zLTEtMS0w_efd07bef-93d0-4e9c-b2d6-e2f30d64baa7"
      unitRef="usd">92770000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7a29caffc2214b65ade72766d8f08cc1_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNC0xLTEtMS0w_44ef089c-96f3-4c24-8b1f-d5e71e41866c"
      unitRef="usd">601381000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id3627b5c69c44353802952f92fbe50f9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNC0zLTEtMS0w_3daac722-78bc-49e6-b3fb-c73521f2c874"
      unitRef="usd">601381000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idb51032a2154465cb9cddfdc52f94dc7_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNS0xLTEtMS0w_37e9f9c6-0129-4ceb-93a9-ef3a5f82f73e"
      unitRef="usd">96925000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia2e76b4ad3e9409e90e86df52d0c70bf_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNS0zLTEtMS0w_aae8250b-18e4-402f-927f-7247ad226406"
      unitRef="usd">96925000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i48a3338f2c4043f2920127348167f2c5_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNi0xLTEtMS0w_c8a29636-f21f-4f4c-9fa4-131c4df788db"
      unitRef="usd">12300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i316e7d3a2c2549989b4056855d453948_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNi0zLTEtMS0w_09d4db39-8842-4840-9ad5-e21a96d4207f"
      unitRef="usd">12300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNy0xLTEtMS0w_b8f45c00-ab46-49fd-bfec-a1cac31dc54c"
      unitRef="usd">947971000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfNy0zLTEtMS0w_0599a9ab-ab3d-4b1e-92f9-19b3a1f267f7"
      unitRef="usd">879597000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOC0xLTEtMS0w_b4c9c895-3a6c-4f14-b6c8-5dd39c12764a"
      unitRef="usd">172276000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOC0zLTEtMS0w_118d6377-3138-4f94-bfa7-37de96c11e95"
      unitRef="usd">98851000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOS0xLTEtMS0w_e621fe54-e5f3-4a2c-8614-580fcc7fac1b"
      unitRef="usd">775695000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfOS0zLTEtMS0w_95d97fd7-1d16-4efd-a6a4-56cf8b620e2f"
      unitRef="usd">780746000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i04e444c7573c4e11ab6a937593087dfa_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTAtMS0xLTEtMA_604ffc96-78b3-4b8a-9f3a-6b2339aaee9d"
      unitRef="usd">616000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3346b7e4394c4a3cb401ea158a7e6f79_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTAtMy0xLTEtMA_1380aab5-bdb7-4306-984d-614222058a25"
      unitRef="usd">2533000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTEtMS0xLTEtMA_6e59b2b8-45d9-45a6-a6e7-edb8e48255ab"
      unitRef="usd">776311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RhYmxlOjMzOGM5MWM3NDI2ZjQ0YjI4MmQ1NTQ5YjBhZWRiMTcxL3RhYmxlcmFuZ2U6MzM4YzkxYzc0MjZmNDRiMjgyZDU1NDliMGFlZGIxNzFfMTEtMy0xLTEtMA_22db9672-7bd0-4907-a41e-2f980dd83c8b"
      unitRef="usd">783279000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjU3_5d8cfd83-43a6-4f38-a1c7-104d06e85577"
      unitRef="usd">10500000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjY0_14b78bbe-1169-4356-ba55-0c6e6b6178b3"
      unitRef="usd">6200000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjg2_f7f305b7-e74d-4294-aa24-8c34ed46b478"
      unitRef="usd">31100000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMjkz_053770b4-7063-4475-bb96-728de560582b"
      unitRef="usd">13800000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTM0_4f067769-4769-48f4-ae09-9f22ae63580e"
      unitRef="usd">25300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTQx_8021db6f-160e-4d08-b0f4-507791c96a56"
      unitRef="usd">15700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTYz_39d76cd7-d7f0-4c31-9c41-5e8837275ebe"
      unitRef="usd">73500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNTcw_35a64fc4-ded2-4e86-a9a4-f261a68c9518"
      unitRef="usd">23600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfMTY0OTI2NzQ0MzIyNA_0a3f3dd4-2b9b-4ad9-b61e-4d93f48c320f"
      unitRef="usd">7000000.0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl8zNy9mcmFnOjRjNjM4NzY3MTE1MTRjZWU5ZTNkOWQxZDM5MDMxNmIzL3RleHRyZWdpb246NGM2Mzg3NjcxMTUxNGNlZTllM2Q5ZDFkMzkwMzE2YjNfNjg4_ea073f78-f1dc-40b0-bc1b-219a8b419391"
      unitRef="usd">5800000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNjQyNA_d7acec7a-5c5c-417a-b959-94694a4a7c00">Commitments and contingencies&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s principal commitments consist of a term loan facility, operating lease obligations for office space, data storage facilities, and other leases, a processing services agreement with a vendor, and contractual commitments related to network infrastructure, equipment, and certain maintenance agreements under long-term, non-cancelable commitments. Except for the $200&#160;million principal prepayment on our term loan facility, there were no material changes during the three and nine months ended October&#160;31, 2020, outside of the ordinary course of business, in our commitments from those disclosed in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company&#x2019;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WageWorks is pursuing affirmative claims against the Office of Personnel Management ("OPM") to obtain payment for services provided by WageWorks between March 1, 2016 and August 31, 2016 pursuant to its contract with OPM. In connection with WageWorks' claims against OPM, OPM has also claimed that an erroneous statement in a certificate signed by a former executive officer constituted a violation of the False Claims Act and moved to dismiss part of WageWorks' claim against OPM as a result. As with all legal proceedings, no assurance can be provided as to the outcome of these matters or if WageWorks or OPM will be successful.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 9, 2018, a putative class action was filed in the U.S. District Court for the Northern District of California (the &#x201c;Securities Class Action&#x201d;). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against WageWorks, its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleges claims under the Securities Act of 1933, as amended, arising from WageWorks&#x2019; June 19, 2017 common stock offering against those same defendants, as well as the members of its board of directors at the time of that offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 22, 2018 and September 6, 2018, two derivative lawsuits were filed against certain of WageWorks&#x2019; former officers and directors and WageWorks (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain former WageWorks&#x2019; officers and directors and WageWorks (as nominal defendant) in the U.S. District Court for the Northern District of California (together, the &#x201c;Derivative Suits&#x201d;). The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages and fees and costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Plaintiffs in the Superior Court action filed an amended consolidated complaint on October 28, 2019, naming as defendants certain former officers and directors of WageWorks and alleging a direct claim of "inseparable fraud/breach of fiduciary duty" on behalf of a class. WageWorks was not named as a party in that complaint. On June 24, 2020, the court granted the defendants&#x2019; motion to dismiss the amended complaint. The plaintiffs subsequently filed a notice of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WageWorks voluntarily contacted the San Francisco office of the SEC Division of Enforcement regarding the restatement of WageWorks' financial statements and related independent investigation. WageWorks is providing information and documents to the SEC and continues to cooperate with the SEC&#x2019;s investigation into these matters. The U.S. Attorney&#x2019;s Office for the Northern District of California also opened an investigation. WageWorks has provided documents and information to the U.S. Attorney&#x2019;s Office and continues to cooperate with any inquiries by the U.S. Attorney&#x2019;s Office regarding the matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WageWorks previously entered into indemnification agreements with its former directors and officers and, pursuant to these indemnification agreements, is covering the defense of its former directors and officers in the legal proceedings described above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its subsidiaries are involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge, that such litigation, proceedings and claims will not have a material impact on the Company&#x2019;s financial position, results of operations and cash flows for the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains liability insurance coverage that is intended to cover the legal matters described above; however, it is possible that claims may be denied by our insurance carriers or could exceed the amount of our applicable insurance coverage, we may be required by our insurance carriers to contribute to the payment of claims, and our insurance coverage may not continue to be available to us on acceptable terms or in sufficient amounts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As required under GAAP, the Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on currently available information, the Company does not believe that any liabilities relating to these matters are probable or that the amount of any resulting loss is estimable. However, litigation is subject to inherent uncertainties and the Company&#x2019;s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company&#x2019;s financial position, results of operations and cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i88892452c8b4467da8e7c754e0bd6661_D20200201-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNDI5_3273705a-cb90-4c8c-80a3-cee5b4723d39"
      unitRef="usd">200000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i70aa4eace1b849b7bc8770af2620a276_D20200801-20201031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfNDI5_5043f5ba-c1a5-4541-b010-e14d90529162"
      unitRef="usd">200000000</us-gaap:RepaymentsOfLongTermDebt>
    <hqy:LossContingencyNumberOfLawsuits
      contextRef="i3e05173272a94406b7f82f6775f29b05_D20180906-20180906"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfMjY2MQ_159a0afe-d9f2-468f-a451-7117f7a9ea61"
      unitRef="lawsuit">2</hqy:LossContingencyNumberOfLawsuits>
    <hqy:LossContingencyNumberOfLawsuits
      contextRef="i7ab953b65e81482fbbdffc410958e5ee_D20180622-20180622"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80MC9mcmFnOmQyYzNlYzJkNDQ3NzQzMDM4YzI4YzM1ZDE0MGNjNWFhL3RleHRyZWdpb246ZDJjM2VjMmQ0NDc3NDMwMzhjMjhjMzVkMTQwY2M1YWFfMjY2MQ_6b0611e5-f950-4f8d-847a-73e9b60c4235"
      unitRef="lawsuit">2</hqy:LossContingencyNumberOfLawsuits>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTk0Mg_321a6f42-31d6-4b96-9214-b0151c6d60f3">Income taxes&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows FASB Accounting Standards Codification 740-270, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes - Interim Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the computation and presentation of its interim period tax provision. Accordingly, management estimated the effective annual tax rate and applied this rate to the year-to-date pre-tax book income to determine the interim benefit or provision for income taxes. For the three and nine months ended October&#160;31, 2020, the Company recorded income tax expense of $2.3 million and $2.0 million, respectively. This resulted in an effective income tax expense rate of 56.7% and 36.8% for the three and nine months ended October&#160;31, 2020, respectively, compared with an effective income tax benefit rate of 31.7% and an effective income tax expense rate of 8.9% for the three and nine months ended October&#160;31, 2019, respectively. For the three and nine months ended October&#160;31, 2020 and 2019, the net &lt;/span&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;impact of discrete tax items caused a 6.0 percentage point expense and a 9.6 percentage point benefit and a 1.1 and 8.7 percentage point benefit, respectively, to the effective income tax rate primarily due to the excess tax benefit on stock-based compensation expense and return-to-provision adjustments, which were partially offset by state apportionment changes recognized in the provision for income taxes relative to pre-tax book income. Due to significantly lower pre-tax book income during the nine months ended October&#160;31, 2020, discrete items had a greater impact on the effective income tax rate than during the nine months ended October&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2020 and January&#160;31, 2020, the Company&#x2019;s total gross unrecognized tax benefit was $10.0 million and $9.4 million, respectively. As of October&#160;31, 2020 and January&#160;31, 2020, a net unrecognized tax benefit of $0.5 million was recorded in the condensed consolidated balance sheets. If recognized, $9.2 million of the total gross unrecognized tax benefits would affect the Company's effective tax rate as of October&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns with U.S. federal and state taxing jurisdictions and is currently under examination with the state of Texas. As a result of the Company's net operating loss carryforwards and tax credit carryforwards, the Company remains subject to examination by one or more jurisdictions for tax years after 2000.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNDc3_09391150-0e7b-4207-9072-4d3d2a3acb67"
      unitRef="usd">2300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNDg0_a030ad08-c5d6-4ae7-a821-68c8373f1f42"
      unitRef="usd">2000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNTU5_c88280d4-e06f-416f-8136-02ff2c58fc6c"
      unitRef="number">0.567</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNTY2_821f1316-59f5-4f11-9097-0724f172dcf8"
      unitRef="number">0.368</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfNjc2_7786090e-8a44-41ab-b32f-0345dcefa65d"
      unitRef="number">-0.317</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTY0OTI2NzQ0Mzc2OA_a6f71a2e-7f3c-4050-96e9-9dd7017dd9f4"
      unitRef="number">0.089</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODE4_ae58fd24-04c0-4b04-942c-de75fddb1a29"
      unitRef="number">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODI1_3a6c46a5-6332-4121-9258-6fb026d85bc4"
      unitRef="number">-0.096</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODU5_19aa5a33-8355-4749-97d4-589e9070eb3e"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfODY2_bc0036f2-eaec-496d-b5a2-059bf60d786a"
      unitRef="number">-0.087</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTMyNg_581e23a4-0a8b-4618-b44e-26b48a7627a3"
      unitRef="usd">10000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTMzMw_a67035b8-ffa9-4314-b0a5-db657c3310b9"
      unitRef="usd">9400000</us-gaap:UnrecognizedTaxBenefits>
    <hqy:UnrecognizedTaxBenefitNet
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTQwMg_04cfe2d5-7ebf-4ee2-a8d2-cae21c4eee0c"
      unitRef="usd">500000</hqy:UnrecognizedTaxBenefitNet>
    <hqy:UnrecognizedTaxBenefitNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTQwMg_75a76cd0-35b7-4b98-923d-403b5aa7e81f"
      unitRef="usd">500000</hqy:UnrecognizedTaxBenefitNet>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80My9mcmFnOjA1MTA0MjhlMDY2MjRjZTNhNzg3YzI1NWE3ZTcwMGMxL3RleHRyZWdpb246MDUxMDQyOGUwNjYyNGNlM2E3ODdjMjU1YTdlNzAwYzFfMTUwMQ_e6b19ac5-9e33-4256-947e-4b4cc101e1ba"
      unitRef="usd">9200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA3OQ_6ef0926d-125b-47e5-8a86-a4dee504b179">Indebtedness&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2020, long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,018.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: unamortized loan issuance costs (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,001.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) In addition to the $17.7&#160;million of unamortized issuance costs related to the term loan facility, $5.3&#160;million of unamortized issuance costs related to our revolving credit facility are included within other assets on the October&#160;31, 2020 condensed consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closing of the Acquisition, on August&#160;30, 2019, the Company entered into a credit facility (the "Credit Agreement&#x201d;) that provided for:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;a five-year senior secured term loan A facility (the &#x201c;Term Loan Facility&#x201d;), in an aggregate principal amount of $1.25 billion, the proceeds of which were used to finance the Acquisition, to refinance substantially all outstanding indebtedness of HealthEquity and WageWorks and to pay related fees and expenses; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&#160;&#160;&#160;&#160;&#160;&#160;a five-year senior secured revolving credit facility (the &#x201c;Revolving Credit Facility&#x201d; and, together with the Term Loan Facility, the &#x201c;Credit Facilities&#x201d;), in an aggregate principal amount of up to $350.0 million, which may be used for working capital and general corporate purposes, including acquisitions and other investments. No amounts were drawn under the Revolving Credit Facility as of October&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Credit Facilities bear interest at an annual rate equal to, at the option of HealthEquity, either (i)&#160;LIBOR (adjusted for reserves) plus a margin ranging from 1.25% to 2.25% or (ii)&#160;an alternate base rate plus a margin ranging from 0.25% to 1.25%, with the applicable margin determined by reference to a leverage-based pricing grid set forth in the Credit Agreement. As of October&#160;31, 2020, the stated interest rate was 1.65% and the effective interest rate was 2.18%. The Company is also required to pay certain fees to the lenders, including, among others, a quarterly commitment fee on the average unused amount of the Revolving Credit Facility at a rate ranging from 0.20% to 0.40%, with the applicable rate also determined by reference to a leverage-based pricing grid set forth in the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans made under the Term Loan Facility are required to be repaid as described in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal year ending January 31, (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;768.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total principal payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,018.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The amount required to be repaid in 2025 reflects the $200.0&#160;million prepayment made in July 2020 with proceeds from the follow-on offering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit, among other things, the ability of the Company to incur additional indebtedness, create liens, merge or dissolve, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;make investments, dispose of assets, engage in sale and leaseback transactions, make distributions and dividends and prepayments of junior indebtedness, engage in transactions with affiliates, enter into restrictive agreements, amend documentation governing junior indebtedness, modify its fiscal year and modify its organizational documents, in each case, subject to customary exceptions, thresholds, qualifications and &#x201c;baskets.&#x201d; In addition, the Credit Agreement contains financial performance covenants, which require the Company to maintain (i)&#160;a maximum total net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than 5.00 to 1.00, which steps down to&#160;4.50 to 1.00 beginning with the fiscal quarter ending July&#160;31, 2021 (subject to a customary &#x201c;acquisition holiday&#x201d; provision that allows the maximum total net leverage ratio to increase to 5.00 to 1.00 for the four fiscal quarter period ending on or following the date of a permitted acquisition by the Company in excess of $100.0 million), and (ii)&#160;a minimum interest coverage ratio, measured as of the last day of each fiscal quarter, of no less than 3.00 to 1.00. The Company was in compliance with all covenants under the Credit Agreement as of October&#160;31, 2020, and for the period then ended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The obligations of HealthEquity under the Credit Agreement are required to be unconditionally guaranteed by WageWorks and each of the Company's subsequently acquired or organized direct and indirect domestic subsidiaries and are secured by security interests in substantially all assets of HealthEquity and the guarantors, in each case, subject to certain customary exceptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA4MA_075603ba-8486-4bf6-b47e-c0d625a507c6">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October&#160;31, 2020, long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Term loan facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,018.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: unamortized loan issuance costs (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,001.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) In addition to the $17.7&#160;million of unamortized issuance costs related to the term loan facility, $5.3&#160;million of unamortized issuance costs related to our revolving credit facility are included within other assets on the October&#160;31, 2020 condensed consolidated balance sheet.</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMS0xLTEtMS0w_796e7903-5481-4636-8a73-c954df458e97"
      unitRef="usd">1018800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMi0xLTEtMS0w_82250c3a-0c68-4576-af56-da4df906cffc"
      unitRef="usd">17700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjIxMWM2NGRkMGRmYzQ1YzlhZjQ5NDFkZTNkYjZkZThhL3RhYmxlcmFuZ2U6MjExYzY0ZGQwZGZjNDVjOWFmNDk0MWRlM2RiNmRlOGFfMy0xLTEtMS0w_bd97e810-0946-451b-a987-906d26f58ab5"
      unitRef="usd">1001100000</us-gaap:LongTermDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTA0_82250c3a-0c68-4576-af56-da4df906cffc"
      unitRef="usd">17700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2df1d6cadbd74ff3acfa8a7a9e8f4b3b_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTcy_e08bae8f-2b72-41b5-83d6-2b87dec112db"
      unitRef="usd">5300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentTerm
      contextRef="i64a2c3285a4640638af6dc4caca32547_D20190830-20190830"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfODc5NjA5MzAyNjM2MA_9d939dd3-fd70-4b15-be7c-6c7455fb2da5">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0e31870db3eb4448bf794556196facad_I20190830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNjA3_f86279fb-d9cb-4c96-b6e8-a1a465c98c8f"
      unitRef="usd">1250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i88890494023a48c186377765d88e48b1_D20190830-20190830"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfODc5NjA5MzAyNjM2MQ_c615afb0-80a5-4927-af6e-bd994871538b">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie457aaaa4999415bb337c567a04585da_I20190830"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTAwNA_24ddaf19-97fa-44d8-a6ed-cd17766eae54"
      unitRef="usd">350000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i07e01aa0156a47859bbf977de876d1c8_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTEyNA_84d25616-d6dd-42ad-aaa0-6671ca1413db"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idde5070b333245fea3d90d1f909b0543_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTM3Mw_b711d823-740b-4f18-83bc-8b4897e2da79"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i61002ef653844eedae5d38c266aea6c9_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTM3OQ_53112851-6454-4fb8-8dd9-11d46b3dbdfe"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic87db426f4e54f909d15c0c1df63c80a_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTQ0MA_c5be833a-95ed-4d71-b79d-0628af040c2c"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iadf62767aaa44d7c83fe6178855f1be7_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTQ0Ng_3c39aa73-23b4-4f3a-8c94-8ef4aa3495f2"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTYwOA_26e5e4cf-b38f-42ef-821e-b7afbce9cd1b"
      unitRef="number">0.0165</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTY0Nw_d1d1a8b1-b053-45d9-9e21-aa331a6119e6"
      unitRef="number">0.0218</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i2e0303734b4942bf81d8cf0ed138de29_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTg1Mw_4c2f985f-b9c5-4432-8f7d-1fa2dff1738d"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic883d663040343718d8ef69b8d96b305_D20200201-20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMTg1OQ_0701cb69-7af4-48c0-96a6-ff52f1c91ebc"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfNDA4Mg_ddecd4a6-c93e-4093-84ae-d0be2fe37cb0">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans made under the Term Loan Facility are required to be repaid as described in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal year ending January 31, (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Remaining 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;768.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total principal payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,018.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) The amount required to be repaid in 2025 reflects the $200.0&#160;million prepayment made in July 2020 with proceeds from the follow-on offering.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMS0xLTEtMS0w_06e2741a-ec3a-4879-9d1a-631432fb020c"
      unitRef="usd">15600000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMi0xLTEtMS0w_54a4ace8-9431-47b0-93dd-858ee76362fe"
      unitRef="usd">62500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfMy0xLTEtMS0w_44bb266c-a5cd-4710-bc51-590013d8f3a3"
      unitRef="usd">70300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNC0xLTEtMS0w_9f217925-6522-4d46-9a5b-3276e4296fca"
      unitRef="usd">101600000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNS0xLTEtMS0w_fccf93ca-7295-4c35-9d91-9553f5429ea2"
      unitRef="usd">768800000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RhYmxlOjA1NTcwNGJjMzZmMzRjYjk4ZDExODU5M2RhM2JmYzBmL3RhYmxlcmFuZ2U6MDU1NzA0YmMzNmYzNGNiOThkMTE4NTkzZGEzYmZjMGZfNi0xLTEtMS0w_17611726-38db-47d1-a81d-62b441c7cebc"
      unitRef="usd">1018800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMjE1Mg_b3d72a44-dae1-4220-afc4-b5ece45b687b"
      unitRef="usd">200000000.0</us-gaap:RepaymentsOfLongTermDebt>
    <hqy:DebtInstrumentCovenantDescriptionLeverageRatio
      contextRef="i704700afcca6430ab84c0cc3541833fc_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzEwNg_5b406ddf-12fa-43ac-8412-06a48fe5dd1c"
      unitRef="number">5.00</hqy:DebtInstrumentCovenantDescriptionLeverageRatio>
    <hqy:DebtInstrumentCovenantDescriptionLeverageRatio
      contextRef="id433c681b1c140598cb0e1ba46723af6_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzEzOA_f0167f8b-1e96-4157-87cf-19a2c874b1b2"
      unitRef="number">4.50</hqy:DebtInstrumentCovenantDescriptionLeverageRatio>
    <hqy:DebtInstrumentCovenantDescriptionLeverageRatio
      contextRef="i8875a13a7bbd43ffa8102b5c080b479f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzMyNA_6342cfa5-41c2-4216-b3ed-87d9343fb46f"
      unitRef="number">5.00</hqy:DebtInstrumentCovenantDescriptionLeverageRatio>
    <hqy:DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzQ1Nw_fe1f7759-2ec3-44dd-bc59-17bb8c4f9f0f"
      unitRef="usd">100000000.0</hqy:DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio>
    <hqy:DebtInstrumentCovenantDescriptionInterestCoverageRatio
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80Ni9mcmFnOjI1NGM1NzkwNGFkNDQyMTY4ZGM0ZGQyZGRhZWJiNzZiL3RleHRyZWdpb246MjU0YzU3OTA0YWQ0NDIxNjhkYzRkZDJkZGFlYmI3NmJfMzU3NA_efda12cc-01ef-4140-b0b6-075621cb4429"
      unitRef="number">3.00</hqy:DebtInstrumentCovenantDescriptionInterestCoverageRatio>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyMA_5212e538-8a24-4f5f-9cd5-c056ff6d84f7">Stock-based compensation&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Technology and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Merger Integration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock award plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incentive Plan.    &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants stock options, restricted stock units ("RSUs"), and restricted stock awards ("RSAs") under the HealthEquity, Inc. 2014 Equity Incentive Plan (as amended and restated, the "Incentive Plan"), which provided for the issuance of stock awards to the directors and team members of the Company to purchase up to an aggregate of&#160;2.6 million&#160;shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, under the Incentive Plan, the number of shares of common stock reserved for issuance under the Incentive Plan automatically increases on February 1 of each year, beginning as of&#160;February&#160;1, 2015&#160;and continuing through and including&#160;February&#160;1, 2024, by&#160;3%&#160;of the total number of shares of the Company&#x2019;s capital stock outstanding on January 31 of the preceding fiscal year, or a lesser number of shares determined by the board of directors. As of October&#160;31, 2020, 6.4 million shares were available for grant under the Incentive Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;WageWorks Incentive Plan.    &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the closing of the Acquisition, and in accordance with the merger agreement related to the Acquisition, certain RSUs with respect to WageWorks common stock, granted under WageWorks, Inc. 2010 Equity Incentive Plan (the "WageWorks Incentive Plan"), were replaced by the Company and converted into RSUs with respect to 0.5 million shares of common stock of the Company. No additional shares were issued under the WageWorks Incentive Plan, and the period during which the remaining 5.3 million shares were available to be utilized expired on May 26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for exercise prices and term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of&lt;br/&gt;exercise&lt;br/&gt;prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;term&lt;br/&gt;(in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;intrinsic&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of January&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$0.10&#160;- 82.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$66.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$0.10&#160;- 44.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$25.45&#160;- 44.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1.25&#160;- 82.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercisable as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted stock units and restricted stock awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU and RSA activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSUs and PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs and PRSAs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except weighted-average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance restricted stock units and awards.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;    In March 2018, the Company awarded 227,760 performance-based RSAs ("PRSAs"). The Company records stock-based compensation related to PRSAs when it is considered probable that the performance conditions will be met. The underlying shares were issued at 200% of the target level of achievement at the grant date. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to two-thirds of the awards to be achieved at 100% and creating a new performance condition related to the remaining one-third of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance condition is based on the achievement of certain financial criteria measured on January 31, 2021. The modification affected 10 team members and did not result in an adjustment to stock-based compensation expense. The PRSAs cliff vest upon approval by the Compensation Committee. The modified performance condition for the one-third tranche allows for a range of vesting from 0% to 200% based on the level of achievement of the performance condition, and the Company believes it is probable that the PRSAs will vest at least in part. As the underlying shares were issued at grant date, they are subject to clawback based on actual Company performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, the Company awarded 129,963 PRSUs. The Company records stock-based compensation related to PRSUs when it is considered probable that the performance conditions will be met. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to one-third of the awards to be achieved at 100% and creating new performance conditions related to the remaining two-thirds of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance conditions are based on the achievement of certain financial criteria measured on January 31, 2021 and 2022. The modification affected 12 team members and resulted in incremental stock-based compensation expense of $6.6&#160;million, which will be recognized over the remaining service period, adjusted for the level of achievement of the performance conditions and any forfeitures. Prior to the modification, the Company did not believe the PRSUs were likely to vest, and as a result, $2.9&#160;million of previously recorded stock-based compensation expense was reversed during the three months ended April 30, 2020. The PRSUs cliff vest upon approval by the Compensation Committee. The modified performance conditions for the two-thirds tranche allow for a range of vesting from 0% to 200% based on the level of achievement of the new performance conditions, and the Company believes it is probable that the PRSUs will vest at least in part.&lt;/span&gt;&lt;/div&gt;During the first and second quarters of fiscal 2021, the Company awarded 277,950 PRSUs subject to a market condition based on the Company&#x2019;s total shareholder return ("TSR") relative to the Russell 2000 index as measured on January 31, 2023. The Company used a Monte Carlo simulation to determine that the grant date fair value of the awards was approximately $20.8 million. Compensation expense is recorded if the service condition is met regardless of whether the market condition is satisfied. The market condition allows for a range of vesting from 0% to 200% based on the level of performance achieved. The PRSUs cliff vest upon approval by the Compensation Committee.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyNw_66b82800-68d0-4d61-9b8d-bfd5e3852a00">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended October 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Technology and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Merger Integration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2abd9f5850614a98b0d975f99da08d3e_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi0xLTEtMS0w_063375d0-3def-4867-875e-ef70740562fc"
      unitRef="usd">2209000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i390b5a0159224ba6bd2b58bc11c2b0ad_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi0zLTEtMS0w_987f7d80-c10c-43a9-82b6-27896f19ca91"
      unitRef="usd">1415000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i92964e404b454b1db362fcdfdeab5c39_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi01LTEtMS0w_ed9376c8-be88-4323-af98-db6acddae291"
      unitRef="usd">5737000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ide2d33d6f2a64d8e852283d3699cd837_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMi03LTEtMS0w_d9448c58-0394-48e9-bc7d-03bb8b9a89ba"
      unitRef="usd">3285000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifd93462fe1f746509d6667375bb9b419_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy0xLTEtMS0w_ed57ab84-b1fb-4978-92fc-1eb8d4f05ec5"
      unitRef="usd">2035000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibd67de1d320a48c38e39d726d50f9f41_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy0zLTEtMS0w_780dfae5-3819-47de-aed1-6c01e1e7cf20"
      unitRef="usd">1304000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i991dc368ad8c4c698b4f083f9a6a0a73_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy01LTEtMS0w_ecdb0884-8db1-4037-a239-a4da2df583b9"
      unitRef="usd">4810000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie4bd7600e6b442a4930e416576424ba6_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfMy03LTEtMS0w_322471f1-b60c-4656-b9ea-a1164205d2b4"
      unitRef="usd">3469000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2fd088dfe1ea487588fdb1a14a83fffb_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC0xLTEtMS0w_7fe3ed2c-875f-4f4f-87f0-9e8c5d33bc4b"
      unitRef="usd">2641000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id9129b833a9b4f6888db58833919b896_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC0zLTEtMS0w_f5717293-35d3-4df0-9d93-707ca2a6ad77"
      unitRef="usd">2171000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibba35bdcc6824faba7770fde57155e08_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC01LTEtMS0w_537bda47-ea9f-4553-ba49-a302e5bbe3cc"
      unitRef="usd">8051000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i75d386528c074f2bbf08a38f3944a4e9_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNC03LTEtMS0w_a19c56d7-d41c-4bd2-8055-1b565dc33ad7"
      unitRef="usd">5600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8e7adb81ce6b4eaab1be9f873a9f4de5_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS0xLTEtMS0w_4f78944d-18cb-4e56-8edf-c22c356c4d97"
      unitRef="usd">4594000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie443b8fdfa9644e38627ed682ec6e547_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS0zLTEtMS0w_0ae56668-8a50-4e81-b7a8-c3d8a9e330c8"
      unitRef="usd">3332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i89d12a4acd5f4578ab68365ed4d50c82_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS01LTEtMS0w_724286f2-1329-4e5d-9616-708c555729ab"
      unitRef="usd">11715000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib2dbf47a274d459a8e0c0007cbc26405_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNS03LTEtMS0w_7845d105-3fd3-49a0-a5b4-5153446108c6"
      unitRef="usd">9486000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic6ee172b218d4f5ba07c1dc8b51df50e_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0xLTEtMS0zNzk_1c391cda-d08c-4435-8d91-b01beb1d7cbb"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if88ef73955ab42f1abe01f3f7c744f9c_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0zLTEtMS0zNzk_8a9af93a-9f76-4a3d-b7f6-6d7de40b3f7e"
      unitRef="usd">1220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie7bcb862987f4d31a41e21ebf117cc84_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi01LTEtMS0zNzk_4799fa69-e136-490d-8752-c1f693cafaa3"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6f58c98c5d3a465b9b500d87b1949821_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi03LTEtMS0zNzk_89684f52-e821-420c-a266-6a48ed530af7"
      unitRef="usd">1220000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i30b4954833a14a5db0d4f1d4321a6f4a_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy0xLTEtMS0zNzk_8be926d4-4923-4da9-954b-227147e74d2b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98fb062772b640c887ba8a960fd86c44_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy0zLTEtMS0zNzk_c39705eb-2f8c-450c-8a70-a7d67717129a"
      unitRef="usd">13714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i64472d16654b400e97654463b5d7e80c_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy01LTEtMS0zNzk_62ddae04-d136-4b8d-b90d-fd8197be5052"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ad3647d44134fbe82f1424566227086_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNy03LTEtMS0zNzk_3234b5a5-84a9-49ae-9abb-2494e93c6176"
      unitRef="usd">13714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0xLTEtMS0w_50b52f8d-d6d4-480b-8b82-7926eddfb28a"
      unitRef="usd">11479000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i118c93b8839e4504ad9d9c40a219986b_D20190801-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi0zLTEtMS0w_a97e75b1-2179-4cac-aa3e-a9c18bf6ec00"
      unitRef="usd">23156000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi01LTEtMS0w_a6f6b385-1350-4069-ba9e-76f0238b2749"
      unitRef="usd">30313000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2a777d7cf5f84168b66090c1ba696bdb_D20190201-20191031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjE5NGNkODVlMzE4MDQzM2Q5Nzk2YThlZTQ4YjIzMDI4L3RhYmxlcmFuZ2U6MTk0Y2Q4NWUzMTgwNDMzZDk3OTZhOGVlNDhiMjMwMjhfNi03LTEtMS0w_f9eb9958-958e-458b-922b-c1e3e4cd4a98"
      unitRef="usd">36774000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic64248ebfff14817a2f075cb756200da_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNjEx_292bfab4-e899-4b89-b27e-6626a0585ee7"
      unitRef="shares">2600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <hqy:SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage
      contextRef="ic64248ebfff14817a2f075cb756200da_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfOTA0_12187119-0df7-48bd-bfe3-46a7445eff8e"
      unitRef="number">0.03</hqy:SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic64248ebfff14817a2f075cb756200da_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTEwMQ_f73e6747-3320-4de4-89db-a6a18e86b9a6"
      unitRef="shares">6400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i9990defe3e97407581f4f0a4af6c6fc4_D20200201-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTUxMQ_3b066623-a645-40ba-b425-897a87b12ff6"
      unitRef="shares">500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia0a41dab082f4d569390c26af5e24b25_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTY2NA_ebf53f28-cb3d-4771-823a-8b70fe921825"
      unitRef="shares">5300000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyMQ_eb781dde-b7fb-48f4-a16f-06d6c8510765">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="27" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for exercise prices and term)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range of&lt;br/&gt;exercise&lt;br/&gt;prices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;exercise&lt;br/&gt;price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;average&lt;br/&gt;contractual&lt;br/&gt;term&lt;br/&gt;(in&#160;years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;intrinsic&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of January&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$0.10&#160;- 82.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$66.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$0.10&#160;- 44.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$25.45&#160;- 44.53&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$1.25&#160;- 82.39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;42,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Exercisable as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0xLTEtMS0w_e1cbd828-4576-4614-9ac1-172671e5f319"
      unitRef="shares">2040000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0zLTEtMS0wL3RleHRyZWdpb246MDNiMGFiN2ZjYWE3NDk4MzhlMDU3Y2NmNjI1ZjE4YjFfODc5NjA5MzAyMjIzMA_fe54a481-359c-48cb-8da9-2af6974e7b32"
      unitRef="usdPerShare">0.10</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi0zLTEtMS0wL3RleHRyZWdpb246MDNiMGFiN2ZjYWE3NDk4MzhlMDU3Y2NmNjI1ZjE4YjFfODc5NjA5MzAyMjIzOA_b4d9e6d0-ee6c-4719-a31d-1563fcef4957"
      unitRef="usdPerShare">82.39</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi01LTEtMS0w_6c58ed8e-228b-4b73-bc8e-0919ba838886"
      unitRef="usdPerShare">30.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ie3646166651746228acb84ea09049053_D20200201-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi03LTEtMS0w_ab15106e-e8e7-403c-a4de-bc4280c3ecd5">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i45cb957efb1b4404baaef91f15061ef9_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMi05LTEtMS0w_eac30a29-779d-4039-92b2-ecef7ffb86f8"
      unitRef="usd">74009000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy0xLTEtMS0w_ec16fe04-9428-4325-b53b-fb46b96faacd"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy0zLTEtMS0w_528c954c-9b52-493f-8c70-566f6defafbe"
      unitRef="usdPerShare">66.06</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfMy01LTEtMS0w_0769e19b-f986-44a7-865f-070b9d5053c2"
      unitRef="usdPerShare">66.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0xLTEtMS0w_7fc66601-4475-4641-97bc-67f2b5283ff3"
      unitRef="shares">183000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0zLTEtMS0wL3RleHRyZWdpb246M2U1NTdlZDgwYmY0NDQxNTg1MDc3NjUwYWIwNDEzN2NfODc5NjA5MzAyMjIzMA_d80ad920-fad4-4c66-b1f7-12f74dfb461f"
      unitRef="usdPerShare">0.10</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC0zLTEtMS0wL3RleHRyZWdpb246M2U1NTdlZDgwYmY0NDQxNTg1MDc3NjUwYWIwNDEzN2NfODc5NjA5MzAyMjIzOA_5f96aca4-8a2b-4508-b649-b98100b138bd"
      unitRef="usdPerShare">44.53</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNC01LTEtMS0w_c9fb9a32-468c-449d-a889-051377c3c654"
      unitRef="usdPerShare">24.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0xLTEtMS0w_23c1a666-3269-40b1-a7db-0c9781b21995"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0zLTEtMS0wL3RleHRyZWdpb246NTkxN2QyZTdlYzcwNDFmM2I5YzAyMmFkMmRjOWI4NjNfODc5NjA5MzAyMjIzMg_19c47fd6-78bd-4a2c-958f-ee7b6f214092"
      unitRef="usdPerShare">25.45</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS0zLTEtMS0wL3RleHRyZWdpb246NTkxN2QyZTdlYzcwNDFmM2I5YzAyMmFkMmRjOWI4NjNfODc5NjA5MzAyMjI0MA_9b1d6253-db5e-4bf1-9c11-fde3d87a6148"
      unitRef="usdPerShare">44.53</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNS01LTEtMS0w_aaaf3bf4-c071-48b0-8514-2d3f526e59a1"
      unitRef="usdPerShare">38.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0xLTEtMS0w_7d748278-4ea7-4a71-b948-2df8fde1f517"
      unitRef="shares">1863000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0zLTEtMS0wL3RleHRyZWdpb246YjZhMDIwYWI4MTU1NDNhNWFhMjc2OTExOWJkZWZlZmNfODc5NjA5MzAyMjIzMA_d23d26dc-27c5-4613-a910-0a021efc993b"
      unitRef="usdPerShare">1.25</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding>
    <hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi0zLTEtMS0wL3RleHRyZWdpb246YjZhMDIwYWI4MTU1NDNhNWFhMjc2OTExOWJkZWZlZmNfODc5NjA5MzAyMjIzOA_83c00920-4e8b-4359-9e8f-8433f60edb6f"
      unitRef="usdPerShare">82.39</hqy:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi01LTEtMS0w_c99122d5-1c41-4c5a-b7ce-8ae2912ff329"
      unitRef="usdPerShare">31.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi03LTEtMS0w_7d37a3c7-5e86-435b-9adb-6426dbdd6646">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNi05LTEtMS0w_0bf03ffb-e8a9-49b7-a846-88d211a3a84f"
      unitRef="usd">42046000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy0xLTEtMS0w_5c7ed8a5-4961-4ee5-bbae-d53b4f53277c"
      unitRef="shares">1863000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy01LTEtMS0w_2bcf6a40-7733-4463-9c55-6f4d1a3060cc"
      unitRef="usdPerShare">31.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy03LTEtMS0w_b7f9d839-befc-4139-b01d-057b81d3ed1d">P5Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfNy05LTEtMS0w_67366f1f-1000-44a2-b26c-fc08dce5ea08"
      unitRef="usd">42046000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC0xLTEtMS0w_83b0e16b-f828-467c-a758-8f158be50a43"
      unitRef="shares">1584000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC01LTEtMS0w_5e24dfb5-20c1-47dc-94c1-31dda0dca475"
      unitRef="usdPerShare">26.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC03LTEtMS0w_4afa1d92-df2f-4d0f-9669-84fc4da66e7c">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib16f9fff56d24738b1519754780c7d7f_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjY3MmZkNWJlZjFmYjRkNjFhYzYxMWU1YWM0Mzk4NDE0L3RhYmxlcmFuZ2U6NjcyZmQ1YmVmMWZiNGQ2MWFjNjExZTVhYzQzOTg0MTRfOC05LTEtMS0w_1d026f7a-5745-4829-b067-a2e0e32546f1"
      unitRef="usd">41025000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTMyNg_6787e41f-ab23-4338-a53b-753ec14a57b0">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU and RSA activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSUs and PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;RSAs and PRSAs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except weighted-average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of January 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;54.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outstanding as of October 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;62.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi0xLTEtMS0w_b6ef44b4-e477-4792-9eb7-fe9a174eeb7c"
      unitRef="shares">1380000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi0zLTEtMS0w_6392ed2c-72bf-4450-8d69-03ba5ff2f7db"
      unitRef="usdPerShare">63.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i70be1d14e5f049ea9990ac6488c46bb2_I20200131"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi01LTEtMS0w_ddb3b071-275f-4376-a828-7ab92801b659"
      unitRef="shares">235000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i70be1d14e5f049ea9990ac6488c46bb2_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMi03LTEtMS0w_6538d277-d765-426c-9018-7c17487523c3"
      unitRef="usdPerShare">61.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy0xLTEtMS0w_2d9dd638-58da-4d3c-b7a9-861d0eea4907"
      unitRef="shares">1220000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy0zLTEtMS0w_f59cc1b6-a044-4ebc-bc5d-671cbd365a7f"
      unitRef="usdPerShare">56.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy01LTEtMS0w_628a8319-c7e3-433e-a78e-a0b0adae1077"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfMy03LTEtMS0w_4691e1f8-1b74-4e06-949a-390860b6f17a"
      unitRef="usdPerShare">74.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC0xLTEtMS0w_46dc9fed-095f-4804-bd38-34009aa0128f"
      unitRef="shares">446000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC0zLTEtMS0w_ddc005b6-0868-429e-89e7-81271c76d889"
      unitRef="usdPerShare">54.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC01LTEtMS0w_37935529-3be6-4435-b8ac-947fb8e665f3"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNC03LTEtMS0w_82e9d148-fa1a-4bbb-8ac4-55b4571138b8"
      unitRef="usdPerShare">62.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS0xLTEtMS0w_f57a084b-5721-40f7-b26f-1e3ff1d4230a"
      unitRef="shares">262000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS0zLTEtMS0w_f2d8d4aa-6c51-4291-ae3a-8a2781b1f5d4"
      unitRef="usdPerShare">66.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS01LTEtMS0w_5832de66-ed1f-40bb-b2bc-d8d5d66e4dd4"
      unitRef="shares">32000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i61c9471a735946c0b70d07b03ad1ab44_D20200201-20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNS03LTEtMS0w_974e1479-5728-47c7-a1f2-bef63f49389a"
      unitRef="usdPerShare">62.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id0c3c36c6fb949c6b668af4f989c6df1_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi0xLTEtMS0w_563f6fdc-b0ac-4d27-b903-52fdafa987dd"
      unitRef="shares">1892000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id0c3c36c6fb949c6b668af4f989c6df1_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi0zLTEtMS0w_e51c7088-c500-4b2b-84a9-094cf17e4b2d"
      unitRef="usdPerShare">60.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i13b43e3e97744f2f99ef7eba9252d568_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi01LTEtMS0w_e65189b9-bd56-4461-8ab1-edddef4bb296"
      unitRef="shares">207000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i13b43e3e97744f2f99ef7eba9252d568_I20201031"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RhYmxlOjhmN2YwNjUxOTI4YzQ5YTE4OTZkNTg5M2VjZmJiNzNkL3RhYmxlcmFuZ2U6OGY3ZjA2NTE5MjhjNDlhMTg5NmQ1ODkzZWNmYmI3M2RfNi03LTEtMS0w_b2cd39ef-e14c-4360-900a-f0e4b6219fad"
      unitRef="usdPerShare">62.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3843854aae914afaa49721b198e544c7_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMTk4Nw_84f3f947-da9c-4ede-b026-3a53d72c82c6"
      unitRef="shares">227760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjE5OQ_a007a393-f99e-4426-ab56-cfbfba9c266c"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjQwOQ_a9db513c-25a8-49bb-9184-b674ee82d57e"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers
      contextRef="ic056760c3b79466b9f0db917e955ed5b_D20200301-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjcxOA_825b8cf3-950f-4912-ab1e-be702675d33e"
      unitRef="member">10</hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i550456057eea4a81a4866ec595bb66fe_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjk2OQ_97758a16-e911-479b-bad9-141faf58206c"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i431c0703f3aa4fdc9056c5520225e6b6_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMjk3NQ_3ab183d7-3c8e-4851-a36f-437466fa3e95"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i66be3136ba174468819065390931d293_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzI3OA_9f941c21-282d-459d-b817-ee356e67ef2e"
      unitRef="shares">129963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzU3OA_68e55588-e053-4f9f-9c62-4b3bd0aa3851"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzg5OA_746072f8-ac4d-47c2-abb5-43aba2d069c4"
      unitRef="member">12</hqy:ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfMzk3OA_d5f99400-b328-4f6d-98d8-b7433e851d47"
      unitRef="usd">6600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <hqy:ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms
      contextRef="i7a099c1732754f4ab7e8540adf0574b5_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDIzNA_2e12015e-1f57-4134-aa0c-be426124bdf6"
      unitRef="usd">2900000</hqy:ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i30ee4b3524be43a9bad2db97c312e887_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDUxNQ_a2803197-d01f-4a17-9e1b-9d249cadc928"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ifb0a184b778d46f6bb8363b0ba93ac1d_D20190301-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDUyMQ_34887a60-402f-4043-ba68-5dd9e92b99e2"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i851da9c28c4d412f8a32c95d3d5bf732_D20200201-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNDczOQ_8dd4ea4f-65ae-4997-8548-2c48b8f7cd54"
      unitRef="shares">277950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
      contextRef="i5035efb5313648a3b06aa3af898d03ce_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTAyMA_51525a47-991a-47cd-8c91-33599da1b842"
      unitRef="usd">20800000</hqy:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1e82ed8bc9eb4b0199285a4985c3e872_D20200201-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTIwMg_3ace3599-2af0-452d-8ce4-e9f2caa68df4"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i92cbf523ebd94e99a62188292dc7a98f_D20200201-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl80OS9mcmFnOjJjZGVhYzhlNDMzNDQzYzA5YzkwZTBhZmQzMDFiOTVjL3RleHRyZWdpb246MmNkZWFjOGU0MzM0NDNjMDljOTBlMGFmZDMwMWI5NWNfNTIwOA_87b2d40c-6bbb-41bd-8544-7bfeda7f811b"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81NS9mcmFnOjk4YjQyYmM4MTJkNTQzOTNiY2M4YmNlNTZkNGFiMjJmL3RleHRyZWdpb246OThiNDJiYzgxMmQ1NDM5M2JjYzhiY2U1NmQ0YWIyMmZfMTY0Ng_1755db64-3192-432b-a38c-a633eced6f89">&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company&#x2019;s market assumptions. These two types of inputs have created the following fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;unobservable inputs based on the Company&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of cash and cash equivalents. The carrying value of cash and cash equivalents approximate fair values as of&#160;October&#160;31, 2020&#160;due to the short-term nature of these instruments.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-term debt is considered a Level 2 instrument and is recorded at book value in our condensed consolidated financial statements. Our long-term debt reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, we believe the fair value of our long-term debt approximates carrying value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjNGZiMjMzYjUwNTQxOGRhY2I4YmRiNDcxMzg1OTJmL3NlYzoyYzRmYjIzM2I1MDU0MThkYWNiOGJkYjQ3MTM4NTkyZl81NS9mcmFnOjk4YjQyYmM4MTJkNTQzOTNiY2M4YmNlNTZkNGFiMjJmL3RleHRyZWdpb246OThiNDJiYzgxMmQ1NDM5M2JjYzhiY2U1NmQ0YWIyMmZfMTY0OA_cc7216d7-31b1-4599-badf-973dbc61b5f5">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company&#x2019;s market assumptions. These two types of inputs have created the following fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;unobservable inputs based on the Company&#x2019;s own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of cash and cash equivalents. The carrying value of cash and cash equivalents approximate fair values as of&#160;October&#160;31, 2020&#160;due to the short-term nature of these instruments.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-term debt is considered a Level 2 instrument and is recorded at book value in our condensed consolidated financial statements. Our long-term debt reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, we believe the fair value of our long-term debt approximates carrying value.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658998912088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Nov. 25, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHEQUITY, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2383166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">15 West Scenic Pointe Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Draper,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-1000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HQY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,990,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001428336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--01-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658998832792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed consolidated balance sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 299,356<span></span>
</td>
<td class="nump">$ 191,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $3,458 and $1,216 as of October 31, 2020 and January 31, 2020, respectively</a></td>
<td class="nump">64,291<span></span>
</td>
<td class="nump">70,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">32,383<span></span>
</td>
<td class="nump">34,711<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">396,030<span></span>
</td>
<td class="nump">297,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">31,774<span></span>
</td>
<td class="nump">33,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">92,314<span></span>
</td>
<td class="nump">83,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">776,311<span></span>
</td>
<td class="nump">783,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,326,793<span></span>
</td>
<td class="nump">1,332,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">34,019<span></span>
</td>
<td class="nump">35,089<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,657,262<span></span>
</td>
<td class="nump">2,564,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,746<span></span>
</td>
<td class="nump">3,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">34,839<span></span>
</td>
<td class="nump">50,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">33,380<span></span>
</td>
<td class="nump">46,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">62,500<span></span>
</td>
<td class="nump">39,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">13,894<span></span>
</td>
<td class="nump">12,401<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">151,359<span></span>
</td>
<td class="nump">151,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of issuance costs</a></td>
<td class="nump">938,558<span></span>
</td>
<td class="nump">1,181,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">76,666<span></span>
</td>
<td class="nump">68,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">2,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">123,993<span></span>
</td>
<td class="nump">130,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">1,150,646<span></span>
</td>
<td class="nump">1,382,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,302,005<span></span>
</td>
<td class="nump">1,534,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (see Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 900,000 shares authorized, 76,951 and 71,051 shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,140,268<span></span>
</td>
<td class="nump">818,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated earnings</a></td>
<td class="nump">214,981<span></span>
</td>
<td class="nump">211,514<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,355,257<span></span>
</td>
<td class="nump">1,030,295<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,657,262<span></span>
</td>
<td class="nump">$ 2,564,981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658999218200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed consolidated balance sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 3,458<span></span>
</td>
<td class="nump">$ 1,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">76,951,000<span></span>
</td>
<td class="nump">71,051,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">76,951,000<span></span>
</td>
<td class="nump">71,051,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923670504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated statements of operations and comprehensive income (loss) (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 179,351<span></span>
</td>
<td class="nump">$ 157,118<span></span>
</td>
<td class="nump">$ 545,401<span></span>
</td>
<td class="nump">$ 330,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">74,793<span></span>
</td>
<td class="nump">61,083<span></span>
</td>
<td class="nump">230,985<span></span>
</td>
<td class="nump">118,565<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">104,558<span></span>
</td>
<td class="nump">96,035<span></span>
</td>
<td class="nump">314,416<span></span>
</td>
<td class="nump">212,228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">12,880<span></span>
</td>
<td class="nump">12,654<span></span>
</td>
<td class="nump">36,502<span></span>
</td>
<td class="nump">30,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Technology and development</a></td>
<td class="nump">30,758<span></span>
</td>
<td class="nump">23,511<span></span>
</td>
<td class="nump">92,490<span></span>
</td>
<td class="nump">46,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">22,099<span></span>
</td>
<td class="nump">19,222<span></span>
</td>
<td class="nump">61,590<span></span>
</td>
<td class="nump">37,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_AmortizationOfAcquiredIntangible', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">19,126<span></span>
</td>
<td class="nump">13,051<span></span>
</td>
<td class="nump">56,905<span></span>
</td>
<td class="nump">16,036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Merger integration</a></td>
<td class="nump">8,193<span></span>
</td>
<td class="nump">17,675<span></span>
</td>
<td class="nump">31,328<span></span>
</td>
<td class="nump">20,459<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">93,056<span></span>
</td>
<td class="nump">86,113<span></span>
</td>
<td class="nump">278,815<span></span>
</td>
<td class="nump">149,764<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">11,502<span></span>
</td>
<td class="nump">9,922<span></span>
</td>
<td class="nump">35,601<span></span>
</td>
<td class="nump">62,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,952)<span></span>
</td>
<td class="num">(10,225)<span></span>
</td>
<td class="num">(28,110)<span></span>
</td>
<td class="num">(10,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(421)<span></span>
</td>
<td class="num">(30,949)<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="num">(8,347)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense</a></td>
<td class="num">(7,373)<span></span>
</td>
<td class="num">(41,174)<span></span>
</td>
<td class="num">(30,119)<span></span>
</td>
<td class="num">(18,702)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">4,129<span></span>
</td>
<td class="num">(31,252)<span></span>
</td>
<td class="nump">5,482<span></span>
</td>
<td class="nump">43,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">2,340<span></span>
</td>
<td class="num">(9,918)<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">3,908<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="num">(21,334)<span></span>
</td>
<td class="nump">3,467<span></span>
</td>
<td class="nump">39,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">$ 1,789<span></span>
</td>
<td class="num">$ (21,334)<span></span>
</td>
<td class="nump">$ 3,467<span></span>
</td>
<td class="nump">$ 39,854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract', window );"><strong>Weighted-average number of shares used in computing net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">76,701<span></span>
</td>
<td class="nump">70,524<span></span>
</td>
<td class="nump">73,358<span></span>
</td>
<td class="nump">65,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">77,845<span></span>
</td>
<td class="nump">70,524<span></span>
</td>
<td class="nump">74,665<span></span>
</td>
<td class="nump">67,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 104,562<span></span>
</td>
<td class="nump">$ 87,620<span></span>
</td>
<td class="nump">$ 319,638<span></span>
</td>
<td class="nump">$ 140,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">65,936<span></span>
</td>
<td class="nump">52,278<span></span>
</td>
<td class="nump">202,195<span></span>
</td>
<td class="nump">92,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_FinancialServiceOtherMember', window );">Custodial revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">48,544<span></span>
</td>
<td class="nump">46,972<span></span>
</td>
<td class="nump">142,352<span></span>
</td>
<td class="nump">132,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">4,762<span></span>
</td>
<td class="nump">4,384<span></span>
</td>
<td class="nump">14,805<span></span>
</td>
<td class="nump">12,716<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_CreditAndDebitCardMember', window );">Interchange revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">26,245<span></span>
</td>
<td class="nump">22,526<span></span>
</td>
<td class="nump">83,411<span></span>
</td>
<td class="nump">57,545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">$ 4,095<span></span>
</td>
<td class="nump">$ 4,421<span></span>
</td>
<td class="nump">$ 13,985<span></span>
</td>
<td class="nump">$ 13,177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_AmortizationOfAcquiredIntangible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Acquired Intangible</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_AmortizationOfAcquiredIntangible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Number Of Shares Used In Computing Net Income Per Share Attributable To Common Stockholders, Basic And Diluted [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_FinancialServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_FinancialServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_CreditAndDebitCardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_CreditAndDebitCardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923687736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed consolidated statements of stockholders' equity (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated earnings</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jan. 31, 2019</a></td>
<td class="nump">$ 477,079<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 305,223<span></span>
</td>
<td class="nump">$ 171,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options, and for restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">462,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">39,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,854<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Oct. 31, 2019</a></td>
<td class="nump">1,017,761<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">806,050<span></span>
</td>
<td class="nump">211,704<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jul. 31, 2019</a></td>
<td class="nump">1,017,031<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">783,986<span></span>
</td>
<td class="nump">233,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options, and for restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(21,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,334)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Oct. 31, 2019</a></td>
<td class="nump">1,017,761<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">806,050<span></span>
</td>
<td class="nump">211,704<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jan. 31, 2020</a></td>
<td class="nump">1,030,295<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">818,774<span></span>
</td>
<td class="nump">211,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options, and for restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">286,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">3,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,467<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Oct. 31, 2020</a></td>
<td class="nump">1,355,257<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">1,140,268<span></span>
</td>
<td class="nump">214,981<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jul. 31, 2020</a></td>
<td class="nump">1,340,336<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">1,127,136<span></span>
</td>
<td class="nump">213,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options, and for restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">1,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Oct. 31, 2020</a></td>
<td class="nump">$ 1,355,257<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 1,140,268<span></span>
</td>
<td class="nump">$ 214,981<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658998968200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated statements of cash flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 3,467<span></span>
</td>
<td class="nump">$ 39,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">85,485<span></span>
</td>
<td class="nump">28,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">30,313<span></span>
</td>
<td class="nump">31,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">3,818<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gains on marketable equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(27,570)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">1,727<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred taxes</a></td>
<td class="num">(973)<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">8,063<span></span>
</td>
<td class="num">(1,901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">3,309<span></span>
</td>
<td class="num">(4,863)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">8,344<span></span>
</td>
<td class="nump">3,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation</a></td>
<td class="num">(15,251)<span></span>
</td>
<td class="num">(8,012)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accounts payable, accrued liabilities, and other current liabilities</a></td>
<td class="num">(7,936)<span></span>
</td>
<td class="nump">14,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="num">(8,361)<span></span>
</td>
<td class="num">(2,859)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Other long-term liabilities</a></td>
<td class="nump">8,712<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">120,717<span></span>
</td>
<td class="nump">74,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(11,388)<span></span>
</td>
<td class="num">(5,180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Purchases of software and capitalized software development costs</a></td>
<td class="num">(37,242)<span></span>
</td>
<td class="num">(17,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible member assets</a></td>
<td class="num">(28,100)<span></span>
</td>
<td class="num">(9,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(53,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,630,066)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(76,730)<span></span>
</td>
<td class="num">(1,715,393)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from follow-on equity offering, net of payments for offering costs</a></td>
<td class="nump">286,779<span></span>
</td>
<td class="nump">458,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="num">(223,438)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_PaymentsToSettleClientHeldFunds', window );">Settlement of client-held funds obligation, net</a></td>
<td class="num">(4,189)<span></span>
</td>
<td class="num">(230,928)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of common stock options</a></td>
<td class="nump">4,491<span></span>
</td>
<td class="nump">7,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30,504)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">63,643<span></span>
</td>
<td class="nump">1,454,405<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">107,630<span></span>
</td>
<td class="num">(186,918)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning cash and cash equivalents</a></td>
<td class="nump">191,726<span></span>
</td>
<td class="nump">361,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Ending cash and cash equivalents</a></td>
<td class="nump">299,356<span></span>
</td>
<td class="nump">174,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest expense paid in cash</a></td>
<td class="nump">22,849<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid in cash, net of refunds received</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">9,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment included in accounts payable or accrued liabilities</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Decrease in goodwill due to measurement period adjustments, net</a></td>
<td class="nump">5,838<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ExerciseofStockOptionsReceivable', window );">Exercise of common stock options receivable</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Equity-based acquisition consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer software intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Purchases of intangible assets</a></td>
<td class="nump">1,346<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember', window );">Acquired HSA portfolios</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Purchases of intangible assets</a></td>
<td class="nump">$ 289<span></span>
</td>
<td class="num">$ (151)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ExerciseofStockOptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise of Stock Options Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ExerciseofStockOptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_PaymentsToSettleClientHeldFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Settle Client Held Funds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_PaymentsToSettleClientHeldFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658917427176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of business and significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of business and significant accounting policies</a></td>
<td class="text">Summary of business and significant accounting policies <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HealthEquity, Inc. ("HealthEquity" or the "Company") was incorporated in the state of Delaware on September&#160;18, 2002. HealthEquity is a leader in administering health savings accounts (&#8220;HSAs&#8221;) and complementary consumer-directed benefits (&#8220;CDBs&#8221;), which empower consumers to access tax-advantaged healthcare savings while also providing corporate tax advantages for employers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of consolidation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of presentation </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements as of October&#160;31, 2020 and for the three and nine months ended October&#160;31, 2020 and 2019 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.  The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Follow-on equity offering</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, the Company closed a follow-on public offering of 5,290,000 shares of common stock at a public offering price of $56.00 per share, less the underwriters' discount. The Company received net proceeds of approximately $286.8 million after deducting underwriting discounts and commissions of approximately $8.9 million and other offering expenses of approximately $0.6 million. The Company used $200.0&#160;million of such proceeds to repay debt under its term loan facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant accounting policies </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the Company&#8217;s significant accounting policies as compared to the significant accounting policies described in the Company&#8217;s Annual Report on&#160;Form&#160;10-K for the fiscal year ended January&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020 using the modified retrospective transition method. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASU 2018-13&#8221;), which amends ASC 820, "Fair Value Measurement." ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying and adding certain disclosures. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The Company adopted the new standard as of February 1, 2020. </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company retrospectively adopted the provision related to the classification of taxes partially based on income, and prospectively adopted the provisions related to intraperiod tax allocation and interim recognition of enactment of tax laws. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The adoption of this standard did not have a material effect on the Company&#8217;s current- or prior-period condensed consolidated financial statements.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919088840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income (loss) per share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net income (loss) per share</a></td>
<td class="text">Net income (loss) per share<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Numerator (basic and diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (basic):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.30)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended October&#160;31, 2020 and 2019, approximately 1.0 million and 3.2 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended October&#160;31, 2020 and 2019, approximately 0.6 million and 0.3 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658917405160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combination<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business combination</a></td>
<td class="text">Business combination<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition of WageWorks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 30, 2019, the Company closed the acquisition (the "Acquisition") of WageWorks, Inc. ("WageWorks") for $51.35 per share in cash, or approximately $2.0&#160;billion to WageWorks stockholders. The Company financed the transaction through a combination of $816.9&#160;million cash on hand plus net borrowings of approximately $1.22&#160;billion, after deducting lender fees of approximately $30.5&#160;million, under a term loan facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Acquisition was accounted for under the acquisition method of accounting for business combinations. Consideration paid was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the Acquisition date. The initial allocation of the consideration paid was based on a preliminary valuation and was subject to adjustment during the measurement period (up to one year from the Acquisition date). The purchase price allocation was finalized in the third quarter of fiscal 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's allocation of the consideration paid in the Acquisition:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Allocation</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Updated Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,330.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,322.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client-held funds obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(237.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(220.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(69.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(128.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total consideration paid</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjustments to the initial allocation were based on more detailed information obtained about the specific assets acquired, liabilities assumed, and tax-related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro forma information</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented below include the effects of the Acquisition as if it had been consummated as of February 1, 2018, with adjustments to give effect to pro forma events that are directly attributable to the Acquisition, which include adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings from the integration of WageWorks. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the Acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations. The estimated pro forma revenue and net income (loss) include the alignment of accounting policies, the effect of fair value adjustments related to the&#160;Acquisition, associated tax effects and the impact of the borrowings to finance the&#160;Acquisition and related expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31, 2019</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,286)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919052360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Supplemental financial statement information</a></td>
<td class="text">Supplemental financial statement information<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected condensed consolidated balance sheet and condensed consolidated statement of operations and comprehensive income components consist of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and equipment</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,907&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,774&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,486&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended October&#160;31, 2020 and 2019 was $4.0 million and $3.6 million, respectively, and $12.0 million and $5.4 million for the nine months ended October&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets. The Company records a receivable when revenue is recognized prior to payment and the Company has unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. As of October&#160;31, 2020 and January&#160;31, 2020, the balance of deferred revenue was $7.0 million and $3.7 million, respectively. The balances are related to cash received in advance for an interchange revenue arrangement, other up-front fees and other commuter deferred revenue, and are generally recognized within twelve months, with the exception of the interchange arrangement, which is recognized over a term of approximately ten years. During the three and nine months ended October&#160;31, 2020, approximately $0.4 million and $2.2 million of revenue, respectively, was recognized that was included in the balance of deferred revenue as of January&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease costs were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net operating lease expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new operating lease obligations</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,394&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other expense, net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(40,712)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30,949)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,347)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658917418008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible assets and goodwill</a></td>
<td class="text">Intangible assets and goodwill<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired HSA portfolios</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">947,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(172,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98,851)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total amortizable intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">780,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in process software development costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">776,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended October&#160;31, 2020 and 2019, the Company expensed a total of $10.5 million and $6.2 million, respectively, and $31.1 million and $13.8 million for the nine months ended October&#160;31, 2020 and 2019, respectively, in software development costs primarily related to the post-implementation and operation stages of its proprietary software. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for the three months ended October&#160;31, 2020 and 2019 was $25.3 million and $15.7 million, respectively, and $73.5 million and $23.6 million for the nine months ended October&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended October&#160;31, 2020, goodwill decreased by $7.0 million and $5.8 million, respectively, due to measurement period adjustments related to the Acquisition of WageWorks.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919052360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and contingencies</a></td>
<td class="text">Commitments and contingencies<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal commitments consist of a term loan facility, operating lease obligations for office space, data storage facilities, and other leases, a processing services agreement with a vendor, and contractual commitments related to network infrastructure, equipment, and certain maintenance agreements under long-term, non-cancelable commitments. Except for the $200&#160;million principal prepayment on our term loan facility, there were no material changes during the three and nine months ended October&#160;31, 2020, outside of the ordinary course of business, in our commitments from those disclosed in our Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company&#8217;s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal matters</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks is pursuing affirmative claims against the Office of Personnel Management ("OPM") to obtain payment for services provided by WageWorks between March 1, 2016 and August 31, 2016 pursuant to its contract with OPM. In connection with WageWorks' claims against OPM, OPM has also claimed that an erroneous statement in a certificate signed by a former executive officer constituted a violation of the False Claims Act and moved to dismiss part of WageWorks' claim against OPM as a result. As with all legal proceedings, no assurance can be provided as to the outcome of these matters or if WageWorks or OPM will be successful.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 9, 2018, a putative class action was filed in the U.S. District Court for the Northern District of California (the &#8220;Securities Class Action&#8221;). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against WageWorks, its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleges claims under the Securities Act of 1933, as amended, arising from WageWorks&#8217; June 19, 2017 common stock offering against those same defendants, as well as the members of its board of directors at the time of that offering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2018 and September 6, 2018, two derivative lawsuits were filed against certain of WageWorks&#8217; former officers and directors and WageWorks (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain former WageWorks&#8217; officers and directors and WageWorks (as nominal defendant) in the U.S. District Court for the Northern District of California (together, the &#8220;Derivative Suits&#8221;). The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages and fees and costs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Plaintiffs in the Superior Court action filed an amended consolidated complaint on October 28, 2019, naming as defendants certain former officers and directors of WageWorks and alleging a direct claim of "inseparable fraud/breach of fiduciary duty" on behalf of a class. WageWorks was not named as a party in that complaint. On June 24, 2020, the court granted the defendants&#8217; motion to dismiss the amended complaint. The plaintiffs subsequently filed a notice of appeal.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks voluntarily contacted the San Francisco office of the SEC Division of Enforcement regarding the restatement of WageWorks' financial statements and related independent investigation. WageWorks is providing information and documents to the SEC and continues to cooperate with the SEC&#8217;s investigation into these matters. The U.S. Attorney&#8217;s Office for the Northern District of California also opened an investigation. WageWorks has provided documents and information to the U.S. Attorney&#8217;s Office and continues to cooperate with any inquiries by the U.S. Attorney&#8217;s Office regarding the matter.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WageWorks previously entered into indemnification agreements with its former directors and officers and, pursuant to these indemnification agreements, is covering the defense of its former directors and officers in the legal proceedings described above. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. While it is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, the Company believes, based on current knowledge, that such litigation, proceedings and claims will not have a material impact on the Company&#8217;s financial position, results of operations and cash flows for the period. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains liability insurance coverage that is intended to cover the legal matters described above; however, it is possible that claims may be denied by our insurance carriers or could exceed the amount of our applicable insurance coverage, we may be required by our insurance carriers to contribute to the payment of claims, and our insurance coverage may not continue to be available to us on acceptable terms or in sufficient amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under GAAP, the Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on currently available information, the Company does not believe that any liabilities relating to these matters are probable or that the amount of any resulting loss is estimable. However, litigation is subject to inherent uncertainties and the Company&#8217;s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company&#8217;s financial position, results of operations and cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919101192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows FASB Accounting Standards Codification 740-270, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes - Interim Reporting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the computation and presentation of its interim period tax provision. Accordingly, management estimated the effective annual tax rate and applied this rate to the year-to-date pre-tax book income to determine the interim benefit or provision for income taxes. For the three and nine months ended October&#160;31, 2020, the Company recorded income tax expense of $2.3 million and $2.0 million, respectively. This resulted in an effective income tax expense rate of 56.7% and 36.8% for the three and nine months ended October&#160;31, 2020, respectively, compared with an effective income tax benefit rate of 31.7% and an effective income tax expense rate of 8.9% for the three and nine months ended October&#160;31, 2019, respectively. For the three and nine months ended October&#160;31, 2020 and 2019, the net </span><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of discrete tax items caused a 6.0 percentage point expense and a 9.6 percentage point benefit and a 1.1 and 8.7 percentage point benefit, respectively, to the effective income tax rate primarily due to the excess tax benefit on stock-based compensation expense and return-to-provision adjustments, which were partially offset by state apportionment changes recognized in the provision for income taxes relative to pre-tax book income. Due to significantly lower pre-tax book income during the nine months ended October&#160;31, 2020, discrete items had a greater impact on the effective income tax rate than during the nine months ended October&#160;31, 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020 and January&#160;31, 2020, the Company&#8217;s total gross unrecognized tax benefit was $10.0 million and $9.4 million, respectively. As of October&#160;31, 2020 and January&#160;31, 2020, a net unrecognized tax benefit of $0.5 million was recorded in the condensed consolidated balance sheets. If recognized, $9.2 million of the total gross unrecognized tax benefits would affect the Company's effective tax rate as of October&#160;31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns with U.S. federal and state taxing jurisdictions and is currently under examination with the state of Texas. As a result of the Company's net operating loss carryforwards and tax credit carryforwards, the Company remains subject to examination by one or more jurisdictions for tax years after 2000.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919052360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Indebtedness</a></td>
<td class="text">Indebtedness<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020, long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loan facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,018.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: unamortized loan issuance costs (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of issuance costs</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,001.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In addition to the $17.7&#160;million of unamortized issuance costs related to the term loan facility, $5.3&#160;million of unamortized issuance costs related to our revolving credit facility are included within other assets on the October&#160;31, 2020 condensed consolidated balance sheet. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Acquisition, on August&#160;30, 2019, the Company entered into a credit facility (the "Credit Agreement&#8221;) that provided for:</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;a five-year senior secured term loan A facility (the &#8220;Term Loan Facility&#8221;), in an aggregate principal amount of $1.25 billion, the proceeds of which were used to finance the Acquisition, to refinance substantially all outstanding indebtedness of HealthEquity and WageWorks and to pay related fees and expenses; and</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;&#160;&#160;a five-year senior secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Facilities&#8221;), in an aggregate principal amount of up to $350.0 million, which may be used for working capital and general corporate purposes, including acquisitions and other investments. No amounts were drawn under the Revolving Credit Facility as of October&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Credit Facilities bear interest at an annual rate equal to, at the option of HealthEquity, either (i)&#160;LIBOR (adjusted for reserves) plus a margin ranging from 1.25% to 2.25% or (ii)&#160;an alternate base rate plus a margin ranging from 0.25% to 1.25%, with the applicable margin determined by reference to a leverage-based pricing grid set forth in the Credit Agreement. As of October&#160;31, 2020, the stated interest rate was 1.65% and the effective interest rate was 2.18%. The Company is also required to pay certain fees to the lenders, including, among others, a quarterly commitment fee on the average unused amount of the Revolving Credit Facility at a rate ranging from 0.20% to 0.40%, with the applicable rate also determined by reference to a leverage-based pricing grid set forth in the Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans made under the Term Loan Facility are required to be repaid as described in the following table:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year ending January 31, (in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,018.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The amount required to be repaid in 2025 reflects the $200.0&#160;million prepayment made in July 2020 with proceeds from the follow-on offering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit, among other things, the ability of the Company to incur additional indebtedness, create liens, merge or dissolve, </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make investments, dispose of assets, engage in sale and leaseback transactions, make distributions and dividends and prepayments of junior indebtedness, engage in transactions with affiliates, enter into restrictive agreements, amend documentation governing junior indebtedness, modify its fiscal year and modify its organizational documents, in each case, subject to customary exceptions, thresholds, qualifications and &#8220;baskets.&#8221; In addition, the Credit Agreement contains financial performance covenants, which require the Company to maintain (i)&#160;a maximum total net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than 5.00 to 1.00, which steps down to&#160;4.50 to 1.00 beginning with the fiscal quarter ending July&#160;31, 2021 (subject to a customary &#8220;acquisition holiday&#8221; provision that allows the maximum total net leverage ratio to increase to 5.00 to 1.00 for the four fiscal quarter period ending on or following the date of a permitted acquisition by the Company in excess of $100.0 million), and (ii)&#160;a minimum interest coverage ratio, measured as of the last day of each fiscal quarter, of no less than 3.00 to 1.00. The Company was in compliance with all covenants under the Credit Agreement as of October&#160;31, 2020, and for the period then ended.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of HealthEquity under the Credit Agreement are required to be unconditionally guaranteed by WageWorks and each of the Company's subsequently acquired or organized direct and indirect domestic subsidiaries and are secured by security interests in substantially all assets of HealthEquity and the guarantors, in each case, subject to certain customary exceptions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658917408200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based compensation</a></td>
<td class="text">Stock-based compensation<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock award plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Plan.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants stock options, restricted stock units ("RSUs"), and restricted stock awards ("RSAs") under the HealthEquity, Inc. 2014 Equity Incentive Plan (as amended and restated, the "Incentive Plan"), which provided for the issuance of stock awards to the directors and team members of the Company to purchase up to an aggregate of&#160;2.6 million&#160;shares of common stock.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Incentive Plan, the number of shares of common stock reserved for issuance under the Incentive Plan automatically increases on February 1 of each year, beginning as of&#160;February&#160;1, 2015&#160;and continuing through and including&#160;February&#160;1, 2024, by&#160;3%&#160;of the total number of shares of the Company&#8217;s capital stock outstanding on January 31 of the preceding fiscal year, or a lesser number of shares determined by the board of directors. As of October&#160;31, 2020, 6.4 million shares were available for grant under the Incentive Plan.</span></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">WageWorks Incentive Plan.    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Acquisition, and in accordance with the merger agreement related to the Acquisition, certain RSUs with respect to WageWorks common stock, granted under WageWorks, Inc. 2010 Equity Incentive Plan (the "WageWorks Incentive Plan"), were replaced by the Company and converted into RSUs with respect to 0.5 million shares of common stock of the Company. No additional shares were issued under the WageWorks Incentive Plan, and the period during which the remaining 5.3 million shares were available to be utilized expired on May 26, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock options</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity is as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="27" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding stock options</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for exercise prices and term)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>contractual<br/>term<br/>(in&#160;years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic<br/>value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.10&#160;- 82.39</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.90</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$66.06</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.10&#160;- 44.53</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$25.45&#160;- 44.53</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.25&#160;- 82.39</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and expected to vest as of October 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercisable as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.70</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,025&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted stock units and restricted stock awards</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and RSA activity is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSUs and PRSUs</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs and PRSAs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except weighted-average grant date fair value)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance restricted stock units and awards.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    In March 2018, the Company awarded 227,760 performance-based RSAs ("PRSAs"). The Company records stock-based compensation related to PRSAs when it is considered probable that the performance conditions will be met. The underlying shares were issued at 200% of the target level of achievement at the grant date. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to two-thirds of the awards to be achieved at 100% and creating a new performance condition related to the remaining one-third of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance condition is based on the achievement of certain financial criteria measured on January 31, 2021. The modification affected 10 team members and did not result in an adjustment to stock-based compensation expense. The PRSAs cliff vest upon approval by the Compensation Committee. The modified performance condition for the one-third tranche allows for a range of vesting from 0% to 200% based on the level of achievement of the performance condition, and the Company believes it is probable that the PRSAs will vest at least in part. As the underlying shares were issued at grant date, they are subject to clawback based on actual Company performance.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company awarded 129,963 PRSUs. The Company records stock-based compensation related to PRSUs when it is considered probable that the performance conditions will be met. In March 2020, the Compensation Committee modified the awards by deeming the performance condition related to one-third of the awards to be achieved at 100% and creating new performance conditions related to the remaining two-thirds of the awards to reflect the state of the Company after the Acquisition of WageWorks. The new performance conditions are based on the achievement of certain financial criteria measured on January 31, 2021 and 2022. The modification affected 12 team members and resulted in incremental stock-based compensation expense of $6.6&#160;million, which will be recognized over the remaining service period, adjusted for the level of achievement of the performance conditions and any forfeitures. Prior to the modification, the Company did not believe the PRSUs were likely to vest, and as a result, $2.9&#160;million of previously recorded stock-based compensation expense was reversed during the three months ended April 30, 2020. The PRSUs cliff vest upon approval by the Compensation Committee. The modified performance conditions for the two-thirds tranche allow for a range of vesting from 0% to 200% based on the level of achievement of the new performance conditions, and the Company believes it is probable that the PRSUs will vest at least in part.</span></div>During the first and second quarters of fiscal 2021, the Company awarded 277,950 PRSUs subject to a market condition based on the Company&#8217;s total shareholder return ("TSR") relative to the Russell 2000 index as measured on January 31, 2023. The Company used a Monte Carlo simulation to determine that the grant date fair value of the awards was approximately $20.8 million. Compensation expense is recorded if the service condition is met regardless of whether the market condition is satisfied. The market condition allows for a range of vesting from 0% to 200% based on the level of performance achieved. The PRSUs cliff vest upon approval by the Compensation Committee.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919085800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value</a></td>
<td class="text"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Fair value</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the following fair value hierarchy:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;unobservable inputs based on the Company&#8217;s own assumptions.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of cash and cash equivalents. The carrying value of cash and cash equivalents approximate fair values as of&#160;October&#160;31, 2020&#160;due to the short-term nature of these instruments.&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt is considered a Level 2 instrument and is recorded at book value in our condensed consolidated financial statements. Our long-term debt reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, we believe the fair value of our long-term debt approximates carrying value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658914678776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of business and significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of consolidation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">Basis of presentation The accompanying condensed consolidated financial statements as of October&#160;31, 2020 and for the three and nine months ended October&#160;31, 2020 and 2019 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January&#160;31, 2020.  The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Certain reclassifications have been made to&#160;prior year amounts&#160;to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent adopted accounting pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently adopted accounting pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires financial assets measured at amortized cost be presented at the net amount expected to be collected. This ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020 using the modified retrospective transition method. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;ASU 2018-13&#8221;), which amends ASC 820, "Fair Value Measurement." ASU 2018-13 modifies the disclosure requirements for fair value measurements by removing, modifying and adding certain disclosures. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. The Company adopted the new standard as of February 1, 2020. The adoption of this standard did not have a material effect on the Company&#8217;s condensed consolidated financial statements.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. The Company adopted the new standard as of February 1, 2020. </span><span style="color:#212529;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company retrospectively adopted the provision related to the classification of taxes partially based on income, and prospectively adopted the provisions related to intraperiod tax allocation and interim recognition of enactment of tax laws. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The adoption of this standard did not have a material effect on the Company&#8217;s current- or prior-period condensed consolidated financial statements.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurement</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are made at a specific point in time, based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company&#8217;s market assumptions. These two types of inputs have created the following fair value hierarchy:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;unobservable inputs based on the Company&#8217;s own assumptions.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 instruments are valued based on publicly available daily net asset values. Level 1 instruments consist primarily of cash and cash equivalents. The carrying value of cash and cash equivalents approximate fair values as of&#160;October&#160;31, 2020&#160;due to the short-term nature of these instruments.&#160;</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt is considered a Level 2 instrument and is recorded at book value in our condensed consolidated financial statements. Our long-term debt reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, we believe the fair value of our long-term debt approximates carrying value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658918756664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income (loss) per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings (loss) per share, basic and diluted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income (loss) per share: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Numerator (basic and diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,334)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (basic):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denominator (diluted):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77,845&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,524&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.30)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658918764744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Preliminary Allocation of Consideration</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's allocation of the consideration paid in the Acquisition:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Initial Allocation</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Updated Allocation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">406.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,330.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,322.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client-held funds obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(237.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(220.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(69.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(72.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(128.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(122.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total consideration paid</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented below include the effects of the Acquisition as if it had been consummated as of February 1, 2018, with adjustments to give effect to pro forma events that are directly attributable to the Acquisition, which include adjustments related to the amortization of acquired intangible assets, interest income and expense, and depreciation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results do not reflect any operating efficiencies or potential cost savings from the integration of WageWorks. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the Acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations. The estimated pro forma revenue and net income (loss) include the alignment of accounting policies, the effect of fair value adjustments related to the&#160;Acquisition, associated tax effects and the impact of the borrowings to finance the&#160;Acquisition and related expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31, 2019</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194,450&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,286)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658917416888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58,907&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,757)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,774&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,486&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease cost</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease costs were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,515&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net operating lease expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,266&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company's operating leases was as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets obtained in exchange for new operating lease obligations</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,394&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Other income (expense), net</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32,932)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(40,712)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30,949)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,347)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140659005514792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of finite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired HSA portfolios</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">947,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(172,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98,851)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total amortizable intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">780,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in process software development costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">776,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of indefinite-lived intangible assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October&#160;31, 2020 and January&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and software development costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired HSA portfolios</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">601,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortizable intangible assets, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">947,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(172,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(98,851)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total amortizable intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">780,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquired in process software development costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">776,311&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">783,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919160008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;31, 2020, long-term debt consisted of the following:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">October 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Term loan facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,018.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: unamortized loan issuance costs (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of issuance costs</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,001.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(1) In addition to the $17.7&#160;million of unamortized issuance costs related to the term loan facility, $5.3&#160;million of unamortized issuance costs related to our revolving credit facility are included within other assets on the October&#160;31, 2020 condensed consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans made under the Term Loan Facility are required to be repaid as described in the following table:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal year ending January 31, (in millions)</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal payments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Remaining 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025 (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">768.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,018.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The amount required to be repaid in 2025 reflects the $200.0&#160;million prepayment made in July 2020 with proceeds from the follow-on offering.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658918739704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Oct. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of share based compensation recognized</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended October 31,</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended October 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Technology and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,479&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,313&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity is as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="27" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding stock options</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for exercise prices and term)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>options</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range of<br/>exercise<br/>prices</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>exercise<br/>price</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>average<br/>contractual<br/>term<br/>(in&#160;years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>intrinsic<br/>value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,040&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.10&#160;- 82.39</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.90</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$66.06</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$0.10&#160;- 44.53</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$25.45&#160;- 44.53</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$1.25&#160;- 82.39</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested and expected to vest as of October 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercisable as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.55&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.70</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,025&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of restricted stock unit activity</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and RSA activity is as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSUs and PRSUs</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:2pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">RSAs and PRSAs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except weighted-average grant date fair value)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average grant date fair value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of January 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(262)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outstanding as of October 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658922578648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of business and significant accounting policies (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,438<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember', window );">Term Loan Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember', window );">Follow on equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock, shares (in shares)</a></td>
<td class="nump">5,290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price per share (in usd per share)</a></td>
<td class="nump">$ 56.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds from follow on offering</a></td>
<td class="nump">$ 286,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Underwriting discounts and commissions</a></td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_StockIssuanceCostsPayable', window );">Other offering expenses payable</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember', window );">Follow on equity offering | Term Loan Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_StockIssuanceCostsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_StockIssuanceCostsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658922737528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net income (loss) per share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator (basic and diluted):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,789<span></span>
</td>
<td class="num">$ (21,334)<span></span>
</td>
<td class="nump">$ 3,467<span></span>
</td>
<td class="nump">$ 39,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator (basic):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">76,701<span></span>
</td>
<td class="nump">70,524<span></span>
</td>
<td class="nump">73,358<span></span>
</td>
<td class="nump">65,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator (diluted):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">76,701<span></span>
</td>
<td class="nump">70,524<span></span>
</td>
<td class="nump">73,358<span></span>
</td>
<td class="nump">65,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted-average dilutive effect of stock options and restricted stock units (in shares)</a></td>
<td class="nump">1,144<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">1,423<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">77,845<span></span>
</td>
<td class="nump">70,524<span></span>
</td>
<td class="nump">74,665<span></span>
</td>
<td class="nump">67,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.30)<span></span>
</td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919099656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business combination (Narrative) (Details) - Wage Works Inc.<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Merger related costs, price per share | $ / shares</a></td>
<td class="nump">$ 51.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate fair value of WageWorks stock acquired</a></td>
<td class="nump">$ 2,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">816.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Borrowing pursuant to term loan facility</a></td>
<td class="nump">1,220.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember', window );">Line of Credit | Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">$ 30.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658999480728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combination (Preliminary Allocation of Consideration) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">14 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Aug. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,326,793<span></span>
</td>
<td class="nump">$ 1,326,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,326,793<span></span>
</td>
<td class="nump">$ 1,332,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, adjustments</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">5,838<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember', window );">Wage Works Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">392,300<span></span>
</td>
<td class="nump">392,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="nump">59,000<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets', window );">Other current assets, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">26,600<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">42,500<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">715,300<span></span>
</td>
<td class="nump">715,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,322,100<span></span>
</td>
<td class="nump">1,322,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,322,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,330,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">5,900<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation', window );">Client-held funds obligation</a></td>
<td class="num">(220,300)<span></span>
</td>
<td class="num">(220,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(220,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(237,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation', window );">Client-held funds obligation, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="num">(72,400)<span></span>
</td>
<td class="num">(72,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther', window );">Other current liabilities, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="num">(26,700)<span></span>
</td>
<td class="num">(26,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(122,200)<span></span>
</td>
<td class="num">(122,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(122,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(128,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes', window );">Deferred tax liability, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total consideration paid</a></td>
<td class="nump">$ 2,122,100<span></span>
</td>
<td class="nump">$ 2,122,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,122,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total consideration paid, adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Client Held Funds Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustment, Current Liabilities, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Client Held Funds Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658916077688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combination (Pro Forma Results) (Details) - WageWorks, Inc - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 194,450<span></span>
</td>
<td class="nump">$ 598,815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (3,286)<span></span>
</td>
<td class="nump">$ 34,559<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hqy_WageWorksInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658915943752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental financial statement information (Property and equipment) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 58,907<span></span>
</td>
<td class="nump">$ 49,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(27,133)<span></span>
</td>
<td class="num">(15,757)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">31,774<span></span>
</td>
<td class="nump">33,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">22,310<span></span>
</td>
<td class="nump">19,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">9,219<span></span>
</td>
<td class="nump">7,929<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 27,378<span></span>
</td>
<td class="nump">$ 22,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923690120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement', window );">Deferred revenue interchange arrangement recognition term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognition</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ContractWithCustomerRecognitionTermInterchangeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Recognition Term, Interchange Arrangement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ContractWithCustomerRecognitionTermInterchangeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658916059544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information (Lease Cost) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 3,777<span></span>
</td>
<td class="nump">$ 3,354<span></span>
</td>
<td class="nump">$ 12,297<span></span>
</td>
<td class="nump">$ 5,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(450)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(1,349)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net operating lease expense</a></td>
<td class="nump">$ 3,327<span></span>
</td>
<td class="nump">$ 3,105<span></span>
</td>
<td class="nump">$ 10,948<span></span>
</td>
<td class="nump">$ 5,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658919009752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information (Supplemental Cash Flow Information) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 9,739<span></span>
</td>
<td class="nump">$ 4,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for new operating lease obligations</a></td>
<td class="nump">$ 17,480<span></span>
</td>
<td class="nump">$ 34,394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658922548776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental financial statement information (Other income (expense), net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Interest income</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="nump">$ 850<span></span>
</td>
<td class="nump">$ 5,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Gain on equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">27,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition costs</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(32,932)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(40,712)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="num">(582)<span></span>
</td>
<td class="num">(348)<span></span>
</td>
<td class="num">(2,780)<span></span>
</td>
<td class="num">(478)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">$ (421)<span></span>
</td>
<td class="num">$ (30,949)<span></span>
</td>
<td class="num">$ (2,009)<span></span>
</td>
<td class="num">$ (8,347)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658998857688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible assets and goodwill (Schedule of intangible assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">$ 947,971<span></span>
</td>
<td class="nump">$ 879,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(172,276)<span></span>
</td>
<td class="num">(98,851)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortizable intangible assets, net</a></td>
<td class="nump">775,695<span></span>
</td>
<td class="nump">780,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">776,311<span></span>
</td>
<td class="nump">783,279<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Acquired in process software development costs</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">116,206<span></span>
</td>
<td class="nump">76,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember', window );">Acquired HSA portfolios</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">121,159<span></span>
</td>
<td class="nump">92,770<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Acquired customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">601,381<span></span>
</td>
<td class="nump">601,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Acquired developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">96,925<span></span>
</td>
<td class="nump">96,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Acquired trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortizable intangible assets, gross</a></td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hqy_AcquiredHSAIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658914707592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost', window );">Software development costs incurred and expensed</a></td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 31,100<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">25,300<span></span>
</td>
<td class="nump">$ 15,700<span></span>
</td>
<td class="nump">73,500<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, adjustments</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,838<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658999611624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 06, 2018 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Jun. 22, 2018 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,438<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_LossContingencyNumberOfLawsuits', window );">Number of derivative lawsuits | lawsuit</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember', window );">Term Loan Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_LossContingencyNumberOfLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number Of Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_LossContingencyNumberOfLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658999283560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 2,340<span></span>
</td>
<td class="num">$ (9,918)<span></span>
</td>
<td class="nump">$ 2,015<span></span>
</td>
<td class="nump">$ 3,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">56.70%<span></span>
</td>
<td class="num">(31.70%)<span></span>
</td>
<td class="nump">36.80%<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Effective tax rate, primarily due to excess tax benefit on stock-based compensation expense (benefit)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(9.60%)<span></span>
</td>
<td class="num">(8.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_UnrecognizedTaxBenefitNet', window );">Unrecognized tax benefit</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact the effective tax rate</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_UnrecognizedTaxBenefitNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefit, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_UnrecognizedTaxBenefitNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658915702232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness Schedule of Long-term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Term loan facility</a></td>
<td class="nump">$ 1,018.8<span></span>
</td>
<td class="nump">$ 1,018.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized loan issuance costs</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net of issuance costs</a></td>
<td class="nump">$ 1,001.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923240232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 30, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized loan issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.65%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Effective interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.18%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio', window );">Acquisition threshold for maximum total net leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio', window );">Minimum interest coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodTwoMember', window );">Debt covenant, beginning July 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtInstrumentCovenantDescriptionLeverageRatio', window );">Maximum leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodThreeMember', window );">Debt covenant, beginning July 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtInstrumentCovenantDescriptionLeverageRatio', window );">Maximum leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodFourMember', window );">Debt covenant, acquisition holiday provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_DebtInstrumentCovenantDescriptionLeverageRatio', window );">Maximum leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate borrowing spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate borrowing spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Customary Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate borrowing spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Customary Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate borrowing spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Secured Revolving Credit Facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Secured Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hqy_CreditAgreementMember', window );">Credit Agreement | Secured Debt | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hqy_CreditAgreementMember', window );">Credit Agreement | Secured Debt | Term Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility, amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hqy_CreditAgreementMember', window );">Credit Agreement | Line of Credit | Secured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility, amount</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized loan issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Description, Acquisition Threshold For Maximum Total Net Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Description, Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtInstrumentCovenantDescriptionLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Description, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtInstrumentCovenantDescriptionLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_DebtCovenantPeriodAxis=hqy_DebtCovenantPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hqy_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hqy_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=hqy_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658922904328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness Schedule of Maturities of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remaining 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">768,800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,018,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,018,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,438<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember', window );">Follow on equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Principal payments on long-term debt</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=hqy_FollowOnEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923523032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Summary of share based compensation recognized) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 11,479<span></span>
</td>
<td class="nump">$ 23,156<span></span>
</td>
<td class="nump">$ 30,313<span></span>
</td>
<td class="nump">$ 36,774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,209<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
<td class="nump">5,737<span></span>
</td>
<td class="nump">3,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=hqy_SalesandMarketingMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,035<span></span>
</td>
<td class="nump">1,304<span></span>
</td>
<td class="nump">4,810<span></span>
</td>
<td class="nump">3,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=hqy_TechnologyandDevelopmentMember', window );">Technology and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,641<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
<td class="nump">8,051<span></span>
</td>
<td class="nump">5,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,594<span></span>
</td>
<td class="nump">3,332<span></span>
</td>
<td class="nump">11,715<span></span>
</td>
<td class="nump">9,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=hqy_MergerIntegrationMember', window );">Merger Integration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,714<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hqy_SalesandMarketingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hqy_SalesandMarketingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hqy_TechnologyandDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hqy_TechnologyandDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hqy_MergerIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hqy_MergerIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658999271032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Performance units awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,220,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockAwardsMember', window );">Performance restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Performance units awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio', window );">Fraction of awards fully achieved</a></td>
<td class="nump">66.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio', window );">Fraction of awards modified</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers', window );">Number of team members modification affected | member</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockAwardsMember', window );">Performance restricted stock awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockAwardsMember', window );">Performance restricted stock awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockUnitsMember', window );">Performance restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Performance units awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio', window );">Fraction of awards fully achieved</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio', window );">Fraction of awards modified</a></td>
<td class="nump">66.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers', window );">Number of team members modification affected | member</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental compensation cost | $</a></td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms', window );">Share-based payment arrangement, decrease in expense due to modification of terms | $</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Wage Works Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of service-based common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hqy_IncentivePlanMember', window );">Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage', window );">Percentage of capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under incentive plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hqy_WageWorksIncentivePlanMember', window );">WageWorks Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of common stock issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fully Achieved, Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Remaining Modified, Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Decrease In Expense Due To Modification Of Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Plan Modification, Incremental Cost, Number Of Team Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Available for Grants, Percentage of Capital Stock Outstanding, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hqy_PerformanceRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hqy_WageWorksIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hqy_IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hqy_IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hqy_WageWorksIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hqy_WageWorksIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923683160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Stock option activity) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of options (shares)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Opening balance (shares)</a></td>
<td class="nump">2,040<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest as of year end (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable as of year end (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract', window );"><strong>Range of exercise prices (usd per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding', window );">Beginning balance, minimum (usd per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding', window );">Beginning balance, maximum (usd per share)</a></td>
<td class="nump">82.39<span></span>
</td>
<td class="nump">82.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted', window );">Granted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised', window );">Exercised, minimum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised', window );">Exercised, maximum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited', window );">Forfeited, minimum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited', window );">Forfeited, maximum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding', window );">Ending balance, minimum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding', window );">Ending balance, maximum (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- average exercise price (usd per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Opening balance (usd per share)</a></td>
<td class="nump">$ 30.35<span></span>
</td>
<td class="nump">30.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest as of year end, weighted average exercise price (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable as of year end, weighted-average exercise price (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding stock options, weighted average contractual term (in years)</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest as of year end, weighted average contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable as of year end, weighted-average contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Beginning balance, outstanding stock options, aggregate intrinsic value</a></td>
<td class="nump">$ 74,009<span></span>
</td>
<td class="nump">$ 74,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Ending balance, outstanding stock options, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Vested and expected to vest as of year end, aggregate intrinsic value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable as of year end, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Forfeited</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Forfeited</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Shares Authorized Under Stock Option Plans, Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hqy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140658923740296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Restricted stock unity activity) (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares) | shares</a></td>
<td class="nump">1,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(446)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, ending balance (in shares) | shares</a></td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, beginning balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 63.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">56.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">54.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">66.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, ending balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 60.51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares) | shares</a></td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, ending balance (in shares) | shares</a></td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, beginning balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 61.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">74.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">62.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">62.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, ending balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 62.66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MEO",\? GL6T3VBT+_X1CYTFR4ST;3=)?HV6L)/2[OQ')3B[9224[%R3OA)/
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M?@#NKX10QQ/]@GS[=_@O4$L#!!0    ( *& B5%CFSEK@P8  *X:   8
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M\,TDL4]UH,K*Z"?NG?%HD-AMD,^21&RZ%_%#;=<LCZ$.&>X]#+I-SBF'=BW
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M1<-<<S"V7>NV:GD_WQ"Z3J]6S\>.<1CE64(GJQ-<R80K"8[_MOH_A/(83U+
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MV0.T7TEI#A.K8'RJK?X&4$L#!!0    ( *& B5'2TI,U*P<  +L0   8
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&ULI5A;<]LV%OXK&*UG5YJA*9&2;"EK
M>\9VV]T\Y#)IVCSL[ -(@B(:$F  T++[Z_L=@*)I6W4ZTX=8!'!PSG?N![G8
M:_/55D(X=M_4REY.*N?:-_.YS2O1<!OK5BB<E-HTW&%I=G/;&L$+?ZFIY^EB
M<39ON%23JPN_]]%<7>C.U5*)CX;9KFFX>;@1M=Y?3I+)8>.3W%6.-N97%RW?
MB9^%^Z7]:+":#UP*V0AEI5;,B/)R<IV\N5D1O2?X58J]'7TSTB33^BLMWA:7
MDP4!$K7('7'@^+D3MZ*NB1%@?.MY3@:1=''\?>#^D]<=NF3<BEM=?Y&%JRXG
MFPDK1,F[VGW2^_^*7I\U\<MU;?U?M@^TR^6$Y9UUNNDO T$C5?CE][T=1A<V
MBS^YD/874H\["/(H?^".7UT8O6>&J,&-/KRJ_C; 245.^=D9G$K<<U<WG<6.
MM2S73285)U-=S!TXT_D\[[G<!"[IGW#9LG=:N<JR'U4ABJ?WYT TP$H/L&[2
M5QE^R%W,EDG$TD6Z>(7?<E!SZ?DMOZ?F[:.:EOWO.K/.(##^_XJ(U2!BY46L
M_J8E7^5".?C&MCP7EQ,DF17F3DR.LF;7^;=.6NF_=<F^((6^4"JS#SCK=@@=
MMER0 9-MQ%PE2/66JP>6U]J*PF_Q$8\I;4Q&7">S)WPC]E;E,9M.AAT0H"JP
MDW42+]>L%<CUBAO!I&(YMU7$<,C;UNA[B?01]0,[2>,%RV1=DT"G1Z 1Z/G7
M2M>%,#9FGT=P2RBL\AXPO*4L#PGM*J.[7<7X$[, \LDF.8NWR)8@A[ P_%9<
M%:RM.\L4BEVF#1PLU<[2E6<PDSA-#S@CQDL'W1#8'02K':L%HMRP4HAC=Y>+
M>'V0';'.DW(&#@VK-5>LY+FLI7L(6HZ]N.<6'LEUIQS4)=.&V\\]U0A7Z<*+
M#M0$BLBS(W$":][BKP2C8*"6RR*(JFN=<Q(%3WCC<K6360UA,)14CTMKA;,!
M@@$Y'=>29Z2&A UPWC78I^I8,.\9(6$?CC]WO.X\"<%USQ0N(#V802KL\/J
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M1M:XUY\$#:]]$+824@3E&E%;:40E"UWKL)\*X("3Q$;4"FD@[++6*TFIY07
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M5O@2(A<%\+ZT-FP>HH/NV^KZ7U!+ P04    " "A@(E18\*C)K<(   V%@
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M(Q3^_83PXU[X,0L__B^Q^\]WB^L@W$+ >C=7O@=@+(RSR^=1^4;08E$Y9$/
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M E$N%IJN0I1#E%66Z@$]5.Y6H:S&';+N)U-;832"?B<M!/53RY"26,Y3".2
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M&[T !X-PUA_?8.96BVN)GK7JDKGKH!Z*Z(X;]ZY4D\3@U:V]^YYVCG-61:\
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MX>(V!D/8I5C4'B^]%]+DPNN5T4N=21/@N<S6)FBS$I4M=*:5%T]NTJ>GY^,
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M<8= K<'G+$9GGT?^C&0BW2_))HK[N4:) />?1$KK^IQYMPLT;7)0IA>7%O]
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M_*R*@Y-&29FT<]^!)C\Z8?J>.9P./\YUWVB_B???U4>F=IQ>M,8MJ8;C//-
M]5] OS&R=6UW(PTU<;>LZ-=$907H?BNE.6ZL@>$?7OT'4$L#!!0    ( *&
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M6];<B2NCOLC,%^>]18]E(N>U\A_-]B_1VA, ID:Y\)]M&]KIM,?2VGE3MLQ
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M1,L"=%\;X_<;-C \N,OO4$L#!!0    ( *& B5%8"PF/( 4  '<,   9
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M:@'@WV\H96\WQ0;-_S06_P)02P,$%     @ H8")49O48^=N @  \04  !D
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M7TO<R:"= ;XOE+);P05HMWSV&U!+ P04    " "A@(E1^\ +"A4#  !@"@
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MB7HN9@)V=F,EH3EADG*&!%D.K3OW=AIIO %\H60MM]9(*UEP_J(W[Y.AY>B
M2$9BI2U@>+R2,<DR;0C"^%';M!J7FKB]WEA_,-I!RP)+,N;95YJH=&C=6"@A
M2UQFZHFOWY%:3ZCMQ3R3YA>M:ZQCH;B4BN<U&2+(*:N>^*W.PQ8!['03O)K@
MM0G! 8)?$_Q3/00U(3C50U@3C'2[TFX2-\$*CP:"KY'0:+"F%R;[A@WYHDSW
MR5P)>$N!IT;SLB@R H57.$-+RC"+*:RDPLJ<(LJJ9M15/?] H"9HS*6Z0.<3
MHC#-Y 6Z0L_S"3H_NT!G $>?4UY*S!(YL!5$J/W8<1W-?16-=R :'SURIE*)
MIBPA20=_<IS?/\*W(3-->KQ->NZ]HP8_Q>H:^>XE\AS/Z8AG?#+=[7?)^3_O
MTW_VOI,,O^D5W]CS#]D3*\SH+],+E] %3/*,)E5K0+W13!"I&\D<\"5Z:-II
MOFDGB;[=+:02<#]\/Q)1T$04F(B"0Q$51( [MD*9Z4SR!O>G)%V-5QF*C"%]
M>;Z._%ZO-[!?MZO9 ?+#8!<TV0>YGM=OF9KNH\+0#1O0CMRPD1L>E3LO%Y5.
MRF*>=\JL#(1;;J^"T&G)[ !Y0;\ELP/D^FW4]"^F=F1&C<SHJ,R/,![YZ96-
M.HKFM2O; 7*=L"5Y'^0Z_>"F)7D?%7I1U))L;UW).1$K,PLEBGG)5/6/:TZ;
M<7MGIDSK_-Z]';L=YQ,8S]4T_6.^FNV/6*PHDY"X);ARKGM0'5'-RVJC>&$&
MPH(K&"]FF<(G!A$: .^7G*O-1CMH/EI&OP%02P,$%     @ H8")48Q)=Q2T
M @  <08  !D   !X;"]W;W)K<VAE971S+W-H965T,S(N>&ULC5513]LP$/XK
MIX@'D 9)DY92U%:",C0>T! =V[.;7!(+Q\YLA[)_O[.3AE):Q$OB.]]]_KX[
MYS)=*_UL2D0+KY609A:4UM:786C2$BMFSE2-DG9RI2MFR=1%:&J-+/-)E0CC
M*#H/*\9E,)]ZWX.>3U5C!9?XH,$T5<7TOVL4:CT+!L'&\<B+TCI'.)_6K, E
MVJ?Z09,5]B@9KU :KB1HS&?!U>!R,7+Q/N WQ[796H-3LE+JV1EWV2R('"$4
MF%J'P.CU@@L4P@$1C;\=9M ?Z1*WUQOT6Z^=M*R8P842?WAFRUEP$4"&.6N$
M?53K']CI\013)8Q_PKJ+C0)(&V-5U243@XK+]LU>NSIL)1#._H2X2XAW$X8'
M$I(N(?%"6V9>U@VS;#[5:@W:11.:6_C:^&Q2PZ7KXM)JVN649^?+IJX%4ELL
M$Y!SR63*:64LL]X+7+97Q=7\^%WT@ID2;ND:P-U;S D<WZ!E7)@3.(6GY0T<
M'YW $<' KU(UALG,3$-+S-WY8=JQO&Y9Q@=83N!>25L:^"XSS-[GAZ2XEQUO
M9%_'GP+^3.T9)(-O$$=QM(?/XLOI@\DG=)*^"XG'2P[@^5+6C&= A016J49:
M0S5+14-Z7?%LB5 A,XUNVZ)R$&0B",Y67'#+T5Q^PF38,QEZ)L-#RFK4U$A9
M0.HXY=1> [E6%:A^QQ^\MXLM]KG'=O/C93X9)U2@E^W2?@P:CL:C/N@=[5%/
M>_1%VFU5M/MZ3U5^VI#!C$$JIUK1O91M.?$U+9DLT-=;TK#944?!@A?^1N\5
M.OJ@83 >7D0[2C]&)<-D,MR1&FY]O17JP@\U ZF[!.V-[KW]W+SRXV+'?TWS
MM!U_;S#M,+YGNN#2D+:<(*.S,3'3[8!K#:MJ/R-6RM+$\<N2_@FH70#MYTK9
MC>$.Z/\R\_]02P,$%     @ H8")4<5@QO)B P  F H  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&ULI5;?3]LP$/Y7K(@'D(#\;E+45H*V;#R@H16V
MAVD/)KDVUA*[LQT*^^MG.VE64M.A[:6U+]]W=]_YXMQHP_@/40!(]%R55(R=
M0LKUA>N*K( *BW.V!JJ>+!FOL%1;OG+%F@/.#:DJW<#S!FZ%"74F(V.[XY,1
MJV5)*-QQ).JJPOSE"DJV&3N^LS5\)JM":H,[&:WQ"A8@']9W7.W<SDM.*J""
M,(HX+,?.I7\Q3S7> +X0V(B=-=)*'AG[H3<W^=CQ=$)00B:U!ZS^GF *9:D=
MJ31^MCZ=+J0F[JZWWJ^-=J7E$0N8LO(KR64Q=E('Y;#$=2D_L\U':/7$VE_&
M2F%^T:;%>@[*:B%9U9)5!A6AS3]^;NNP0U!^[(2@)01]0O0&(6P)X7LC1"TA
M>F^$N"48Z6ZCW11NAB6>C#C;(*[1RIM>F.H;MJH7H;I/%I*KIT3QY&11K]<E
MJ(.7N$1+0C'-B%H)B:6Q(D*;9M2G>OQ)%L"5*6,5H&-X5MTJX.0449 GZ'@&
M$I-2G* S]+"8H>.C$W2DP.B^8+7 -!<C5ZJ4=6 W:].[:M(+WD@O1+>,RD*@
M.<TAM_!GA_G# WQ7E:JK5["MUU5PT.&G3)ZCT#]%@1=XEGRF[Z;[0YN<_XL^
M_^?HKXH1=LT3&G_A6_[X"E/RRS3'*9HR*EA)\J97U'FC.PY"=Y8QL"6Z[OIK
ML>TO@;Y=/@K)U87Q_4!&49=19#**WLCHADI0067;H[:&:QP,C -]BSY-_"0:
MN4^[A[B/";QH\!HTVP>EL?<:,]_'Q$$2=J!7&N-.8WQ0XP=U^R-54/A9$_F"
M!&0U)Y* ]?5J7,4["?12G.XC@C3N2?VKE[G%2Q(GGEWIH%,Z.*CT,E,2!3'M
MDS$AK0H'>Y'/_+"GT8()@V$8]&1:8,FP)]2"B;S$#^Q*DTYI<E!I<[&V%ZI-
M9;(?-DY[^4\MH#!*>R(MH"!)^^=I045):A>9=B+3@R+OF?[(L%VIYM-ATYON
MO3AG4>#W]%I H3>,>D<VL\#4&-4_6 LJ#:.D)]G=^=16P%=FQA&J.VLJFXNS
MLW9CU*69'GKV*_]BZEOL,S5V-5/2'_?-S':+^8I0@4I8JE#>>:).AS=S4+.1
M;&T^](],JK'!+ LU.@+7 /5\R9C<;G2 ;AB=_ 902P,$%     @ H8")4;M[
M_]44!   ?Q   !D   !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULO5A;;]LV
M&/TKA-"'!$@BD;)NA6T@3=8U1=<%<;L]%'N@)=HB2HDJ2<7I?GVIBR79DF5C
M0_P2D])W.=_YR$,JTPT7WV5,B (O"4OES(B5RMZ:I@QCDF!YPS.2ZC<K+A*L
M]%2L39D)@J/2*6$FLBS73#!-C?FT?/8HYE.>*T93\BB S),$BY_O"..;F0&-
M[8,GNHY5\<"<3S.\)@NBOF:/0L_,)DI$$Y)*RE,@R&IFW,*W=\@I'$J+ORC9
MR,X8%*4L.?]>3!ZBF6$5B @CH2I"8/WS3.X(8T4DC>-''=1H<A:.W?$V^ONR
M>%W,$DMRQ]G?-%+QS/ -$)$5SIEZXIL/I"ZH!!AR)LN_8%/;6@8(<ZEX4CMK
M! E-JU_\4A/1<8"3 PZH=D"G.MBU@UT66B$KR[K'"L^G@F^ **QUM&)0<E-Z
MZVIH6K1QH81^2[6?FC^D"J=KNF0$8"F)D@"G$5AS'FTH8^!BH==-E.NW? 7H
MONTEN+@G"E.F1]?@Z^(>7+RY!&^T(?@2\USJ4')J*@VS2&:&-:1W%21T -*?
MH;H!-KP"R$+6@/O=N/M'G!YR-S4Y#4.H80B5\>P#\=[3E"IR_4FOM@ATZ+JM
MZ/KV2=N#!T42^<](-KO)9I?9)@>RW29<*/HO+C+T^+X":\'E(*555+>,6FS=
MYWDP\0(/3LWG+G5],]\+G,!KS'9 3QK0DW'089@G.<-*,X3K HI-.@2TBN1T
M$%Q##R'/W4,Z8!?XO@.'D3H-4F<4Z1>N,&LP'B Y)6H(N=-#Y'F.&SA[P ?,
M?,N;N,/ W0:X.[H*>POO"GS6(G_QVTO(\HBF:_![O6<OP;?;I51""^38@O2:
MQ-X)C)W.DC? DFO#_84X8.;;R N&6?(;L/XHV(<4/ H>$BG!$Y$$BS N]>R>
M/.L#*]/'CQJA)&BR!$=ZH<^)2A78_U,%:+4R;1W98C]R*G0NK:U97:+D*[7!
M@NACJRD/A%RJ8=&U>I2[<'_7#1@AQ[:'NP([APP<1;_8(BV:<2KLW5RM7,-S
MZ#5L!1N^CF+78;M40^@BJ]>2OIWG(G1 "&&KV?"8:-<KZL/B%F2ZAA5GE(_V
MH%59Z)RC!ZTX0O=U>N#V>X @=(+]'O3M N1YUH$>M-H*Q\6UZ4%UTR-"WXQ9
M>73*F&:CO6@E$?KGZ$4KCC!XG5X$?7VRH.WOGQS'[7:O>:W$HA,EMM8E/5(D
MC%/.^/KGV$6RE4$$S] *U+FYHE=I11UV9[F[ =J_Z1PUVX7=*BHZHJC;1NA+
M3$1 BA,RMA50*WEH<@[^6QE$X[?-_\R_T[NF0V1;UC[_Q\PJV&;GZ[#X-/\#
MBS5-)6!DI?VL&T^'$=77;C51/"L_&)=<:5$JAS'1G1"%@7Z_XEQM)\4W:/,_
MA_DO4$L#!!0    ( *& B5%B:GS#\ (  (H(   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;*5637/:,!#]*QI/#\E,&G]A0S+ # 3:YI V$YKVT.E!
MV *KD24JR3CMK^]*-B[!ALFT%[#D?>_IK=>['I9"/JF,$(V><\;5R,FTWER[
MKDHRDF-U*3:$PYV5D#G6L)1K5VTDP:D%Y<P-/"]V<TRY,Q[:O7LY'HI",\K)
MO42JR',L?TT)$^7(\9W=Q@-=9]ILN./A!J_)@NC'S;V$E=NPI#0G7%'!D22K
MD3/QK^>QB;<!7R@IU=XU,DZ60CR9Q6TZ<CQS(,)(H@T#AK\MN2&,&2(XQL^:
MTVDD#7#_>L?^SGH'+TNLR(U@7VFJLY$S<%!*5KA@^D&4'TCM)S)\B6#*_J*R
MBNU#<%(H+?(:#"?(*:_^\7.=AST \'0#@AH0' )Z1P!A#0A?J]"K ;W7*D0U
MP%IW*^\V<3.L\7@H18FDB08V<V&S;]&0+\I-G2RTA+L4<'I\RS7F:[ID!&&E
MB%8(\Q2MA4A+RA@Z^XBEQ.99GJ.S&=&8,G6.WJ+'Q0R=O3E';Q#EZ',F"@4P
M-70U',D0NTDM/ZWD@R/R(;H37&<*S7E*T@[\[#3^Z@3>A50T^0AV^9@&)PD_
M)?H2A?X%"KS ZSC/S:OA_E67G?]3G_^S^HMDA$UQA)8O/,+W?E<&IB;V*F52
M5<J,JH0)54B"ODV62DMXZ[^?D.TULCTKVSLBNQ K76)@3<D6&MD&VI)&B5 @
M27E22$E2>R+R#-U2=9;-M%*(K8+IE=NQ[T4>Y'2[_S#;47%P&#1K!X6^?Q@U
M[Q ,!WM1+S(1-9F(3F9BD@NIZ6]L>VIMM\MMQ1+MB0=1V'(;M8\8]5MVVUS]
ML)6Y>8=B&!^S&S=VXY-V=_5V@7#Z WJ?>?"=325N.0$?AT;:0=$@'!SX: <=
M>G#WFFM.Y-I.-07U6'!=O4K-;C,X)W9>'.Q/_>L;OV-_!H.VFHM_Z:LI?8?E
MFG*%&%F!E'?9AWS+:O)5"RTVMK4OA89!82\S^%@@T@3 _940>K<P LWGQ_@/
M4$L#!!0    ( *& B5$[9Y+BLP(  !,(   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;+56W6_:,!#_5ZRH#ZVTD9"0T%40:86B=>HV5-KM8=J#20ZP
MZH_,=D@K[8^?[:01K$!Y6'D@=G*_#]\=%P:5D ]J!:#1(Z-<#;V5UL6%[ZML
M!0RKCBB FR<+(1G69BN7OBHDX-R!&/7#($A\A@GWTH&[-Y7I0)2:$@Y3B53)
M&)9/ET!%-?2ZWO.-6[)<:7O#3P<%7L(,]'TQE6;GMRPY8< 5$1Q)6 R]C]V+
M2=_&NX#O!"JUL4;V)',A'NSF.A]Z@34$%#)M&;"YK&$$E%HB8^-WP^FUDA:X
MN7YFG[BSF[/,L8*1H#](KE=#[]Q#.2QP2?6MJ#Y!<Y[8\F6"*O>-JCHVCCV4
ME4H+UH"- T9X?<6/31XV &%W#R!L .&Q@*@!1,<">@V@=RP@;@#QL8"D 20N
M]W6R7*;'6.-T($6%I(TV;';ARN70)L&$V\:::6F>$H/3Z4@P1K3I%*T0YCG*
M!->$+X%G!!0Z'8/&A*HS=(((1W<K42H3I0:^-MJ6P<\:G<M:)]RC,X.B@X+D
M'0J#[CG%E2J)WL$R.LSRN>0=%(:OL8P/LWS+= =%7<L2!O>S,3H].=O!<O5?
M6"9'LW0_[&3Q347;LH9M64-'&^VAO1%*H=%6+7_>F!ATK8&I7P<4HE8A<@J]
M/0I320QO@2DJ\%/=/V904,&7[S5(9G[=\UVEN:I9$\=JI]XZ#<.H%YT/_/5F
MUEZ&!6W$EM]>Z[=WT._7DLU!(K$PSB198SO04--""OU!^[OILB:.-RUONQT=
MBMAR&[=NXX-N[VP*;P3F:((S0HE^,A9= <T!1A+R?YUNJ22M2O)&7=)O%?IO
MT27C_LLN">QG.^]7KX;5IOV-^6A?EU^P7!*N$(6% 0:=OBF&K%]!]4:+PHW,
MN=!F +OERKRU0=H \WPAA'[>V"G<_@](_P)02P,$%     @ H8")43:^Y\MX
M P  '@P  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULI5=MC^(V$/XK
M5G256.F6O)% 5H"T+&Q[E4Y=W=ZV'ZI^,,D UB8VM9V%ZZ_OV,GF8 E9VN,#
MQ)-YGO$S'MO#>"?DL]H :+(O<JXFSD;K[8WKJG0#!55]L06.;U9"%E3C4*Y=
MM95 ,PLJ<C?PO-@M*./.=&QM#W(Z%J7.&8<'2519%%1^FT$N=A/'=UX-7]AZ
MHXW!G8ZW= V/H)^V#Q)';L.2L0*X8H(3":N)<^O?W"?&WSK\SF"G#IZ)4;(4
MXMD,/F43QS,3@AQ2;1@H_KS '>2Y(<)I_%US.DU( SQ\?F6_M]I1RY(JN!/Y
M'RS3FXDS<D@&*UKF^HO8_0*UGLCPI2)7]IOL:E_/(6FIM"AJ,,Z@8+SZI?LZ
M#P< Y&D'!#4@> L8G &$-2"\-,*@!@PNC1#5@.A20%P#8IO[*EDVTW.JZ70L
MQ8Y(XXULYL$NET5C@ADWA?6H);YEB-/33SP5!1!-]Z!(;PZ:LEQ=D6OR]#@G
MO0]7Y -AG'S=B%)1GJFQJS&H@;II'6!6!0C.! C)9\'U1I$%SR!KP<^[\4D'
MWD6QC>+@5?$LZ"3\+=5]$OH?2> %7LM\[BZ&^TF;G!^+OOBQZ/?=\%\I/Q?]
M*)=A4SVAY0N[J^<KW9,Y4VDN5"F!_'F[5%KBF?%71XA!$V)@0PS>+5 ">SQ.
M%;358,416PYSEKY,@W" "E\.%_;4Z3I)_-&QU[R%RO.C8Z?%J5.8>-^9CI1&
MC=*H4^EBM0)[SEJQDNI6I=T<4=P?>C^U574WKA?Z!GC55M#=R##NCUHC+KIQ
MHW[R%G:4M;C)6OP?L_:1;"7#6Y+EWTA6HEU@Y:2@E/58 H<5TP1O-3Q<T^=K
M<R]E!(O,%!>UUUU=:*17.[>E9=8]K;COM:]#-ZSG]_TSR_ .,.G'[<#%.\!1
MR\(?K<2P68EA)]//4F".2RXA%6O._L&L'B2\]>H8GFPCW\//FQUYD=?]J5<R
M.' ZDC1J)(TZ)3V=$=.FI6**#N)')THN\+D?G>B(SLE(&AG)_Y*!.V)#-?9^
M99X15FSQR$8+$+CH)$I.$QZ<*'['J9+C'O0O!<BU[305[LF2Z^HR:JQ-,WMK
M>[@W]IE_<^>WV.?^S:+J5;_35YWS9RK7C"N2PPI#>?TA+HZLNM%JH,76=D]+
MH;$7LX\;;.!!&@=\OQ)"OPY,@.8OP?1?4$L#!!0    ( *& B5'6F 0)5P(
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M6M"CVGS"-AXO,%?"^"]L&M_1(("\-J2J%FP55%PV?_;:YF$'$!\")"T@^5]
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M<-HQ[Y#,>YY\HL727>I/0IL6P0T7ID\$:3>8YS,A]'IB!<K.<_@?4$L#!!0
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MB":JEW^8[?D+6[#_1Q'_!5!+ P04    " "A@(E1EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( *& B5&EI<!EN ,
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *& B5$<"8.V[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( *&
MB5&97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ H8")42W=ZP15!0  "A8  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( *&
MB5%CFSEK@P8  *X:   8              " @9@-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " "A@(E1998A\PL#  !1"@  &
M        @(%1%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ H8")4<YV&A;8!P  FB0  !@              ("!DA<  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( *& B5&W>KDS'@4  ) 8   8
M              " @: ?  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " "A@(E1JM_=FJP(   %)0  &               @('T)   >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ H8")4>W>>P\&"0
M91@  !@              ("!UBT  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( *& B5%##*,JJ@,  +8)   8              " @1(W
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "A@(E1TM*3
M-2L'  "[$   &               @('R.@  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ H8")43QPHY=P!@  D1   !D
M ("!4T(  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "A
M@(E1P9+-P3 $  "-"@  &0              @('Z2   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( *& B5$3 T1S=@L   T>   9
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M970Q-BYX;6Q02P$"% ,4    " "A@(E1+M[X>@T*  !8'   &0
M    @(%?=@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M *& B5$X7LH'2@,  ),'   9              " @:.   !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ H8")4>_X RZD!0  X P  !D
M             ("!)(0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " "A@(E1, #GW;D$  "5"P  &0              @('_B0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( *& B5&,[*QZ= ,
M .4*   9              " @>^.  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ H8")470?,KQ< P  ? <  !D              ("!
MFI(  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "A@(E1
M6 L)CR %  !W#   &0              @($ME@  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( *& B5$/44*N[P,  (4.   9
M      " @82;  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ H8")4<R5U!4(!   5@\  !D              ("!JI\  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "A@(E165LIL,P"   "!P
M&0              @('IHP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( *& B5$3ZB"E,@4  -\8   9              " @>RF  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ H8")49O48^=N
M @  \04  !D              ("!5:P  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " "A@(E1^\ +"A4#  !@"@  &0
M@('ZK@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( *&
MB5&;;.W\+0,  &T)   9              " @4:R  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ H8")48'F\Q[X @  P @  !D
M         ("!JK4  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " "A@(E1C$EW%+0"  !Q!@  &0              @('9N   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( *& B5'%8,;R8@,  )@*
M   9              " @<2[  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ H8")4;M[_]44!   ?Q   !D              ("!7;\
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "A@(E18FI\
MP_ "  "*"   &0              @(&HPP  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( *& B5$[9Y+BLP(  !,(   9
M  " @<_&  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MH8")43:^Y\MX P  '@P  !D              ("!N<D  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " "A@(E1UI@$"5<"  "5!0  &0
M            @(%HS0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( *& B5'2.'^&)04  '(9   9              " @?;/  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ H8")45H0D<,N P
MA0H  !D              ("!4M4  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " "A@(E1K\(F[1T$  "-$@  &0              @(&W
MV   >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( *& B5'Y
M(09PAP4  'L;   9              " @0O=  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ H8")48$.I9]*!0  [!@  !D
M     ("!R>(  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *& B5%''&"YI $  )L:   :
M          "  1OT  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *& B5$NTOC K@$  ,H:   3              "  ??U  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     T #0 (PX  -;W      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>150</ContextCount>
  <ElementCount>343</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>46</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed consolidated balance sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Condensedconsolidatedbalancesheets</Role>
      <ShortName>Condensed consolidated balance sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed consolidated balance sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical</Role>
      <ShortName>Condensed consolidated balance sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited</Role>
      <ShortName>Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed consolidated statements of stockholders' equity (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited</Role>
      <ShortName>Condensed consolidated statements of stockholders' equity (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed consolidated statements of cash flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited</Role>
      <ShortName>Condensed consolidated statements of cash flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of business and significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies</Role>
      <ShortName>Summary of business and significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Net income (loss) per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Netincomelosspershare</Role>
      <ShortName>Net income (loss) per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Business combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Businesscombination</Role>
      <ShortName>Business combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Supplemental financial statement information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Supplementalfinancialstatementinformation</Role>
      <ShortName>Supplemental financial statement information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - Intangible assets and goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Intangibleassetsandgoodwill</Role>
      <ShortName>Intangible assets and goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Commitmentsandcontingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2125107 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Incometaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - Indebtedness</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Indebtedness</Role>
      <ShortName>Indebtedness</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - Stock-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Stockbasedcompensation</Role>
      <ShortName>Stock-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - Fair value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/Fairvalue</Role>
      <ShortName>Fair value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of business and significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies</Role>
      <ShortName>Summary of business and significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Net income (loss) per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/NetincomelosspershareTables</Role>
      <ShortName>Net income (loss) per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Netincomelosspershare</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Business combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/BusinesscombinationTables</Role>
      <ShortName>Business combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Businesscombination</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Supplemental financial statement information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</Role>
      <ShortName>Supplemental financial statement information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Supplementalfinancialstatementinformation</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Intangible assets and goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IntangibleassetsandgoodwillTables</Role>
      <ShortName>Intangible assets and goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Intangibleassetsandgoodwill</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - Indebtedness (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IndebtednessTables</Role>
      <ShortName>Indebtedness (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Indebtedness</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Stock-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/StockbasedcompensationTables</Role>
      <ShortName>Stock-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthequity.com/role/Stockbasedcompensation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Summary of business and significant accounting policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails</Role>
      <ShortName>Summary of business and significant accounting policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Net income (loss) per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/NetincomelosspershareDetails</Role>
      <ShortName>Net income (loss) per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/NetincomelosspershareTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Business combination (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/BusinesscombinationNarrativeDetails</Role>
      <ShortName>Business combination (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/BusinesscombinationTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Business combination (Preliminary Allocation of Consideration) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails</Role>
      <ShortName>Business combination (Preliminary Allocation of Consideration) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/BusinesscombinationTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Business combination (Pro Forma Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/BusinesscombinationProFormaResultsDetails</Role>
      <ShortName>Business combination (Pro Forma Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/BusinesscombinationTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Supplemental financial statement information (Property and equipment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails</Role>
      <ShortName>Supplemental financial statement information (Property and equipment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Supplemental financial statement information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails</Role>
      <ShortName>Supplemental financial statement information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Supplemental financial statement information (Lease Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails</Role>
      <ShortName>Supplemental financial statement information (Lease Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Supplemental financial statement information (Supplemental Cash Flow Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails</Role>
      <ShortName>Supplemental financial statement information (Supplemental Cash Flow Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Supplemental financial statement information (Other income (expense), net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails</Role>
      <ShortName>Supplemental financial statement information (Other income (expense), net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/SupplementalfinancialstatementinformationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Intangible assets and goodwill (Schedule of intangible assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails</Role>
      <ShortName>Intangible assets and goodwill (Schedule of intangible assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/IntangibleassetsandgoodwillTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Intangible assets and goodwill (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails</Role>
      <ShortName>Intangible assets and goodwill (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/IntangibleassetsandgoodwillTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Commitments and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/CommitmentsandcontingenciesDetails</Role>
      <ShortName>Commitments and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/Commitmentsandcontingencies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IncometaxesDetails</Role>
      <ShortName>Income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/Incometaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Indebtedness Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails</Role>
      <ShortName>Indebtedness Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Indebtedness (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IndebtednessNarrativeDetails</Role>
      <ShortName>Indebtedness (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/IndebtednessTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Indebtedness Schedule of Maturities of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails</Role>
      <ShortName>Indebtedness Schedule of Maturities of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Stock-based compensation (Summary of share based compensation recognized) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails</Role>
      <ShortName>Stock-based compensation (Summary of share based compensation recognized) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/StockbasedcompensationTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Stock-based compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/StockbasedcompensationNarrativeDetails</Role>
      <ShortName>Stock-based compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/StockbasedcompensationTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Stock-based compensation (Stock option activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails</Role>
      <ShortName>Stock-based compensation (Stock option activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/StockbasedcompensationTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hqy-20201031.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Stock-based compensation (Restricted stock unity activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails</Role>
      <ShortName>Stock-based compensation (Restricted stock unity activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthequity.com/role/StockbasedcompensationTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="hqy-20201031.htm">hqy-20201031.htm</File>
    <File>exhibit311-ceo302xfy21.htm</File>
    <File>exhibit312-cfo302xfy21.htm</File>
    <File>exhibit321-ceo906xfy21.htm</File>
    <File>exhibit322-cfo906xfy21.htm</File>
    <File>hqy-20201031.xsd</File>
    <File>hqy-20201031_cal.xml</File>
    <File>hqy-20201031_def.xml</File>
    <File>hqy-20201031_lab.xml</File>
    <File>hqy-20201031_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hqy-20201031.htm": {
   "axisCustom": 1,
   "axisStandard": 17,
   "contextCount": 150,
   "dts": {
    "calculationLink": {
     "local": [
      "hqy-20201031_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hqy-20201031_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "hqy-20201031.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hqy-20201031_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hqy-20201031_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hqy-20201031.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 420,
   "entityCount": 1,
   "hidden": {
    "http://healthequity.com/20201031": 6,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 11
   },
   "keyCustom": 32,
   "keyStandard": 311,
   "memberCustom": 16,
   "memberStandard": 28,
   "nsprefix": "hqy",
   "nsuri": "http://healthequity.com/20201031",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://healthequity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Supplemental financial statement information",
     "role": "http://healthequity.com/role/Supplementalfinancialstatementinformation",
     "shortName": "Supplemental financial statement information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - Intangible assets and goodwill",
     "role": "http://healthequity.com/role/Intangibleassetsandgoodwill",
     "shortName": "Intangible assets and goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - Commitments and contingencies",
     "role": "http://healthequity.com/role/Commitmentsandcontingencies",
     "shortName": "Commitments and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125107 - Disclosure - Income taxes",
     "role": "http://healthequity.com/role/Incometaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - Indebtedness",
     "role": "http://healthequity.com/role/Indebtedness",
     "shortName": "Indebtedness",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - Stock-based compensation",
     "role": "http://healthequity.com/role/Stockbasedcompensation",
     "shortName": "Stock-based compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - Fair value",
     "role": "http://healthequity.com/role/Fairvalue",
     "shortName": "Fair value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of business and significant accounting policies (Policies)",
     "role": "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies",
     "shortName": "Summary of business and significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Net income (loss) per share (Tables)",
     "role": "http://healthequity.com/role/NetincomelosspershareTables",
     "shortName": "Net income (loss) per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Business combination (Tables)",
     "role": "http://healthequity.com/role/BusinesscombinationTables",
     "shortName": "Business combination (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed consolidated balance sheets",
     "role": "http://healthequity.com/role/Condensedconsolidatedbalancesheets",
     "shortName": "Condensed consolidated balance sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Supplemental financial statement information (Tables)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationTables",
     "shortName": "Supplemental financial statement information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Intangible assets and goodwill (Tables)",
     "role": "http://healthequity.com/role/IntangibleassetsandgoodwillTables",
     "shortName": "Intangible assets and goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - Indebtedness (Tables)",
     "role": "http://healthequity.com/role/IndebtednessTables",
     "shortName": "Indebtedness (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Stock-based compensation (Tables)",
     "role": "http://healthequity.com/role/StockbasedcompensationTables",
     "shortName": "Stock-based compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Summary of business and significant accounting policies (Narrative) (Details)",
     "role": "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails",
     "shortName": "Summary of business and significant accounting policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i6c55ef614d5b456eb0d0a2a04514d187_D20200701-20200731",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Net income (loss) per share (Details)",
     "role": "http://healthequity.com/role/NetincomelosspershareDetails",
     "shortName": "Net income (loss) per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ied9feb80b5a64b01bbfd227ff97374ae_I20190830",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Business combination (Narrative) (Details)",
     "role": "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
     "shortName": "Business combination (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ied9feb80b5a64b01bbfd227ff97374ae_I20190830",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionSharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Business combination (Preliminary Allocation of Consideration) (Details)",
     "role": "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
     "shortName": "Business combination (Preliminary Allocation of Consideration) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ied9feb80b5a64b01bbfd227ff97374ae_I20190830",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Business combination (Pro Forma Results) (Details)",
     "role": "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails",
     "shortName": "Business combination (Pro Forma Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i51c7777007da4090aa6f1b2a490750b2_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Supplemental financial statement information (Property and equipment) (Details)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails",
     "shortName": "Supplemental financial statement information (Property and equipment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed consolidated balance sheets (Parenthetical)",
     "role": "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical",
     "shortName": "Condensed consolidated balance sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Supplemental financial statement information (Narrative) (Details)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails",
     "shortName": "Supplemental financial statement information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Supplemental financial statement information (Lease Cost) (Details)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails",
     "shortName": "Supplemental financial statement information (Lease Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Supplemental financial statement information (Supplemental Cash Flow Information) (Details)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails",
     "shortName": "Supplemental financial statement information (Supplemental Cash Flow Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Supplemental financial statement information (Other income (expense), net) (Details)",
     "role": "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails",
     "shortName": "Supplemental financial statement information (Other income (expense), net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeNonoperating",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Intangible assets and goodwill (Schedule of intangible assets) (Details)",
     "role": "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails",
     "shortName": "Intangible assets and goodwill (Schedule of intangible assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Intangible assets and goodwill (Narrative) (Details)",
     "role": "http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails",
     "shortName": "Intangible assets and goodwill (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Commitments and contingencies (Details)",
     "role": "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
     "shortName": "Commitments and contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i3e05173272a94406b7f82f6775f29b05_D20180906-20180906",
      "decimals": "INF",
      "lang": "en-US",
      "name": "hqy:LossContingencyNumberOfLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lawsuit",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Income taxes (Details)",
     "role": "http://healthequity.com/role/IncometaxesDetails",
     "shortName": "Income taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Indebtedness Schedule of Long-term Debt (Details)",
     "role": "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails",
     "shortName": "Indebtedness Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Indebtedness (Narrative) (Details)",
     "role": "http://healthequity.com/role/IndebtednessNarrativeDetails",
     "shortName": "Indebtedness (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ib16f9fff56d24738b1519754780c7d7f_I20201031",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)",
     "role": "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
     "shortName": "Condensed consolidated statements of operations and comprehensive income (loss) (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i45cb957efb1b4404baaef91f15061ef9_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Indebtedness Schedule of Maturities of Long-term Debt (Details)",
     "role": "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails",
     "shortName": "Indebtedness Schedule of Maturities of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i45cb957efb1b4404baaef91f15061ef9_I20200131",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Stock-based compensation (Summary of share based compensation recognized) (Details)",
     "role": "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails",
     "shortName": "Stock-based compensation (Summary of share based compensation recognized) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ia1b0a075709f4d5fa60e0ce4f741f7db_D20200801-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i77c4e52ee53c4454ac874c5015ca7fc7_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Stock-based compensation (Narrative) (Details)",
     "role": "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
     "shortName": "Stock-based compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i3843854aae914afaa49721b198e544c7_D20180301-20180331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i45cb957efb1b4404baaef91f15061ef9_I20200131",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Stock-based compensation (Stock option activity) (Details)",
     "role": "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails",
     "shortName": "Stock-based compensation (Stock option activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Stock-based compensation (Restricted stock unity activity) (Details)",
     "role": "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails",
     "shortName": "Stock-based compensation (Restricted stock unity activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "i4553f5ff3ecf41b7954c3e8fb43d31bf_I20200131",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "if66fb9a6498840c584531c192cbb750f_I20190131",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed consolidated statements of stockholders' equity (unaudited)",
     "role": "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited",
     "shortName": "Condensed consolidated statements of stockholders' equity (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "if66fb9a6498840c584531c192cbb750f_I20190131",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed consolidated statements of cash flows (unaudited)",
     "role": "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
     "shortName": "Condensed consolidated statements of cash flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of business and significant accounting policies",
     "role": "http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies",
     "shortName": "Summary of business and significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Net income (loss) per share",
     "role": "http://healthequity.com/role/Netincomelosspershare",
     "shortName": "Net income (loss) per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Business combination",
     "role": "http://healthequity.com/role/Businesscombination",
     "shortName": "Business combination",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hqy-20201031.htm",
      "contextRef": "ibf5b9811269a4c4b9d01f2dda810950a_D20200201-20201031",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 46,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://healthequity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hqy_AcquiredHSAIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Acquired HSA Intangible Assets [Member]",
        "label": "Acquired HSA Intangible Assets [Member]",
        "terseLabel": "Acquired HSA portfolios"
       }
      }
     },
     "localname": "AcquiredHSAIntangibleAssetsMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_AmortizationOfAcquiredIntangible": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization of Acquired Intangible",
        "label": "Amortization Of Acquired Intangible",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfAcquiredIntangible",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents",
        "terseLabel": "Cash and cash equivalents, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Client Held Funds Obligation",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Client Held Funds Obligation",
        "negatedLabel": "Client-held funds obligation, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentClientHeldFundsObligation",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Income Taxes",
        "negatedLabel": "Deferred tax liability, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredIncomeTaxes",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Current Assets",
        "terseLabel": "Other current assets, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherCurrentAssets",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustment, Current Liabilities, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustment, Current Liabilities, Other",
        "negatedLabel": "Other current liabilities, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdjustmentCurrentLiabilitiesOther",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Client Held Funds Obligation",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Client Held Funds Obligation",
        "negatedTerseLabel": "Client-held funds obligation"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedClientHeldFundsObligation",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseRightofuseAssets",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_ContractWithCustomerRecognitionTermInterchangeArrangement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract With Customer, Recognition Term, Interchange Arrangement",
        "label": "Contract With Customer, Recognition Term, Interchange Arrangement",
        "terseLabel": "Deferred revenue interchange arrangement recognition term"
       }
      }
     },
     "localname": "ContractWithCustomerRecognitionTermInterchangeArrangement",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hqy_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hqy_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "[Domain] for Debt Covenant Period [Axis]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_DebtCovenantPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Covenant Period Four",
        "label": "Debt Covenant Period Four [Member]",
        "terseLabel": "Debt covenant, acquisition holiday provision"
       }
      }
     },
     "localname": "DebtCovenantPeriodFourMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_DebtCovenantPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Covenant Period Three",
        "label": "Debt Covenant Period Three [Member]",
        "terseLabel": "Debt covenant, beginning July 31, 2021"
       }
      }
     },
     "localname": "DebtCovenantPeriodThreeMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_DebtCovenantPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Covenant Period Two",
        "label": "Debt Covenant Period Two [Member]",
        "terseLabel": "Debt covenant, beginning July 31, 2020"
       }
      }
     },
     "localname": "DebtCovenantPeriodTwoMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Description, Acquisition Threshold For Maximum Total Net Leverage Ratio",
        "label": "Debt Instrument, Covenant Description, Acquisition Threshold For Maximum Total Net Leverage Ratio",
        "terseLabel": "Acquisition threshold for maximum total net leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_DebtInstrumentCovenantDescriptionInterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Description, Interest Coverage Ratio",
        "label": "Debt Instrument, Covenant Description, Interest Coverage Ratio",
        "terseLabel": "Minimum interest coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDescriptionInterestCoverageRatio",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hqy_DebtInstrumentCovenantDescriptionLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Description, Leverage Ratio",
        "label": "Debt Instrument, Covenant Description, Leverage Ratio",
        "terseLabel": "Maximum leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDescriptionLeverageRatio",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hqy_ExerciseofStockOptionsReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise of Stock Options Receivable",
        "label": "Exercise of Stock Options Receivable",
        "terseLabel": "Exercise of common stock options receivable"
       }
      }
     },
     "localname": "ExerciseofStockOptionsReceivable",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_FollowOnEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Follow On Equity Offering [Member]",
        "label": "Follow On Equity Offering [Member]",
        "terseLabel": "Follow on equity offering"
       }
      }
     },
     "localname": "FollowOnEquityOfferingMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incentive Plan [Member]",
        "label": "Incentive Plan [Member]",
        "terseLabel": "Incentive Plan"
       }
      }
     },
     "localname": "IncentivePlanMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liability, Noncurrent",
        "label": "Increase (Decrease) In Operating Lease Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset",
        "negatedTerseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_LossContingencyNumberOfLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency Number Of Lawsuits",
        "label": "Loss Contingency Number Of Lawsuits",
        "terseLabel": "Number of derivative lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfLawsuits",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hqy_MergerIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Merger Integration",
        "label": "Merger Integration [Member]",
        "terseLabel": "Merger Integration"
       }
      }
     },
     "localname": "MergerIntegrationMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_PaymentsToSettleClientHeldFunds": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments To Settle Client Held Funds",
        "label": "Payments To Settle Client Held Funds",
        "negatedTerseLabel": "Settlement of client-held funds obligation, net"
       }
      }
     },
     "localname": "PaymentsToSettleClientHeldFunds",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_PerformanceRestrictedStockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Performance Restricted Stock Awards [Member]",
        "label": "Performance Restricted Stock Awards [Member]",
        "terseLabel": "Performance restricted stock awards"
       }
      }
     },
     "localname": "PerformanceRestrictedStockAwardsMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_PerformanceRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Performance Restricted Stock Units [Member]",
        "label": "Performance Restricted Stock Units [Member]",
        "terseLabel": "Performance restricted stock units"
       }
      }
     },
     "localname": "PerformanceRestrictedStockUnitsMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_SalesandMarketingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales and Marketing [Member]",
        "label": "Sales and Marketing [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SalesandMarketingMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fully Achieved, Ratio",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fully Achieved, Ratio",
        "terseLabel": "Fraction of awards fully achieved"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFullyAchievedRatio",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hqy_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Remaining Modified, Ratio",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Remaining Modified, Ratio",
        "terseLabel": "Fraction of awards modified"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodRemainingModifiedRatio",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Exercised",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Exercised",
        "terseLabel": "Exercised, minimum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Forfeited",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Forfeited",
        "terseLabel": "Forfeited, minimum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Lower Range Limit, Outstanding",
        "periodEndLabel": "Ending balance, minimum (usd per share)",
        "periodStartLabel": "Beginning balance, minimum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Exercised",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Exercised",
        "terseLabel": "Exercised, maximum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Forfeited",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Forfeited",
        "terseLabel": "Forfeited, maximum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Upper Range Limit, Outstanding",
        "periodEndLabel": "Ending balance, maximum (usd per share)",
        "periodStartLabel": "Beginning balance, maximum (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Granted",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Granted",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hqy_ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Decrease In Expense Due To Modification Of Terms",
        "label": "Share-Based Payment Arrangement, Decrease In Expense Due To Modification Of Terms",
        "verboseLabel": "Share-based payment arrangement, decrease in expense due to modification of terms"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementDecreaseInExpenseDueToModificationOfTerms",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Plan Modification, Incremental Cost, Number Of Team Members",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost, Number Of Team Members",
        "terseLabel": "Number of team members modification affected"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementPlanModificationIncrementalCostNumberOfTeamMembers",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hqy_SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Available for Grants, Percentage of Capital Stock Outstanding, Percentage",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional Shares Available for Grants, Percentage of Capital Stock Outstanding, Percentage",
        "terseLabel": "Percentage of capital stock"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardAdditionalSharesAvailableforGrantsPercentageofCapitalStockOutstandingPercentage",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hqy_StockIssuanceCostsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock Issuance Costs Payable",
        "label": "Stock Issuance Costs Payable",
        "terseLabel": "Other offering expenses payable"
       }
      }
     },
     "localname": "StockIssuanceCostsPayable",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_TechnologyandDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Technology and Development [Member]",
        "label": "Technology and Development [Member]",
        "terseLabel": "Technology and development"
       }
      }
     },
     "localname": "TechnologyandDevelopmentMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_UnrecognizedTaxBenefitNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefit, Net",
        "label": "Unrecognized Tax Benefit, Net",
        "terseLabel": "Unrecognized tax benefit"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitNet",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hqy_WageWorksInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "WageWorks Inc. [Member]",
        "label": "WageWorks Inc. [Member]",
        "terseLabel": "WageWorks, Inc"
       }
      }
     },
     "localname": "WageWorksInc.Member",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_WageWorksIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Wage Works Inc.",
        "label": "Wage Works Inc. [Member]",
        "terseLabel": "Wage Works Inc."
       }
      }
     },
     "localname": "WageWorksIncMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_WageWorksIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "WageWorks Incentive Plan",
        "label": "WageWorks Incentive Plan [Member]",
        "terseLabel": "WageWorks Incentive Plan"
       }
      }
     },
     "localname": "WageWorksIncentivePlanMember",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hqy_WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted Average Number Of Shares Used In Computing Net Income Per Share Attributable To Common Stockholders, Basic And Diluted [Abstract]",
        "label": "Weighted Average Number Of Shares Used In Computing Net Income Per Share Attributable To Common Stockholders, Basic And Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares used in computing net income (loss) per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesUsedInComputingNetIncomePerShareAttributableToCommonStockholdersBasicAndDilutedAbstract",
     "nsuri": "http://healthequity.com/20201031",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r206",
      "r208",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r206",
      "r208",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r138",
      "r201",
      "r203",
      "r335",
      "r367",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r138",
      "r201",
      "r203",
      "r335",
      "r367",
      "r369"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r204",
      "r206",
      "r208",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r204",
      "r206",
      "r208",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r368",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r18",
      "r141",
      "r142"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $3,458 and $1,216 as of October 31, 2020 and January 31, 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r27",
      "r172"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Supplemental financial statement information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Supplementalfinancialstatementinformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r245"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r242",
      "r243",
      "r244"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r209",
      "r211",
      "r247",
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r211",
      "r234",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r24",
      "r143",
      "r153"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r54",
      "r73",
      "r317"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r73",
      "r158",
      "r165"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r82",
      "r127",
      "r130",
      "r136",
      "r146",
      "r295",
      "r298",
      "r306",
      "r343",
      "r356"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r42",
      "r82",
      "r146",
      "r295",
      "r298",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r213",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Customary Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r205",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r205",
      "r207",
      "r277",
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails",
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of service-based common stock (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "verboseLabel": "Merger related costs, price per share"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r275",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "negatedLabel": "Acquisition costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r288",
      "r289",
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate fair value of WageWorks stock acquired"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Borrowing pursuant to term loan facility"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business combination"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Businesscombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Merger integration"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r282"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "totalLabel": "Total consideration paid, adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total consideration paid"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r279",
      "r280"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment included in accounts payable or accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r25",
      "r75"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r69",
      "r75",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Ending cash and cash equivalents",
        "periodStartLabel": "Beginning cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r69",
      "r307"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r38",
      "r178",
      "r347",
      "r361"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (see Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Commitmentsandcontingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of common stock issuable (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r87",
      "r88"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r17",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value, 900,000 shares authorized, 76,951 and 71,051 shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r44",
      "r46",
      "r47",
      "r51",
      "r350",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r159",
      "r163",
      "r285"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Computer software intangible asset"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r81",
      "r297"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "verboseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r56",
      "r335"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditAndDebitCardMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Card issued to user to facilitate payment for purchase of product and service paid directly to merchant by issuer, or from user's checking account.",
        "label": "Credit and Debit Card [Member]",
        "terseLabel": "Interchange revenue"
       }
      }
     },
     "localname": "CreditAndDebitCardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Acquired customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Indebtedness"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Indebtedness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r344",
      "r345",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Variable rate borrowing spread"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r14",
      "r190",
      "r345",
      "r355"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Term loan facility",
        "totalLabel": "Total principal payments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails",
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r84",
      "r194",
      "r195",
      "r196",
      "r197",
      "r315",
      "r316",
      "r318",
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Facility term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r28",
      "r317"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Less: unamortized loan issuance costs",
        "verboseLabel": "Unamortized loan issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r253",
      "r254"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r253",
      "r254"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r73",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r73",
      "r125"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Acquired developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Stockbasedcompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r52",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r104",
      "r106",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r351",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income (loss) per share:",
        "verboseLabel": "Net income (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r52",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r106",
      "r111",
      "r112",
      "r113",
      "r117",
      "r118",
      "r351",
      "r364"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r119"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Netincomelosspershare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r249",
      "r256"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "Effective tax rate, primarily due to excess tax benefit on stock-based compensation expense (benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r92",
      "r101",
      "r103",
      "r120",
      "r150",
      "r193",
      "r198",
      "r242",
      "r243",
      "r244",
      "r264",
      "r265",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]",
        "terseLabel": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]",
        "terseLabel": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Gain on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Fairvalue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialServiceOtherMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial assistance, including, but not limited to, management and maintenance of depositor account, credit card, merchant discount, trust, investment and insurance, classified as other.",
        "label": "Financial Service, Other [Member]",
        "terseLabel": "Custodial revenue"
       }
      }
     },
     "localname": "FinancialServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r159",
      "r161",
      "r164",
      "r167",
      "r336",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r164",
      "r340"
     ],
     "calculation": {
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortizable intangible assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r159",
      "r163"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r164",
      "r336"
     ],
     "calculation": {
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total amortizable intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "negatedLabel": "Gains on marketable equity securities"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r154",
      "r155",
      "r342"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Intangibleassetsandgoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r156",
      "r273"
     ],
     "calculation": {
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, adjustments",
        "verboseLabel": "Decrease in goodwill due to measurement period adjustments, net"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r55",
      "r82",
      "r127",
      "r129",
      "r132",
      "r135",
      "r137",
      "r146",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r49",
      "r127",
      "r129",
      "r132",
      "r135",
      "r137",
      "r341",
      "r348",
      "r353",
      "r365"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r257",
      "r260",
      "r261",
      "r266",
      "r268",
      "r270",
      "r271",
      "r272"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Incometaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r83",
      "r102",
      "r103",
      "r126",
      "r255",
      "r267",
      "r269",
      "r366"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax provision (benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid in cash, net of refunds received"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities, and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other.",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r107",
      "r108",
      "r109",
      "r113"
     ],
     "calculation": {
      "http://healthequity.com/role/NetincomelosspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted-average dilutive effect of stock options and restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r160",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Acquired in process software development costs"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r160",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r157",
      "r162"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets",
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r48",
      "r124",
      "r314",
      "r317",
      "r352"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r68",
      "r70",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest expense paid in cash"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.",
        "label": "Investment Income, Nonoperating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r326",
      "r327"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net operating lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r82",
      "r131",
      "r146",
      "r296",
      "r298",
      "r299",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r23",
      "r82",
      "r146",
      "r306",
      "r346",
      "r359"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r82",
      "r146",
      "r296",
      "r298",
      "r299",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r14",
      "r15",
      "r82",
      "r146",
      "r296",
      "r298",
      "r299",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r14",
      "r345",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Effective interest rate percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility, amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r14",
      "r191",
      "r345",
      "r357"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r85",
      "r188"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r85",
      "r188"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r85",
      "r188"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r85",
      "r188"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Remaining 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r36",
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/IndebtednessNarrativeDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r69",
      "r71",
      "r74"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r43",
      "r45",
      "r50",
      "r74",
      "r82",
      "r91",
      "r96",
      "r97",
      "r98",
      "r99",
      "r102",
      "r103",
      "r110",
      "r127",
      "r129",
      "r132",
      "r135",
      "r137",
      "r146",
      "r306",
      "r349",
      "r362"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator (basic and diluted):"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r98",
      "r117",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r262",
      "r263",
      "r264",
      "r265",
      "r337",
      "r338",
      "r339",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent adopted accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosures of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Intangible Assets Acquired",
        "terseLabel": "Purchases of intangible assets"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses [Abstract]"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r127",
      "r129",
      "r132",
      "r135",
      "r137"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r320"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r322",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r2",
      "r86",
      "r121",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of business and significant accounting policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Summaryofbusinessandsignificantaccountingpolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r301",
      "r304"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenseMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other expense.",
        "label": "Other Expense [Member]",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/SupplementalfinancialstatementinformationOtherincomeexpensenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": {
     "auth_ref": [
      "r77",
      "r78",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Given",
        "terseLabel": "Equity-based acquisition consideration"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForSoftware": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments for Software",
        "negatedTerseLabel": "Purchases of software and capitalized software development costs"
       }
      }
     },
     "localname": "PaymentsForSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Underwriting discounts and commissions"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r60",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash paid"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Acquisition of intangible member assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r213",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CondensedconsolidatedbalancesheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from follow-on equity offering, net of payments for offering costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r63",
      "r237"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of common stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r27",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r26",
      "r171"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r173",
      "r360"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets",
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r171"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Principal payments on long-term debt",
        "terseLabel": "Principal payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/CommitmentsandcontingenciesDetails",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r251",
      "r384"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Technology and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research and development expense during the period related to the costs of developing and achieving technological feasibility of a computer software product to be sold, leased, or otherwise marketed.",
        "label": "Research and Development Expense, Software (Excluding Acquired in Process Cost)",
        "terseLabel": "Software development costs incurred and expensed"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "netLabel": "Restricted stock units",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r198",
      "r245",
      "r358",
      "r377",
      "r382"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r92",
      "r101",
      "r103",
      "r150",
      "r242",
      "r243",
      "r244",
      "r264",
      "r265",
      "r373",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r122",
      "r123",
      "r128",
      "r133",
      "r134",
      "r138",
      "r139",
      "r140",
      "r200",
      "r201",
      "r335"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "verboseLabel": "Remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Secured Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets obtained in exchange for new operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds from follow on offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Common stock, shares (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price per share (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r277",
      "r278"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationNarrativeDetails",
      "http://healthequity.com/role/BusinesscombinationPreliminaryAllocationofConsiderationDetails",
      "http://healthequity.com/role/BusinesscombinationProFormaResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r36",
      "r84",
      "r194",
      "r195",
      "r196",
      "r197",
      "r315",
      "r316",
      "r318",
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of earnings (loss) per share, basic and diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r211",
      "r233",
      "r246"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of share based compensation recognized"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r159",
      "r163",
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r159",
      "r163"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of finite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r166",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r166",
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r27",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationPropertyandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Preliminary Allocation of Consideration"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/BusinesscombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r213",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails",
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r217",
      "r228",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Performance units awards (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested, ending balance (in shares)",
        "periodStartLabel": "Unvested, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested, ending balance (usd per share)",
        "periodStartLabel": "Unvested, beginning balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails",
      "http://healthequity.com/role/StockbasedcompensationSummaryofsharebasedcompensationrecognizedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant under incentive plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable as of year end, weighted-average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Ending balance, outstanding stock options, aggregate intrinsic value",
        "periodStartLabel": "Beginning balance, outstanding stock options, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r219",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Opening balance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of options (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (usd per share)",
        "periodStartLabel": "Opening balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest as of year end, aggregate intrinsic value (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Exercisable as of year end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest as of year end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest as of year end, weighted average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental compensation cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r210",
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails",
      "http://healthequity.com/role/StockbasedcompensationRestrictedstockunityactivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Beginning of Period [Abstract]",
        "terseLabel": "Range of exercise prices (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeBeginningOfPeriodAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable as of year end, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable as of year end, weighted-average contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding stock options, weighted average contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest as of year end, weighted average contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and software development costs"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r40",
      "r87",
      "r88",
      "r89",
      "r92",
      "r101",
      "r103",
      "r120",
      "r150",
      "r193",
      "r198",
      "r242",
      "r243",
      "r244",
      "r264",
      "r265",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r120",
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r16",
      "r17",
      "r193",
      "r198",
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/StockbasedcompensationStockoptionactivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Other issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r16",
      "r17",
      "r198",
      "r212",
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock upon exercise of stock options, and for restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r17",
      "r21",
      "r22",
      "r82",
      "r144",
      "r146",
      "r306"
     ],
     "calculation": {
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets",
      "http://healthequity.com/role/Condensedconsolidatedstatementsofstockholdersequityunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedbalancesheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r323",
      "r327"
     ],
     "calculation": {
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/SupplementalfinancialstatementinformationLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessScheduleofMaturitiesofLongtermDebtDetails",
      "http://healthequity.com/role/SummaryofbusinessandsignificantaccountingpoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow data:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofcashflowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Acquired trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IntangibleassetsandgoodwillScheduleofintangibleassetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r252",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IncometaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/IndebtednessNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r105",
      "r113"
     ],
     "calculation": {
      "http://healthequity.com/role/NetincomelosspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator (diluted):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r104",
      "r113"
     ],
     "calculation": {
      "http://healthequity.com/role/NetincomelosspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Weighted-average common shares outstanding (in shares)",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/Condensedconsolidatedstatementsofoperationsandcomprehensiveincomelossunaudited",
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Denominator (basic):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://healthequity.com/role/NetincomelosspershareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r385": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r386": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r387": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r388": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r389": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001428336-20-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001428336-20-000031-xbrl.zip
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M6ITT54I@BJ2P!O'H.-)<1D1BY(DRSA3W0*T@1JFM?EI;_5C9:+2=;4 8TX!
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MX:^'?F=?/; 2QRE!PA- /T<QLM18E,?-C/)2>F]+])MI]+M_.>HX1W>>!HJ
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M?;_;S1/@,PN 0XWS;KU@Q]<8DT%HL(XJG].)W7[C[M!,"3@SI@5D?A&'+96
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MO<-V!_ YE/F$B>A@E7SE25@O=4".1(NX=!R99#%R>2IV@.^!RA^@V+WZ] (
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MUNYG7EO;I/O-]?SWO$K_;FZMA4;UZ"/9:^ZGJ[&'3_CT:\1>1A(#(D9IQ(7
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MLJP0 HH77 *5$"HAG,4C9>FM88PKZR" MY&RS&-TAE$KJ:LNBHTBA(6+PL7
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M6)QQ<]82CB>3-)JU7WX,[I -%">G.K+2UVWI*[1%B1#,6D<U2=DE D$(8IU
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M<WLMFGO.;][/A7'.>.A9F9!*/TO1SZL+.B)ZRHRGD8A(+8&,7XR3@K@0C8;
M,I6NBT>PU1VQ,6<=%<)W .&6@O H]ZE5B61%2T]U*HBWB1)M(YH""4E9Q9U=
M0?N20C<"G[;6#7%MT\3KLGP>=_IR1T\]OI*L^-/9_-5DQ95=%TVR8A L131S
MM @$O #BH\S$Z2A<T-E%DW=VE>@KN)JI>#MKIV8N;S(%=*!58J6 ]3D]2@J8
ME%*;;$EF41 PJL1JH^4A ZXT8,+3Y(K/ R3T@:XK>Z0F+=\*J6<]SWO?Q=.N
MYW\K15GF-=^:3C?X3<EO_8AP&*WF'WE4O':?TJ:06OG_Q6*>?DO3V6009BDV
M=:1&\>(O6G_Y"SZ)<3Q;!\]/5P'^/#PN<_+B<SAPH_?I-S=++W).H3J$;^N1
M06X42:64%)IOWI2#Y>B)=Q&7@&7X;"5:=Z+X@ZDNU:CNNH_LIKIJ-I]'.E_9
MI3)*MQFE%0SK:>":<L*2E 2"0%M+^D2<TIYYZ01G%!G%J+YE:\B,ZYC,VA37
MT8_I_6 T:JI_K%59;>\A.,C@K=0IXRH&H."=2QEW22:I8OC='R\;_<0>2C95
MSEJ*LR[T $H2J(W*$*[!$] V$RL92J&4M&8I>%"EHI5E?<VOUN.LX2V;C>RL
M5/;6*;#&  W2@!0L,,N#]UK27)"-@J8B>V.0O5 C' 4(33$1*]#(0=I&(1*T
M)\;PP!/51O'2)U2Q/NAMJ!MR*H?F%_N&(NJ>*GDQBDM)DI6>QE>5XXT,MVX\
ML/]YH">RV83OF<H6GX94D8,6QC/)K):@#0UHV>:YE'LX#U@E_*4(__>+C:&3
MT,E&@O.G"0C\XI*/1 =N&/<\^J!W=KFU?2%7EG)K!=4].;QNM$-<5HB5:"O1
MWH)H11:!.V$8) I..J,,3Q:49T;DQ-1<65>BW1RB72AK[4V.QFMB?&EXEX&C
MQJ:2:!UT,MI(ZW+IY@U]*?56$&VCR?_>M+'$?^/@X^X_\,O9H _=Y/U@U'R\
M:+ASG8!L+O/]8(;#"G\-43ZOII-Z+H3Q(0[AI"CJT7B6IKW9N, SIE'I=('?
M-8_((2S.@L;<$ >,OV@")Y^<S\[E6SW]+.#SQ/^C\;Q#U_>3-'2SP<?TPZ=!
MG!V<T47KC:<31Q=O<1X'<3S[^EM:4Q1P5&FRGB?+Z+>XKGF01)&+3Z']]6!R
M-H@C]SX1/TGN W$9Q_B]&WYR)].=OU]<(;@\+CVZRW<]O[?=?_@)OO6:#[[C
M]<;@TE/1USZ5?R8WG#4\.COI]UZ.PI/&6IL>^^D@#MRD'7%X-NS['-^SZQ?Y
M8FF?=Y&;5T?_[GCDCN, _^9OO>_*!C88'>/W7UW_IX_^=#4K'-.5R3AM=GNV
M[!MFPIL>NJ-I^O[LFQ_B8'HT="??#T;-331ONLQ!>,W%,GE"YTOEU#-P>OW3
MEY\T+UWBTOEK2CSA7'_U9?J$??6UO[HL4T\ Q*TN^]>O"0-W,UAUH\M^R_NR
MV&GXS?3S^47LMR_R#4_-O:O *QB;QQ[C;WJ'^&<'TUX:E=CC_3 ;^S3I"=:_
ML*]_XV%VR"EU_9U^-QCU9@?C8[Q$G%XYGUSNCCHR><6]L<2-W* WPR;<,[/+
MK,OE _LVPL7Z^OCH:%YH$<7>^1[8PQW2W:X7R#)/Y59-/KK[ 8^AB-;+HKG1
M?NZEST=%4_6.W"">162NDLVS3<Z>+7+9W&>8Z-G:^@67U%[:EJBKO>'^F^)1
MB<-7SS^4L7W9>_YO'%,<[#]_*G&,_-7/KSZ_/7SY^;(WYBW_7;YZ\_++'O_]
MT_Z;IVSO^2NZ]Y^7= _OZ]7SX9]O_WS[Z>V7GP9O__PIGWMB7M-/?X3 N3"1
M$RY+>8YH%+&&:Y(5BR&Z0)DSI1IYW\#*/4ZZEU5;66?C66<-,:656M9(+5_.
MJ87'S(2ECB3#*0%#(S$9<NF?9)!QN(',D5HZQ2N/H6#ZRU$8'Z;>S'U.TPN:
M[+S9VR3-2Z=/4DB#CRG6>,X'%#IELMZ4N:J$M#PA[3UK:9V8*&6,>2*YM 2\
MX\0Z)XC/U#O)4.[8<N[4IW)=^;PU4K,KF+W/W-R*V54QNQ 1*EK-(3M<-2X0
M8)83+Z,C@7O/)<N:2[6S:_N,KWQ2W($8S,WR <;!- S'TV-4RT4UX*,GC5MP
M<-8TNSG;J[V#MTU _C(9'^$83IKI+3&V1TT5ND&3%9<:.5E""([+<>F1.VG.
M,\>3\KO),;X\'#@_&%Y;76;EC:D;#^CF]OAU][79&^T:Q/'E,*VC$KWRHCB1
MXV!6V 8WV./)),4?CV=[X]G;U-CJ=8]=9H\=M'2QU"IKD0,)PI7 UU#J_$M-
MC,["0V24>XFZ6'5IAUV3*JZ$L_&$LW8'8"6<NR&<A:BWX)E2@I/@=2DE;(%8
MQ1/ALH3XB@ RL4(X5Y.\-U[2=UK8O1[GV2<W2:<95 T,\-WX@,]>B.EC&H[G
M>J\I,OR7JJ]_G>;KM[5@"31-HVG3GK'6*[X8 8\P0%:+RDF'>[*W4IIH<#^V
M@IL0XUH+"HY'Q7+;G_SB)K/3'YX&5/;S6-N7:.Z-W@]P1I].IVDV;5Y".F25
M I>AP/:Y*TAFE$^*6,<\ 9-CR1L'0K4--@IC-6U\D0+6E6K4H6/71XYLFFA.
M4?$<? 0+8%4 \-(YHSV-ABZM6"I\[P>^"P7C T0/U)*4#2J8B%K&E]B)S(V)
M7E(>F=K9%:Q+X'T,KJG%4N\=IL,24^R:);\.Y]0C/T&QN#-!Y-SG8$&S7*1(
M]IP:+91BRB_MV*FL=0^LM=\^ !4^1AY](I"-(&!1?KB0/6$R@> H,:DL&<[7
MM(G>>$?/-H)WF=)[.@BNE',J:PF@J,.)I]9XRJW)02Q5>J_"^"%@W#H3]6@C
M>"Y)2H:C^%!H.]BH2=":RN2-<A9AS.35KJRU8?0=0?&L,F21%^_'X_AI,!SV
MXG$JB;.'^,+QI#DT[1TU]21[+OYY/)TU"85-T%5U?3Q8@-7/I[/UR_$D'. ,
M/IV+PU)"?3%)E:N6"0)]<Z&- @T)K=PDB(U"$C#!$2M")!$W([1_!6H1O[,K
M^T:L[.ZMGHZ. 7G-45=?Z[E6,7PG&%Y4[/#22Y>L)U(J1X '32P/G' 6I6L.
MB#WO8O.UQ^#R..N2WE0F&!\>CLO'CL.'WGC>1?TTBKLX.JI'XVY"50[^>_+]
MV32,<[N%_6_GS[[2SU+TTVK^^.;E'X8E+2T @:PS6CP,B/%&D*BX\9GQF%C:
MV:U^BZV#Z-J".RI$[P*B)RV("ITE2XJD(!,!+<N!)D+4)YD<J*Q,5#N[_*I/
M8O-".I:IE-MMZ=#482+>E8)';N&S:XH?#? >5X[+N/&CVA*^NJ<FT_NS@S1Y
MC4]CD/')C,[<KF\F>)/S0?[;#8_3?G[6GLB?!Q_3J/I=;RU$_GS_A[0Z)YX]
M,31(5",J$*\#D""]H5G9Z'%"UVP(+4TW72P#6TFC&[EIE3D>0A\A<T#R-E!C
M"9?2$?#*$0-@B,K9!H<F3,C('**O];W4EJY536M5T]M4-=5_4=6TC++A!1X@
M>RZ$EU0",]$%;Y#'0#-AI.7Y#\YW[KP4ZC4/).<U/Y Y8)!JQW.>_!Y1F";E
MKW9VW\Q#BW+O6>'Z=@N*BX_LZX5;EWB><N?*%6M!UZ;8Y"V ?KOJK79MI73Y
MC>]LOC&P)[VS(=_7Q__5PC]5/GO'AWCEL ;[Z)*"F;QWH\&7YF.?G4\E_O!T
M%'^9I&G)32X_[N>?SN;V]?G4/C]/6<:_;LF@Q8G1+WB]@*OV#8[YQ^$X?'A8
MK7.R=Z9U#O\]W/OR O_^O=C_^2U_]^=OAZ]^_A7>_?R2OCO<&[Q[\P'>_?G3
M\!7_J6B=8?KG;R?O_A.// ?U[C^_XS51LSP/^#?XUS^_1;V$GXG7>,O_A7KH
MX/#5?W[_\O8_O^6]-T\_[3W]PP+:.=X;(A,S!"P'XAD31*&$"0Q"D"A7>N<5
MCY\6[2F!0_2JS*<"DYEGBEF1.5B&?\W,3B^A@#PJF]CD.)5D\D/$STGA2'\\
MQ;4SG<[)8S$O9[&:9<\^.IV9WID^.EUAEU@37SL=5K,,YK/W[:%=O)48'% N
MG$DR@E+:BI"]2#(P[:6.8N?FO*#6Q@N7=Z3K>>''TT=Y.Q:[N]%>+RBNV3^^
MVVG_<J=$YZ+1TMMY-I=O.W_K?7)-0.]X<E3H9Q[46_ZDH?"RG)ZC\&KRE7#^
M7Z>C61,*?$J6IM\K#/.DU_Z4W@"77F^8'+)8$R(<46<,IJA"RLH[:/ZR-W4?
M\:?I(G[XNV+H<_K#/U\_G3;?LA_^-L^=PJ&>EDG ]5TVG+)421Q,4NDET?-I
ME/*@=85GSW\\OT*_]^E@$ YZZ?!H_ F'<_;V9AO#SRXPF;G/Q,6/B! 43?%T
M@*'<\=D@\1HH/]! '/>.)N./@WE[K+-'5B[0.[_ M-B/Y?.&XQ/\G"=7 '6'
M='Z!PAOR/7FTU/O\@WSUZ8_@:62)(>&&<MB%VH\8J]"Z2R7PSWM0C%ZFT@[@
M^WHV^@4!% 8(AGGE_/9DKU.SW(QL>OC?9M#B&V2S)13K67I#PX+G](0/_ +'
M%68JI#.GH?F/H],?VH+]2>_I<'AA%QX40_/4?%Y<OUQ@MG <37L'[F-";DNC
M7AH.D$#/N/G"M%]BE\M[^<//R/4+^8YI\$<W'4SW\R4=>O+H"1%>_?I'M"5)
MSGBB8RDDZ2D09\HA(XI4+JA+2:;+ LXG$%&AOJ/40I+2 @JYQ+SA,GFIX#*!
M-L^_(.:H94)\0VD^_%*]GCRNE\#??"(-Z5SPDBW#0*YY>J>='.922[ BM3B=
MEX$ZE7&S@TF:)YB/OM8'XIIW%[]WK\B;\WXKS:\7A(/3=H2OG]%-\8<7ROLT
M0-W6MB$6V]%[U& 3-QPVA%8TXKF,_'W4?$!C-39W];29?8?*].>G3W_9F6N\
MAFJ/CA"?C:-G<EPN6EZ8I/?'0S=G1'QS^;O7*1Q/FJ2RYB]>? X';O0^]5#2
M'@ZFTS)'W^V\?O$,+XWO=I-&K#6D.SAL/6Z\Q_&DW,<35,K-A<='*%/QW?@Y
MAVZ$4JY,1K]YZ>SMI3[_V?Z 'X_,?B'ZO#GJG5?K&H^&)_-"7I/#YM-*T8NF
M<-?%</6B0(NN+5/J>MD-)A=1<WK3^*OCX6QZ/O-G YK'P.,N\RQ-9@Z?^6 T
M/[XH[VT6QA@%:KNXV'Q .+@+67PC7-[#ZQ=C>S64V9]$_)LT7PUE"EL+9['&
M<9AC7#1EZH^.)]/CLO&AXIX>HQ:_=G:?]! QDX2#3\TCGRZW9T\/QL?#8@O@
M-=W9POWS>#0_+VK&.IO+@&]![_297<QR+.\]-9G^=]I[.G]:OS4KJ)A%/^$S
M[3%*_K_S^<F#<KS3.TEN<HK'?SE\T^3D(AZ?],IMM_^:I,;DN?;.O1LVCWYZ
MD-)LOA:+]89F5BDLV\N3\6'O#-'7W5R_YX_Q?>-F%9S7&&N6<7N%3-(\JZCG
M3YH)?M(P=YL$=S=$^=VQSD ]/I[\TB#PMQ2&#LFG:+S&?W:.\N>X-TX&37C4
M8U0<I3J#B$;(2)S2)=Z9)6*YTP0?MA$^J6B2OJP@SMAL<NFQMF7QH2L:?3P'
MU%&9BCG<W&&CJ.>_GSNK"R46^FDHH!0?0C9J_K9-M4\N"Y3.+?+KQ?1/X^%P
M_(D@#:6Y:3+.N7&UW-%9P<V@AWOJOXYQERG8Z;?YLU=XID@.Y,JS@1\=>]SZ
MSP=>-KVO'OE/#W SFEXZ]5=!RI05@R@]2)70ZJ>..PH2?\6,/@6S/@4SU1=/
M_5_N_;3$L?]K-TS[\[!'7"JHL?"'9E OIU.4S"]'K0" \V-^^LC _^K/%V+_
MUS]$"EKH8(D&)Q#\WA 3LB+*6:FHE)P*7A*6N*5]7(973NM[\^F^$H_OT.2^
MLFR0!$+CLOR?OPH80<)NINMRX(AE/O+D><X* GZ3C5826/#6LQ3=O!OYM2OG
MJ\OCES*@Q><]VJ7P\LO>KW\D)71F5A-OE23@< NP@**),Z5%D_E2J@]+]>2Z
M98 Z=[X4^KUAX[,]*.8+*I]/: JD_Y^]+V]J*TGV_2H*[GWO]D2HF-H7]P01
MC+%]W6\DVC8]#OB'J!6$A<1H,89/_[+..5I8C4!@ 6=B&DLZ2VV9OUPJ*W,P
M_)]"@\G 7RB24["99-TOLO&?#/H^QE!0$U@;@_X/6,51!)2ZE6"6BS5(W ]J
M+L00?:Z&M7TMULA71V"M<U T=!0P_8 PV1)'/&5% U0\E @F%)00RG-4$-5R
M_>KAR 8(OFYA,^5H"5BN,/:%'3<ELOQE0F/#R<9$97 ^(XKZTYX5MD!%55ED
M99OB;<X_]XH)Z-/I]N8^8USBJ!P25D9 *(.1Y=8C&CGSUG@BC%C;T.M7C\;,
MR ?HHI_# F=2J:K8]D :N9]XNA-IY.,<5XGASS*?SVNFB:S ))XP-Y@B4=17
MQ_#'2L[A*S"LB9@J9M8V\/K50,,)35P42..L^RZR\$R;:$$^ GY%($]EG9<^
M"TZO1'31+Q,</L>3*3S\J]\[V(F#XZWH1J^8"/XZ;6WN6TMD2DPBPU(&!JV1
M<Q$F'&Q78AFCWL9<VA2O7U5=2CMT@@^  84/;*J*@%6:_6MGL&1N5$J;8E\)
MI-!QH]L'<RU9GY-HG=T<,KE2YNB7GP:<K-8H;MPS',0Y9T.OW\B@G5_<*/W-
MPTM^P>*<@OI]^-.(&SLL0AH*EVKED_C9(Z'P(;DKOLAIFY<]DB719;=D%:AQ
M']_D4T8NM./IW';=H-^#C[[T6M:;=Z4K#4PH+R7%6B=D10!KFD2,C*(:R9AL
MI-AXAM7ES;L8&14A1I-R@DRB-=54)&8"Q\YC%9]-]$.V>7JCO,44^L4.TX6M
MJ'F*>1X04WC(>C%OQ\G20S:-L6S,>"'OG/6"'8"H^&<?_FG\MO9^\\L_U_[6
MZ!3>INMO_>LD[QC O9M?_H);<Q.(L.920UNGHUSP_,!LE!][0Z"Y<M\%-=X"
M('9&C7_UAZ LOVFTYC(]Y<#O^:O%GLMUKVG^@CB8,L"LVC09SFV\5-DRJY15
MH?!9'><]Q_-B8V<XRMM5E0>ZO)R)(#LJ2A=V83D4(6X@)ES>O.IVB^]9H^P
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MKXD\(.,$0YCS0*,2DB9?*#7+<MC6.%/CS/)QYH'^XQIG'@=G9JJ,TBR J@G
M BN"N!8<E!JJ4 @..QUEM%%EG)&KE$CC@45,RY?=T1&]FEZG:E-DT>#%12;@
M12#K?<;],I#WL=U6%076V+L0]GZ<=UQQ&5G41B)*F$5<)(RL)1(4/4U-Q"Z
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M+L9,UJ,.FE#.^L\P_U<B/ SN"0'^H6<&:^9]*N:%SW@?IM\Z*BT@NBAJ+0'
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MD"]F[56[@4_WB;2.XF 1F$L.<9HP,BP&I$Q,L"K$<"(ONW576@E)?9!8IX5
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MC.W@K$&:#:!%W6R<=D:'#7L180XZWR<MY:^S'L;OY2V'=M2P&6  )?RH>]8
M!!ATW+B UPE&S?4-FCGL^,/I2.;;FZ!(]90%Y!IUSBNL2E,L@F<OU4-IYI\
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M#@7Z,CXYZ<:\%VZ[U89UCI$8CNRH^/5B'-AE+K\4%S;/\>6*_;P[%[O/$A@
M/DGO0SYL2K5CT6OMK=0D.LY_$KOT*Z-5OL0<A5*$70 C]8;EIP)ZBTU^9[M%
M-,#P,,91L?U_PXVSN;\8WE$^<GPRB(?P5 ZSJ*SJ_&._5X0S%"=!A]-XA-3O
M=HMXA#>K%O%S8_@AC'=4AL5$4$Q.\CP\9?SAI =_PF*--GOAW:03KQJ+#O8C
MTUY%$E$,Q:&4*)%F-*#@//&)2:I86"C,\%>RZO5D-F&>'#5\B7VJD,%JX[D4
MV>7N,\7%2_ZPO1Q+>/'*@YANQ<)Y)%NG]'YQ-[>]ELAUSMDS"><I.BL?-9SG
M-<7R/(/8DXN1)A0O9;@/"=EY!G-60>'U<[;TZ)S5#]#Y5[3#>-COAAPK.NA_
M+U2[*[FCES8!+\+OM_"@G[??ST:O3-2!6XTY#23GW7!26\+A@_?LAM.&B[C[
M;M1K/PQ6R<=W3^VV]/$=_7&XNQ..M[?^"?=LTO;1Y^[VUJYH[_C3]O&_C]I;
M[<.]G4^G[:WW1Y=]?*WC]X=MNLM;H &WMG8I:,*\??2-M,\WZ=[7%F[1]]WV
MUB9N?6W/Q^F<[D=N)3>>(2E<0-Q'@RS/Z;!M-,0P(QS&N?Y7DY%'#]%9M2B=
M1PG4J?'N^>.=YPP#R@6PT W'6EM!F/4Q,<7 &A"QQ#M,:KQ;$;R;U1MR-B7I
M"4%<4('R9A4"G,LU36%)<=!.)Y5C$IN4/QN\^XE2NMKJY?OQ !@M'[7*?H@$
MC &?[U*:Y+GDJ%P 5R3V!C,@0F(QES'I('1D(FF0S<$'5^M1*X4KG3D]BLE
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M?^,A+/*TFQ^W@_Q-649KP*P!<^5"1&K O"=@SGQ#+FD94G*(J6013\XA)Y-
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MJ<.50,[E;1RJ0Q02"TWS(6*VKF\F$%BM0F/I@1:TF)YS$8DZO5LV4!LG R"
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MPPV]CFW\EF_*6@K%OW\!Q!H4CHH,0\,"A:#!XBKY_6_KC:*/9PTBF]6.I2U
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M5NSU:I6I*KZ!2/4=M:8+J>8/D@+>MN/),#NG=M)B,&LN^/VD$\+W]P*P9!!
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MEHI2>E=*!0IYL'MO5BGD;SJO;B!"5DN.[2'L^G[$ZL2_G\TO^<N>X5?;N$B
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MT 7-8ZJ/H"*TWP>-'6#N<PVV<_0&K?YSUV<= ]30S=J#!-=.O38W-J?JLV@
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MA0$#1A%1H?7?"; P6LZP"JF+X)R]+_=Q4( 6$P9;:;#H!07;WG+FC0P\P*A
MZ3]72*,HFX."M99?_NO.VST=@HA6)**DC4084&[ 9M,$V$T[G4H?I #Y59:;
M1JX(HZB$R<+YFFT!0QW%\8)C?4G,U23X__T?S6CY&SHULRL'M_)@T .N!Z,
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M7DRU Y19@=V;=<SC66O?5J<9"0U=7VDIHR-,=*]LVNZ2BV+I_ B(Z 1/WNM
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MBYLV%N=9C>)SNM-K=S(\L*SU)=[IN5S;H6F&+UL!:(F[:K]?[5VK^,+F#IW
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M'7[P=G=>TA8E-;1TIMWL^10E>?M[+B?[K=,$OV1]\<!GX/K(Q>+\-G,$"(/
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MOW)[@Q,RM!=O<7YZH"?*11B=?7=X:/_S5G]^UJL9NY[71IN;>#.#GCOHM_Z
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MGZ0B&PIQ#DL5RV5$.&VL-(Q=W0H_T'3T'6"\N%>D2(=%2IB%2[*<ZI9@1RS
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M8%\8^KF6J'3A;Y$426#@@L#0X<PH9[2 L1?3X@B=.HH&R!FV0-FA,P?,$V>
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M:]K )4^?M?*4JB[8 X<>2I'GD0BZSO^0,43*:10E][YY.,-+"[-;5$YNX9K
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M>M(J,2VUM-2R@\;?'[I7O=8^;E5^&RNN]@TXO&B5GP(2WU/'^A\;/*V@?AY
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MP1!(X^^?WM&$7J;'52BBH.M\9MKF!6DC-;3F.X$P[Z0G&2Q>=SCXIC*0;3<
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M;])SX68 +4$QRI1V!FK90FG^KA.154!9UKV>%16 K109B^LEQ3X!E^(;QNU
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MU/H2Y^$$(645UBT[KL3BI'*F#J<-M_4GK3CY.EH<6ZV7.K%_DPHA*5)S^CF
MMT/.A$S$89(R78A@BTH=<F6(3FHT5H._0,@B. HRJ5\/1CT['LIR!JEK*K4/
MY" 5?D:0WHD]<JZS3@932=G,B+)2(P/%C(#807!2F UETE))*W++@NJ3Z;R
M"LQ0:T1)!Z?Z)8'MC,FAXOWP,49E203,FOX0K(2&L57A(R-[$9X&K!K?J/%U
M+]JF=<KT5LEU50W*K8C9>=P<!K2G$O=/#FJC K[[$8ZMKQ7,)*6/6^%)O=ZP
MF9,:=;NBCV\W[+1RQPDLS%KE6V%)FYRVD8XA0,D";!?9<L<42)2#RP1#9"%2
MJT5R;:P78[W]-M9[$;'>HZ+5^QKE?.]$& IZ4CR1/"7#L96;Q]E+GEV(7?:3
MF"1KNXK!]@A&V :%4[Q5PDV=3:&WO9:,)SW=I(Y();_."=2O*8 -0%W!&&0I
M$&/T$=IFW5XX6H$^0*E/^.GL%E31&??E07$KBU5*!9UVPYULE8%AEW&\R%I1
MK*^W^6G-D%%O*%!_!2TYN"=-N;[@AN,B",LLF>?X2X 98*A@04/:3Y&S5R2H
M_XV*J#32/0CX-A51"#C%&:$JA(9:@KOFK',E;#8IK?> U"@FLT)6K.<EQZ[E
M^:VWA$M>7H*ZCPCO:W/S:^[T/4F$7><SNWME62]'SQ29<,IH'J+.C!<IR\>E
M_ZKL<_=)F2QO&A R8,<A/Z@L8]MIS< H^:79K(6K#SADA2X52_KCJIDN]E-J
M"\4$[E")D!FY24K>0:-VD_5,9[WCHZ(=:"VKU?,P4SL*S&Z2'"^%N+'>5$C^
MK;E_!TR>OD"]W$4G!"X=10\7%IXJU]LJWZ*=9[?H-&/> ^@Z)Q\:^WUK(@VN
MM%.JGQ(3TF"T+EGQ4?(L!=(>R-X^Q@J0^U:Z%S4XQR".O\S$6_7'#V!#+R-_
M]3:,"0[T4,U@4:.J@.E/ZHJ<=RK7EU]WZ:M*UW7^[FK0];SKC5_WNOV-WVU;
MMG_5'0X'!RV[_;O!>/@\F[W::=F'9LJ:"05>_82"C>, )@\O8J_3A&;_:Z8F
MH> OFU0E!Y2+?0;T[CEG]_@G?4/.]J3(L/W(=Z6C[7VBAEP>*K%['&0C-I_7
MF?N3QPV.EF.R-\XG>8!P&S U^A>1[Q:LWW=T^,XP>1'S??8^= .'E8"RY5[W
MKP^;%+\/"3SKE)Y]]K/S0*L6I\\4IZ^';N^ZUU"4WEO<R.E(9R)1R&U.\>%U
MTVNCJK'#<*QS&7[UYOK*O1[TUO3#/:_W&#/-GF)FV=E<2Q^DW,@=3 8GN9E#
M=<PS(7I;C:SSK!Q$^#4@:#*&70W<J[V'G]=?\S%4I4<1_YE=3=\=CH;NL+?O
M$.0GO)V7*?4_6+75&].('R/U'Z=[-P7]>M?NU6!??71?"!QW$.I^)M;%7?F;
M_OC*G?3'>RL;S3,_SD(3^4F7]CTM&SHW03<!-=?;=_QNJX0<XVX&5Z"&7)^A
M"K+G6.:&<8:?.>UE9[;P6&A<EK?PR8'20,+U)A-W,'JFF>8-5>\>M]^=/>PM
M35TH3?6OA^YHM&_4J2DT19+T>\K2V3<K:'SRVH#W.V1.G:H]^\YQZ4-Z<.K)
M/W1LK#.P6E .["'PRZC(2D,\U[LFVZT#QR/[X0<;!-'KK,:O;FU/9DH*##,L
MAYQ9/3M@HV-KHS6]@[A"!SN#$B1#2H;%-U3+@E1#(=UX_;65K+Q3!NLS(/.)
MT*,_>0 ])G:K7\*/W>ZY;S?]W1VEO+%]S;OB1M]T'K?'SAZ$"SV[P+\.S[#;
M+'7$XAI9RG.4.:VERMYRR]JSJ8(O,\FZ:.:IF.3[A\*L>Y<QE%'_]<":K8[O
MT*GN5BHW]1_37UCS6MWU#OBE(D)N6*]FH\B^0*J:F9M+]*UV$]CCL\ F)K(L
M%#/]031S/QM$-YY$W\0$YH?OZ0 N56Y<QT4?=O_]C0-E$"> 05S)"-54D38R
M.EDJJ$?4\$64X/X@D8\LP;1> ,['IX:QCT2N4?GQ'9!#HM7D,*0\4X95%X4]
MH5;W+"_=$T0G./E.P?''Z[(/-,G1C7&LWC>/ZTP@Y^V)KR*=A:RR\#?)4A/4
MZZ'1BE6G-U9 -K:]?.UY XOW$T6K4GA=2:OF/I::ZS")#RW>H!@O#Q#,<]7Y
M8NZ\C[#P!RXJ"F213@(@N.&Y5$T4)#NG63R-V@OF<TI%-TJI]+R2S'B@LKK:
M6>+U<#2V9HVLM8*Y=J^O/'>TM>N2:N G$1BV;1!88:Z[(UI>6[,#=D7+TN@3
M)2U5MR?&KJUH=6PILEMS0*S537T<U1G9>VTB"?S\=2:6N59L*Z7^IM!^>YU]
M6.K4@K:1;"\1)]BX1^ ^M2FT/U=VJ3X4"%0I8TD: )6FV/NF2!D?S3A9B=*S
M^DM0=)+ 8]AAA5O*R&?>\1#9WP7WUY2]J_J]SG^9B87ERE^QH?M;VV  &PQX
M;8.!BV@P<-)6K+_.YQW9R!,D'=9)^VF*K&91"D.>NM/,H1TF7>ELRH%]$A\$
M<XHBKY'@CF@H-KF&'#U7I3%U&ZO,R78,PH#JFKF_7TR2>0LDN2>]W0]8EO3&
M <CR]=V(K\LPY9Y"LG<>#UO]>W*/PS)=I41N9>;8_BZDAD2F@T(JL/LR->(+
MPOEJO272^EZLKLFZ"-VN.N>SK3^'9C*_^H;Z1H3<T95[PO&"TEFZ'=KDDR1Y
MF&-[)FPUR],PI:0*T$$9T!Q"#*I0E73I)AJJZ*"?8D:]==1D>&<)!YBIRGZ[
MQ\7"CWU&)0<]-J@7-%(EPD9D9J^R'7E&RD*196:4EA^MLC"SQCQR$WIVSLB^
M!C6]X@D/V+M=+"4&%+%?!"'WRJC%!?,&W9Q1-TDB\IT*(=4UV98;;R0-3%>O
MO[U[]QMC.?]*^[RYY<-!.U D1.TVL4F%_T68NR40_*L(;OBWW&^!IGY(]YJD
M'NY]PKWII+NR1&>RPW(F^]/+J?+.K]3<#8S5!+$. !HRNQ!W?E302 YJ*/<
M@NK=4ML8ZKY)/3ST(0!(MR$8.RDM@Z]/P1R9L5L-OL0! 4DANW_B 8J%M(GH
MP/>F-PAWOTJYFSL*736*.DQGQ0+Y*'6B-JY' @G?\1SU4-D?-&2?(P ;3V,
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M''4]J]$":M#F\$:55ZUN[N30[LJXQTI?L'T3_2:-3/0;DN<!]2Y6UW[#(ND
M\_H:PU"W'N)GKEB0U_I!IR6>RZGJF;%)K+:&@E,5.(T3M2:3OV<?L<Z_?G\;
MBKGS\U<!MCIZ6'_%F:*H?&%<@;XSZ1#R.Y>2>%3IAZQ6)]L$E7O4KS:\RR2!
M*MV=H;W4T"Z'Q!TC4.@=F-\PMX?<6SD#E*;WWP4<66#RV'JZ]G\SLR6^*M/1
M']Z/JY+!?6RE-E>Y_+\7H$8Z_8'?Z8_>B._HH?XHD/_2D@7 ROH'%G*XSD+
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M>A@#Z15"C'U5[DBP<V\NS;5[W2XAQ4S0KVD((ICSU52[#_WFI.&-8P!%8)@
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M0\[#\-J7/U@K5UY-9E\NK0D>P+%L2<%!W<TN4CF@WU]M/ZR;X.+:RDSQ$#'
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MTJ&M^(T@Z''7W[KCJ*&&'BLG;E#=\Y"G=\Y6>E?P/)\='X_79TUIU#1;':?
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M]E8.RO82?0OWJ")Z-9N=8_[Y?#H<?WB#T^$D_R>,SO'JTKAF2I[5T,!%0.G
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M%JA#2#)X*[PP42:=MYCGV\NG$546Q;"&BSAP_/J)/#$<XR%6@CO?>TA:=!?
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M-@$-R]B2Q I+YC'M&V(!48P5I-CCD,5>),,H"&+N5/-\?IBY?9-[7DQ.BR]
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M>]$=][BM8;?<W1X#S+'WM0V.I=#M#I'3T.$ZXS7H5K;UX--N8KMB<K)][?P
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M%^GU+.;'A15[%@+/:"D:@#9[1XS=>B_?M-Y+\^<%:,&T  U0H$8*[* "+:R
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MDWSV%]5J/_'+%P[]G%\_J,U]L;K_;;/^:_O%VCUL]6.A8:P($P@@F"@ XTP
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MV?X8;5_;I,D3^_51?5[_OI;& A2597BGS7[XH5QPF"F<* 7R%'( )6* P$P
M)62<29GP.'&L2!U,)I\/>YI2UMUC]J_-,3O;:W83R48W&XC6] F*Y*.RY^P/
M'06M1]!68O(HG!=FEOMY^%EF;I((BI=/(R.Z4]8J%;U=[?)@C5[1YW74U2RZ
MT]'GYY@R]])]DT_=1)7]IIM"K_)_0>'NJ0X89IS)B@<&A:5;6S#L@P>&28HO
M2C[:EA V1U,7JV*KWIE57+XU7\'JOM@Y53Y;_\HBY3B%=KNB2(K,HBH3P',!
M 8D9T4QFB,?:*]C1:_BY[55:Z>WJMY<?5 I$>PU:?^J?E1*^#6+\)LAM7S(>
M[&,O?F$1]P_\&P1<T/ ]/PFF#<(;A,Y1*-VPITP<)O[Z?QZ+[8^WJW*[J4R&
MVHUL-D6KI^5UK-A-R2PL-.%80L $M)'B5 "B\Q3$A&@L,JH)$U/60?-78::'
MDYWZ:)-'A@]X#QPY>F;3^M/$A]?Z1QT FFJV6P/!4<$U<_^<RJT-G[Q9Q(@/
M$/_G"!,?/B_!(L6O$&'8VFC;=.\SE7<MG5%JS'R>2H#S- %0Q#DPFP&S!V 4
MH2S-S'+FE?!T>IBYV?I5+_ANCO[E[LX^H+JM"==#-3)]#T#)FUO[00A)@V=&
MFI2Q^K4]))<+5P_C@5T%@T]J\ZT0JN*=M@\'U(@*C  E1!@RD-38M% !G5&6
MY*F".,8^9- SUMP8X=5CN5U+6\9CH[ZIU:/GP6,?JFYL$ BKD2EA7^VD$;.)
M$!NA-J,#("'IH6^X23G"0>]#HG"Y9>".6BW-;^]O5_)WMOFGVIJ?&Q?F(L%8
ML8RG0/#4D(4T-@2AF=D TYPG!"F68J<Z;9>'FAM7V*Z[915'^=!*ZKD_/8^J
MXW8R"%9C[_YJ(2N@=F*V)R !=V<7L0BZF3H_VK1[GXM:'VU5+M\QC"-L3WI6
M?OFP67\KI)(O?_Q1VEU+0TIF1!M)4 5G+I3"E#"6 ZJ)!I#Q!% F!>!$Z@33
M'',M?+*AW(?VXI )$J&,Y)$PHD=?&]FM'T2W<D=L)[@?LWC,A1O3C(/PR,QC
MP;521Q\ZX+ZPDD?%ZI=H)WQT>QEF;S[R1RPD/WF,/BE?^:-RR%\#GC",SSZJ
M)GBFO-/OUJM[>S)KMV(+EBN&4BP RR4#D'(.:!S;7%H,4T8$R;1N7?YN_'5N
MJ &N^9'YZL.F,"A_-89_*W&T7G6:MDDCM1]5G84YUGG.M4X %YH#F)$4,$XS
MD"0:"ATK1I77+O0JD*?L9#H=Q&[<'P*XD9E^+Z(]1'ZWP^K7/JR\*?T2$"$)
M_.Q8D]+U)8T/R?GB]4.IN/+%?%2V<H+A^$X#SSN^+.[KJ#.NN4SRC-A4',/+
MC*6 YRD#2E"1&C+1,4-NP:%>X_I\!M,$@.[DM9DZNW:SZYW$ONSA KXKE00&
M='1>J>2U694MI-T.OGN9;Z+;A_5CR*YX7E"%91Z7@2>F(0\LCCG)Y^99%29L
M:B=669#W]YO*PGN[VAH#H2S$W]GR42U0K@47(@4I-\P'*3964F:,)HQ(CLP/
M*$[F4*GPLB9S,\/<2Q?>1*Q5R>PK&YVB;U:ID6L C_96.;H??X9W96SOYE2U
M#SNHF,5F]\+M@(DJ9&80[1)J<F<1^W*U,C]')$RH.9NH@J*'0 ,[D2RK#Z2I
MDW.D0'M*0Q6C,F4YB"7' "+$ 5>V'6ZLXHSD3(G$JVB^V[!S6RD_6S]Y5&[7
MXI\-P8DN$:H+)SW73(#;.A4>U@D7E9.Y1,%/S_P@"MH\Q&WD:3N&>*%QU";$
M[^Z!!;?8TNY@/GU1:OMN76</W7XORH5-BI4J1B!C-D46J@Q0!*4E)IG)'&+#
M4CZ<=&Z@N;%0(V=4"1JUDD9_6ED]P_G.8NM&-R$0&YE@AH'E7^;I A)!:S.=
M&VO:@DH7-#ZJ@G3I^J#52Q8L99F$. :<Y!F 7#! !9= X8Q+GC%)J=>9RIEQ
MYL8-OVW691D]GJM"$J2XR'750V;$#6?+@XQ>^6,,6C@WU!QJ=YPCA4N7#RP3
M7Y76_63-]-K)@V,I"#60*87-[B57,:!$2+./23*5YBF66>Q5(OY@@+FQP*NF
MMK 5\";Z/_'?XCA.HJ]L4_OJ;B(:QS?FW]KJP^QQ^V6]L9-P$^'\AJ*D<LW@
MY"8V/S87%67YV/ALNM6*:P_AG=BN;6G=++F)[/M97?9?;/7(-C]V_W@3F>=\
MK>NL+!T[O)Z=4S<2NF:F1F:?9I(^U9/T]WIBWE8@!RQ3?T;_H"7J#\>8MCS]
M&0V/2M.?NVX8Q_RV7LN_BJ5M '^8V'LB/R:5+$8B-[2#4F.-)!P!IGALD-00
M(<U@EGM9(UZCSXV=6N$KCCC.>@^0I>0W.6Y,,AKD(]-,4+2]^6<0:B')R4^
M29EK$#:'M#;L(8,SJ<X5,WA7K-3;K7HH%PK#+!5:  7-;,!8)H!2E8&$I!G!
M:6XLL,PSI>KBH'-CN#<7ZGI8P:-*<D]B<YH!-SX+C>O(-!8"TB$96<X8!4[-
MNCSNU#E:SDB<2-9RO_>*J!1^^?2-GSE]ZQRS/3U=2Q8HU0*A! (!,3([1B(!
MRV,)D@R2W&P<58*8=]C)**+.C04[DKK'D0R(&QEGWCT"0YY]-G^BR(\GP1WC
MAG2,.BW!8S;&D7;ZH(Q143\9=3'NB,,6I&Y(>-.S89$GFBE-C3VLE5E)!,\
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M/5OZR[&V?1DP)ZX>1A)O5V*C6*E^5?6?;U>W0MC6$>5')90A)AN%+?(DY<9
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MEM7R$V'B2EN#\#DNOC7L,0.+'5151NTY[GIE;*Q?UP^L6"UTAG NB0:2Q+;
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M2&=GP6RMH%%UJ1_''$'H1B?7 #,R<U2B195L(_##.<5#4L'1&)-^]><T//S
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M@6%RS(WZNA&4Q>%A=+$_C/:IEW7M5+D9<A-,P,A<V\6^$PCP[G0@P$0QK(/
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M*5(&.2)F:ZHR2%,A8:P88WE"$4^=%/(OZ\[2HEWM3;5F48T_1OS&R*L,IN:
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M62VPNL^K2:J]QI0E'EE7+_<%!P&EJ,VW!?.2%_1-'*?O4C:N+6R$JF'ET0'
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MF^1 .ZSLQ>8.$%)[GDW7GS:W+N?Y^6)>?3V<I[H40_RP2@@PM;.FTD6!KY.
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MS&#0N&NT!Y53!\![BY\O_)#7Y=5B_H&,_Z=?,:XG I-W,A3PNIY?1A<A>,V
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MH&/P.*!PN@AG+CGWYJP.0ESALY069_--&^G\'V?G#497$^L=$YO!W3DFXIC
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MXOVN)@CJ(3=IPY=5;'M[.6P20PXY)P51%@3%/7EJE14X2M^4]E&)W*6'VI3
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M&$+6#=9PDFC?B&3U0?VCWO[_/__SOU!+ 0(4 Q0    ( *& B5%!;W#S9 @
M #0N   :              "  0    !E>&AI8FET,S$Q+6-E;S,P,GAF>3(Q
M+FAT;5!+ 0(4 Q0    ( *& B5$.W^[/: @  "TM   :              "
M 9P(  !E>&AI8FET,S$R+6-F;S,P,GAF>3(Q+FAT;5!+ 0(4 Q0    ( *&
MB5&)23"B&@4  (\7   :              "  3P1  !E>&AI8FET,S(Q+6-E
M;SDP-GAF>3(Q+FAT;5!+ 0(4 Q0    ( *& B5$M/Y& ) 4  ,(7   :
M          "  8X6  !E>&AI8FET,S(R+6-F;SDP-GAF>3(Q+FAT;5!+ 0(4
M Q0    ( *& B5%R@U+TB[T! .PD$P 0              "  >H;  !H<7DM
M,C R,#$P,S$N:'1M4$L! A0#%     @ H8")4:S4->M4#@  BI(  !
M         ( !H]D! &AQ>2TR,#(P,3 S,2YX<V102P$"% ,4    " "A@(E1
M326@9CLA  "17 $ %               @ $EZ $ :'%Y+3(P,C Q,#,Q7V-A
M;"YX;6Q02P$"% ,4    " "A@(E19Q+>J"1%  #>\P( %
M@ &2"0( :'%Y+3(P,C Q,#,Q7V1E9BYX;6Q02P$"% ,4    " "A@(E1I[**
M]-?%  ")<0@ %               @ 'H3@( :'%Y+3(P,C Q,#,Q7VQA8BYX
M;6Q02P$"% ,4    " "A@(E1Y2.4[<-Q  #I204 %               @ 'Q
M% , :'%Y+3(P,C Q,#,Q7W!R92YX;6Q02P4&      H "@"D @  YH8#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
